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The emergence of a harm reduction approach for drug users has prompted 
extensive debate in many countries. However, in Malaysia the pertinent issues regarding 
the bases of such an approach and its consonance with the criminal justice approach have 
received little attention. This thesis examines the justifications for the harm reduction 
approach in Malaysia, its compatibility with the existing criminal justice approach and 
ways of reconciling both approaches in the event of conflicts between them within a 
socio-legal sphere of analysis. Building on philosophical and scientific judgements, this 
thesis argues that Malaysia should implement the harm reduction approach and argues 
that it is congruent with public health ethics, utilitarianism, human rights protection and 
the Islamic principles of ‘hajiyyat’ (needs), ‘darurah’ (necessity) and ‘al-∂arar al-ashadd 
yuzalu bi’l-∂arar al-akhaff’(tolerating a lesser harm to eliminate a greater one). The 
approach also fits in with the abstinence orientation adopted within drug prohibition 
policy and the confines of the international drug control conventions. The Methadone 
Maintenance Therapy (MMT) and Needle and Syringe Exchange Programme (NSEP) 
harm reduction measures are further justified by their efficacy and cost-effectiveness in 
decreasing drug use and HIV pathogen transmission. This thesis also argues that any 
alleged unintended adverse consequences of harm reduction are limited or absent 
altogether. Moreover, with regard to the issue of compatibility between the harm 
reduction and criminal justice approaches, this thesis emphasises that there are significant 
theoretical and practical conflicts between the two approaches as they are currently 
understood and practised in Malaysia. The tensions arises principally from law 
enforcement practices, predominantly the street-level policing activities, reflecting the 
lack of commitment of criminal justice actors to the harm reduction strategy, despite the 
existence of government initiatives to support harm reduction. The thesis suggests 
viii 
 
important options for reconciling both approaches, particularly at a conceptual level. 
Finally, this thesis argues for incorporating the harm reduction approach as an important 
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Harm reduction in the context of drug use is by no means a new concept. It has a long 
history, as evidenced by practices including the medical prescribing of opiates in the 
United Kingdom (hereinafter referred to as the UK) since the 1920s. However, the 
concept was revitalised in response to the emergence of Human Immunodeficiency Virus 
(hereinafter referred to as HIV)/Acquired Immune Deficiency Syndrome1 (hereinafter 
referred to as AIDS) during the mid-1980s, with harm reduction policies and strategies 
being adopted by countries in Western Europe, particularly the Netherlands and the UK, 
to control HIV/AIDS and other blood-borne transmissions among drug users. 
The outbreak of drug-related HIV/AIDS epidemics has spurred the global 
development of harm reduction policies and practices since the late 1980s and early 
1990s. The approach has been endorsed as important for national policy and strategic 
planning, and delivered on all continents. Moreover, it has engaged various interventions 
including Methadone Maintenance Therapy (hereinafter referred to as MMT), the Needle 
and Syringe Exchange Program (hereinafter referred to as NSEP), supervised injection 
facilities, condom programming, and education and counselling designed primarily to 
reduce the risk of HIV/AIDS infection among drug users. The services also aim to 
                                                          
1 AIDS was first clinically uncovered as a disease syndrome that attacks the human body’s immune system 




decrease drug taking and its harmful consequences including other blood-borne diseases 
such as Hepatitis C Virus (hereinafter referred to as HCV) and fatal and non-fatal 
overdoses, as well as promoting referrals to drug treatment, health and support services. 
Harm reduction embraces a number of key principles including pragmatism; humanism in 
which drug users’ rights and dignity are acknowledged; emphasis on the mitigation of the 
harmful effects of drug taking rather than on the behaviour; costs and benefits 
assessment; and giving priority to realisable goals of addressing individuals’ and 
communities’ most critical immediate needs.2 
In 2005, Malaysia began to emulate the international initiatives of exercising a 
harm reduction approach, with the goal of curbing the spread of drug-injection-driven 
HIV/AIDS. In the fight against drugs, however, the country still maintains a punitive 
criminal justice approach rooted in a paradigm of abstinence and deterrence. The criminal 
law retains a dominant role within Malaysia’s strict prohibitionist and zero-tolerance drug 
controlling framework.  
Considerable controversy exists over whether the Malaysian government should 
practise a harm reduction approach. Some scholarly writings in Malaysia highlight the 
practice of stringent law enforcement against drug users, including MMT and NSEP 
clients.3 This practice raises the question of the compatibilities between harm reduction 
and criminal justice approaches. The question is also sparked by the international 
literature showing that the criminal justice approach has been a significant obstacle to the 
                                                          
2 D. Riley et al., "Harm Reduction: Concepts and Practice. A Policy Discussion Paper," Substance Use & 
Misuse 34, no. 1 (1999).11–12. 
3 For example, S. Narayanan, B. Vicknasingam, and N.M.H. Robson, "The Transition to Harm Reduction: 
Understanding the Role of Non-Governmental Organisations in Malaysia," International Journal of Drug 
Policy 22, no. 4 (2011).315. 
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initiation and efficient implementation of harm reduction efforts in many other 
jurisdictions.4 There is increasing concern within the literature about how to address the 
contradiction between the two approaches.5 Unsurprisingly, the debate within Malaysia 
replicates the wider global debate to some extent. Taking a stance that is supportive of a 
harm reduction approach, the research presented here will examine these issues and their 
application in Malaysia. 
 
The Context of the Emergence of the Harm Reduction Approach: Drug Prohibition 
Policy and Differing Perspectives on the Drug Use Problem 
 
Drug Prohibition Policy 
Drug prohibition constitutes the predominant drug policy at international and national 
levels. Within this policy, which derives from the international drug conventions,6 drug-
related activities including production, use, possession and distribution are restricted 
except for limited medical and scientific purposes. The prohibition framework covers two 
key policies: supply reduction and demand reduction. The goal of supply reduction is to 
decrease the availability of illegal drugs, through eradication of illicit crops and 
                                                          
4 For example, C.S. Davis et al., "Effects of an Intensive Street-Level Police Intervention on Sringe 
Exchange Program Use in Philadelphia, P.A.," American Journal of Public Health 95, no. 2 (2005).233-34. 
5 For example, Lawyers Collective HIV/AIDS Unit, Legal and Policy Concerns related to IDU Harm 
Reduction in SAARC Countries: A Review Commissioned by UNODC  (New Delhi: United Nations Office 
on Drugs and Crime Regional Office for South Asia, 2007).9-10,132. 
6 The Conventions are the 1961 Single Convention on Narcotic Drugs (hereinafter referred to as the 1961 
Convention) and the 1972 Protocol Amending the Single Convention on Narcotic Drugs (hereinafter 
referred to as the 1972 Protocol), the 1971 Convention on Psychotropic Substances (hereinafter referred to 
as the 1971 Convention) and the 1988 United Nations Convention against Illicit Traffic in Narcotic Drugs 
and Psychotropic Substances (hereinafter referred to as the1988 Convention). 
4 
 
interception of drug processing, dealing and trafficking.7 At the other end, demand 
reduction aims to halt the demand for illicit drugs through prevention and treatment. Both 
supply reduction and demand reduction share the ultimate abstinence-based goal of 
mitigating or eliminating illegal drugs and behaviour. Prohibition policy is effectuated 
through criminal law and its enforcement.8 States are warranted to determine the 
magnitude of domestic controlling law, including arrest, prosecution and punishments, to 
deter people from prohibited activities involving drugs. This has contributed to 
divergence in approaches among nations, with some adopting heavily punitive measures 
such as the death penalty while others take a less stringent attitude, for example, by 
decriminalising personal drug possession. Prohibition-oriented policies are mainly 
implemented by the criminal justice system, along with medical and public health 
authorities.  
 
Different Perspectives on the Drug Use Problem 
The moral-legal, medical (disease), criminal justice and public health stances referred to 
in this thesis principally represent varied perspectives on drug use. The moral-legal 
perspective renders drug using as a moral failure or a violation of the law. Involvement in 
drug consumption is classified as an individual option influenced by lacking moral 
values. The essential tenets of this notion also include the belief that drug approaches 
including treatment must engage elements of punishment.9 The significant problem with 
this standpoint is that it overlooks physiological, psychological and sociological reasons 
                                                          
7 S. Pryce, Fixing Drugs: The Politics of Drug Prohibition  (New York: Palgrave Macmillan, 2012).51. 
8 Ibid.79. 
9 J.A. Schaler, "Drugs and Free Will," Society 28(1991).43. 
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for compulsive drug ingesting. Drug users are regarded as wrongdoers, whatever the 
factors leading to their behaviour.  
The medical perspective connects drug use with drug dependency, which is 
regarded as a disease. According to many medico-scientific communities, biochemically 
created dependency results in the condition where control over drug taking is impaired. 
Thus, any person with such a condition obtains drugs under compulsion and is therefore 
absolved of responsibility for their actions.10 The underpinning predisposition is that a 
drug dependant is a sick person who needs treatment. Given its incurability, drug 
dependency can be addressed only by a lifelong commitment to absolute abstention. 
Although this outlook benefits drug users by rendering guilt unnecessary and pointing the 
way towards treatment rather than punishment, it does have its defects. Allegiance to this 
standpoint positions drug takers as passive individuals who have a sense of victimised 
and learned helplessness and low commitment to end their consumption of drugs.11 
Moreover, consistent with the moral perspective, the medical lens does not consider 
psychosocial determinants of drug using such as cognitive and environmental factors. 
Despite the ostensible contrast between the moral-legal and medical perspectives 
concerning the nature and course of drug use and users, both seek to achieve drug-free 
status, which considerably shapes the prohibitionist paradigm of ‘zero-tolerance’ towards 
drugs and fighting against drug-related activities.  
A particularly dominant perspective on drug use holds that it is essentially a 
criminal justice issue. The criminal justice approach focuses primarily on promoting 
                                                          
10 H. Abadinsky, Drug Use and Abuse: A Comprehensive Introduction, Seventh ed. (Belmont: Wadsworth, 
Cengage Learning, 2011).76. 
11 W. Wilbanks, "The Danger in Viewing Addicts as Victims: A Critique of the Disease Model of 
Addiction," Criminal Justice Policy Review 3, no. 4 (1989).413. 
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public safety and enforcing criminal laws,12 a methodology that significantly shapes the 
global drug prohibition system. The approach focuses on drug users and illicit drugs, 
rather than on environmental risk influences over private behaviours, and emphasises 
using criminal law and criminal sanctions against drug use and possession for personal 
use. Instead of being oriented squarely on morality, these strategies are widely premised 
upon instrumental factors including economic rationale such as unhealthy money transfer 
in communities and lost productivity as a result of drug consumption,13 the social hazards 
of drug using such as children abandonment and devastation of family life,14 rates of 
crimes particularly acquisitive crimes related to drug taking,15 and the physical and 
psychological harms of using drugs.16 Further, the crime control model within criminal 
justice methodology is strongly linked with political hue as policy-makers continue to 
retain their commitment to drug policy because they perceive that any fundamental 
reform would trigger objections from interest groups and the electorate.17 
The criminal justice approach aims to contain drug taking and possession through 
deterrence, incapacitation and rehabilitation.18 The threat of enforcement actions such as 
arrest, prosecution and imprisonment upon drug taking or possession is intended to deter 
people from initiating or continuing these behaviours. Incarceration for contravening drug 
using and/or possession laws is also intended to prevent perpetration of further acts. In 
addition, the criminal justice approach seeks to address the conducts by rehabilitating the 
                                                          
12 W.R. LaFave, Criminal Law, Fifth ed. (St. Paul: Thomson Reuters, 2010).27. 
13 Pryce, Fixing Drugs: The Politics of Drug Prohibition.31–32. 
14 Ibid.33. 
15 D. Husak, "For Drug Legalization," in The Legalization of Drugs, ed. R.G. Frey (New York: Cambridge 
University Press, 2005).67–69. 
16 Ibid.42. 
17 Pryce, Fixing Drugs: The Politics of Drug Prohibition.48. 
18 T. Babor et al., Drug Policy and the Public Good  (Oxford: Oxford University Press, 2010).164–65. 
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actors, through treatment that is usually predicated within the punishment matrix; mainly 
via treatment in prison, referral to treatment through criminal justice procedures (for 
instance, confinement in compulsory drug treatment centres, drug diversion programmes 
and drug courts) and strict penalties or actions upon relapse. However, the types and 
severity of criminal justice methods against drug use and possession for personal 
consumption vary considerably among states. Although both voluntary participation and 
coercion play roles within the realm of criminal justice practice, the application of 
compulsion or force or its threat is given greater significance in criminal justice than in 
other approaches.  
Further, drug use is also frequently viewed as an issue of social and public health, 
because it expands beyond the individual to groups of people.19 As a social conduct it 
adversely impacts upon wider communities and societies. The perspective that drug 
consumption causes negative effects upon both personal health, including physical and 
mental impairment, and public health, via injection-driven spread of communicable 
diseases like HIV/AIDS, is prevalent in the public health system. Drug using is treated as 
being similar to other serious health conditions within public health management, which 
seeks principally to prevent diseases and to protect the health of populations. Based on 
such understanding of drug use, the public health approach focuses on extensive 
strategies including prevention, educational, pharmacological, psychosocial and harm 
reduction programmes ensuring drug users’ access to drug treatment, decrease of harms 
and risks associated with drug using, and improvement of life and health. The 
contemporary public health standpoint prioritises voluntary cooperation and promotion of 
                                                          
19 B.P. Bowser, C.O. Word, and T. Seddon, Understanding Drug Use and Abuse: A Global Perspective  
(Hampshire: Palgrave Macmillan, 2014).7. 
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community participation, with intervention in individual behaviour being generally 
conditioned by the threat to population health.20 It is significant that public health 
concerns with respect to drug taking are also closely connected to the criminal justice 
approach, which in turn is also deeply rooted in public health principles, as one of its 
main aims in controlling drug-related activities is to enhance individual and public health. 
(Further discussion is found in Chapter 2, Section 2.2.) 
 
Explanation of Terms 
 
In light of the abovementioned context, it is important now to clarify the term ‘harm 
reduction’, along with other important terms used frequently within this thesis. The 
purpose here is to explain their use within the thesis, rather than to give exhaustive 
analysis of any terms or theories. 
 
Harm Reduction 
To date, there is no universally recognised meaning of harm reduction in the context of 
drug use. The existing literature shows a variety of interpretations, with some presenting a 
broad definition of harm reduction as a goal, describing it as any policy, programme or 
intervention seeking to decrease the negative effects of drug using. Despite its coherence 
                                                          
20 Z. Lazzarini, "Forensic Epidemiology: Strange Bedfellows or the Perfect Match? Can Public Health and 
Criminal Law Work Together without Losing Their Souls?," in Criminal Law, Philosophy and Public 
Health Practice ed. A.M. Viens, J. Coggon, and A.S. Kessel (Cambridge & New York: Cambridge 
University Press, 2013).199. 
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and potentiality to integrate a range of drug responses, however, this conception is less 
plausible since it is very wide, and practically covers entire policies and methods 
including abstinence-oriented approaches that aim in some manner to minimise drug-
related harms, thereby increasing terminological dubiety. 
Others propose an empirical definition of harm reduction for policies or 
interventions that demonstrate actual decrease of net harm.21 This definition seems to be 
objectively creditable for inclusion of any harm reduction programme or service based on 
not belief or deontology but instead on evidence-based analysis. However, this type of 
conception creates terminological imprecision, and elucidating harm reduction policy and 
programmes’ coverage becomes timely and costly. Moreover, as with the unclear limits 
of the broad definition, this empirical-related definition could comprise any policy or 
programme that indicates a net gain, a disadvantage that is also applicable to Lenton and 
Single’s socio-empirical definition of harm reduction.22 However, this latter definition is 
more concerned with the probability of a policy or programme’s efficacy in mitigating net 
harms rather than what it stands for, which renders it unlikely to be more convincing than 
the purely empirical definition. 
This thesis adopts a narrower definition of harm reduction as a strategy, 
construing it exclusively as the policies, programmes and interventions aimed at 
decreasing the adverse consequences associated with drug use without requiring 
individuals to stop using drugs. This interpretation is also favourable to many scholars23 
                                                          
21 S. Lenton and R. Midford, "Clarifying 'Harm Reduction'?," Drug and Alcohol Review 15, no. 4 
(1996).412. 
22 S. Lenton and E. Single, "The Definition of Harm Reduction," Drug and Alcohol Review 17, no. 2 
(1998).216. 
23 For example, E. Single, "Defining Harm Reduction," Drug and Alcohol Review 14, no. 3 (1995).289. 
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and international agencies including the World Health Organization (hereinafter referred 
to as the WHO),24 as it specifies strategies that focus on mitigating drug-related harms 
while drug consumption continues. This narrower conception could provide conceptual 
clarity, distinctively describing harm reduction and distinguishing it from policies and 
measures grounded within the abstinence paradigm. It may also help to determine the 
focus and boundaries of harm reduction strategies.  
Another contentious issue relates to what denotes harm and to whom it accrues. 
The argument has been made that harm expansively refers to the economic costs of trying 
to control drug taking and the unintended effects of such approaches.25 The stance 
presented here, however, is consistent with the broad agreement within the literature that 
harm, including riskiness, should be particularly attributed to illegal drug use and its 
resultant behaviours. This meaning gives the concept of harm a distinctive set of clear 
limits, categorising it into health, social and economic domains that affect individuals, 
communities and society.26 Harm within the drug use context is frequently understood 
specifically to include HIV and other blood-borne viruses including HCV infections and 
transmission, resources expenditure, criminal behaviour, and discarded injection 
equipment affecting public amenity. 
 
                                                          
24 World Health Organization, Lexicon of Alcohol and Drug Terms  (Geneva: World Health Organization, 
1994).40. 
25 For example, B. Fischer et al., "Charting WHO—Goals for Licit and Illicit Drugs for the Year 2000: Are 
We ‘on Track’?," Public Health Reports 111, no. 5 (1997).272. 
26 R. Newcombe, "The Reduction of Drug-related Harm: A Conceptual Framework for Theory, Practice and 
Research," in The Reduction of Drug-Related Harm, ed. P.A. O'Hare, et al. (London: Routledge, 1992).3–4. 
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Defining Drug Use/Misuse 
The term ‘drugs’ within this thesis denotes psychoactive substances that are proscribed or 
controlled by legislation and that, by their chemical nature, affect mental functions 
including perception, mood and cognition. They comprise the commonly forbidden 
narcotic and synthetic drugs as well as diverted medical pharmaceuticals. In line with the 
narrow focus of this research, the definition does not cover licit psychoactive substances 
such as tobacco, alcohol and caffeine, even where they fit the meaning of drugs 
pharmacologically. As this thesis concentrates on MMT and NSEP, the ‘drugs’ (and drug 
users) principally referred to are injectable opiates and other injectable substances (and 
users of injectable opiates, etcetera). However, it is useful to clarify that although this 
work has injectable substances as its primary scope, use of other forbidden substances has 
relevance for the wider harm reduction debate.  
The term ‘drug misuse’ has been widely applied and diversely interpreted. 
Generally, it implies illegal drug using outside therapeutic purpose in a manner that 
results in problems to self, others and wider communities.27 In other words, it signifies 
deleterious use. However, ‘drug misuse’ is regarded by many as value-laden and vague 
since, as in Ghodse’s words, ‘sometimes it seems to mean that the drug is being used 
without medical approval, sometimes that it is being used excessively’.28 Notably, the 
alternative term, ‘drug abuse’, frequently employed including in international drug 
treaties, also has the connotation of social disapproval and conceptual ambiguities 
including with respect to when and how drug use turns into drug abuse. Nelson et al. 
                                                          
27 Abadinsky, Drug Use and Abuse: A Comprehensive Introduction.4. 
28 H. Ghodse, Ghodse's Drugs and Addictive Behaviour A Guide to Treatment, Fourth ed. (New York: 
Cambridge University Press, 2010).5. 
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rightly characterise it as ‘an unstandardised, value-laden, and highly relative term used 
with a great deal of imprecision and confusion, generally implying drug use that is 
excessive, dangerous, or undesirable to the individual or community and that ought to be 
modified’.29 
A third and more recent term, ‘problem drug use’, despite its apparent neutrality 
and objectivity, carries similar theoretical difficulties and an overtone of judgement. Not 
only is it imprecise but it also bears unexamined inference regarding its causal link to the 
costs attributed to it.30 More importantly, categorising people as ‘problem drug users’ 
could lead them to display social characteristics that are more likely to bring them to the 
attention of the authorities. This is particularly prevalent in the criminal justice regime, in 
which the notion of drug-related crime ignites important focus. Seddon compellingly 
argues: 
[…I]t is through the awareness of this type of effect that interactions happen 
between the classification and the people who are classified. It influences how 
people categorised as problem drug users interact with their drug workers, 
probation officers, social workers, solicitors and so on. This, in turn, reshapes 
how these ‘authorities’ understand what problem drug use is and what kinds 
of people problem drug users are.31 
Considering all of the above, the term ‘drug use’ has fewer pronounced negative 
implications and so is employed broadly throughout this thesis, described variously as 
                                                          
29 J.E. Nelson et al., eds., Guide to Drug Abuse Research Terminology, vol. 26 (Rockville: US Department 
of Health and Human Services & National Institute on Drug Abuse, 1982).33. 
30 F.E. Zimring and G. Hawkins, The Search for Rational Drug Control (Cambridge, New York & 
Melbourne: Cambridge University Press, 1992).34. 
31 T. Seddon, "What is a Problem Drug User?," Addiction Research & Theory 19, no. 4 (2011).339. 
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‘drug consumption’, ‘drug taking’ and ‘drug using’, as a generic term for any using of 
illegal or controlled drugs. Expressions such as ‘misuse’, ‘abuse’, ‘problematic use’ and 
‘recreational use’ of drugs are not employed unless considered important to clarify a point 
or they constitute part of a quote. The term ‘recreational drug use’ simply refers to drug 
taking for pleasure.  
In this thesis, the term ‘drug dependence’ is also applied to alternate drug 
addiction, given that it is a comparatively more comprehensive and formalised medical 
conception. While drug addiction restrictively relates to physical dependency on drugs, 
which is commonly characterised by the withdrawal syndrome developing upon 
deprivation, drug dependence encompasses both physical and psychological dependency. 
Drug dependence is defined by the WHO’s Expert Committee as:  
A cluster of physiological, behavioural and cognitive phenomena of variable 
intensity, in which the use of a psychoactive drug (or drugs) takes on high 
priority. The necessary descriptive characteristics are preoccupation with a 
desire to obtain and take the drug and persistent drug-seeking behaviour. 
Determinants and the problematic consequences of drug dependence may be 
biological, psychological or social and usually interact.32 
Thus, drug dependence has psychobiological characteristics including loss of control over 
drug using and preoccupation with getting more drugs that influence continued drug 
consumption regardless of the adverse effects. 
 
                                                          
32 World Health Organization, WHO Expert Committee on Drug Dependence. Twenty Eighth Report. 
Technical report series 836  (Geneva: WHO, 1993).7. 
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Aims and Significance of the Research 
 
In broad terms, the objective of this research is to develop our understanding of the harm 
reduction approach for drug users in Malaysia including its roots, the drug use and policy 
contexts, its goals and the current practice. The central objectives of the research are to 
critically examine the justifications for the harm reduction approach, to evaluate its 
compatibility with the existing criminal justice approach and to explore ways of 
reconciling the two approaches in the event of conflict. 
The questions of whether the harm reduction approach should be implemented 
and whether it is compatible with the existing criminal justice approach are significant not 
only for academics, practitioners and service providers, but also, and more importantly, 
for drug users and society. Given the potentially severe impact of drug use upon 
individuals, families and communities, any issue regarding drug use and ways of 
addressing it has relevance and implications for them. Further, these questions are critical 
when it comes to determining the potential role of the harm reduction approach. Such 
questions are vital in informing policy-makers, public health managers, law enforcement 
officials and advocates as they try to support and/or implement the harm reduction 
approach. 
Despite the significance of these issues, they have not received sufficient 
consideration in Malaysia, so this research aims to remedy such lack of attention. It 
attempts to contribute to our knowledge by providing a thorough discussion of important 
aspects related to justifying the harm reduction approach and its compatibility with the 
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criminal justice stance. The research also aims to address the following particular 
limitations of the available literature in Malaysia.  
Consideration of the ethical and ideological challenges to the harm reduction 
approach is missing from the literature while insufficient attention is paid to 
consequentialist concerns. Existing local studies regarding the efficacy and cost-
effectiveness of the harm reduction approach are very limited, inconclusive and scattered. 
This is a situation that must be rectified, as currently there is much scepticism and 
opposition to the harm reduction approach among people in Malaysia, which may impede 
its delivery and reduce its impact. On the other hand, valid concerns about the harm 
reduction approach should be taken into account to avoid unethical, illegitimate and 
counterproductive practices.  
There is also very little discussion of the actual or potential conflicts between the 
harm reduction and criminal justice approaches in Malaysia. At present, the official 
position and widespread assumption is that the approaches are compatible, and this 
assumption, which I argue is mistaken, acts as a disincentive to serious exploration of this 
important issue. To date there is no research on this aspect of the problem, and while 
there are a few somewhat related scholarly articles and non-academic reports, they 
contain only short descriptions of some inconsistent legal provisions and law enforcement 
practices. None has engaged in legal analysis or addressed the many important facets of 
the issue including the nature and impact of any conflicts, or the reasons behind them. 
Considering this issue is vital as it affects the harm reduction approach’s sustainability 
and accessibility. The ultimate goal is to add to the available literature by exploring the 
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criminal law and its enforcement practices that either support or undermine the harm 
reduction approach.  
Finally, what is currently absent from the Malaysian literature and what this 
research aims to identify are the options for mitigating conflicts between the harm 
reduction and criminal justice approaches. Examination of this question will help to 
ascertain the compatibility and rightful domains of the two responses to drug use. This 
research intends to argue that it is feasible to include both approaches within a general 
prohibition policy if appropriate ways can be found to reconcile them.  
Overall, this research is a significant contribution to knowledge, particularly in 
relation to drug use, public health and criminal justice. The research breaks new ground in 
the existing literature by analysing the harm reduction approach in the Malaysian context. 
It also adds to the Malaysian literature through its interdisciplinary approach and by 
examining in depth crucial issues that are frequently overlooked. This research is further 
expected to disclose an important gulf between international and local literatures and 
hopes to serve as a compelling catalyst for local studies including those employing 
fieldwork on each issue. In addition, the research findings could serve as advocacy and 
reference tools for the harm reduction approach, and might also foster positive ideas and 
suggestions towards bettering harm reduction practices. Some of these findings are 
relevant to, and may be adaptable for, other countries, especially those seeking to practise 




Research Questions and Methodology 
 
There are three central questions that guide this research. The first question is whether 
Malaysia should implement the harm reduction approach for drug users? The second 
question is if so, whether the harm reduction approach in Malaysia is compatible with the 
existing criminal justice approach against drug users? The final question is if there are 
conflicts between these approaches, is there a way of reconciling them, or must one or 
other of these approaches be abandoned? 
This research deploys a legal research methodology involving several approaches: 
doctrinal analysis (‘black letter’), socio-legal analysis and comparative analysis. Fisher et 
al. argue that ‘a commitment to the value of methodology is not a commitment to a 
particular methodology,33 but is a commitment to developing methods that are ‘best 
suited’ to the types of questions asked’,34 which indicates the need for methods to be 
responsive and supportive of research questions. 
Doctrinal analysis is concerned with legal doctrine, namely, ‘the rules, principles, 
and concepts set out in law books and authoritatively stated in legislation or deduced from 
judicial decisions’.35 This method of analysis comprises processes including procuring 
and interpreting (analysing) the law and communicating the results to other persons.36 
The relevant sources for doctrinal analysis can be classified into two types: primary 
                                                          
33 D. Feldman, "The Nature of Legal Scholarship," Modern Law Review 52, no. 4 (1989). –cited by E. 
Fisher et al., "Maturity and Methodology: Starting a Debate about Environmental Law Scholarship " 
Journal of Environmental Law 21, no. 2 (2009).227. 
34 "Maturity and Methodology: Starting a Debate about Environmental Law Scholarship ".227. 
35 R. Cotterrell, Law's Community: Legal Theory in Sociological Perspective  (New York: Oxford 
University Press, 1995).50. 
36 M.D. Murray and C.H. DeSanctis, Legal Research And Writing  (New York: Foundation Press, 2006).1. 
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sources and secondary sources. The former principally consists of legislation (such as 
statutes, law codes and treaties), administrative regulations and rules, and case law, while 
the latter covers interpretations of and commentaries on the law in legal textbooks, 
journal articles, legal encyclopaedias and other materials.  
Doctrinal research employs the conventional legal research method to identify and 
critically examine the body of law that regulates drug using and its related conducts, and 
that affects the harm reduction approach in the Malaysian case. The thesis refers to and 
evaluates the relevant doctrinal sources, such as relevant federal laws, which are 
identified through electronic databases and crosschecked with the indices of federal 
statutes, and court decisions, which are traced through case databases and written reports. 
The ultimate purpose is to determine the main applicable legal grounds for the criminal 
justice approach against drug use and other related activities, the extent of its theoretical 
consistency and its potential impact upon the harm reduction approach. The research 
considers questions such as: Are the laws framed correctly? Do they address the key 
issues? Are courts’ decisions consistent? Is legislative reform necessary? Additionally, 
this approach is a valuable device for looking critically at the international law 
instruments and relevant secondary sources in terms of tackling the issues relating to the 
harm reduction approach’s incongruity with the international drug controlling regime and 
its connection to human rights protection. 
In contrast, the socio-legal method moves beyond legal doctrine to study the law 
as a social phenomenon, which involves examining how law operates in a social context. 
In socio-legal research/analysis, law is also considered based on its theoretical positions 
including as a social change instrument. According to Salter and Mason, socio-legal 
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research/analysis engages ‘an interdisciplinary approach focusing on a variety of 
contextual factors shaping law in action, as well as different theoretical perspectives on 
the operation of law in society which seek to explain the different functions of law as a 
social phenomenon’.37 
In the course of this approach, the law and its applications are studied from 
various perspectives within and across disciplines such as ethics, sociology, criminology, 
politics and economics. As Lobhan argues, ‘It is only with the aid of the ‘external’ 
perspective that we can make sense of the ‘internal’ developments’.38 
This research adopts a socio-legal approach for several reasons. First, it seeks to 
explain how and why the harm reduction and criminal justice approaches have taken their 
present forms in Malaysia, so socio-legal analysis provides a contextual understanding of 
the historical, legal, social and political circumstances that have come to bear on 
Malaysia’s drug controlling and harm reduction policies. In addition, the socio-legal 
method enables description and exploration of the attitudes and arguments of both 
proponents and opponents of the harm reduction approach, thereby facilitating better 
understanding of the dimensions of the debate surrounding it. Further, socio-legal 
analysis is necessary for achieving the research objective of assessing the philosophical 
and scientific justifications of harm reduction approach. This method of analysis involves 
exploring the ideological impetus behind the approach, as well as its efficacy, cost-
effectiveness and the extent to which it achieves the goals it sets out to attain, along with 
any unintended consequences that flow from the approach. 
                                                          
37 M. Salter and J. Mason, Writing Law Dissertations: An Introduction and Guide to the Conduct of Legal 
Research  (Essex: Pearson Education Limited, 2007).138. 




Furthermore, in examining the compatibility between the harm reduction and 
criminal justice approaches in the case of Malaysia, the research requires that attention be 
paid to the criminal provisions pertaining to drug use and its related activities and, 
equally, their enforcement, which intersects to shape the criminal justice regime. Socio-
legal analysis is used significantly to effectuate a critical examination of how the legal 
rules operate in action and other related concerns including whether the mechanisms 
intended to avoid clashing legal practices work or not and how any discrepancy actually 
impacts on the operation of harm reduction. Such questions are beyond the capabilities of 
exclusively doctrinal analysis. 
This particular socio-legal analysis relies on data sourced from materials including 
parliamentary debates, official statistics, published and unpublished public and private 
sector reports, policy documents, scholarly articles and study findings. Some of these 
materials are not publicly available, so they were obtained through a series of meetings 
with certain government agencies such as the Ministry of Health (hereinafter referred to 
as the MOH) and NGOs including the Malaysian AIDS Council.  
Part of the research involved conducting informal, unstructured interviews and 
discussions with higher and senior officers from key government bodies and 
academicians involving in drug controlling and harm reduction works and research.39  
                                                          
39 The informal face-to-face interviews, discussions and/or online communications took place with the 
Senior Principal Assistance Director and the Head of the Malaysia Harm Reduction Programme of the 
MOH, the Deputy Director General of the National Anti-Drug Agency, the Director of Malaysian Drug 
Research, an Associate Professor of Law from the International Islamic University Malaysia, an Associate 
Professor of Addiction Studies and Behavioural Studies from the Malaysian University of Science, and a 
Policy Manager from the Malaysian AIDS Council. Key informants were chosen from government 
publications, studies and suggestions by government personnel. My professional relationship with these 
government agencies, based on past research experience, facilitated access to the key informants. I 
conducted all discussions with participants’ consent, in accordance with ethical standards, and guaranteed 
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These discussions provided the opportunity to verify the reliability of unpublished 
resources and to address the data’s limitations in elucidating several aspects including the 
nature, scope and prospect of drug controlling and harm reduction policies and practices 
in Malaysia. They were also valuable for exploring the opposition and concerns regarding 
the harm reduction approach and the measures that should be taken to prevent 
inconsistent criminal law practices. 
Formal interviews with key informants and other actors in this research were not 
conducted primarily because gaining access to government personnel in Malaysia, 
including the police and prosecution services, for the purpose of conducting research is 
difficult, time-consuming and not particularly effective. The administrative ‘red tape’ is 
considerable, including circulating an application through many departments and 
subjecting the interview questions to rigorous scrutiny. Worse is that, after all that, the 
data collected from the interviews are unlikely to be sufficient or reliable owing to the 
officers’ unwillingness to extensively discuss anything, or to highlight the problems or 
critically comment on government policies and practices. This is strongly evidenced by 
my experiences of conducting informal discussions as part of this study and by my 
previous experience as a member of an academic research team involved in national 
studies using interviews with multi-ranked officers including police, prosecutors, 
chemists and medical practitioners.40 This has been the experience of many other 
researchers, too, including the recent study done by the United Nations Country Team in 
                                                                                                                                                                             
that the information obtained through the discussions would be used solely for this PhD study and treated as 
strictly confidential. 
40 For example, when I asked nine prosecution officers about problems that actually or potentially impact 
the non-conviction of drug prosecution cases, they responded unanimously, and very briefly, that there are 
no such problems at all. Responses commonly given by key informants from government bodies in previous 
research have circled around the smoothness and effectiveness of government efforts.  
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Malaysia in which interviews with key bodies including prosecution services could not be 
conducted.41 Such constraints may well explain the lack of socio-legal research in 
Malaysia, particularly that involving government bodies.  
Malaysia’s cultural and political spheres are characterised by the workers’ 
submission to and fear of higher-ranked officers. Influenced by deep concerns about 
possible negative implications and the reactions of the authorities, it is not surprising that 
they generally avoid expressing views on or criticising institutions or senior officers. I am 
also doubtful of the importance of ascertaining the officers’ responses as they seemingly 
have limited knowledge and experience regarding the operation of harm reduction in 
Malaysia, which is still new and in the development stage.  
  Conducting interviews with drug users is also complicated as it involves timely, 
costly and arduous steps. Accessing this group, which is still highly stigmatised and 
marginalised in Malaysia, is connected to various strict administrative and ethical 
procedures. Moreover, this population frequently lives ‘underground’, owing to a 
heightened fear of law enforcement, and so is hardly approachable. Therefore, even in the 
event of securing authorities’ approval, it is still uncertain whether a sufficient number of 
drug users who were willing to participate and to provide accurate responses could be 
traced.  
The research also includes considerable reference to the literatures from other 
countries with experience in harm reduction policies and practices, including the UK, the 
United States of America (hereinafter referred to as the USA) and Australia. As was 
                                                          
41 United Nations, Review and Consultation on the Policy and Legal Environments Related to HIV Services 
in Malaysia  (Kuala Lumpur: United Nations, 2014).35. 
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noted above and will be evident in the thesis discussion, there is a dearth in Malaysia of 
literature and evidence on the issues involved. Considering international literature gives a 
much fuller picture of the issues, debates and recent developments in the field, and 
provides deeper insights and support for arguments.  
I also use comparative analysis here to explore how other jurisdictions address 
conflicts. Considering other jurisdictions’ experience could assist Malaysia in identifying 
how applicable different means are to addressing societal issues, including those related 
to law.42 For this research, comparative analysis assists in identifying problems and their 
implications from the concurrent implementation of the two responses in other settings, as 
well as the merits and demerits of possible strategies for minimising clashes. This is 
particularly relevant in evaluating the Malaysian criminal justice response that affects 
harm reduction and in offering suggestions for achieving compatibility between both 
approaches. In addition to the potential opportunities, however, undertaking comparative 
analyses on other jurisdictions does present limitations. A number of scholars have 
highlighted difficulties that arise when comparing international policies or legal contexts. 
For example, Newburn and Sparks explain the tendency of comparative analysis to focus 
on similarities in policies, ideas and practices in local jurisdictions based on the 
understanding of their global transferability, at the expense of considering the influences 
of national and jurisdictional cultural, political and social influences upon their ultimate 
pattern.43 According to Lacey, ‘it is crucial to recognise […] that the salience and 
                                                          
42 A. Yaqin, Legal Research and Writing  (Kelana Jaya, Malaysia: Malayan Law Journal Sdn. Bhd., 
2007).18. 
43 T. Newburn and R. Sparks, "Criminal Justice and Polictical Cultures," in Criminal Justice and Political 
Culture: National and International Dimensions of Crime Control, ed. T. Newburn and R. Sparks (Devon: 
Willan Publishing, 2004).9–10. 
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politicisation of criminal justice vary from country to country’.44 The writings of many 
scholars further remind us of the possibilities of divergent substance for the ostensibly 
convergent symbolisms in policies in every locality.45 Clearly, there are local divergences 
even though the policies, terms, rhetoric and dictions between settings are apparently 
similar. Therefore, while it is helpful to analyse these different jurisdictional policy or 
legal approaches, the different cultural, political and social contexts in which they operate 
must be kept in mind. This means that they are not necessarily directly comparable, and 
that what works in one jurisdiction may not necessarily be appropriate in another 
jurisdiction. 
In short, this research uses a combination of methods suited to the questions 
raised. 
 
Scope and Limits of the Research 
 
This research focuses primarily on the justifications of the harm reduction approach and 
its compatibility with the criminal justice approach against drug users in Malaysia, but 
operates within certain self-imposed limits. Although there are varied measures that fall 
under the harm reduction approach, each of which has ethical and legal issues, the 
research is limited to MMT and NSEP. This limit arises from space constraints and from 
the fact that MMT and NSEP are the core and most widely practised harm reduction 
                                                          
44 N. Lacey, "Principles, Politics and Criminal Justice," in The Criminological Foundations of Penal Policy: 
Essays in Honour of Roger Hood, ed. L. Zedner and A. Ashworth (Oxford: Clarendon Press, 2003).86. 
45 For example, T. Jones and T. Newburn, "The Transformation of Policing? Understanding Current Trends 
in Policing Systems," British Journal of Criminology 42, no. 1 (2002).143. 
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strategies, not only in Malaysia but also at the international level. Additionally, within the 
Malaysian context, both measures are the most ethically and legally controversial. 
Further, the examination in this research of the effectiveness of the harm reduction 
approach will focus particularly on a subset of outcomes of MMT and NSEP 
interventions, namely, reduced HIV and HCV transmissions, decreased drug taking, cost-
effective drug using and HIV and HCV preventions, absent symbolic effects of drug 
consumption promotion, and absent negative consequences in terms of increased crimes 
and discarded needles and syringes. Of course, this does not indicate that other results are 
insignificant. The selected effects are considered given their position as targeted 
outcomes for Malaysian harm reduction measures as highlighted in most government 
publications. Also, these effects always ignite Malaysian concerns and empirical 
investigations. While this research will examine the effectiveness of MMT and NSEP, it 
will not make a detailed assessment of the characteristics, operation and factors of each 
individual measure. 
With regards to the criminal law that affects the harm reduction approach, this 
research is principally concerned with Malaysian federal drug laws, regulations and 
practice guidelines relating to the use and possession of illegal drugs and drug 
paraphernalia and methadone prescribing. State and local laws are excluded from the 
research, because existent state practice guidelines are merely administrative summaries 
of the federal legal documents and have no legal effect. Even more significantly, all state 
drug legislation has been deprived of its importance since the enactment of the Dangerous 
Drugs Act 1952 (hereinafter referred to as DDA 1952) and other federal drug-related 
statutes. By virtue of Articles 74 and 75 and the Ninth Schedule of the Malaysian Federal 
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Constitution, federal laws are given supremacy over local laws with respect to different 




The thesis is structured as follows: 
Chapter 1 considers the origins of harm reduction in Malaysia. To set out a clear context, 
this chapter presents a detailed account of historical phases of the drug use problem and 
controlling drug policy before the adoption of the harm reduction policy. It then tracks the 
initiation and development of the harm reduction approach. 
The thesis then pays attention to the justifications of the harm reduction approach, 
focusing on MMT and NSEP strategies in two main chapters: 
Chapter 2 examines the normative and philosophical basis of the harm reduction 
approach, giving a particular account of the conceptual arguments for and against it that 
arise most commonly in drug discourse.  
Chapter 3 addresses the efficacy and cost-effectiveness of MMT and NSEP strategies. 
For each measure, it summarises and examines the relevant debates as well as scientific 
and other interrelated evidence on the important outcomes with respect to drug use and 
blood-borne pathogen transmissions.  
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Chapter 4 centres on the compatibility between the harm reduction and criminal justice 
approaches in Malaysia. It examines and evaluates the current criminal justice approach 
that impacts upon the implementation of harm reduction, starting with an analysis of the 
main legislative and regulatory provisions relating to drug use. This leads to a review of 
the effect on harm reduction of government initiatives to support the approach and of the 
impact in practice of the operation and implementation of the legislative and regulatory 
framework.  
Expanding on issues highlighted in the previous chapter, Chapter 5 explores and 
examines the possible ways of moving towards a reconciliation of the two approaches. 
The main focus is on three related aspects, namely, the feasibility of the harm reduction 
approach within a larger prohibition-based drug policy, its workability alongside an 
abstinence-oriented goal and its relationship to the criminal justice approach.  
Chapter 6 summarises and draws together the research’s conclusions, overall findings 
and implications. This is followed by an outline of recommendations for change and 





HISTORICAL OVERVIEW OF DRUG POLICIES IN MALAYSIA: FROM 




Although Malaysia has longstanding prohibition-based responses for drug-related 
activities, the year 2005 witnessed a significant evolution in its drug policies during 
which the government, which had initially adopted control methods based on the 
philosophies of deterrence and total abstinence, moved towards considering the harm 
reduction approach. This chapter will depict Malaysian drug policies across several 
historical periods. What almost all studies undertaken in Malaysia disregard are the 
processes involved in setting drug policies and regulations. The research often accepts the 
drug problem as provided objectively by the government. While the discussion presented 
here will consider how drug use has been constructed and engages with its moral and 
social responses, it will not substantially examine the accuracy of the varied relevant 
contentions. It will further explain the integration and present practices of harm reduction 
running concurrently with other drug policies.  
It is crucial to note the significant methodological limitations encountered in 
attempting to obtain historical data that would have been useful to inform this study. The 
existing literature in this area is greatly underdeveloped, partly because of the constraints 
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that researchers face in gaining access to this type of information. This places great limits 
upon what knowledge is made available. The Malaysian government’s approach towards 
availability and openness of data renders such research difficult. This is despite other 
countries, especially developed jurisdictions, relatively making this type of information 
readily available. In Malaysia, materials such as state policy and legislative reports, 
criminal justice practice records especially in relation to charges and convictions, and 
debates regarding drug policies and laws are unavailable or have very limited access. 
Some of the data presented in this chapter was partially obtained during my previous 
studies. It is important to be careful in relying on the available official statistical data, 
even though little alternative information or data from other agencies or sources is 
available. The statistical data available in Malaysia has not been contested so far. 
Additionally, I made several data applications to key government agencies including the 
National Anti-Drugs Agency, but were rejected based on the government’s policy of 
credential information. Moreover, there is little debate regarding historical data in 
Malaysia. All limitations hinder effective assessment of the historical aspects and restrict 
the scope of this study and future research in this area. As Gummesson claims, gaining 
access to people (or data) is often one of the biggest challenges that researchers face.46 
This has proved to be true in the context of this research. In the light of these 
methodological limitations, this first chapter provides a historical backdrop to current 
policy approaches, giving details of the policy and legislative paradigms that will be 
critiqued in subsequent chapters. Therefore, this chapter examines pertinent literature on 
the historical context to drug policies in Malaysia as a basis for elucidating the shift from 
a focus on deterrence and abstinence, to a greater emphasis on harm reduction. 
                                                          
46 E. Gummesson, Qualitative Methods in Management Research  (Thousand Oaks: Sage, 1991).21. 
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1.2 The Legalisation Period (Mid-19th Century to 1924) 
 
Drug use in Malaysia originated from the mid-19th century, while it was under British 
rule. Opium smoking was routine among immigrants from China who had migrated to 
work in tin mines in Malaya47. Cannabis taking was also traced during that time, but only 
narrowly practised among Indian migrant workers and native people.48 Historically, 
opium had been prevalent as a vital commodity in Asian countries, particularly China, 
since the early 19th century. It was shipped to the Far East mostly from India by the 
British-owned East Indian Company.49 
Opium was generally used by Chinese immigrants in Malaya to relieve aches and 
pains after their strenuous day’s work as well as for relaxation. It was also thought to 
have therapeutic effects on certain illnesses including diarrhoea and malaria. Opium 
consumption became customary among Chinese entrepreneurs, too, as they felt it 
reflected their high status.50 Some of the contemporary writings supported these 
recreational and medicinal rationales for Chinese opium taking.51 Opium using was thus a 
widespread normalised practice among the Chinese during this time, rather than a typified 
moral or social problem.  
                                                          
47 Before September 1963, Malaysia was called Malaya. 
48 M.N. Mohamed, Perubahan dalam Senario Rawatan dan Pemulihan Dadah: Cabaran dalam 
Pengurusan Pemulihan Dadah di Malaysia dan Arah Masa Depan [The Changing Scenario of Drug 
Treatment and Rehabilitation: Challenges in Managing Drug Rehabilitation in Malaysia and Future 
Directions]  (Sintok, Malaysia: Universiti Utara Malaysia, 2008).10.  
49 W. Bailey and L. Truong, "Opium and Empire: Some Evidence from Colonial-Era Asian Stock and 
Commodity Markets," Journal of Southeast Asian Studies 32, no. 2 (2001).174–75. 
50 M.K. Majid, Dangerous Drugs Laws  (Kuala Lumpur: Malayan Law Journal Sdn. Bhd., 1995).1; R.A. 
Rogers, Segi Tiga Emas: Perniagaan Narkotik di Asia Tenggara [Golden Triangle: Narcotic Business in 
the Southeast Asia]  (Kuala Lumpur: Universiti Malaya, 2008).22. 
51 For example, H.E. McCallum, Memorandum on the Opium Traffic, Straits Settlements by the Colonial 
Engineer’ in Correspondence on the Subject of the Consumption of Opium in Hong Kong and the Straits 
Settlements  (London: Great Britain Colonial Office, 1892/1896).53. 
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Opium also became an important revenue-generating commodity for the British 
administrators. Through the so-called ‘revenue farm system’, the British contracted out 
opium distribution and sale to Chinese merchants and collected excise duty from them. 
Imported opium trade in the Straits Settlements52 was then enlarged by the supply from 
domestic poppy plantations after 1884.53 The revenue from opium transactions was very 
extensive. For instance, the average yearly proceeds of opium from 1842 to 1882 
accounted for 44.3 per cent of the whole Straits Settlements earnings.54 Lucas asserts that 
‘opium and Chinamen go together and opium licenses […] are all-important to the 
revenue’.55 Opium continued to hold its value for Chinese personal and business uses 
right up towards the end of the 19th century, a fact that is confirmed by the majority of 
publications, both old and more recent.56 Some contemporary scholarship contradicts this, 
claiming that the drug problem emerged during this time.57 However, the opium taking 
was not commonly looked upon as a moral or social issue, and was even thought to be 
useful at that time. 
The late 19th century, though, saw the emergence of the anti-opium sentiment, 
particularly among a small number of enlightened Chinese. Having raised concerns about 
                                                          
52 The Strait Settlements comprising Penang, Malacca and Singapore were part of Malaya. 
53 Agensi Antidadah Kebangsaan, Rawatan dan Pemulihan: Dulu dan Kini [Treatment and Rehabilitation: 
Then and Now]  (Ampang, Malaysia: Creative People Ent. @ Shout ACS (M) Sdn. Bhd., 2009).25.  
54 T. Kenji, "Anti-Opium Movement, Chinese Nationalism and the Straits Chinese in the Early Twentieth 
Century," Malaysian Journal of Chinese Studies 1(2012).85. 
55 Minute, 26 Aug. 1984, on Mitchell to Secretary of State, 8 Mar. 1894, 273/194. –cited by R. Heussler, 
British Rule in Malaya: The Malayan Civil Service and Its Predecessors, 1867-1942  (Oxford: Clio Press 
Ltd., 1981).169. 
56 For example, S.F. Swettenham, British Malaya: An Account of the Origin and Progress of British 
Influence in Malaya  (London: George Allen and Unwin Ltd., 1948).253–55; C.A. Trocki, "Opium as a 
Commodity in the Chinese Nanyang Trade," in Chinese Circulations: Capital, Commodities, and Networks 
in Southeast Asia, ed. E. Tagliacozzo, W.C. Chang, and W. Gungwu (Durham: Duke University Press, 
2011).96–101. 
57 Mohamed, Perubahan dalam Senario Rawatan dan Pemulihan Dadah: Cabaran dalam Pengurusan 
Pemulihan Dadah di Malaysia dan Arah Masa Depan [The Changing Scenario of Drug Treatment and 
Rehabilitation: Challenges in Managing Drug Rehabilitation in Malaysia and Future Directions].9. 
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the dangers of using opium, the anti-opium movement, which arose in the early 20th 
century, made repeated calls for rendering opium use a social issue in need of the state’s 
prohibitive efforts.58 Opium’s critics frequently highlighted the destructive moral and 
social consequences of its use, including moral degeneracy. For example, Lim Boon 
Keng, in The Straits Chinese Magazine, says: 
The Government of every civilized country recognizes as its duty the 
repression of all sources of vice and crime […] We wish to call the attention 
of the Straits Government to its position in regard to the baneful habit of 
opium smoking, to the revenue which it derives from this luxury and to the 
duties which it morally owes to the poor and helpless victims of the opium 
habit.59 
Meanwhile, the British, many Europeans and the rich Chinese leaders defended 
opium taking as a habitual act and a Chinese ‘necessity’, rather than a problem 
demanding state control.60 Some further contended opium’s impetus as a merchandise or 
form of remuneration by Chinese employers.61 These justifications arose out of the 
standpoint regarding the relevance of opium taking to the Chinese populace’s culture and 
circumstances. Significant support was also provided by the 1907 Opium Commission’s 
investigation into the magnitude of opium consumption in Malaya. The report concluded 
that the harmful effects of opium use were usually exaggerated and that prohibition was 
inessential. It mentioned that ‘under existing circumstances, there can be no honest 
                                                          
58 C.U. Wen, "Opium in the Straits Settlements, 1867-1910," Journal of Southeast Asian History 2, no. 1 
(1961).56. 
59 L.B. Keng, "The Attitude of the State towards the Opium Habit," Straits Chinese Magazine 2(1898).47. 
60 Ibid.48; Kenji, "Anti-Opium Movement, Chinese Nationalism and the Straits Chinese in the Early 
Twentieth Century."88. 
61 Heussler, British Rule in Malaya: The Malayan Civil Service and Its Predecessors, 1867-1942.156. 
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alternative to the course of frankly recognising that the habit is one which cannot, in the 
near future, be eliminated, one which exists as a personal right of its habitués and one 
which it would be worse than futile to attempt to prohibit’.62 Unsurprisingly, the British 
administrators were satisfied with the report findings despite their defects, including bias 
against anti-opium testimonies and failure to gather fundamental information regarding 
the overall group size of opium users and the extent of opium used.63 The results 
apparently conformed to the British stance regarding legitimate opium consumption.  
The British continued the revenue farm system until 1909. In the light of the 
British’s recognition of the vast power bestowed on farmers through the system, it was 
abrogated in 1909 and replaced by a government monopoly system a year later. Under the 
new system, the government undertook entire control over the wholesale trade but could 
license Chinese opium retail shops subject to fees and tax payment. The premises were 
known as the ‘Government’s Opium Shops’,64 and were indicators of the British’s 
constant unpreparedness to suppress opium sale and use. Indeed, the system was 
developed to further increase Britain’s authority over opium commerce. Opium thus 
continued to be positioned not as a problem but as a legitimate source for Chinese 
consumption and state revenue.  
                                                          
62 International Opium Commission and C.H. Brent, Report of the International Opium Commission 
Shanghai, China, February 1 to February 26, 1909, vol. I-Reports of the Proceedings (Shanghai: North-
China Daily News & Erald Limited, 1909).44. 
63 Wen, "Opium in the Straits Settlements, 1867-1910."73. 
64 Mohamed, Perubahan dalam Senario Rawatan dan Pemulihan Dadah: Cabaran dalam Pengurusan 
Pemulihan Dadah di Malaysia dan Arah Masa Depan [The Changing Scenario of Drug Treatment and 
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The opium discourse frequently explains British’s clear attitude in tolerating 
opium smoking across this period in terms of economic interest.65 While the contention is 
plausible owing to the evident large financial returns from opium duties, it does not 
account for opium smoking being perceived as beneficial and a natural way to relax. In 
this vein, it is possible to argue that the British and other claim-makers’ justification 
relating to the circumstantial and cultural conditions of Chinese opium smoking had 
merits. Nevertheless, determinants for opium legalisation went beyond that to also cover 
economic and political factors. The facts as discussed clearly demonstrate that opium 
taking was a normalised activity among Chinese immigrants and simultaneously a 
profitable source that supported the British administration in Malaya during this period. 
These factors also likely explain the failure of anti-opium sentiments to significantly 
impact opium transactions and consumption.  
In sum, opium was prevalently legalised during the period from the mid-19th 
century to 1924. The presenting social, economic and political contexts dissuaded the 
construction of opium use as a problem to be at a central stage, thereby disregarding the 




                                                          
65 For example, Rogers, Segi Tiga Emas: Perniagaan Narkotik di Asia Tenggara [Golden Triangle: 
Narcotic Business in the Southeast Asia].23. 
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1.3 From Regulation to Prohibition Period (1925 to 1970s) 
 
British administrators’ gradual efforts towards restricting drug use can be traced back to 
1925. Britain made a profound change from legalisation to restriction of opium in its 
opium policy in response to strong international demands. The British has passed Opium 
and Chandu Ordinances and Enactments for every state since 1925 in compliance with 
the 1925 Geneva Convention–International Opium Convention aimed at limiting the 
numbers of opium smokers. Through the legislation, only registered opium smokers, 
labelled as bona fide users, were permitted to buy and use opium.66 In 1929, there were 
73,000 registered opium smokers in the states of the Strait Settlements, while in the 
Malay States, there were 52,313 registered opium smokers.67 
A further restriction against opium was set in 1934, whereby use of opium was 
limited to only those with medical certification supporting their health need of opium, 
consistent with the suggestions of the League of Nations Commission of Enquiry into the 
Control of Opium Smoking in the Far East in 1930. The year 1934 also witnessed Britain 
abolishing the government monopoly system. In spite of the increasingly restrictive 
measures against opium, however, claims still came, particularly from anti-opium groups, 
for British to seriously address opium use as a moral and social issue through absolute 
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prohibition. Chen from the Anti-Opium Society even contended that the moral problem of 
opium using ‘presented nothing incapable of solution and that its abolition could only be 
accomplished by the state, and not by a private individual or a charitable organisation’.68 
That said, it is important to note that the suggestions for prohibitive strategies were 
negligible. Although likely agreeing to the problem status of opium taking, the British 
believed that its level was controllable through the existing regulatory measures. 
Governor Thomas, for instance, reported in 1936 that opium dependants accounted for 
not more than 35,000 or about 5 per cent of the estimated Chinese populace as of 
September 1935.69 But many recent studies have found that the average figure of 
dependants in the 1930s was greater. Majid, for example, reveals that the number reached 
approximately 60,000.70 Thus, it could be argued that the British in Malaya potentially 
diminished the data in order to hide the inadequacy of its regulatory measures against 
opium. 
British’s firm reluctance to proscribe drugs in Malaya continued despite 
increasing international and domestic pressures to discontinue drug dealings, such as by 
the International Labour Organization in the USA and by anti-opium movements in 
Malaya. Though the British Foreign Office was enthusiastic to cooperate, the British in 
Malaya were uneasy about altering the regulatory system. The arguments forwarded in 
rejection of prohibiting opium included that the majority of users were old, that there 
would be increased risk of people resorting to illegal drugs to alleviate their painful 
                                                          
68 S.L. Chen, Opium Problem in British Malaya  (Singapore: Anti-Opium Society, 1935).22. 
69 H. Goto-Shibata, "Empire on the Cheap: The Control of Opium Smoking in the Straits Settlements, 1925-
1939," Modern Asian Studies 40, no. 1 (2006).77. 
70 Majid, Dangerous Drugs Laws.2. 
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cravings and that deterrence was already achievable through pricing opium highly.71 
Arguably, this thesis argues that the British defence was no longer born so much out of 
the view that opium consumption was tied to Chinese circumstances and culture; but 
rather out of financial considerations. The available data showed that opium was no 
longer part of Chinese daily life at this time but still continued to provide revenues even 
much lower than in past decades. For example, 1938 statistics demonstrate that the 
revenue derived from opium in the Straits Settlements and the Malay Federated States 
was not more than 10 per cent of overall revenues.72 This argument is also based on the 
earlier declaration of British Committees built by Clifford in 1928 on their expectation to 
continuously gain revenue income from opium in subsequent years.73  
The issue of opium prohibition was still unresolved when the Japanese arrived in 
Malaya in 1942. During the Japanese colonial rule from 1942 to 1945, opium sale and use 
was not restricted at all, and was even encouraged.74 Arguably, this was related to the 
Japanese political interest. The residents’ indulgence in the habit could have been a 
benign way of avoiding their resistance to the Japanese occupation in Malaya. The 
Japanese were completely tolerant of drug use in all their occupied nations.75 But, no 
record or data have been found so far regarding the scale of opium use during the 
Japanese occupation, likely given the war situation. The British administrators who 
subsequently took over Malaya in 1945 undertook the criminalisation of possession of 
                                                          
71 Goto-Shibata, "Empire on the Cheap: The Control of Opium Smoking in the Straits Settlements, 1925-
1939."78. 
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opium and equipment for opium smoking through the Opium and Chandu Proclamation 
in 1946. In an emergency declaration in 1948, the British announced a complete ban on 
all drug dealings.76 The British expeditiously assuming the prohibition fortified the 
designation of opium consumption as a pressing problem. The sudden change was 
unsurprising, though, considering how rife were the international calls for drug 
suppression during that time, including from the USA. There are no data showing the 
presence of any controversy in the aftermath of the announcement, thereby reflecting that 
the drug prohibition was generally welcomed. 
In addition to the external socio-political factor, the developing initiatives of the 
British towards regulatory and prohibitive measures in this period were somehow 
supported by several domestic conditions. Consumption of opium was changed from a 
matter of personal gratification to one of public evil. The standpoint against ‘evil’ drug 
taking of the state, its supporters and anti-movements was accentuated in the mass media 
during this period. The representative claim came from Tan Cheng Lock: ‘The pernicious 
habit of opium smoking should be completely done away with, and more drastic steps 
should be taken to eradicate the evil which has caused a marked deterioration in the 
character and physique of the Chinese who indulge in it […]’.77 The moral discourses 
were also increasingly rumbled by the connecting of drug consumers to moral 
irresponsibility to family and society. Likewise, opium-using individuals were 
increasingly seen as less productive and more health problematic. Prohibiting drugs was 
reiterated by the state as an important pathway towards curbing the rapid increase of drug 
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Pemulihan Dadah di Malaysia dan Arah Masa Depan [The Changing Scenario of Drug Treatment and 
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users in colonised Malaya. This was the case even though the rise was evident only in the 
Federated Malay States, not in the Strait Settlements where opium consumption continued 
to decrease, as discussed before. For example, by 1940 the available data indicated that 
the number of users in the Federated Malay States had jumped from 52,313 to 75,000 in 
1929.78 Decades of opium promotion were seemingly responsible for the high rate of 
opium use in these states.  
International pressures, moral and social discourses and increasing opium usage 
collectively influenced the classification of opium taking as a moral and social problem at 
this time. This status was not granted much importance during the early British and 
Japanese periods, and generally people were inattentive towards restrictive or 
prohibitionist responses against opium during that time. Designating drug using as a 
social problem gave Britain a resilient basis for moving towards prohibition-oriented drug 
policies and strategies. 
The British government’s commitment to strict measures towards addressing the 
drug use problem in Malaya after the Japanese period triggered the promulgation of the 
Dangerous Drugs Ordinance 1952 based on the English Dangerous Drugs Acts of 1920 
and 1925.79 The Ordinance continued to be enforced after Independence Day, 31 August 
1957. Its intention was to combine past state enactments and ordinances, thereby 
establishing uniform drug control policies and techniques across the country.80 It 
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outlawed the manufacture, sale, exportation, importation, sale, possession and use of 
opium and other drugs and substances listed as dangerous drugs in the First Schedule.  
The Malaysian government then gave further serious attention to prohibitionist 
drug policies. Drug control was sustained primarily under the auspices of the criminal 
justice system, with progressive governing structures and mechanisms. Before 1972, the 
various law enforcement machineries acted on an ad hoc basis without any 
coordination.81 Then, in 1972 the Central Narcotics Bureau was formed under the 
Ministry of Judiciary, for the purpose of coordinating all drug control efforts. The Bureau 
was replaced by the Narcotics Secretariat in the Ministry of Home Affairs (hereinafter 
referred to as the MOHA) in 1979.82 
Drug taking was strictly regarded as a crime and there was no focus on the issue 
of drug treatment before 1975. Drug dependants who were imprisoned and suffered 
withdrawal were not provided with any medical therapy.83 One possible reason is that the 
state saw drug users as criminals who deserved deterrence-based punishment, rather than 
treatment. The other potential reason is that by the end of the 1950s, the majority of 
opium dependants were old Chinese males. It could be argued that the ruling government 
at that time perceived that the drug dependency problem would be relatively short-lived 
as the old generation taking opium would die. However, certain Chinese groups set up 
several premises for opium rehabilitation in the early 20th century.84 
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The high level of importance attached to punitive approaches against drug-related 
activities in the 1960s and 1970s was manifested by the arrest rate. For example, in 1969 
the total number of persons arrested for offences such as drug trafficking and possession 
under the Dangerous Drugs Ordinance 1952 was 1,091.85 This rate had increased 
significantly to 5,512 in 1979.86 Notably, gradual development of drug treatment had 
emerged since 1975 after the government recognised the need to help drug dependants. It 
aimed to comprehensively rehabilitate drug dependants towards reshaping them as 
responsible and productive citizens.87 Arguably, the acknowledgement was late, 
considering the long history of local drug use. Nevertheless, the state was commended, as 
accentuated by the mass media and scholars, for its growing enthusiasm and efforts to 
treat drug dependency, particularly for its imperative to reduce the demand to drugs.88 
The state-mandated treatment, however, did ignite certain criticisms owing to its 
compulsory nature and strict focus on total abstinence. The government counter-claim 
was that compulsion and emphasis on abstinence were integral to the smooth 
implementation of state interventions for protecting the health and safety interests of 
individuals and society.89  
Treatment for drug dependants was through detoxification and rehabilitation at 
selected hospitals under the management of the Ministry of Social Welfare.90 
                                                          
85 Source: Royal Malaysian Police (hereinafter referred as RMP); S.M. Haq, Three Decades of Drugs on the 
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Detoxification was through ‘cold turkey’ whereby no drugs or substitutions were used.91 
Medication was given only to alleviate withdrawal symptoms. The Dangerous Drugs 
(Amendment) Act 197592 was passed to insert Section 37B, authorising the police or a 
Ministry of Social Welfare officer to detain suspects for medical examination or 
observation by a government medical officer and for treatment at approved institutions. In 
1975, the Minister of Social Welfare approved 17 hospitals as detection centres and seven 
hospitals for detoxification.93 This indicated that, in practice, the focus was on treatment 
exclusive of rehabilitation. In 1975, 1,757 drug dependants were treated in hospitals. But 
while this did demonstrate that treatment was being implemented, it covered fewer than 
half of the total number of drug dependants detected (5,063).94 
In 1977, treatment options were structurally improved, giving more consideration 
to rehabilitation and aftercare. The Dangerous Drugs (Amendment) Act 197795 was 
promulgated to insert Part VA comprising 15 sections of DDA 1952, sanctioning 
institutional treatment and rehabilitation (minimally six months and maximally one year) 
or supervision (two years). Section 37B was hence repealed. The 1978 statistics show that 
those who underwent the institutional drug programmes and supervision numbered just 
855 and 987 respectively, thereby indicating how low the participation were.96 
The state’s prohibitionist measures against drugs, including the legislative 
provisions of the 1960s and 1970s, were mostly uncontroversial and were approved 
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without difficulty in Parliament. The impetus for the extensive government interventions 
including drug treatment was enhanced during these decades by the claimed upsurge in 
drug using, mainly involving diverse drugs, greater supply and local youth. The 
government contended the existence of a rapid upturn in the number of drug use cases in 
the 1970s. The 1975 official statistics, for example, show a total number of 10,076 drug 
users, significantly higher than the 1970 rate of 711.97 Support for the government’s 
contentions regarding the national drug use situation increasingly came from domestic 
studies. For example, work by the Drug Research Centre at the Malaysian Science 
University, while validating official data, further concluded that drug use levels had 
changed significantly.98 Claims that drug use had increased worryingly dominated drug 
discourse during this time, despite the presence of certain contradictory research findings. 
Nowlis and Teng’s epidemiological study of drug abuse concluded that the drug problem 
in Malaysia during this time was mild. The study suggested that there were increasing 
concerns about drug use even though the number of drug dependants was not 
substantially high.99 
To further invite public concern, the state revealed the increased availability of 
multiple types of drug other than opium on the illegal market since the 1960s. Opiates 
including cannabis, heroin, morphine and psychotropic substances grew in popularity.100 
At this time, the local drug market was fuelled by the growing production of opium and 
its derivatives in the neighbouring Golden Triangle; areas shared by Laos, Cambodia and 
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Thailand. Malaysia consequently became a transit centre and market for drug trafficking 
syndicates in the late 1970s.101 Moreover, in the 1960s and 1970s, the government and its 
supporters began profiling drug users as almost young persons: youths portrayed as 
submitting to ‘hippy-culture’ and indulging in unhealthy activities including taking 
cannabis.102 As claimed, they were also affected by the heroin and morphine consuming 
habits of American soldiers103 who made recreational visits to Penang.104 The prevalence 
of drug taking among the youth was further confirmed by local research findings. For 
example, results of a survey of drug cases in police and hospital records for 1968–70 by 
the Society of Contemporary Affairs showed a 10 per cent increase among teenage drug 
users and a 20 per cent increase in the 20–29 and 30–45 age groups.105 In comparison, 
there was a 50 per cent decrease in the 45 and above age group.106 
The government found the drug use problem, especially among the youth, 
sufficiently pressing to implement stiff measures including criminalising drug-related 
activities and subjecting drug dependants to compulsory treatment and rehabilitation. This 
was so, despite some study findings disclosing that local youths particularly resorted to 
drugs merely for experimental or occasional consumption.107 Also, the new socio-
economic developments that followed in the aftermath of Independence Day furnished 
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the government with another justification for taking an aggressive stance against the drug 
problem.108 
In short, Malaysia’s shift from legalisation to prohibition of drugs was related to 
the elevation of drugs to the status of a social problem. This status was catalysed by the 
external socio-political forces, the dominant drug discourses and the drug use situation in 
Malaysia between 1925 and the 1970s. All of the state’s restrictive and prohibitionist 
efforts that had erupted since the mid-1970s, including drug treatment, had prompted a 
new era of Malaysian drug policy in which dual supply and demand reduction strategies 
were endorsed. 
 
1.4 The Prohibition Period (1980s to 2000s) 
 
In the 1980s, the government further reinforced the moral and social issue status of drug 
using to justify taking yet stiffer measures against drugs. Drug use was similarly 
associated with the decay of moral values and familial and social duties as in the previous 
period. The moral dimension of the prohibitionist measures was further augmented by the 
government’s claim rendering drugs a ‘menace’ and a ‘social scourge’.109 This period 
also witnessed drug using being designated as a disease that adversely impacts the 
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physical and mental health of consumers. Drug takers were classified as sick persons.110 
Additionally, the 1980s saw discourses claiming the link between drug use and crimes. 
The state and its advocates continually reiterated that drug users were highly likely to 
involve themselves in other criminal behaviour including theft, robbery and other violent 
acts as a result of the financial pressures of supporting their habit and the effects of the 
drugs. Drug use was also typified as a major peril to national safety as it would weaken 
citizens, especially youths and security forces, thereby exposing the country to enemies 
and subversive attacks.111 There was even an official declaration by the government on      
19 February 1983 labelling drugs the number one enemy and threat to national security. 
Moreover, despite being outlawed, the state considered drug use to be at a critical 
level in the 1980s, as evidenced by domestic data indicating its high cases. Uncontested 
official estimates show that between 1980 and 1989, 199,952 drug users were 
cumulatively identified of which 100,018 were new users.112 The number of new users 
peaked at 14,624 in 1983.113 As contended by the government, the country’s drug using 
problem had reached an alarming, epidemic level and it spearheaded increased stringent 
strategies to keep it under control.114 Youths and Malay race were often portrayed as the 
majority groups engaged in drug taking, and seen as being vulnerable and in need of 
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protection.115 This profiling seemed to erase the Chinese connection to drug consumption 
of previous decades.  
The government’s contentions related to the moral and social effects of drug use 
plus the critical nature of the drug use situation were further catalysed in print and other 
forms of information delivery by advocating media and scholarship.116 Very few 
contradictory discourses regarding drug use existed, and, besides, these were overturned 
by the dominant claims,117 which triggered the construction of drug use as a moral and 
social problem and substantiated the state’s stringent interventions in the 1980s. 
The declaration of drugs as a security issue influenced the governance of drug 
control. The mandate to manage drug control action was shifted to the MOHA.118 Further, 
a National Drug Policy was developed in 1983 that sought to address the drug problem by 
incorporating two major strategies –supply reduction and demand reduction. These 
strategies were deployed based on the justification that the national drug problem can be 
eliminated if the supply of and demand for drugs were removed.119 This somehow 
indicates the growing recognition of the government to the limitations of law enforcement 
in mitigating drug taking. Its priorities were increasingly tailored to prevention and 
rehabilitation as reflected by the drug control plans outlined under the two-pronged 
strategy; covering prevention and rehabilitation as the main strategies, and human 
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resource development and evaluation, international cooperation and coordination as 
supporting strategies.120 
Despite growing attention to prevention and rehabilitation, the 1980s also saw the 
intensification of the tough punitive approaches against drug-related activities that were 
largely undertaken by criminal justice system. Since 1983, deterrence and abstinence-
oriented policies had been enhanced through stiff laws, wide law enforcement powers and 
heavy punishments. DDA 1952 was amended to raise penalties the most blatant of which 
was the death penalty for drug trafficking. Three specific tightly prohibitionist statutes 
were also promulgated to support DDA 1952, namely: the Drugs Dependants (Treatment 
and Rehabilitation) Act 1983121 (hereinafter referred to as DDTRA 1983), which aimed to 
repeal Part VA in DDA 1952, thereby becoming the main legislative instrument to deal 
with drug treatment and rehabilitation aspects; the Dangerous Drugs (Special Preventive 
Measures) Act 1985,122 which was intended to empower preventive detention of persons 
suspected of being involved in drug trafficking-related activities for a period of two years 
without trial subject to extension; and the Dangerous Drugs (Forfeiture of Property) Act 
1988,123 which was mainly passed to authorise the detection, seizure and forfeiture of 
property derived or obtained from or used in drug trafficking activities. These legislative 
provisions were made largely in compliance with UN drug conventions.124 Many 
practitioners and scholars including Ishak and Adel affirm the government’s arguments 
relating to the comprehensiveness and importance of the drug laws. As they write, the 
                                                          
120 Ibid.60. 
121 Act 283. 
122 Act 316. 
123 Act 340. 
124 Malaysia ratified all UN drug conventions: the 1961 Convention and the 1972 Protocol, the 1971 
Convention and the 1988 Convention. 
49 
 
laws are sufficient to effectively curtail Malaysia’s drug problem.125 They further argue 
that such prohibitive legislations should be supported by intensive and meticulous 
enforcement to ensure the desired results of demand and supply reduction.126 
Enforcement of drug laws indicated a growing trend in the 1980s. For example, 
the 1986 statistics show that a total of 17,058 drug dependants were detected, a number 
that increased to 20,118 in 1989.127 Also, more drug offenders were arrested under DDA 
1952 in 1989 than in 1986. In 1986, those arrested for trafficking, possession of drugs and 
other offences wholly totalled 9,341, a figure that rose to 10,776 in 1989.128 Additionally, 
there was an increase in the rate of persons arrested and detained under the Dangerous 
Drugs (Special Preventive Measures) Act 1985, with 454 arrested and 382 being given a 
detention order under the Act in 1989 as compared with 218 and 183, respectively, in 
1986. The value of the property related to drug trafficking activities that was seized under 
the Dangerous Drugs (Forfeiture of Property) Act 1988 in 1988 amounted to 
MYR610,442.21, and it increased to MYR727,646.25 in 1989.129 
Further, drug treatment was expanded in terms of periods, programmes and 
mechanisms, driven principally by the growing medicalisation of drug use as a disease at 
this time. The DDTRA 1983 extended institutional treatment and rehabilitation from six 
months as implemented before 1983 to two years. From 1983, a certified drug dependant 
could be ordered by a magistrate to undergo two years’ institutional treatment followed 
by two years’ aftercare at rehabilitation centres or supervision in the community for any 
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period between two and three years. Authority over the voluntary drug dependant was 
conferred on rehabilitation officers. The treatment and rehabilitation procedures were 
jointly conducted by multi-governmental agencies including the MOHA, MOH and 
Ministry of Social Welfare.130 They were also provided in prisons for drug dependants 
jailed for drug-related offences.131 In 1985, there were six governmental rehabilitation 
centres.132 By 1989, those detained in the rehabilitation centres numbered 4,242, while 
12,854 were under supervision and another 7,649 were undergoing treatment and 
rehabilitation in prisons.133 This shows a significant increase of drug dependants in the 
treatment and rehabilitation in the 1980s as compared with the previous decade. 
The drug system provided physical, psychological and psychosocial rehabilitation 
for drug dependants consisting of eight components: detoxification, health and medical 
treatment; physical rehabilitation and discipline; psychological and mental rehabilitation; 
religious and moral education; skills and vocational training; socialisation and recreation; 
civics and patriotism; and reintegration into society.134 Detoxification was still done by 
‘cold turkey’, a process that was indeed painful but that was aimed at deterring drug 
dependants from drug taking. Thus, clearly, in the 1980s, Malaysia enhanced its drug 
control commitment by implementing drug treatment and rehabilitation within a multi-
modality approach. However, it was still strongly attached to absolute abstinence and 
deterrence principles and discounted any drug substitution or medication approach for 
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drug dependency. The state’s intensified approaches to treatment and rehabilitation 
mirrors the emerging counter-claims regarding the flaws inherent in such measures being 
ignored and rejected by the government. The major criticisms include association of the 
treatment and rehabilitation system with a highly punitive ethos, disciplinary control, 
bureaucracy and drug dependants participating involuntarily, thereby negatively impact 
the system’s effectiveness.135 
In sum, Malaysia’s drug policy evolved in the 1980s to adopt a bifurcated strategy 
of supply and demand reduction. Deterrence and abstinence-based drug treatment for 
drug dependants together with other extensive methods under the strategy widened the net 
of strict prohibition. Implementing such prohibitionist approaches was in accordance with 
the government’s claims about the need for stringent moral and social regulation against 
drugs. 
In the 1990s and early 2000s, the supply and demand reduction-oriented 
framework was preserved by the Malaysian government. The National Drugs Council, 
which undertook the responsibility in formulating the National Drug Policy and 
coordinating anti-drug programmes in 1996, restructured the drug strategies to encompass 
new priority areas of prevention, law enforcement, rehabilitation and international 
cooperation. All anti-drugs actions under these strategies were put under the management 
of the National Narcotics Agency, which was formed by the MOHA in the same year.136 
During this phase, deterrence-based measures and abstinence-oriented treatment and 
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rehabilitation for drug consumption were enhanced. The powers of medical professionals 
were still limited to detection and detoxification procedures.  
Increasing law enforcement efforts were reflected in the number of arrests made. 
For example, the total number of arrested drug dependants in 1998 was 74,452, and it 
climbed to 137,159 in 2003. There was also an upsurge in the proportion of those arrested 
for trafficking, possession of drugs and other offences under DDA 1952 in 2003 as 
compared with 1998, with cumulatively 16,007 arrested in 1998, rising to 28,706 in 2003. 
Further, there was growth in the enforcement of other drug legislations. By illustration, in 
1995, 994 persons were arrested while 584 were detained without trial under the 
Dangerous Drugs (Special Preventive Measures) Act 1985. By 2003, the rates had 
jumped to 2,110 and 830, respectively. Moreover, in 1995, the values of seized and 
forfeited property under the Dangerous Drugs (Forfeiture of Property) Act 1988 were 
MYR8,695,130.50 and MYR938,335.23, respectively. These values had escalated to 
MYR14,697,045.74 and MYR1,633,407.78, respectively, by 2003.137 
The number of rehabilitation centres rose gently from 24 to 28 with a total 
capacity of 9,250 residents by 1997.138 In 1998, the aftercare system was abolished 
through the Drugs Dependants (Treatment and Rehabilitation) (Amendment) Act 1998.139 
Drug dependants discharged from compulsory rehabilitation programmes had to undergo 
supervision under rehabilitation staff and police officers instead of aftercare for two 
years. The figures reveal a greater overall number of drug dependants undergoing 
government-mandated treatment and rehabilitation in the early 2000s, particularly 
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through supervision, as compared with 1990s figures. For instance, in 1994 a total of 
11,553 were treated in rehabilitation centres, 10,572 were put under supervision and 
8,612 were in prisons. By 2001, there were 8,232 in rehabilitation centres, 35,325 under 
supervision and 10,615 in prisons.140 
Malaysia’s 2004 National Drug Policy further reinforced all prohibitionist 
strategies with the aim of making the country drug free by 2015. The objective of the 
National Drug Policy is to eliminate drug supply and demand to create drug-free families, 
schools, workplaces and communities. This policy likely extends the original objectives 
of the 1983 drug policy by specifying targeted outcomes. The coordination and 
supervision of all strategies towards this major target are the province of the Coordination 
Machinery on Implementation of Policy to Eradicate Drug Menace, which replaced the 
National Drugs Council. 
In 2004, law enforcement powers were broadened by the promulgation of the 
National Anti-Drugs Agency Act 2004.141 Under this Act, a National Anti-Drugs Agency 
(hereinafter referred to as NADA) – a new name for the National Narcotics Agency – was 
formally provided with law enforcement functions and powers relating to prevention, 
treatment, rehabilitation, investigation, special preventive measures, forfeiture of property 
and administration of the offences provided under all drugs Acts.142 
The strict prohibition was emphasised during this time despite growing criticisms 
contending the inefficacy of prohibitionist approaches including drug laws in harnessing 
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the drug problem in Malaysia. The claims were based on increasing numbers of arrested 
drug users and traffickers.143 Further, the limitations of the government treatment and 
rehabilitation have been increasingly the subject of drug discourses that find such 
measure ineffective in ensuring prolonged cessation of individuals from drugs and 
inefficient owing to factors such as reduced emphasis on psychological approaches and 
overload of subjects in rehabilitation centres.144 There were also negligible ideas that 
provided alternatives to the prohibition policy including Islamic legal approaches.145 
Harring says: 
Malaysia’s experience demonstrates the application of a ‘drug war’ model to 
the drug problem. In spite of draconian measures – including over a hundred 
executions, hundreds of death penalties imposed, the conversion of a huge 
paramilitary police force from fighting communists to fighting drugs, 
emergency trial processes that circumvent many due process protections, and 
a police force unfettered by search warrants – hundreds of thousands of 
Malaysians are still dependent on drugs, and tens of thousands of Malaysians 
are trafficking in drugs to meet those needs […] However the lesson of 
Malaysia’s failed war on drugs is that other approaches to the drug problem 
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should be tried because sanctioned state violence under the rubric of a 
mandatory death penalty does not solve the problem.146 
It was during the 1990s and early 2000s that the dominant moral and social 
discourses, identical to those of the 1980s, were presented and constantly reproduced by 
the government and its supporters to maintain the entrenched construction of drug taking 
as a severe moral and social problem requiring vigorous strict measures.147 In parallel, 
there appeared a number of studies suggesting that state drug control measures, 
particularly punishments for drug offences including the death penalty, imprisonment, 
preventive detention and forfeiture of property, are useful and suitable for curbing the 
drug problem.148 Justification for the state’s continued tough intervention was also 
substantiated by the claimed increase in the drug use level in Malaysia, based on local 
data. In 1995, 34,104 new drug users were detected, and this number climbed slightly to 
35,359 in 1999. As compared with the 1980s figures, there appeared to be a gradual 
decline in the number of new drug users. The rate of new users in 1990 was 
approximately half the 1983 rate.149 For the government, however, it is unlikely that this 
statistic provided sufficient persuasion that the drug use problem was decreasing, 
especially considering the high percentage (around 50 to 70 per cent) of relapsing cases150 
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in the 1990s.151 While heroin, marijuana and opium were still most prominently used, 
matters had by now been further compounded with synthetic drugs, particularly 
Amphetamine–Type Stimulants (hereinafter referred to as ATS), which had been in use 
since 1996 when the first 23 cases were uncovered.152 This shows that local drug 
consumption was no longer limited to traditional drugs. 
Further, in the span between 2000 and 2004, the number of drug users seemed to 
soar. Available statistics show cumulatively 202,518 registered drug users in that period. 
In 2000, the number of drug users recorded was 30,593, which leapt to 31,893 in 2002 
and then again to 38,672 in 2004. The drug use problem was once more labelled critical 
in the early 2000s in line with increased synthetic drug consumption. Cases demonstrated 
a sharp rise since their first being traced in 1996, jumping to 1,860 in 2000.153 
Furthermore, the rate of relapse cases was extremely high, with data indicating that 70 to 
90 per cent of drug users failed to sustain a drug-free lifestyle in the first year following 
their discharge from the government’s abstinence-based treatment.154 
Clearly, during the 1990s and early 2000s, the state did not change its firm focus 
on the rigid prohibitionist drug control approaches of the previous decade. Despite the 
conventional responses showing no signs of producing promising outcomes, the 
Malaysian government continued to emphasise its punitive methods against drugs during 
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this policy phase. This is unsurprising given the government’s ceaseless, strong reliance 
on deterrence and abstinence philosophies in handling drug issues that were designated as 
a serious moral and social problem. 
 
1.5 The Harm Reduction and Prohibitionist Policies Period (2005 to Date) 
 
The Malaysian government overhauled its longstanding conservatism over drug control in 
2005 when it adopted a harm reduction approach with MMT and NSEP as its two major 
components. Initially, and for a number of years, the proposal to adopt such an approach 
from NGOs such as the Malaysian AIDS Council was viewed negatively by the 
government and its advocates. It was thought to be inconsistent with the existing 
deterrence and abstinence-oriented drug policies and the national vision of a drug-free 
nation by 2015. Moreover, as signified, the government considered that, without 
extensive investigation, any new approach would probably result in ineffective 
intervention that would simply aggravate the drug use problem.155 Members of the civil 
society, particularly the 2004 Harm Reduction Working Group hosted by the Malaysian 
AIDS Council, along with various medical professionals and scholars, held that the 
approach was necessitated by the grave local HIV/AIDS scene. Many further contended 
that the harm reduction model was worth a trial.  
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In October 2005, the government finally approved a national MMT pilot at 17 
sites involving 1,241 drug users.156 The project resulted in decreased drug use and 
criminality, and increased quality of life among the subjects, which led in the following 
year to official acknowledgement and implementation of a fully fledged MMT provision 
for opiate dependence by medical professionals. Drug treatment in Malaysia had finally 
shifted from mere detoxification to include a pharmacological approach. The National 
Policy on MMT fixes that involvement in the programme is voluntary subject to 
eligibilities and medical assessment.157 Registered clients take methadone in liquid form 
in front of dispensing medical personnel. Additionally, in 2006, the government launched 
its NSEP pilot scheme at three sites through local NGOs. This occurred with more than 
4,300 clients through 34,300 contacts. Again, the scheme showed positive results, 
including a significant reduction in the proportion of injecting drug users (hereinafter 
referred to as IDUs) passing on used injecting equipment to their colleagues, which 
decreased from approximately 56 per cent before NSEP’s introduction to 43 per cent at 
the end of the pilot programme.158 The government decided to upscale NSEP at the end of 
its first year.159 NSEP operates by providing a free kit containing four needles, four 
syringes, 16 cotton balls and 16 alcohol swabs in exchange for used injecting instruments, 
which are safely disposed of.160 MMT’s objective as outlined by the government is to 
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improve the health and quality of life of persons with opiate dependence (with specific 
aims to decrease blood-borne infections, reduce relapse, improve physical and mental 
conditions, improve psychosocial functioning and minimise criminality among opiate 
dependants). NSEP’s objective, on the other hand, is to mitigate transmission of HIV and 
other blood-borne viruses among IDUs, their sexual partners, children and society. 
Although the state reserved its commitment to harm reduction measures until their 
effectiveness had been somehow demonstrated in the pilot phases, Malaysia’s migration 
to systematised services is an encouraging progression.  
The government’s financial resources allocation and scaling-up efforts have 
enlarged its harm reduction measures. For example, MYR15 million and MYR6 million 
were apportioned for MMT and NSEP, respectively, in 2009,161 and there appears to have 
been a steady rise in harm reduction sites and clients over recent years. MMT facilities 
under medical practitioners’ authority, including government and private healthcare 
centres, mosques, prisons and NADA sites, expanded from 10 in 2005 to 674 in 2011, 
with 44,428 drug users enrolled.162 Notably, since its inception in 2008, MMT in prisons 
has climbed from just one to 18 prisons in 2013.163 NADA has also implemented MMT at 
its open-access services (‘Cure and Care 1 Malaysia Clinic’164) since 2010.165 While 
NSEP is widely undertaken by civil society groups that also recruit NSEP clients as 
distributors, it started to engage health practitioners in 2008. As of 2013, there were 576 
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access points and 152 government clinics providing NSEP, reaching out to 72,686 
IDUs.166 However, NSEP is not offered in prisons or at any of NADA’s facilities. This 
demonstrates how the extension of harm reduction services into varied settings correlates 
with stakeholders’ collaborative efforts. 
The real impetus for Malaysia’s harm reduction approach was the explosion in the 
number of HIV/AIDS cases among IDUs. Since the first case was traced in 1986, HIV 
cases in Malaysia have increased drastically. As of 2005, there were 70,559 cases, 10,663 
of whom had AIDS.167 This demonstrates an upturn of approximately 17 cases per day, 
largely centralised in IDUs. This rate ranked Malaysia second highest in HIV prevalence 
among adults (0.62 per cent) and the highest in HIV infection involving IDUs (76.3 per 
cent) in the Western Pacific Region.168 
The government has used the fact that HIV/AIDS cases are largely driven by 
IDUs to treat development of the harm reduction approach as urgent for HIV/AIDS 
control. A huge number of IDUs share injection equipment, which leads to a high risk of 
HIV. Estimates of the United Nations Reference Group on Drug Injecting show that there 
are between 150,000 and 240,000 IDUs in Malaysia in 2004.169 The supporting study by 
Fauziah et al. found that 91.6 per cent of IDUs infected with HIV/AIDS were sharing 
syringes.170 The government highlighted that efforts to tackle HIV/AIDS risks among 
opiate dependants could not depend solely on abstinence-based drug treatment, given the 
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high recidivism rates (80 to 90 per cent).171 This implicitly shows the government’s 
acknowledgement of the failure of its abstinence-oriented interventions in adequately 
addressing opiate dependency and its adverse consequences.  
Perhaps the strongest force behind Malaysia’s move towards harm reduction 
methods was the United Nations (hereinafter referred to as the UN) and its 2005 Report 
on the Millennium Development Goal, in which it stated that of the eight Millennium 
Development Goals, Malaysia had yet to attain the one about reversing HIV/AIDS 
transmission.172 Malaysia was a signatory to the Declaration of Commitment on 
HIV/AIDS adopted by the UN General Assembly Special Session on HIV/AIDS 
(UNGASS) in 2001. This Declaration demanded signatories to undertake varied 
preventive HIV/AIDS strategies including harm reduction interventions. Clearly, the 
main triggering factors for the integration of a harm reduction approach in Malaysia are 
government and public fears over HIV/AIDS transmission through drug users and 
international pressures.  
Against the backdrop of HIV prevalence among IDUs, the government 
underscored the harm reduction approach’s status as a vital HIV prevention strategy in 
the National Strategic Plan on HIV/AIDS 2006–2010, as well as in its successive 
National Strategic Plan on HIV/AIDS 2011–2015.173 It explicitly states:  
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As a key intervention for slowing the growth of the epidemic and preventing 
transition to a generalised epidemic, the National Strategic Plan promotes a 
harm reduction approach to reducing HIV vulnerability among IDUs. Harm 
reduction programmes recognize that for many drug users, total abstinence is 
not a practical option. It aims to help drug users reduce their injection 
frequency in a safe environment.174 
This manifests the official recognition of harm reduction as a public health policy, 
provides clear mandates for the public health community and advocates involvement in 
implementing harm reduction policy and measures at state and district levels. Harm 
reduction resides under the MOH in collaboration with other government bodies 
including the Prison Department, NADA, NGOs coordinated by the Malaysian AIDS 
Council and private health professionals.175 A National Task Force on Harm Reduction 
Committee consisting of the abovementioned stakeholders and law enforcement 
representatives was formed to oversee these interventions.176 Thus, the design, delivery 
and monitoring of harm reduction interventions are now supported by a multi-sectoral 
partnership of public, private and civil society stakeholders. 
Despite the progress of Malaysia’s harm reduction interventions, they have still 
been criticised and opposed by politicians, professionals and the public. For example, one 
claim is that MMT and NSEP contradict conservative abstinence and Islamic 
philosophies, and another is that they are expensive and ineffective in reducing drug using 
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and its related harms. This has continued even in the face of efforts of government and its 
supporters, particularly media to persuade people mainly based on scientific standards of 
rationality relating to HIV/AIDS prevention and other benefits of the interventions.177 
This somehow denotes a significant change in the government towards acknowledging 
the role of science in the drug discourse. Nevertheless, this has had little real effect in 
terms of quietening the continual criticisms of the harm reduction approach. 
Moreover, the National Anti-Drug Strategy has no mention of either the harm 
reduction approach generally or MMT and NSEP specifically. This mirrors the notion 
that the approach is not yet being taken seriously as an important drug response. Further, 
as some critics have posited, this exclusion has limited the harm reduction paradigm to 
the HIV/AIDS issue, rather than to wider issues involving overall drug using 
population.178 The existing drug policy specifically aims to achieve a drug-free nation by 
2015 with the listed strategies of prevention, law enforcement, treatment and 
rehabilitation, and international cooperation.179 In the light of this goal and the desire to 
eradicate demand and supply of drugs, the state maintains its commitment to deterrence 
and abstinence-oriented measures. Drug use is still treated as a criminal justice issue that 
demands moralistic and punitive responses. This status, however, does not prevent the 
government and its supporters from depicting drug consumption as a public health issue 
that requires the harm reduction approach, too, from the point of view of health 
imperatives. Simultaneously, the state still uses its compulsory powers in penalising drug 
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taking and treating drug dependency.180 The government reinforces that it is essential to 
persevere with these strategies to fix the moral and social interests, by ensuring individual 
liability upon drug taking and commitment to treatment and rehabilitation.181 
The government and its advocates have constantly considered the moral and social 
characteristics of drug using including moral degeneracy, high costs, risks to health, 
safety, young people, and economic and social progress for many decades to justify its 
drug control strategies.182 In the era from 2005 to date, government’s claims regarding the 
close relationship between drug using and crimes have also continued to attract public 
attention even when not adequately supported.183 These claims are conjoined by the 
hardened assertion that the drug use problem in Malaysia is worse than before. Though 
the number of detected drug users substantially fell from 38,672 in 2004 to 32,808 in 
2005,184 the government has argued that such a picture belies the reality, given the likely 
greater actual volume covering those undetected. According to the 2005 MOHA estimate, 
between 9,000,000 and 1.2 million Malaysians were dependent on drugs.185 The 
government has further portrayed the seriousness of the drug use problem by indicating 
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the rapid growth of synthetic drug consumption from 1,860 cases in 2000 to 4,609 cases 
in 2005.186 The government’s estimation and statistical data so far go unchallenged even 
they showed high figures.  
The government and its supporters constantly defend the need of strict 
prohibitionist measures to address the national drug problem despite its long term appeal 
and debate regarding their viability. Major arguments against the government approach 
include that it is ineffective given particularly high drug using and recidivism rates and 
counter-productive in terms of increased risk behaviours among drug users, stigmatisation 
and hindered public health approaches.187 Moreover, there are ongoing calls by 
contemporary politicians, professionals and scholars for policy and legislative reforms 
such as decriminalisation of drug use and possession,188 emphasis on rehabilitative 
philosophy and practices in the sustained criminal justice approach,189 and provision of a 
voluntary health-based approach that operates totally outside the criminal justice system 
for non-violent drug dependants.190 However, the government has silenced these calls, 
and has seemingly not sufficiently and effectively responded to the criticisms regarding 
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its drug treatment approaches. Despite the adoption of harm reduction approach, there 
appear to be criticisms such as that the government has put greater emphasis on absolute 
abstinence orientation and that it has given inadequate attention to medical standpoints.191 
On the contrary, research findings and writings do exist that support the government’s 
drug control approach. For example, the research conducted by Fauziah et al. at eight 
government-run rehabilitation centres found that a substantial majority (98.5 per cent) of 
the respondents were satisfied with the effectiveness of the programme in making them 
aware of the importance of a healthy lifestyle.192 The researchers conclude that the 
government-run rehabilitation programme is effective in changing drug dependants into 
normal, functional, productive individuals. Many also claim that the state-mandated 
recovery programme has a variety of inputs and medical aids while participants undergo 
the ‘cold turkey’ process that can diminish drug users’ physical and psychological 
dependence on drugs.193 
The government is keeping its commitment weighted on the side of law 
enforcement, partly evidenced by the substantial growth of arrest indicators of drug 
offences. For instance, between 2005 and 2007, the number of drug users detained for 
urinalysis significantly increased from 133,954 to 158,426.194 A total of 6,534 persons 
underwent treatment in government rehabilitation centres, with 37,282 under supervision 
and 18,784 in prisons in 2005. In 2007, the proportion demonstrated an upward trend in 
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those treated at rehabilitation centres (7,135), but a slight fall in those under supervision 
(33,317) and in prisons (16,237).195 Arrest of other drug offenders went up, too. As an 
illustration, the figures show that 64,043 were arrested under DDA 1952 in 2007 as 
compared with 43,106 in 2005.196 Clearly, law enforcement efforts against drug users and 
other drug offenders stayed high despite the relentless criticisms and the adoption of harm 
reduction approach. 
Given the remaining extensive focus on the criminal law and practices, discourses 
also appear concerning the issue of compatibility between the harm reduction and 
criminal justice approaches that affect the sustenance and efficiency of the former 
approach.197 But the state and other supporting scholars contend that both approaches can 
coexist harmoniously through collaborative efforts and appropriate administrative 
arrangements between the public health and criminal justice regimes.198 
Furthermore, as indicated by the WHO review of Malaysian harm reduction 
programmes in 2006 and 2007, although there was encouraging development in the 
services including through their scaling up, clear aims, funding, organisational structures, 
managed staffing and targets, the participation of drug users therein was low (for 
example, around 5 to 10 per cent for MMT) and the interventions were still surrounded 
with issues and challenges such as critiques regarding their effectiveness and the 
enormous focus on law enforcement hindering their operations.199 Years later, there have 
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been no major forward changes in the delivery of harm reduction services. Their coverage 
lags behind the UN’s suggested target of 60 per cent of Malaysia’s projected 170,000 
IDUs. In 2010, it achieved just 13 per cent,200 which could reflect the insufficient 
availability, accessibility and inefficiency of the interventions.  
Their actual coverage as defined by the WHO may even be worse. According to 
the WHO, health service coverage refers to ‘a concept expressing the extent of interaction 
between the service and the people for whom it is intended […] not being limited to a 
particular aspect of service provision but ranging over the whole process from resource 
allocation to achievement of the desired objective’.201 The coverage of harm reduction, 
like other health service, thus depends on five spheres: availability, accessibility, 
acceptability, contact and effectiveness.202 The existing literature still falls short of data 
regarding Malaysian harm reduction’s accomplishment of the spheres. However, 
considering aspects including disintegration from drug control policy, limited 
participation of key agencies in NSEP, low coverage of the targeted population, limited 
attention to drug users in general and remaining issues including those relating to the 
justifications of the approach and its compatibility with the dominant criminal justice 
approach, it is doubtful whether Malaysia has attained the overall domains of coverage. 
Its government therefore needs to address all of the deficiencies and issues that impact the 
coverage and efficiency of harm reduction interventions.  
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This chapter has given an overview of the four phases of Malaysia’s drug control policy 
since the mid-19th century. The first phase (the legalisation period from the mid-19th 
century to 1924) witnessed the normalisation and legalisation of drugs, particularly 
opium. While prohibitionist policies and methods were adopted in the second phase (from 
regulation to prohibition period-from 1925 to the 1970s), the state still put little 
consideration into drug treatment and rehabilitation. As the construction of drugs as a 
moral and social problem continued to evolve, Malaysia’s drug policy moved into a third 
phase (the prohibition period from the 1980s to the 2000s) that focused significantly on a 
dual-pronged strategy of supply reduction and demand reduction. This era also saw keen 
attention paid to drug control approaches based on deterrence and absolute abstinence 
philosophies including compulsory treatment for drug dependants. These policies and 
strategies, against the backdrop of entrenched designation of drug using as a critical moral 
and social issue, went on to characterise the Malaysian drug policy in its current fourth 
phase beginning in 2005. It is during this contemporary period that the government has 
begun to tailor its drugs policy to a harm reduction measures; MMT and NSEP in 
particular. The government’s designing the local drug problem has significantly shaped 
the landscape of Malaysian drug policies across all historical phases. 
The Malaysian government’s adoption of harm reduction measures manifests a 
brave transformation from the previous highly punitive policies and measures. 
Contributory factors include public fears about accelerated HIV/AIDS transmission 
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among drug users and international demands. The MMT and NSEP services show notable 
progress since their inception in 2005, supported by the political leadership’s commitment 
to their initiation, management and expansion; by multi-sectoral involvement; and by 
increased diverse access points. Against this backdrop, it can be presumed that the harm 
reduction approach will continue to receive official endorsement and further support in 
Malaysia.  
However, so far Malaysia has not managed to develop its harm reduction 
approach into sufficient coverage and efficiency. Additionally, the approach still faces 
limitations and challenges including low coverage of drug users, less impact on drug 
policy, worsening drug problem and endless criticism regarding its worth and 
compatibility with the preserved criminal justice approach. These are relevant concerns. 
The issues related to the justifications of harm reduction approach and its congruity with 
the criminal justice approach are given considerable focus in this thesis and will be 
discussed in the subsequent chapters. It is pertinent to note that some essential historical 
points for this chapter could not be covered or extensively elaborated owing to limitations 
of available data, especially regarding the policy and legislative reports and relevant 
debates. Caution is also advised because much of the data retrieved from governmental 













Despite significant developments in many countries including Malaysia, harm reduction 
policy and strategies are still surrounded with unsettled issues pertaining to their ethical 
and ideological justifications. The purpose of this chapter is to examine the normative and 
theoretical imperatives of harm reduction approach in the light of relevant debate at 
international and Malaysian levels. The discussion will cover several main aspects 
relating to the imperatives including the importance of harm reduction measures within 
ethical values, their connection with the protection of drug users’ human rights, their 
congruity with Islamic values, their compatibility with the abstinence-oriented paradigm 
within drug prohibition policy and their consistency with international drug control 
conventions. Embracing these aspects may assist in establishing the ethical and 






2.2 The Importance within Ethical Values 
 
While traditional drug policy focuses on the need for individuals to abstain from illicit 
drugs, the harm reduction approach prioritises the reduction of adverse consequences 
from drug taking regardless of whether the conduct continues. This leads to intense 
attacks on the response’s ethical legitimacy. This section examines the important issue of 
whether and how the approach is ethically justified. 
The harm reduction approach is subject to ethical questions relating to its apparent 
non-emphasis on abstinence and sanctioning of persistent intake of illegal drugs. 
Abstinence-based strategies including law enforcement, prevention and treatment are 
rendered as the solely acceptable and ethically justifiable drug responses. Mangham 
exemplifies the disagreement with the harm reduction approach in preference to 
prohibitionist approaches: ‘We cannot have a drug policy ideologically attached to harm 
reduction and also achieve the vital goals of prevention […] Placing harm reduction 
ideology aside, reduction of cannabis use (and other illicit drugs) onset is defensible as a 
drug policy goal’.203 This shows a type of antagonism towards harm reduction that stems 
from beyond the concern for the approach’s impacts. The objection reflects opponents’ 
strong embedment to the core values related to intolerance to drug use and abstinence 
ideal, constituting the so-called deontologist response.204 
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The responses of many harm reductionists are made in terms that are inconsistent 
with the opponents’ ideological language. They lie on a technocratic argument regarding 
the pragmatism of the approach and scientific evidence of its efficacy and cost-
effectiveness in decreasing drug-related harms. They also offer rhetorical amoral 
standpoints regarding drug taking, drug takers and acceptable state responses. Erickson et 
al. articulate that ‘harm reduction programs are not dogmatic and coercive structures. 
Rather, they are designed on the basis of accurate, scientific knowledge about drugs and 
drug use’.205 The essence of the proponents’ argument is that the harm reduction 
approach denotes a justifiable pragmatic drug response given that it is not founded on 
abstract normative claims but instead on objective evidence-based scientific grounds. In 
the face of this, harm reduction measures are assessed based on their actual outcomes, 
rather than on their moral worth. This clearly signifies the consequentialist perspective, a 
value-neutral orientation that is viewed as part of the approach’s strength. Keane asserts 
that the value-neutrality makes harm reduction a ‘powerful rhetorical intervention’ in 
deeply value-laden drug policy discourses.206 
Mere silence on the ethical perspective in favour of scientific justification renders 
the defending argument fundamentally handicapped. The value-freedom does not, 
however, denote perfect neutrality. Values are entrenched within harm reduction, as 
indicated by its outlined principles. However, the ethical principles are seemingly hidden 
or discounted by its proponents in responding to the condemnations. Their argument 
ignores the important link between scientific and value positions, and therefore does not 
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address the deontological vis-à-vis consequentialist drug debate. Indeed, making inroads 
on both standpoints is important if the intention is to provide a strong basis for any drug 
response. Steven affirms this, claiming that despite the effectiveness of drug treatment, it 
is still not justifiable in the case where it contradicts morality and ethics.207 This 
manifests that self-reflexive pragmatic argument alone is inadequate for sidestepping 
inevitable ethical disputes about harm reduction. Neglecting to engage values will hinder 
proponents’ capability to better convince the critics of the approach’s validity. This is 
reflected in the fact that ideological challenges to the harm reduction approach continue 
to be brought forward despite its extensive scientific support. As MacCoun states: ‘It may 
be hard to persuade others to acknowledge the full complexity of harm-reduction logic 
unless the values that support it become more salient in drug policy discourse’.208 It is 
clear that a value-free approach that prioritises scientific impetus may limit the 
justifiability and potentiality of the harm reduction approach. It is therefore necessary to 
highlight explicit and clear ethical underpinnings of harm reduction as well, so that they 
balance the approach’s scientific aspects and enhance its justification. 
Notably, the harm reduction approach is strongly rooted in public health. It fits 
well with the prevention strategies for illness and health risks that exist within the 
traditional public health framework. Through the provision of strategies including MMT 
and NSEP, the harm reduction approach moves towards preventing the incidence of 
diseases and health problems such as HIV/AIDS and other blood-borne infections 
connected to drug consumption via injection instrument sharing and progression to drug 
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dependence. Dependence on drugs is classified as a chronic health problem which is 
associated with a ‘chronic relapsing condition’ with a series of recovery and relapse prior 
to the last cessation.209 Harm reduction strategies also seek to address drug-related 
harmful consequences including overdose mortality. Infectious diseases and other health-
related impacts from drug taking pose threats to the health and well-being of the wider 
population. For example, infected HIV drug users could transmit the virus to others 
prenatally and sexually. Harm reduction interventions become important tools for 
modifying drug users’ risky behaviours in order to lessen drug-related harms, and for 
bridging the group to drug treatment and mainstream healthcare services. In support of 
harm reduction, Hickman stresses the approach’s aim in inhibiting the adverse effects of 
drug taking, which is to mitigate the disease-related problems and to ameliorate their 
health status.210 
Additionally, this thesis argues that the harm reduction approach can be 
considered as a part of health promotion work grounding on the principle of new public 
health. Health promotion as a concept refers to enabling people to involve and control 
over health determinants and hence effectuate improvements to their own health.211 It is 
commonly characterised as empowering health citizenship. Similarly, harm reduction 
programmes empower drug users to achieve control over their health and behaviour 
change. In the light of health citizenship values, individuals including drug takers have 
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both the right and the duty to maintain their own health. This responsibility could to some 
extent justify state’s extensive intervention in drug users’ territories if it is evidently to 
optimise common health. The argument here is that this notion of health citizenship 
within the drug use context must also be made subject to limitations and other ethical 
elements. This will be further discussed in Chapter 5, Section 5.3. 
Harm reduction is hence an important strategy for addressing the public health 
aspect of drug using. It is worth elaborating (pursuant to the explanation in the 
Introductory Chapter) that the health or public health imperative in relation to drug taking 
is not only embraced by the public health system but also dealt with by the criminal 
justice regime. The criminal justice approach’s role in mitigating drug use and its adverse 
health and other effects mainly underlies the international drug controlling conventions. 
For instance, the preamble of the 1988 Convention considers that the production of, 
demand for and trafficking in prohibited narcotic substances ‘pose a serious threat to the 
health and welfare of human beings and adversely affect the economic, cultural and 
political foundations of society’. Notably, the public health and criminal justice 
approaches converge and vary conceptually in many ways. While the two approaches 
connect to a larger political system in which their legitimacy and scopes are significantly 
shaped,212 both differ in their primary goal. While the public health approach centrally 
aims to inhibit diseases and safeguard the health of populations, the criminal justice 
approach holds the principal goal of protecting public safety and order. The former 
approach regards drug use as a threat to population health, but the latter approach views it 
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mainly as a threat to societal order and safety. As public health, public safety and public 
order are important goods for communities and society, they are covered under the ambit 
of the public good goal and state responsibilities for their promotion and protection. In 
fact, both approaches share the grounding principle of protecting social interest. But, 
while the public health approach is more attentive to the health interest, the criminal 
justice approach has concerns that extend beyond and even encompass the public health 
interest. In the drug use problem context, the criminal justice approach is created to 
achieve not solely public health aims but also social, welfare, economic and other aims 
given the numerous types of drug use harm (refer to the Introductory Chapter). In other 
words, health is just part of a number of values stimulating criminal justice actions.  
The two approaches also differ in the substance of the social interest principle 
including the preferred measures for advancing the health interest. The public health 
approach typically engages operations including surveillance, disease investigation and 
control activities as well as provision of services for disease prevention and health 
promotion.213 On the other hand, the criminal justice interventions encompass a wide 
array of activities including policing, investigation, prosecution, punishment and crime 
preventive acts.214 Such legal measures are applied to achieve structural or behavioural 
changes or to enable the delivery of measures for the public good. The legal strategies are 
considered vital for controlling and protecting human conduct, rather than other 
interventions including educational methods as prioritised by the public health 
community. 
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Further, public health is distinguished from criminal justice as it focuses on 
preventing harm before it occurs with supplementary consideration tailored to treatment 
and other therapeutic measures.215 Criminal justice, in contrast, seems far more reactive 
as it commonly takes actions after an offence has happened. Another variance between 
public health and criminal justice responses is that the former primarily concentrates on 
reducing harms, but the latter turns its attention towards deterring wrongful acts. 
Additionally, while the goals of public health and public safety are similarly attuned to 
the state’s power to act, yet another significant contrast between the public health and 
criminal justice approaches is that the former is particularly attentive to voluntary 
cooperation between public health officials and the community, while the latter relies 
heavily on the employment of coercion or the threat of coercion over individuals. 
Ashworth states: ‘Criminal liability is the strongest formal censure that society can inflict, 
and it may also result in a sentence which amounts to a severe deprivation of the ordinary 
liberties of the offender’.216 From all of the above, it is clear that drug use has been put at 
the centre of the concerns of both public health and criminal justice approaches, which 
have shared and divergent characteristics. 
Given the public health approach’s basic features and its consideration of the 
common good, it also aligns with the consequentialist approach of utilitarianism which is 
famously connected with John Stuart Mill and Jeremy Bentham. This theory justifies 
action based on whether it produces ‘the greatest happiness to the greatest number of 
people’. The action is ethical if its benefits outweigh the costs. It could also be argued that 
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this notion is impliedly intended by the harm reduction approach owing to its emphasis on 
harms or costs mitigation as a consequence. Approaching MMT and NSEP from a 
utilitarian perspective clearly shows their effectiveness. There is strong evidence 
demonstrating the positive impacts of both interventions in decreasing drug use, HIV-risk 
behaviours and infection incidents, and in increasing referrals to drug treatment and 
health services, and cost-saving. Moreover, the assessments suggest that the strategies do 
not appear to lead to negative effects such as increased drug taking, crime and discarded 
syringes. (Detailed discussion regarding the scientific implications of harm reduction 
strategies can be found in Chapter 3). Drawing on these positive outcomes and the 
absence of harms and burdens, this thesis claims that both measures are intended to 
achieve good for both individuals and entire communities. Thus, there is no reason to 
believe that utilitarianism as a theory does not apply to harm reduction. However, 
arguably, this philosophy alone insufficiently entails a strong case for the approach. 
Criticisms arise surrounding the risk of wider state actions that may extend to undermine 
individuals’ rights in the name of the common good.217 This is likely reasonable given 
that there is no key rule as to the definition and measurement of good. Additionally, many 
still reject the harm reduction approach’s utility owing to its perceived conflict with their 
desirable normative belief. It is therefore important that the utilitarian grounds for harm 
reduction are enhanced and balanced with other values related to the public health realm. 
An increasing orientation has appeared towards invoking normative principles to 
justify the harm reduction approach. Some provide its moral stand through the lens of 
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virtue ethics, which is a theory concerned with the moral qualities of the person doing the 
action. It suggests that virtues including courage, compassion, fairness, honesty, kindness 
and loyalty are essential parts of the individual character.218 Christie et al. use the virtue 
of compassion to defend the harm reduction approach. For them, harm reduction is an 
aspiration brought about by the trait of compassion within people engaging in the 
programmes. The initiatives are implemented to assist the drug using population to 
mitigate their suffering and pain and to gain health and well-being.219 Although the 
techniques under harm reduction manifest a compassionate response to commonly 
marginalised drug users within which their risk behaviours are dealt with in a way that is 
respectful of the group, it is doubtful whether this value could offer a compelling ethical 
argument for the practices. Adopting this value would mean that less weight is given to 
actions and obligations. Thus, drug users could not be obliged to take actions to protect 
their health as in the health citizenship conception. Moreover, the degree to which 
compassion should be practised is uncertain. Reflectively, policy-makers and harm 
reduction service providers lack guidance on how to strike the balance between excessive 
and insufficient compassion. Additionally, while there are divergent interests and 
perceptions among individuals and communities that may impact harm reduction, the 
missing clear mean to reconcile these makes this value less applicable for the approach.  
Further, the harm reduction approach is discussed in terms of its consistency with 
communitarian ethics, which attribute the highest priority to public interests and the 
common good. Communitarian ethics as a theory ‘emphasises social connectedness, and 
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sees individuals as members of a community embedded in the community norms and 
history, and not as the atomised individuals of classical liberalism’.220 This means that the 
good of action is evaluated in terms of the community’s preferences. Some scholars such 
as Fry et al. promote the engagement with communitarian ethics within the harm 
reduction realm.221 It might be reasonable to elicit this ethical theory in harm reduction 
considering its ground in public health and social relativism. Thus, the conceptual setting 
of the harm reduction approach needs to be consistent with valued societal interests. This 
may go some way towards addressing the clash between relevant theories. However, 
guidelines pertaining to these are absent from the existing literature. Further, 
communitarianism is not without other problems. Similar to virtue ethics, it is unclear 
whether communitarian ethics are capable of providing equitable consideration to 
differing ethical perspectives of various communities in tackling ethical problems. This 
makes the notion of a shared stance of common good with regard to harm reduction or 
other matters less likely. Another facet of fundamental criticism relates to the fluid and 
ambiguous conception of community itself. The community notion is of dubious 
importance to social, welfare and criminal justice innovations because it is fraught with 
inherent inconsistency and a plethora of positions. The term is commonly employed in the 
literature in two different senses: first when referring to small and face-to-face 
communities such as villages, and second when discussing wider political or cultural 
communities. Both types have contesting accounts of certain aspects including how 
liberal values are deliberately excluded in the latter’s case but unnecessarily so in the 
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former’s case.222 Further, the complex label of ‘community’ attracts various terms 
including culture, society, state and nation, theories, values and preferences.223 Critics are 
also concerned about some of the conceptual issues related to communitarian theory 
including the terminology’s indefinite elements, and the scope and methods of its 
appropriate application.224 Additionally, there is the risk of ‘the tyranny of the majority’ 
as a consequence of the unclear ambit of common good.225 The majority viewpoint, while 
inequitably discounting the interest of minority drug users, could give preference to the 
policies infringing drug users’ human rights to attain a drug-free environment.226 Based 
on these limitations, this value is unlikely to be a candidate for the ethical basis 
underpinning the harm reduction approach. 
Another option is principlism, which some champion as the underlying ethical 
basis for harm reduction.227 Principlism is a kind of bioethics umbrella term incorporating 
four principles, namely: respect for autonomy (respecting the personal right to make 
decisions of actions, privacy and confidentiality); beneficence (maximising benefits); 
nonmaleficence (mitigating harms and risks); and distributive justice (equitably 
distributing benefits and burdens). These principles seem to be a worthy framework for 
harm reduction measures. For instance, MMT and NSEP comply with respect for 
autonomy as the strategies recognise and aid drug users in making informed judgements 
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about how to address their high-risk behaviours and drug dependence, all conducted 
within a maintained confidential and non-compulsive sphere. Further, the measures 
satisfy beneficence and nonmaleficence principles through their effectiveness and safety 
in reducing drug-related harms and increasing admissions to and retention in therapeutic 
and healthcare services. Moreover, in concordance with justice, the government’s 
financial support of the programmes for well-being and health improvement denote fair 
allocation of resources for the needs of the drug using population including those unable 
or unready to respond to abstinence-based efforts. Despite its distinctive appeal based on 
simple conceptualisation and practicality for clinical and public health professionals, 
there are problems underpinning principlism that deserve to be mentioned. There is no 
certain method that is specified to address the potential conflicts among the four 
principles. For critics, there are also concerns that autonomy dominates over the other 
three principles228 (in clear contrast to communitarianism theory), that the theory 
disregards other important life aspects including moral values and the public good229 and 
that it decontextualises  ethical problems230. These suggest the challenges of utilising the 
philosophy in support of the harm reduction approach.  
Moreover, growing attention has been focused on human rights perspectives of the 
harm reduction approach. Human rights privilege individual dignity and rights, rather 
than the public interest. Cohen and Csete write: ‘Human rights inhere to the person and 
are not contingent on consensus or majority view’.231 Drug users, like all other 
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individuals, have human rights as enshrined in international human rights law. Article 55 
of the UN Charter conversely mentions that the UN ‘shall promote […] solutions of 
international economic, social, health, and related problems; and universal respect for, 
and observance of, human rights and fundamental freedoms for all without distinction as 
to race, sex, language or religion’. The states therefore have duties to respect, protect and 
fulfil human rights. In the light of this notion, appropriate and effective ways to protect 
drug users’ rights must be implemented without any barriers. This might include harm 
reduction measures that are clearly initiated towards securing drug users’ health and well-
being-related needs and benefits. The human rights paradigm has therefore significant 
potential for justifying harm reduction initiatives and counterbalancing the utilitarian 
stance of public health, thereby satisfying personal and societal interests as well as 
professional integrity. More explanation of the human right imperative and relevant 
debates about how it fits with the harm reduction approach can be found in Chapter 2, 
Section 2.3.  
To summarise, absolute evidence-based arguments are not compelling enough to 
crack the opposition to the harm reduction approach, especially from those who take a 
deontological stance towards drug prohibition. The value-laden, as opposed to value-free, 
nature of the harm reduction approach should be explicitly highlighted through debate 
and dialogue. This would assist in providing strong ethical justification for the approach. 
Harm reduction is a firmly public health approach. It matches the components of 
prevention of diseases and health risks under the traditional public health framework and 
health promotion under the new public health. Utilitarianism offers more insights into the 
theoretical paradigm of harm reduction. Additionally, the approach is linked to the human 
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rights imperative. This value could be a relatively more appropriate resource than other 
ethical theories as it effectuates the idea of reinforcement and counterbalances the public 
health and utilitarianism bases for harm reduction.  
 
2.3 Connection with the Protection of Drug Users’ Human Rights 
 
Human rights have acquired increasing significance in drug use discourse since the mid-
1990s. However, the importance of the harm reduction approach from a human rights 
perspective is still the subject of debate. This section presents a perspective regarding this 
aspect while considering the existing debate.  
Providing harm reduction measures is crucial to secure drug users’ internationally 
accepted right to the highest standard of health. The Universal Declaration of Human 
Rights (UDHR) states that ‘everyone has the right to a standard of living adequate for the 
health and wellbeing of himself and of his family, including […] medical care and 
necessary social services’.232 Similarly, the International Covenant on Economic, Social 
and Cultural Rights (ICESCR) attests ‘the right of everyone to the enjoyment of the 
highest attainable standard of physical and mental health’.233 The UN Committee on 
Economic, Social and Cultural Rights (CESCR)234 specifies the ambit of right of health, 
pointing out that ‘the right to health must be understood as a right to the enjoyment of a 
variety of facilities, goods, services and conditions necessary for the realisation of the 
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highest attainable standard of health’.235 In other words, the right to health covers the 
reach of available diverse medical and healthcare services and support. Drug users are 
therefore entitled to the same respect and dignity as other persons to get healthcare 
protections including through harm reduction services. 
To effectuate the right of health, the international law commits states to taking 
steps including ‘those necessary for […] the prevention, treatment and control of 
epidemic, endemic, occupational and other diseases’ and ‘the creation of conditions 
which would assure to all medical services and medical attention in the event of 
sickness’.236 Specifically for the control of HIV transmission, the International Guidelines 
on HIV/AIDS and Human Rights (IGHHR) encourage countries to ensure ‘the 
availability and accessibility of quality goods, services and information for HIV/AIDS 
prevention, treatment, care and support’.237 This means that national governments are 
obliged to undertake positive action and to move progressively towards promoting health 
and making adequate, effective and good-quality healthcare measures accessible to 
individuals. 
Harm reduction programmes would perfectly fit as components of states’ positive 
actions in promoting health and preventing diseases and other drug-related effects 
detrimental to the health of drug users and the wider population. MMT is scientifically 
and medically pertinent to ameliorating or decreasing opiate dependence and its adverse 
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health consequences. NSEP further contributes in constraining the dangers associated 
with risky behaviours among IDUs including HIV/AIDS and other blood-borne 
infections. Additionally, both services could bridge the gap to other healthcare services. 
Certainly, the harm reduction approach, according to Paul Hunt, UN Special Rapporteur 
on the Right to Health, ‘enhances the realisation of the right to health’ of the drug-using 
population.238 This significance is also affirmed by UN human rights monitors.239 Thus, it 
can be argued that states are legally bound to implement harm reduction strategies.  
Further, delivering harm reduction services constitutes a stepping stone for states 
to be compliant with the right of freedom from inhuman and degrading treatment. 
International human rights law unequivocally recognises the individual entitlement to be 
protected from torture and ill-treatment. Article 5 of the Universal Declaration of Human 
Rights (UDHR) provides: ‘[N]o one shall be subjected to torture or to cruel, inhuman or 
degrading treatment or punishment’. Countries have a positive legal obligation to realise 
this right based on the term of right and provisions calling them to forbid all acts of 
torture and other cruel, inhuman or degrading treatment or punishment.240 The states’ 
duty engenders their responsibilities in practising effective measures for freeing all 
persons from acts or conditions amounting to torture and ill-treatment, potentially include 
preventable painful physical ailments and suffering. 
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MMT and NSEP are evidence-based techniques to reduce drug consumption and 
its negative effects, thereby securing drug users against harms and suffering. Writing in 
the context of drug users’ human rights in closed settings, Bruce and Schleifer note: 
‘[…S]tates’ failure to provide available and necessary medical attention to opioid-
dependent prisoners, thus increasing their vulnerability to HIV and other blood-borne 
diseases, could result in prisoners being subject to inhuman and degrading treatment in 
violation of basic legal obligations to prevent such occurrence’.241 By analogy, the same 
can be claimed of harm reduction programmes in the community, given the life and 
health threats faced by street drug users. Denied or interrupted access to the programmes 
may seriously affect drug users’ physical and mental health and well-being. The 
population would be susceptible to avoidable harms and risks including HIV/AIDS and 
other virus transmissions, withdrawal symptoms and fatal overdose. Thus, the national 
government’s failure to ensure accessibility to harm reduction measures seems to cause 
inhuman and degrading treatment in breach of fundamental responsibility to inhibit such 
incidents. Arguably, the failure, however, could not be directly equated with de facto 
‘inhuman and degrading treatment’ without taking into account other national conditions 
including economic capacity. 
Clearly, harm reduction practices precondition the safeguard of drug users’ rights 
to health and protection from inhuman and degrading treatment. The human rights 
discursive style presented in this thesis obviously disregards the notion of drug-taking 
entitlement grounded on civil liberties as promoted by a few commentators. In critiquing 
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the value-neutral discourse of harm reduction, which, as claimed, neglects its embedded 
human rights values, Hathaway materially considers drug using a right within the ideals 
of freedom of will and autonomy of the individual.242 It is reasonable to argue that this 
human rights theme could not make a strong case for the harm reduction approach. The 
liberal humanism account of drug consumption clashes with both health-optimising and 
prohibition imperatives, and is thus inappropriate to be considered as underpinning the 
approach’s ideals. Additionally, adopting a libertarian foundation would oppose the harm 
reductionists’ mainstream call for state intervention to protect the health and welfare of 
drug users, thereby possibly sparking fruitless conflict within the harm reduction domain. 
(Further comments regarding the liberalist view on drug use can be found in Chapter 5, 
Section 5.3.) 
Ezard offers the other dimension of the rights-oriented viewpoint of harm 
reduction. This scholar invokes a wider human rights basis encompassing social and 
economic rights to point to the state’s duty to provide care and protection to individuals 
through decreasing drug-related harm, its risks and vulnerability. In particular, she claims 
that human rights duties are connected to drug using in a number of ways. First, the state 
has the duty to ensure the availability of interventions and conditions that mitigate drug-
related harms and risks. Second, the state’s failure to fulfil human rights duties potentially 
increases individual vulnerability to harms associated with taking drugs.243 In the light of 
her distinctively enlarged harm reduction spectrum covering the minimisation of 
vulnerability to and risks of drug-related harms, Ezard firmly relates the approach’s 
                                                          
242 A.D. Hathaway, "Shortcomings of Harm Reduction: Toward a Morally Invested Drug Reform Strategy," 
International Journal of Drug Policy 12, no. 2 (2001).134–36. 
243 N. Ezard, "Public Health, Human Rights and the Harm Reduction Paradigm: From Risk Reduction to 
Vulnerability Reduction," International Journal of Drug Policy 12, no. 3 (2001).215–16. 
90 
 
adoption to the human rights commitment to protect people from harms, risks and 
vulnerability.244 While impressive as far as it goes in applying a human rights lens other 
than that of civil libertarian entitlement to drug-ingesting as is integral in Hathaway’s 
view, it is unclear whether Ezard’s human rights analysis for harm reduction based on 
vulnerability protection undertaking is useful. At present, this notion is not within the 
harm reduction common accounts. Vulnerability to risk is also relatively more remote and 
beyond those risks directly related to drug consumption.  
Notably, injecting a rights-based perspective into harm reduction is important, as 
such values would strengthen the legitimacy of harm reduction strategies. While 
acknowledging the inadequacy of available scientific evidence to effectively assuage 
ideological objections to harm reduction, Wodak and McLeod highlight the approach’s 
justifiable use for human rights protection.245 Additionally, human rights analysis could 
be a potent weapon for insisting on the state’s positive involvement in harm reduction 
interventions as part of its legal obligations under the international human rights norms 
and standards.246 Article 103 of the UN Charter suggests that priority should be given to 
states’ duties under the document including with regard to human rights over duties in 
any other conventions. This indicates that human rights obligations would prevail even in 
the case of their conflict with the duties embodied within the international drug treaties, 
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which is explicitly confirmed by the Commentary on the 1988 Convention.247 
Nonetheless, the government’s being able to provide interventions is undoubtedly 
impacted by economic considerations and the availability of resources. Regard for the 
country’s particular economic conditions should be treated as an essential compromise to 
the obligations it has assumed under the human rights treaty.248 That said, resource 
constraints must not be paraded as excuses for the state’s desertion from meeting its 
obligations. The state must be held fundamentally responsible for ensuring ‘at the very 
least minimum essential levels of every right’ under Article 2 of the International 
Covenant on Economic, Social and Cultural Rights in whatever economic circumstances. 
One of the core obligations proposed by the UN Committee on Economic, Social and 
Cultural Rights is ‘to adopt and implement a national public health strategy and plan of 
action, on the basis of epidemiological evidence, addressing the health concerns of the 
whole population’.249 Arguably, this should cover immediate actions to provide drug 
users with evidence-based services including harm reduction at a realistic standard 
adapted to a country’s economic faculty, considering the serious detrimental effects of 
drug taking including blood-borne viruses transmission. Harm reduction measures are a 
necessary, efficacious and cost-effective way of saving lives and ameliorating or 
preventing avoidable harms to individuals and the population as a whole (further 
discussion regarding the scientific imperative of harm reduction appears in Chapter 3). 
Further, it is incumbent upon national governments to address the policies, legislations 
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and other approaches that hinder harm reduction programmes’ efficiency or that result in 
negative impacts that counteract their objectives.  
However, critics find problem with respect to applying human rights dimensions 
to social issues including drug use. One of their important arguments is that human rights 
result in undue constraints on states’ public good efforts including decreasing the harmful 
effects of drug taking. Keane writes: ‘[I]ndividual rights […] are a way of defending 
individual desires against the competing claims of collective goals and general benefits, 
such as the reduction of harm’.250 Such an ambivalent attitude towards individualism is 
prevalent in Asian countries including Malaysia. The premise upon which the criticism is 
based is that the pursuit of individual rights is incompatible with the commitment to 
community good. Whilst I here agrees that human rights might clash with state 
undertakings for advancing public interest in certain cases, especially when states take 
action to limit individual freedoms such as through mandatory quarantine on the basis of 
societal benefit, adopting human rights norms is important for checking and balancing 
public interest strategies. Cohen et al. argue that ‘human rights provide the moral and 
legal ‘brakes’ to redirect public health (and other social interests) to more constructive 
tactics’.251 This would prevent unnecessary rights infringement by states in the name of 
public good, which in turn would lead to effective and just rights-oriented public 
strategies that may substantially benefit individuals and wider community. Therefore, 
attaching human rights principles to drug use and other social issues does not mean the 
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loss or subordination of public interest to personal interest; rather, it would be a mistake 
to disregard them.  
Resistance to human rights conceptions based on ‘Asian values’ is a distinctive 
feature of debate in Asian settings including Malaysia. The popular argument is that 
human rights dignifying the individual are exclusive values emanating from Western 
culture that are not well suited to Asian cultural traditions. This implies that a cultural 
relativism separates Asia from the West, but this justification is fundamentally flawed 
owing to the absence of two major fixed sections of Asian and Western values. Traditions 
continually evolve as a result of intercontinental cultural exchange.252 Additionally, 
human rights are not necessarily culturally specific to the West; they can be traced in non-
Western morality, religions and traditions. For instance, the Western conceptions of the 
rights of health and freedom of movement are considerably consonant with Islamic 
values.  
The notion of human rights’ universality as frequently highlighted by many in 
response to the Asian values premise has merit only to the extent that it is not construed 
as a global homogeneity of cultures but instead as a group of essential minimal general 
principles that are still open to interpretation and application by local circumstances and 
cultural traditions. This is consistent with the Universal Declaration of Human Rights 
reminder that ‘the significance of national and regional particularities and various 
historical, cultural and religious backgrounds must be borne in mind’ while applying 
human rights universally. Consideration of domestic particularities would mediate 
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considerable differences in Asian human rights conceptions. This would also give ethical 
and political weight to using human rights to attain a ‘dignity life’.253 
Moreover, there is widespread suspicion that human rights norms and practices 
will threaten national social and economic progress. Asian leaders believe in the 
justifiable prioritising of measures to ensure political and security stability towards 
attaining undisturbed economic growth, though they need to curtail civil and political 
liberties. This manifests in individual rights being necessarily compromised to 
accommodate material necessities. To refute this, the argument is oversimplified as there 
appears to be no evidence demonstrating a general causal link between protection of 
rights and handicapped economic development. Instead, fulfilling individuals’ and 
groups’ rights might mobilise them to participate in activities that are geared towards 
social and economic preservation.254 It is hence invalid to generalise the priority of 
enhancing political and security stability. Furthering public good including national 
security while constraining individual rights is permissible only for a short term in 
specific cases where there is a true necessity for the former and a sound analysis to 
reconcile the clashing interests.  
Precisely, there is a clear relationship between harm reduction interventions and 
protection of individual rights to health and freedom from inhuman, cruel and degrading 
treatment. The practice of harm reduction is agreeable to and in many ways demanded by 
states’ duties under the international legal instruments. The human right norms further 
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give a philosophical basis for harm reduction services delivery in Malaysia and other 
nations. The principles help to ensure their efficient and equitable implementation, 
thereby benefiting both personal and public interests. 
 
2.4 Congruity with Islamic Values 
 
While the relevant data are scant, vehement protest from Muslim communities about the 
approach’s claimed contradiction to Islamic values can be somehow detected in Malaysia 
and other countries predominated by Muslims including Jordan, Oman and Syria.255 In 
quick response, some harm reductionists seem reluctant to consider the religious 
perspective on harm reduction because of its perceived hindrance to the approach.256 Such 
a negative assumption is problematic, as Islamic values will not necessarily cause 
predicament, but will instead potentially provide more justification for the approach in 
Islamic settings. Moreover, Muslims’ deep concern regarding any issue cannot simply be 
abandoned as they represent the majority of citizens in those countries. Harm reduction 
can only continue with their support. Also, within the Malaysian context, Muslim Malays 
are the majority of drug users and HIV patients.257 It is therefore inevitable to consider 
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this type of opposition and respond accordingly. The following discussion is assigned to 
an analysis of this issue. 
As invariably stressed by opponents, harm reduction strategies connote assistance 
with and promotion of sinful illicit drug using and neglect of the abstinence-based 
philosophy towards prohibited conducts. The Fatwa Committee National Council of 
Islamic Religious Affairs Malaysia258 issued a ‘fatwa’ (Islamic legal reasoning) regarding 
the impermissibility of NSEP.259 In a similar vein, Perak’s260 ‘mufti’261 submits that 
NSEP would incite more people to get involved in injecting drugs, thereby bringing about 
negative effects.262 A serious weakness of this argument is that it is not backed up by 
coherent support. The reasoning is straightforward, based on the relevance of harm 
reduction measures to drug consumption.  This mirrors the opponents’ strict adherence to 
the Islamic jurisprudence principle of ‘sadd al-dhara'i’ (blocking the means), which 
signifies that any method that leads to evil or harm is prohibited, whether the particular 
result was intended or not.263 Thus, harm reduction programmes are seen as pathways to 
sinful and harmful drug taking. This argument has flaws, though. In pointing out the 
Islamic ruling, the opponents do not comprehensively take into account the pivotal role of 
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harm reduction techniques in reducing drug use and its adverse consequences. 
Furthermore, there is no consideration of the alarming rate of HIV/AIDS cases or of the 
lack of success of the abstinence-based response to the drug consumption problem. Given 
the interventions’ importance and relevant issues, it would appear that harm reduction has 
become a specific case meriting conclusive Islamic legal analysis that looks beyond its 
connection to drug using and individual interest. The analysis must acknowledge the 
wider scope of issues as well as both public and personal good.  
This thesis posits that MMT is justifiable in Islam owing to the ‘hajiyyat’ (need) 
for treating dependency to drugs and its-related harms. This conforms to the Islamic 
principle that ‘anything which is prohibited due to the concept of ‘sad al-zarai’k’ could 
then be permitted if there is ‘hajiyyat’ (need).264 Though the majority of classical jurists 
including al-Zarkashi, al-Ruyani, al-Bazazi and al-Nawawi originally ruled on the 
impermissibility of drug use, an exemption is given when there are ‘hajiyyat’ (need) of 
using drugs for medication on the conditions that there is no better lawful substitute and 
that it is verified by trusted experts.265 While drugs are generally prohibited because they 
are analogised to ‘khamr’ (intoxicants) that are impermissible in Islam,266 there is an 
exemption to the prohibition when drugs are used for medical purpose. The same 
exception, however, is inapplicable to ‘khamr’ (intoxicants). This is given that drugs are 
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not totally similar to intoxicants.267 The ‘khamr’ is prohibited by the Quran and the 
Sunnah owing to its ‘zat’ (evil nature) and intoxicant effects, while drugs are prohibited 
only for their intoxicant implications.268 The permissible use of drugs for medicinal 
purpose is reaffirmed by contemporary Islamic jurists. Al-Zuhaili, for instance, states that 
it is allowable to use drugs in treatment when there is either ‘hajiyyat’ (need) or ‘darurah’ 
(necessity) to save life. This includes using drugs for surgical operation and pain relief.269 
Therefore, concurring the Fatwa Committee National Council’s ruling regarding MMT270 
this thesis argues that the strategy is lawful as a form of drug treatment. Conventional 
abstinence-oriented treatment should not be the only acceptable practice, given its failure 
to reduce drug consumption and the high number of relapse cases. MMT also complies 
with Islamic rules as it is supervised and controlled by medical experts including in terms 
of the eligibility of clients and the amount of methadone dispensed.  
Through a different lens, the Malaysian government and some Muslim scholars 
defend harm reduction interventions based on the Islamic legal maxim of ‘al-darurah 
tubihul mahzurat’ (necessity legalises what are prohibited). As contended, the originally 
impermissible provision of methadone and syringes for drug users is authorised 
temporarily to address a critical level of HIV prevalence.271 Mohd Safian in her PhD 
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thesis concerning ‘darurah’ suggests that Malaysian MMT and NSEP meet the 
preconditions of ‘darurah’ and are hence temporarily legitimate ways of preserving the 
life and health of drug users and the communities endangered by the HIV epidemic and 
drug dependence.272 The ‘darurah’ principle makes what is prohibited permissible owing 
to arising absolute necessities. As al-Suyuti noted, ‘darurah’ refers to ‘a situation in 
which one reaches a limit where if one does not take a prohibited thing, one will perish or 
be about to perish’.273 In relation to the ‘darurah’ principle, supporters also invoke the 
Islamic legal maxim of ‘al-∂arar al-ashadd yuzalu bi’l-∂arar al-akhaff’ (a greater harm is 
eliminated by tolerating a lesser harm) 274.275 In the light of this principle, any action, 
even one with associated harm, is morally justifiable if it is to avoid a relatively greater 
harm. Both dictums are connected to the main underlying maxim of ‘la ∂arara wa la 
∂irar’ (let there be no infliction of harm nor its reciprocation) proposing that harms need 
not be inflicted on oneself or others. 
Generally, the perils in terms of HIV infection and drug dependence determine the 
necessity for harm reduction programmes. However, to be justifiable under ‘darurah’, 
these programmes need to comply with its requisites. The preconditions include that what 
is legalised owing to necessities will be permissible to the extent that is sufficient to 
secure the necessities that exist, as says the maxim ‘al-darurah tuqaddar biqadriha’ 
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(necessity is estimated by its extent thereof). Thus, when necessity disappears, the 
permissibility will cease, too.276 
MMT might thus fall squarely within ‘darurah’ preconditions. It is implemented 
along with certain safeguards and limitations to avert HIV transmission and drug 
dependence, which are inimical to life. However, to fully adhere to ‘darurah’ 
requirements, MMT has to be ended when the life threat or real necessities vanish. As 
noted by Ibn Hajar, critical drug dependence detrimental to life is a necessity that justifies 
the use of drugs and that lasts until the abolition of the harms.277 Arguably, the ‘hajiyyat’ 
principle would provide a sufficient and powerful Islamic ethical basis for MMT, without 
demanding recourse to ‘darurah’. Consequently, the programme is not required to 
comply with stricter requisites under ‘darurah’. Within ‘hajiyyat’, it would also enjoy 
prolonged permissibility as long as the individual needed to be dispensed with methadone 
for treating drug dependence certified by medical professionals. 
However, the dictums of ‘darurah’ and ‘al-∂arar al-ashadd yuzalu bi’l-∂arar al-
akhaff’’ might be relatively more applicable to NSEP. Many drug users have difficulty 
quitting or are reluctant to quit their habit. Despite enabling drug injecting, provision of 
syringes is essential to avoid broader harms including HIV infection detrimental to the 
life of individuals and society. But, based on the ‘darurah’ concept, NSEP must be 
restricted. It should be offered only to critical IDUs who are unlikely to respond to more 
therapeutic methods. Moreover, it should be persistently controlled by the authorities 
including with regards to quantity and duration for syringe provision. 
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Arguably, ‘hajiyyat’ and ‘darurah’ give stronger philosophical justifications for 
harm reduction strategies than other Islamic ethical principles. Several commentators 
invoke ‘maqasid al-Shariah’ (the objectives of ‘Shariah’) to validate the interventions. 
The programmes are regarded as part of ‘dharuriyat’ (essentialities); all the things 
necessary to preserve – religion, life, intellect, progeny and property of mankind – which 
are endangered by drug use and HIV/AIDS epidemics.278 The significance of this 
argument is mitigated by the fact that applying ‘maqasid al-Shariah’ as a direct basis for 
the ruling is inaccurate as seen through the lens of Islamic law. In fact, ‘maqasid al-
Shariah’ signifies the core objectives or goals of Islamic law towards the ‘masalih’ 
(benefits) of the public. An understanding of ‘maqasid al-Shariah’ is important for legal 
reasoning.279 It is applied for ‘tahqiq manath’ (verification of ‘nas’ (Islamic textual 
references; Quran and Sunnah)) in the process of issuing ruling. If there is no specific 
‘nas’ concerning an emerging new issue including with respect to the harm reduction 
approach or drug treatment, the issue needs to be resolved by ‘ijtihad’, or legal reasoning. 
The legal reasoning should derive its ruling from general or indirect ‘nas’ by employing 
the methods embodied in Islamic jurisprudence. ‘Maqasid al-Shariah’ assists the Islamic 
jurists in using the appropriate method for a particular issue. It becomes a tool for guiding 
the understanding of the meaning and objectives of ‘nas’ and applying it to the new 
issues, rather than a direct source for producing judgment or legal reasoning. It is also 
vital to ensure that Islamic jurists give prominent consideration to the effects of their 
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deduced ruling. Thus, the proponents’ justification for a harm reduction policy directly 
based on ‘maqasid Shariah’ is invalid.  
In a nutshell, the ideological resistance to harm reduction strategies based on the 
argument that they are contradictory to Islamic teachings has no ground. Harm reduction 
programmes are in line with Islamic values. MMT is warranted under the ‘hajiyyat’ 
principle, while NSEP is permissible on the basis of ‘darurah’ and ‘al-∂arar al-ashadd 
yuzalu bi’l-∂arar al-akhaff’’. This provides more foundational support for harm reduction 
operations in Islamic nations. However, to ensure constant legality under the Islamic 
dimension, appropriate controls over and limits to the interventions should be pursued in 
accordance with the preconditions of the ‘hajiyyat’ and ‘darurah’ rules.  
 
2.5 Compatibility with the Abstinence-Oriented Paradigm within Drug 
Prohibition Policy 
 
An old but unresolved challenge to the harm reduction approach exists internationally and 
domestically on the premise of its contradiction to abstinence-based policies and 
practices. It is essential to address this issue given that the abstinence paradigm is still 
dominant in the majority of prohibitionist countries including Malaysia and hence it 
might affect the acceptability and feasibility of harm reduction interventions therein. 
Accordingly, this section explores this significant issue.  
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The standard claim spouted by prohibition enthusiasts is that the harm reduction 
approach deviates from the prohibition regime, considering its ostensibly different 
philosophy and practices for drug control.280 Khalib illustrates the depth of ideological 
defiance of prohibition within Malaysia’s context: 
There is an urgent need to answer the question: ‘How does harm reduction, 
especially in the context of providing free needles, fall into place with 
Malaysia’s more than 30 years of aggressive fight against drug abuse?’ […I]t 
is unacceptable to assume that Malaysians should and can switch their 
perception to a tolerance of drug use practically overnight.281 
The opponents’ main argument seems to focus on the harm reduction approach’s 
separate paradigm which is regarded inharmonious and detrimental to abstinence. In fact, 
the abstinence paradigm generally exists in the criminal justice and public health systems. 
Most substance abuse interventions including drug treatment in numerous jurisdictions 
including Malaysia incorporate abstinence as a goal. Perhaps, one could argue that 
emphasising abstinence is much more associated with criminal justice goals as it aims to 
prevent illegal behaviour alongside benefits to health, and plays a direct role in practising 
states’ duties with regard to drug prohibition as embedded in the international drug 
control treaties. Bean states that abstinence ‘has the obvious virtue of making treatment 
compatible with the goals of criminal justice’.282 However, in some states, the criminal 
justice regime turns out to be tolerant of the aims of abstinence. For example, despite 
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emphasis on total separation from illegal drugs in prison settings, European probation 
systems including the UK’s, which are concerned with individual rehabilitation, have 
turned their focus away from the total abstinence ideal. Drug taking while on probation is 
usually countenanced provided that no other criminal behaviour is done.283 Even though 
harm reduction initiatives have not been established to do away with abstinence-oriented 
strategies within either the criminal justice regime or the public health regime, the 
speculative inconsistency between both appears to be owing to the initiatives’ disparity in 
shifting the focus away from getting people off drugs to decreasing their harms. 
Criticisms of harm reduction for its deviation from the abstinence ideal somehow mirror 
the stringent ‘zero tolerance’ perspective on illegal drug use. This also presumably 
explains the most vehement allegation that the approach constitutes a platform towards 
drug legalisation.284 Contained in this is that harm reduction is a part of liberal idealism 
that departs from prohibition. 
Recent times have seen further criticisms of harm reduction measures by ‘new 
abstentionists’, particularly in the UK and Australia. Ashton mentions: ‘Around Bonfire 
Night 2007 a rocket shook the peak of England’s drug treatment structure-someone asked 
how many patients ended up drug-free. Clothless as the fabled emperor, 3% was the 
answer […] The new abstentionists were on the march and the statistics seemed to be 
with them’.285 Some consider harm reduction as a paradigm to be in conflict with 
abstinence recovery, considering its inefficacy in producing individuals who are clean 
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from drugs. The claim frequently relies on the statistical data demonstrating the low 
abstinence achievement among MMT clients. The 3 per cent attainment of abstinence in 
England, as disclosed by the chief executive officer of the National Treatment Agency, 
has triggered the abstentionists to demand the prominent reorientation of abstinence.286 
They correctly questioned about the 97 per cent failing to quit drug dependency. Several 
UK studies also found a small percentage of MMT patients in Scotland and Ireland (8 per 
cent and 19 per cent, respectively) totally separating themselves from drugs after 
approximately three years of treatment.287 While the ‘new abstentionists’ inherit the 
‘traditional abstinentionists’ deep concerns for abstinence as an ultimate result of drug 
interventions, the former has begun to bring empirical support, rather than merely based 
their concerns on ideology as the latter do. The failure of harm reduction interventions to 
ensure absolute abstinence from illegal drugs is rendered as an indication that they only 
control through medium- and long-term maintenance on substitute drugs rather than truly 
treating or stopping the drug consumption. This means that the initiatives seemingly do 
not contribute to demand reduction, which is key to the elimination or reduction of 
substance use prevalence underlined in the prohibitionist eventual aim.  
In response to the objections, numerous harm reductionists are adamant in their 
traditional views privileging harm reduction solutions at the expense of abstentionist 
techniques. As argued, the abstinence-based goal is unrealistic because it ignores the 
reality of drug using as part of the world. Embedded in this claim is the perspective that 
attaining the abstinence is highly difficult if not impossible owing to the inevitability of 
drug taking. Thus, appropriate methods for addressing drug-related harms must be 
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emphasised. Moreover, the strict emphasis on abstinence restricts the admission and 
retention of certain drug users, including those who use drugs recreationally,288 those who 
resist to immediately abstain from drugs at initial stage of treatment, those who have the 
history of failure of abstinence in previous treatment programmes, those who pursue 
taking drugs while in the abstinence-oriented treatment,289 and those take drugs for self-
medicating or relieving pain and suffering.290 In other words, abstinence-based 
approaches would not benefit all drug users because they can not cater to this 
population’s varied classifications and problems. Accordingly, in the face of pragmatism, 
harm reduction is promoted as a rational response because it accepts the incapability and 
disinclination of many to be free from drugs and risk of relapse and works towards the 
more achievable goal of decreasing the adverse consequences of continued drug use.291 
This claim likely engages the understanding that mitigating drug-related harms is more 
necessary than reducing drug using. The argument is weak in terms of rebutting the 
ideological protests against harm reduction, given its self-consciousness about the 
significance of the approach while overlooking the worth of abstentionist strategies. 
Perhaps the most troublesome aspect is that the argument concentrates on a narrow 
question concerning the harmful effects of drug taking while avoiding other wider issues 
about abstinence and use prevalence reduction. The unabated drug use in the world hardly 
makes the case for surrendering from considering these issues. 
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 The existing arguments from both sides seem futilely to polarise the abstinence-
oriented and harm reduction paradigms. Countering this, the argument presented in this 
thesis is that harm reduction neither necessarily stands in marked contrast to abstinence-
based strategies nor relates to drug legalisation. Both paradigms basically function 
consistently in the direction of protecting drug users’ health and well-being, but through 
different processes. Abstinence-oriented methods involve procedures including 
detoxification, withdrawal and rehabilitation for persons searching for cessation from 
drugs or with the ability to change rapidly, while harm reduction strategies including 
MMT and NSEP commonly provide immediate and feasible ways to mitigate high-risk 
behaviours, HIV and other pathogens transmission and other drug-related harms for those 
who are unready or unable to discontinue consuming drugs. Considering the functions of 
abstinence-oriented and harm reduction interventions, they can operate together alongside 
other drug supply and demand reduction techniques to effectively tackle drug use and its 
associated harms. It is worth thinking about integrating the harm reduction and 
abstinence-based paradigms since both are clearly underlined by a shared concern to 
secure drug users’ health and well-being.  
Undeniably, abstinence is a coherent goal for drug treatment and the ultimate key 
to the elimination or reduction of drug taking and its associated harms. Sustained 
abstinence leads to betterments in drug-using individuals’ physical, psychological and 
social functioning. While arguing for the abstinence pursuit, Zelvin considers spiritual 
recovery from abstinence achievement to include: ‘not only breaking the compulsion to 
use the addictive substances in spite of adverse consequences, but along with quantifiable 
improvements in the quality of life in such areas as work, health, and interpersonal 
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relations, the recovery of hope, optimism, and self-confidence’.292 Research findings 
provide further evidence regarding an association between achieved abstinence and varied 
outcomes including greater health, social network, employment and educational 
participation and reduced engagement in excessive drinking, attempted suicide, self-harm 
and criminal behaviours including acquisitive crimes and risk of mortality.293 
Despite the range of health, legal and social benefits in attributable to enduring 
abstinence from illicit drugs, it does have limitations. An emphasis on abstinence seems 
to be inefficient for those who are indisposed, unable or otherwise lacking in motivation 
to embrace it. Numerous drug users, if not most, are equivocal about abstaining at the 
outset of treatment. Based on research findings relating to addictive behavioural changes, 
Prochaska et al. suggest large variances in substance users’ personal goals concerning 
substance use, their motivation and readiness to alter their behaviour. They contend that a 
huge majority of individuals do not seek abstinence at the precontemplation stage of drug 
treatment.294 This could be because they believe they are being subservient to the 
authorities by abstaining, they perceive negative effects from abstaining such as 
disconnection from their varied social web, they are sceptical about the benefits of a drug-
free life or they have had negative experiences in relation to drug treatment.295 Also, 
                                                          
292 E. Zelvin and D.R. Davis, "Harm Reduction and Abstinence Based Recovery: A Dialogue," Journal of 
Social Work Practice in the Addictions 1, no. 1 (2001).126. 
293 For example, N. McKeganey et al., "Abstinence and Drug Abuse Treatment: Results from the Drug 
Outcome Research in Scotland Study," Drugs: Education Prevention and Policy 13, no. 6 (2006).541; M.l. 
Dennis, M.A. Foss, and C.K. Scott, "An Eight-Year Perspective on the Relationship between the Duration 
of Abstinence and Other Aspects of Recovery," Evaluation Review 31, no. 6 (2007).605; C.K. Scott et al., 
"Surviving Drug Addiction: The Effect of Treatment and Abstinence on Mortality," American Journal of 
Public Health 101, no. 4 (2011).742. 
294 J.O. Prochaska, C.C. Diclemente, and J.C. Norcross, "In Search of How People Change," American 
Psychologist 47, no. 9 (1992).1103, 1105. 
295 A. Tatarsky, "Harm Reduction Psychotherapy: Extending the Reach of Traditional Substance Use 
Treatment," Journal of Substance Abuse Treatment 25, no. 4 (2003).250; S.H. Kellogg, "On “Gradualism” 
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many drug users are incapable of committing to stopping from using drug. The existing 
literature suggests that majority patients in drug treatment are unable to achieve or 
maintain abstinence.296 This frequently results in early dropout or discharge of drug-using 
clients from abstinence-based treatment. Similarly, abstinence-oriented treatment is often 
criticised for its high rate of relapse. Available studies revealed the low rate of sustained 
abstinence (around 25 per cent on average) over a year.297 Wodak and McLeod, on the 
drawbacks of abstinence, say: ‘Abstinence after drug dependence has been established is, 
however, inevitably precarious as relapse to drug use is an ever-present risk, especially if 
abstinence has only recently been achieved’.298 
 Therefore, the abstinence only orientation is an inappropriate treatment approach. 
It should be supported by other perspectives for handling drug use behaviour and 
reducing its associated effects and other risks including relapse. Harm reduction methods 
could assist in preserving the life, health and well-being of drug users, particularly those 
who are present unwilling or unready to quit using drugs, relapsing and out of treatment. 
This is not tantamount to softening or legalising drug using or disregarding the abstinence 
impetus. Further, abstinence is inclusive in the harm reduction paradigm given its position 
as the most effective pathway to preventing overall drug-related harms. Despite the 
objection and neutral stance of part of harm reductionists to abstinence-based ends, a 
                                                                                                                                                                             
and the Building of the Harm Reduction-Abstinence Continuum," Journal of Substance Abuse Treatment 
25, no. 4 (2003).243; Haug et al., "Relapse Prevention for Opioid Dependence."153. 
296 L.L. Judd et al., "Effective Medical Treatment of Opiate Addiction," Journal of the American Medical 
Association 280, no. 22 (1998).1937. 
297 R.A. Roffman and R.S. Stephens, "Harm Reduction and Cannabis," in Harm Reduction: Pragmatic 
Strategies for Managing High-Risk Behaviors, ed. G.A. Marlatt, M.E. Larimer, and K. Witkiewitz (New 
York: The Guildford Press, 2012).156. 




number of contemporary harm reductionists consider abstinence a desirable element of 
the hierarchy of harm reduction aims.299 
 Abstinence-oriented and harm reduction measures could hence be included as a 
series of steps under an extensive consecution of protection for drug users. Harm 
reduction strategies could form important steps in similar consecution towards drug use 
reduction, well-being improvement and cessation from drug taking, particularly for those 
who are unable, unready or resistant to quit using drugs at the beginning phase of 
treatment. It is not limited to those who consume drugs addictively and may move or 
support all drug users throughout the spectrum of steps, shifting from a low to high 
motivational state to abstain and from high-risk behaviours towards managed 
consumption and abstinence as the optimal outcome. The consecution towards 
behavioural modification and reduction of use and risk levels is commonly in agreement 
with a continuum model as espoused by scholars including Marlatt and Tapert,300 and 
Pomeroy and Steiker.301 There are also case studies in drug-free settings including the 
Alberta Alcohol and Drug Abuse Commission in Alberta302 and We Help Ourselves in 
                                                          
299 Harm Reduction International, "What is Harm Reduction? A Position Statement from Harm Reduction 
International " Harm Reduction International, http://www.ihra.net/what-is-harm-reduction. (Last visited: 
14/04/2015) 
300 G.A. Marlatt and S.F. Tapert, "Harm Reduction: Reducing the Risks of Addictive Behaviors," in 
Addictive Behaviors across the Life Span: Prevention, Treatment and Policy Issues, ed. J.S. Baer, G.A. 
Marlatt, and R.J. McMahon (California: Sage Publications, Inc., 1993).250. 
301 E.C. Pomeroy and L.H. Steiker, "Prevention and Intervention on the Care Continuum " Social Work 57, 
no. 2 (2012).103, 105. 
302 D. James, "Harm Reduction: Policy Background Paper. Prepared for the AADAC Board ", no. 2012, 6 
February (2007), http://www.albertahealthservices.ca/Researchers/if-res-policy-harm-reduction-
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Australia303 showing the practicality of combined harm reduction initiatives and 
abstinence-based treatments for managing drug dependence.  
 This integration may provide spaces for both approaches to cooperate, apply their 
strengths and minimise their weaknesses, thereby creating a viable drug use, dependency 
and relapse management system. It would also enhance the availability and accessibility 
of multifaceted services for drug-taking behavioural change, prevention, treatment and 
harm mitigation. Harm reduction measures’ welcoming ambience might increase drug 
users’ participation and length of stay in drug programmes and improve their therapeutic 
alliance with services staff.304 Most importantly, the dichotomies between abstinence and 
harm reduction paradigms could be transcended, with the protection of drug users’ health 
and welfare and their cessation of drug consumption potentially to be realised through 
this framework.  
 Arguably, the integrated harm reduction and abstinence paradigms on the 
consecution basis could be situated within both criminal justice and public health 
systems, not either one of them alone. This is basically owing to the position of drug use 
as not only a public health issue but also a criminal justice issue, with the shared concerns 
of both approaches to health impacts from drug using, as stated previously. However, it is 
pertinent to note that conflicts might arise, particularly when the criminal justice 
platforms remain inconsistent with public health strategies including the harm reduction 
approach. Nonetheless, this thesis suggests that the tensions between criminal justice and 
                                                          
303 World Health Organization (Western Pacific Region), Integration of Harm Reduction into Abstinence-
Based Therapeutic Communities : A Case Study of We Help Ourselves, Australia  (Geneva: World Health 
Organization, 2006).4–23. 
304 R. Futterman, M. Lorente, and S. Silverman, "Integrating Harm Reduction and Abstinence-Based 
Substance Abuse Treatment in the Public Sector," Substance Abuse 25, no. 1 (2004).5–7.  
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public health responses are addressable where both are given paramount focus, clear 
spheres, and reconciled accordingly. These will be further discussed in Chapters 4 and 5. 
 Summarily, the harm reduction paradigm is congruent to abstinence orientation 
adopted in drug prohibition policy. Despite dissimilar focuses, neither is totally exclusive 
or competing. They have common concerns about protecting the health and well-being of 
drug users, and thus could be united within a consecution of protection framework. Such 
integration would reinforce both capabilities to contribute benefits to individual drug 
users and wider communities. The notion of consonance and incorporative prospect 
between the harm reduction and abstinence perspectives would positively impact the 
acceptance of and support for harm reduction interventions in prohibitionist settings. 
Prohibition-oriented nations should not then sacrifice the approach in favour of 
abstinence. Specific discussion regarding whether the abstinence-oriented goal should be 
a fundamental end target or a recommendable but unnecessary aim within the drug 
treatment context is discussed in Chapter 5, Section 5.4.  
 
2.6 Consistency with the International Drug Control Conventions 
 
Intense debate pertaining to the legal implication of harm reduction approach vis-à-vis the 
international drug control treaties sparks at the international level. Yet, there has been 
relatively little discussion on the issue in Malaysian literature. However, it considerably 
impacts Malaysia and other states that have ratified and implemented drug policies 
modelled on the international instruments. The answer to the issue is unlikely to be found 
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directly in the 1961 Convention as amended by the 1972 Protocol, the 1971 Convention 
and the 1988 Convention. The possible reason for the loophole of specific guidance 
therein is that the harm reduction concept to primarily confront HIV/AIDS threats was 
unforeseeable at the time when the convention texts were drafted. Engagement with the 
issue is crucial in making a legal case for the approach. In light of this, this section would 
examine the issue with particular reference to MMT and NSEP. 
Indeed, the harm reduction approach brings a new paradigm of dealing with the 
drug problem that is significantly different from punitive methods enshrined in 
prohibition-based treaties. This seemingly causes many critics and prohibitionist national 
governments to see the approach as contravening the conventions. An example can be 
found in a statement in the Declaration of the World Forum Against Drugs in 2008: 
‘‘Harm reduction’ is too often another word for drug legalisation or other inappropriate 
relaxation efforts, a policy approach that violates the UN Conventions’.305 The criticism 
forwarded frequently relies on the interventions’ discrepancy from the law enforcement-
oriented framework underlined by the drug conventions. Consequently, the treaties arise 
as leading hurdles to state responses to mitigate the adverse consequences of drug use. 
The argument manifests the opponents’ application of strict convention interpretation, 
and constitutes another comfortable ground for the opponents’ disagreement upon the 
paradigm.  
In response, it is unquestioned that drug treaties sought to codify criminalisation 
and penal sanctions upon acts associated with illicit drugs. The conventions impose 
elemental obligation on parties to proscribe the acts including production, cultivation, 
                                                          
305 World Forum against Drugs, "Declaration of World Forum Against Drugs Stockholm Sweden, 2008" 
(paper presented at the World Forum against Drugs, Stockholm, 8-10 September 2008).para.3. 
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manufacture, export, import, distribution, trading and possession of illegal substances 
except for medical and scientific reasons.306 The signatories are also urged by the 1988 
Convention particularly to criminalise possession of controlled substances for personal 
consumption.307 However, there is no any provision in the treaties expressly blocking any 
approach to reduce drug-related harms. More importantly, there also exist important 
flexibility of interpretation and qualifications permitted under the treaties to accommodate 
harm reduction programmes. Many scholars are of identical attitude regarding these 
latitudes. Elliot et al., for instance, correctly submit that the initiatives may invoke 
‘exceptions, caveats or particular interpretations of drug treaties’.308 In similar vein, 
Bewley-Taylor and Krajewski suggest that there is interpretative leeway for states in 
adhering to their obligations under the conventions based on several factors such as 
domestically interpreting space, particular clauses and vagueness of wording plagued to 
the drug conventions.309 
The main spaces for considerable interpretation of drug treaties to permit harm 
reduction strategies are outlined here. First, the 1961 and 1971 Conventions permit the 
production, distribution or possession of controlled substances exclusively ‘for medical 
and scientific purposes’.310 The phrase ‘for medical and scientific purposes’ is left 
undefined and hence provides states with discretion in its interpretation and application. 
                                                          
306 The 1961 Convention, Article 4, 33, 35 and 36; the 1971 Convention, Articles 21 and 22; the 1988 
Convention, Article 3. 
307 The 1988 Convention, Article 3(2). 
308 R. Elliott and T. Kerr, "Harm Reduction, HIV/AIDS and the Human Rights Challenge to Global Drug 
Control Policy," Health and Human Rights 8, no. 2 (2005).114. 
309 D. Bewley-Taylor and M. Jelsma, "The UN Drug Control Conventions: The Limits of Latitude," 
Transnational Institute (TNI) & International Drug Policy Consortium (IDPC), 
http://www.undrugcontrol.info/images/stories/documents/dlr18.pdf.47–48 (Last visited: 20/12/2012); K. 
Krajewski, "How Flexible are the United Nations Drug Conventions?," International Journal of Drug 
Policy 10, no. 4 (1999).330–31. 
310 The 1961 Convention, Article 4(c); the 1971 Convention, Articles 5 and 7.  
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Thus, the phrase could be inclusively construed to allow the provision of methadone for 
reducing opiate using and its risks. 
Second, it can be understood from the conventions that parties enjoy freedom to 
determine the practicable measures for prevention of use of illicit drugs, treatment, 
education, aftercare, rehabilitation and social integration they are warranted to take.311 
This is because the treaties do not particularise what constitutes the measures. Harm 
reduction strategies are feasibly encompassed under the practicable measures facet. NSEP 
is to decrease risky behaviours among IDUs and to limit HIV/AIDS and other blood-
borne pathogens transmission; hence is permissible under the conventions. Despite the 
advice of Resolution II of the UN Conference for the Adoption of the 1961 Single 
Convention for drug-free treatment, it does not forbid states to implement other types of 
treatment or ‘practicable measures’ as provided in the conventions. Further, while drug-
free treatment is considered as the often quoted and used treatment for drug dependency, 
the Commentary to the 1988 Convention also expressly recognises pharmacological 
treatments including MMT.312 MMT is also included under treatment in other treaty 
commentaries.313 
Third, it seems evident that all treaties leave countries with the autonomy to 
provide the abovementioned practicable measures for drug use to substitute or 
supplement the criminal sanctions for offences of a minor nature committed by drug 
                                                          
311 The 1961 Convention, Article 38; the 1971 Convention, Article 20. 
312 United Nations, Commentary on the United Nations Convention Against Illicit Traffic in Narcotic Drugs 
and Psychotropic Substances 1988, Done at Vienna on 20 December 1988, E/CN.7/590 (New York: United 
Nations, 1998).109. 
313 Commentary on the Convention on Psychotropic Substances, Done at Vienna on 21 February 1971, 
E/CN.7/589 (New York: United Nations, 1976).332; Commentary on the Protocol Amending the Single 
Convention on Narcotic Drugs, 1961, Done at Geneva on 25 March 1972, E/CN.7/588 (New York: United 
Nations, 1976).84.  
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users.314 Consequently, even personal consumption and drug possession for use are 
criminalised, MMT and NSEP that operate to ensure health, care and support for drug 
users can be legally implemented either as addition or alternative to punishments for the 
offences.  
Fourth, signatories are granted leeway in medically prescribing controlled drugs if 
they consider that the prescription is necessary or desirable and not contradictory to the 
general purposes of the convention. However, some regulations including with regard to 
medical prescriptions, record keeping and other controlling methods should be complied 
with.315 States are therefore exempted from prohibition of supply and distribution of any 
controlled drugs including methadone listed in Schedule 1 when it is deemed necessary or 
desirable along with specified safeguards in their national law. 
Fifth, the parties’ duty for criminalising drug possession for personal consumption 
under the 1988 Convention connects to the prohibition of drug consumption in both prior 
conventions.316 Arguably, the successor convention has no backward effect of 
criminalising drug consumption as some believe.317 As much literature and this analysis 
find, states still sustain their discretion to make drug use a criminal offence in accordance 
with the 1961 and the 1971 Conventions.318 Arguably, this is significant to avoid the 
criminal justice approach for minor drug offences to be inappropriately employed under 
national laws. Therefore, adopting techniques including MMT and NSEP alternative to 
                                                          
314 The 1961 Convention, Article 36(1)(b); the 1971 Convention, Article 22(1)(b); the 1988 Convention, 
Article 3(4)(b).  
315 The 1961 Convention, Article 30.  
316 The 1988 Convention, Article 3(2). 
317 D.R. Bewley-Taylor and C.S. Fazey, "The Mechanics and Dynamics of the UN System for International 
Drug Control,"  www.forward-thinking-on-drugs.org/reviewl-print.html.15. 
318 For example, Elliott and Kerr, "Harm Reduction, HIV/AIDS and the Human Rights Challenge to Global 
Drug Control Policy."114. 
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criminal measures falls within the treaties’ flexibility. This elasticity is further supported 
by the understanding of the 1988 Convention provision that the criminalisation of 
personal consumption is not required if it breaches the state constitution and fundamental 
legal principles.319 
Clearly, drug conventions contain leeway that concedes sufficient legal room for 
harm reduction strategies. The international documents could be construed so as to 
authorise engagement with the measures. MMT and NSEP practices are hence legitimate 
within the convention framework parameters. 
This thesis’s point regarding consistency is generally in line with that of the Legal 
Affairs Section (LAS) of the then UN International Drug Control Programme (UNDCP). 
In its 2002 legal opinion commissioned by the International Narcotics Control Board 
(INCB), it makes clear the view that almost all harm reduction interventions including 
MMT and NSEP are congruous with the terms of the drug treaties.320 In contrast to the 
conclusive remark on legality under treaties which this thesis makes, the legal opinion 
subject it to the specific qualities and implications of each harm reduction measure at the 
national level.321 Implicit in this is the conditionality of the strategies’ permissibility 
within the conventions upon domestic operations. Such partial legitimacy is less 
compelling as it might not absolutely support the approaches and might make individual 
domestic service require a separate legal case. 
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Furthermore, it is significant to acknowledge that there are international 
declarations and resolutions seemingly providing milestones for harm reduction practices. 
The Declaration on the Guiding Principles of Drug Demand Reduction of the UN General 
Assembly Special Session in 1998 states: ‘Demand reduction shall (i) Aim at preventing 
the use of drugs and at reducing the adverse consequences of drug abuse’.322 A similar 
kind of commitment is subsequently documented in the Action Plan supplementing the 
Declaration,323 the other UN General Assembly (GA) and the Commission on Narcotic 
Drugs (CND) resolutions.324 While the political declarations and resolutions likely denote 
collective undertaking towards the harm reduction paradigm at the international level, this 
thesis posits that they could not concretely underlie legal mandate for the measures, as 
contended by some including the Legal Affairs Section (LAS) regarding the 1998 
Declaration.325 
There are several factors that apply here. In particular, the majority of declarations 
and resolutions do not employ the term ‘harm reduction’. Coverage of the approach under 
the terms used is hence exposed to varied perspectives. Additionally, they are non-
binding soft laws. Thus, they could not become the main basis, constituting only 
supplementary support for the legally binding treaties that justify harm reduction. Finally, 
they may not be deemed representative of the whole voice of the international community 
on harm reduction, given the constantly unfixed and splintered consensus under the UN 
                                                          
322 United Nations Special Session of the General Assembly Devoted to Countering the World Drug 
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system. As evidence, the explicit term ‘harm reduction’ is still confounded in the 
Commission on Narcotic Drugs (CND) resolutions, and political strife occurs over the 
strategies within the new 2009 Declaration and Action Plan.326 The USA, some other 
prohibitionist states and UN bodies also move on the track of sluggish support for the 
approach. Particularly, the International Narcotics Control Board (INCB);327 the strong 
bulwark of prohibition-based UN regime, has never publicly endorsed the measures and 
the legal analysis of the Legal Affairs Section (LAS). Though agreeing on the approach’s 
consistency with the conventions in its 2003 annual report,328 the International Narcotics 
Control Board (INCB) also still casts doubt on the interventions through its precarious 
interpretation of conventions, unsubstantiated alarm about their negative potential and 
calls for its strict operation.329 
Considering the ongoing tension, it is reasonable to expect that there are more 
practicable ways to enable harm reduction interventions than merely basing them on 
interpretative leeway within drug treaties. Elliot and colleagues encourage signatories to 
form a coalition to jointly announce their interpretation of the approach’s legality and 
their partially opting out of the UN regime. These, as commentators believe, are more 
feasible alternatives than making amendments to drug conventions or building a new 
treaty on harm reduction that is politically arduous, costly and time-consuming.330 While 
this thesis accepts the possibility of state withdrawal from treaties, either single or 
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collective, based on the rebus sic stantibus principle relative to the drug problem 
metamorphose, this thesis could not agree more on its viability. States’ exercise of 
doctrine has shortcomings, given its potential impact upon treaties’ validity.331 It may 
cause the conventions to lose their binding effect upon the signatories. This could 
eventually undermine the convention regime’s solidity. Therefore, revision and 
amendment of the conventions, despite the potential challenges, seems more legitimate 
and beneficial for ensuring the clarity and sustainability of harm reduction under the 
treaties. Moreover, the measures deserve clearer and stronger basis under the treaties, 
than merely to act, borrowing the words of Bewley-Taylor ‘…through glitches in the 
software’ in the treaties which hardwire the zero-tolerance332.333 The suggestion is 
parallel to the proposals of many that drug treaties should be revised in order to resolve 
tensions about their terms of unclear meanings and outdated provisions.334 
In short, the discussion in this section puts forward a legal argument for harm 
reduction operations within the confines of drug conventions. It is evident that the 
international documents do not wholly resist MMT and NSEP programmes but instead 
allow their implementation at state levels, including within Malaysia. This thesis 
advocates the amendment of treaties to explicitly sanction the measures given the 
fractured international and domestic political consensus regarding how the interventions 
                                                          
331 D.R. Bewley-Taylor, "Challenging the UN Drug Control Conventions: Problems and Possibilities," 
International Journal of Drug Policy 14, no. 2 (2003).177. 
332 The international drug treaties need to be amended to explicitly legalise harm reduction interventions. 
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tolerance policy but not for the harm reduction approach. 
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334 For example, K. Malinowska-Sempruch, J. Hoover, and A. Alexandrova, Unintended Consequences: 
Drug Policies Fuel the HIV Epidemic in Russia and Ukraine. A Policy Report Prepared for the UN 
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are compatible with the conventions. By embedding this explicit legalising provision, 




The oppositions to the harm reduction approach, influenced by a deontological stance or 
strict prohibitionist ideological belief, are weakened by the approach’s ethical and 
theoretical imperatives as explained in this chapter. The harm reduction response is 
ethically justifiable mainly on the basis of public health, satisfying the components of the 
prevention of diseases and health risks under the traditional public health framework and 
the health promotion under the new public health framework. It also complies with the 
utilitarian analysis for its efficacy in attaining good for both individuals and entire 
communities. These theoretical bases are further reinforced and counterbalanced by the 
approach’s importance for the protection of human rights of health and freedom from 
inhumane and degrading treatment. Moreover, MMT and NSEP are permissible within 
the Islamic values, respectively falling under ‘hajiyyat’ principle and the notions of 
‘darurah’ and ‘al-∂arar al-ashadd yuzalu bi’l-∂arar al-akhaff’. Additionally, the 
validation of harm reduction is extended by its congeniality with abstinence-oriented 
paradigm within drug prohibition policy due to the shared concern for the protection of 
drug users’ health and wellbeing. Further, the harm reduction approach is in harmony 
with the international drug control conventions.  
122 
 
Together, these positions entail strong philosophical justification of the harm 
reduction approach and measures in Malaysia and across the globe. The justifiability can 
be further strengthened in several ways including making the ethical and theoretical 
foundations for harm reduction clear in drug discourse; integrating the approach with 
abstinence-oriented paradigm within a consecution of protection under a broader drug 
prohibition framework; and amending the international drug treaties to explicitly endorse 
it. 
However, the scientific-based lens of harm reduction approach should not be 
discounted as they have the potential not only to cripple consequentialist-based attacks 
against it but also to supplement theoretical justifications in providing powerful 








THE EFFECTIVENESS AND COST-EFFECTIVENESS OF HARM REDUCTION 





The harm reduction approach is adopted in Malaysia to control drug use and HIV 
transmission. Controversy has erupted on the main issue of whether harm reduction 
strategies are effective and cost-effective in achieving the outcomes. This chapter seeks to 
determine the effectiveness and cost-effectiveness of MMT and NSEP with regards to 
drug use and HIV-related implications, and their scientific evidence from Malaysia and 
international sources. Consideration is also given to efficacy and economic efficiency in 
relation to HCV disease control, given its prevalence among drug users. Focus will be 
given to the most common effects relevant to harm reduction approach effectiveness; 
namely, reduction of HIV and HCV virus transmission, decrease of drug use, cost-
efficacy for drug consumption, HIV and HCV prevention, absence of symbolism for drug 
use encouragement, and absence of negative consequences diminishing the public 
amenity. The discussion in this chapter is important to provide further justification for 




3.2 Effectiveness in Reducing HIV and HCV Transmission 
 
As highlighted in the previous chapters, the primary rationale underpinning the adoption 
of harm reduction measures in Malaysia is to contain HIV transmission among drug 
users. The issue that arises is whether MMT and NSEP are actually efficacious in 
decreasing HIV infection and prevalence. Accordingly, this section attempts to address 
this issue along with related evidence. Consideration is also given to the issue of whether 
the interventions could effectively contribute towards halting other blood-borne viruses. 
The available literature deals more with the measures’ effectiveness with regards to the 
HCV virus and is therefore focused upon in this discussion.  
 Notably, MMT and NSEP are considered important strategies when seeking to 
restrain HIV spread through syringe use, by providing substitute drugs and adequate 
sterile syringes to drug users. The underlying prediction is that, as a consequence, drug 
users will no longer take part in syringe-related HIV risk behaviours including sharing, 
lending, borrowing and reusing of syringes and needles, thereby avoiding HIV infection.  
 An impressive volume of studies from many jurisdictions, including Malaysia, 
contain evidence regarding the actual efficacy of MMT and NSEP for risk behaviours. 
There is research available that has discovered the relationship between MMT attendance 
and reduced HIV vulnerability.335 Findings are also documented by a meta-analysis of 
                                                          
335 For example, K. Wong et al., "Adherence to Methadone is Associated with a Lower Level of HIV-
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multiple studies in Asia, Europe and North America.336 Although it is remarkable that 
vast studies from various jurisdictions reveal similar findings on the beneficial impact of 
MMT on risk behaviours, opponents still invoke negative or neutral research results to 
propose a contradictory outcome. A study in a Malaysian hospital found that most of the 
subjects continued with HIV risk behaviours despite their MMT use.337 A study by Van 
Ameijden et al. in Amsterdam found negative or no benefit of ‘low threshold’ MMT in 
mitigating risk behaviours.338 Some research has reported no difference between 
attendees, post-attendees and non-attendees of MMT programmes in needle-borrowing 
and lending.339 Arguably, these negative or mixed findings are limited exceptional cases 
that are insufficient to exclude conclusive evidence on MMT efficacy from larger positive 
empirical data sources. 
 Further, the outcome of risk behaviour reduction is achievable via NSEP use. 
Theoretically, NSEP may affect diminution in patterns and time of syringe circulation. 
This is accomplished by adding more new syringes per IDU over a particular time period 
and increasing the volume of syringes evacuated from circulation through exchanging 
practice. Thus, the time for risk behaviours, including contaminated syringe sharing and 
reusing and the presence of used injection items in public settings, are possibly lessened, 
thereby decreasing HIV spread. The theoretical causality is confirmed by practical data in 
Malaysia and other countries regarding NSEP effectiveness. Numerous studies 
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demonstrate the decrease of self-reported risky behaviours among NSEP clients.340 The 
WHO comprehensive assessment discovers ‘detectable impact (of Malaysian NSEP) on 
reducing needle and syringe sharing among PWUD (IDUs)’.341 The WHO review of 
NSEP found convincing evidence for the protective effect of NSEP against drug-related 
risks. The review found that most (23) of the 29 studies located showed results 
confirming the NSEP efficacy. There was only one piece of research finding negative 
outcomes and five studies reporting no effect.342 All evidence strongly shows the NSEP’s 
outcome to lower HIV risk behaviours.  
Despite evidence of the benefits of NSEP, there is much criticism of it which 
arises from the negative or mixed research findings. For example, the studies by 
Valenciano et al. and Hope et al. reveal the association of NSEP use to high risk 
behaviours.343 Some others discover no significant difference between NSEP attendance 
and non-attendance in the frequency of needle-sharing.344 Within this thesis it is argued 
that these data sources are inconclusively used to point towards NSEP inefficacy and  
give less consideration to the other potential factors affecting HIV risk behaviours such as 
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homelessness and depression symptoms.345 Braine et al. noted that the attributes of NSEP 
clients and environmental factors should be considered in analysing the subsisting risk 
behaviours.346 Therefore, the argument for NSEP influence on increased risk behaviours 
is unpersuasive. 
 Additionally, some critics raise the methodological issue of self-reporting. They 
question the accuracy of self-reported data about risk behaviours.347 As contended, self-
reporting potentially results in social desirability, recall or observational bias that affects 
the accuracy of derived data. Accepting this argument means evidence for risk behaviours 
reducing efficacy have less strength as they mostly come from studies relying on self-
reported data. However, the claim has less merit when considering the sufficient validity 
and reliability of self-reporting achieved in most research involving using drugs and risk 
behaviours.348 Further, the self-reported behaviour change could be considerably verified 
by options including comparing HIV seropositivity rates among IDUs obtaining supplied 
injection items and those who do not,349 conducting computer-assisted self interviews350 
and corroborated urinalysis.351 Thus, the data derived from self-reporting, with or without 
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verification, is valid and reliable enough to show the efficacy of harm reduction 
interventions for reducing HIV risk behaviours.  
Drawing on evidence regarding MMT and NSEP outcomes of decreased drug-
related risk behaviours, it seems plausible to claim their potential to decrease the rate of 
HIV seroconversion and prevalence. However, opponents argue that the modest risk 
behavioural change, if any, would not necessarily effectuate into actual reduced HIV 
infection. As a response to this, there is evidence that sufficiently demonstrates the 
contrary. The studies in Malaysia and other countries evaluate the impact of MMT on 
HIV prevention and have found a positive association between the programme admission 
and decreased HIV infection.352 The results of a study in Tampin Health Clinic, Malaysia, 
demonstrate that none of the 143 subjects were infected with HIV during the course of the 
study from November 2006 to March 2009.353 The findings are further confirmed by 
international research, including by Metzger et al. recording a high difference in HIV 
seroconversion levels between those continuing with MMT compared to those not 
receiving MMT.354 
Moreover, the intervention can significantly affect HIV prevalence in many 
settings. Indeed, in the WHO collaborative study using longitudinal cohort design, the 
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term, Socially Rehabilitated Methadone Maintenance Patients," Archives of Internal Medicine 150, no. 1 
(1990).97–98; D.S. Metzger and H. Navaline, "Human Immunodeficiency Virus Prevention and the 
Potential of Drug Abuse Treatment," Clinical Infectious Diseases 37, no. Suppl 5 (2003).S454; M.N. 
Mohamed and M.D. Kasa, "Research Report. Drug Substitution Therapy: Success and Limitations of the 
Methadone and Buphrenorphine Maintenance Programs," (Sintok, Malaysia: Universiti Utara Malaysia, 
2006).54. 
353 A. Norsiah et al., "Can Primary Care Clinic Run MMT Service Well?," Malaysian Family Physician 5, 
no. 1 (2010).21. 
354 D.S. Metzger et al., "Human Immunodeficiency Virus Seroconversion among Intravenous Drug Users 
In- and Out-of-Treatment: An 18-Month Prospective Follow-Up," Journal of Acquired Immune Deficiency 
Syndrome 6, no. 9 (1993).1054. 
129 
 
data from opiate substitution treatment programmes, principally MMT, in selected 
developing countries (China, Indonesia, Thailand, Lithuania, Poland, Ukraine, Iran and 
Australia) indicates the protective effect of the substitution treatment in decreasing HIV 
prevalence. The rate of HIV prevalence reduced significantly in almost all the studied 
countries that provide the service. The report concludes that such positive implication 
achieved in high-resource countries could also be gained in countries with fewer 
resources.355 Many systematic reviews of studies confirm this effectiveness.356 All 
positive findings constitute strong data on the impact of MMT on the decrease of HIV 
infection and prevalence.  
Despite the evidence, the opposition to MMT efficacy is based on a few study 
results showing less favourable outcomes of MMT on HIV seroconversion. The studies 
involved cocaine and heroin injectors357 and ‘low threshold’ MMT.358 This outcome is 
unsurprising considering the absence of any pharmacotherapeutic treatment for cocaine. 
The few negative findings should also not be interpreted as overall inefficacy of MMT in 
HIV prevention as it is outweighed by the amount of research with positive results. 
Rather, the findings can be treated as a factor to ameliorate the service’s quality and 
intensity. This may cover incorporating MMT with psychosocial facilities including 
healthcare and rehabilitation, ensuring longer retention in treatment and dispensing of a 
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sufficient dosage of methadone. Such comprehensive strategies would increase MMT’s 
benefits in halting adverse consequences including HIV infection from consumption of 
drugs including cocaine.359 
Further, despite the limited findings in Malaysia, a handful of international studies 
using diverse research designs indicate that participation in NSEP is substantially 
associated with decreased HIV infection.360 By contrast, the lack of NSEPs may have 
resulted in the growth of HIV incidence, as suggested by high seroconversion levels 
observed in Pakistan and the USA.361 This data concerning the reversed situation supports 
the consistency of efficacy arguments. The accumulated evidence strongly indicates the 
NSEP’s protective effects against HIV seroconversion. 
Additionally, there are studies that provide compelling evidence on this 
intervention’s efficacy in reducing HIV prevalence. For instance, Hurley et al. conduct a 
large ecological analysis of HIV rates and NSEP use, comparing 81 cities across Asia, 
Europe, North America, South America and the South Pacific. 52 cities without NSEP 
had a mean annual growth of 5.9 per cent in HIV prevalence, compared to a mean annual 
fall of 5.8 per cent for 29 cities with NSEPs.362 More recently, the study of McDonald et 
al. involving 99 cities discloses the difference in HIV prevalence rates in cities with and 
without NSEPs; there was a decline of 18.6 per cent and an increase of 8.1 per cent 
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respectively.363 The results lend strong support to the argument that NSEP is effective in 
minimising HIV prevalence. The capability of NSEP as part of a comprehensive set of 
measures to decrease HIV prevalence also extends to settings where HIV is already 
developed, including New York City.364 The outcome of NSEP on HIV infection and 
prevalence is consistently supported by comprehensive reviews.365 
On the contrary, several studies did not discover the effect of NSEP attendance 
against HIV seroconversion. Higher levels of HIV infection substantially connected to 
NSEP access are observed by prospective cohort research in Montreal and Vancouver.366 
Additionally, Strathdee et al. research reported the outburst of HIV prevalence subsequent 
to the five-year operation of vast NSEPs in Vancouver.367 Consistent with the above 
findings, the results of some studies in Amsterdam indicate no significant link between 
the presence of NSEPs and decrease in HIV incidence.368 These findings are deduced by 
opponents to attribute the greater HIV incidents to NSEP presence.  
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As Strathdee et al. suggest, the negative result is considerably affected by the 
insufficiency of NSEP on its own as a HIV prevention tool.369 Despite the coherent 
argument given the complexity of HIV transmission, this thesis argues that stronger 
explanation considering selection bias could be provided for mixed or negative results of 
research that compare NSEP clients and non-clients. The NSEPs attracted IDUs who 
were significantly associated with higher risk activities, than non-attendees.370 This 
position is supported by studies and commentaries.371 Further, there is the possibility of 
the dilution factor. The Dutch, Canadian and UK studies with counterintuitive results 
were carried out in settings where lesser risk IDUs might have obtained syringes from 
alternative sources such as pharmacies, giving NSEP access to relatively individuals of 
greater risk of HIV seroconversion. This confounded the findings.372 All these arguments 
could give potential explanations for the discouraging data. 
 By taking into account the high efficacy of MMT and NSEP for the most 
dangerous virus of HIV, it is likely tenable to claim their potential for HCV, another 
blood-borne pathogen. Some scholars including Bastosa argue for the efficacy of 
interventions to decrease HCV seroconversion rates among IDUs.373 The argument is 
backed up by research findings in Malaysia and other countries. For instance, the research 
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conducted by Norsiah et al. involving the MMT at Tampin Health Clinic, Malaysia, found 
only one new case of HCV infection among 143 subjects during the study period.374 The 
positive research finding has also been documented in Tacoma and New York, showing a 
dramatic decline in HCV acquirement connected to the participation in NSEPs.375 
 The detected reduction, however, is unlikely to provide strong evidence for harm 
reduction measures to halt HCV transmission, considering the persistent very high HCV 
prevalence and incidence among IDUs across jurisdictions. A review of literatures found 
that HCV prevalence ranged from 65 to 80 per cent in almost all IDU populations in 
European nations.376 This confirms the high prevalence in Europe shown by prior 
reviews.377 The prevalence of high levels of HCV is also reported in non-European 
countries, accounting to more than 50 per cent.378 Furthermore, IDU populations show 
high incident rates of HCV despite the presence of MMT and NSEP. A study in Australia 
discovered large HCV incidence among MMT clients who were HCV-seronegative at 
baseline and the similarity of incidence levels between participants in the service and 
those not participating.379 The same finding of high HCV incidence is documented by 
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other research.380 This practical data confirms the results of studies using epidemiological 
and analytical models showing how the measures have little efficacy for HCV when 
compared to HIV.381 This makes the argument for their protective effect on the HCV 
virus less compelling.  
Clearly, important evidence from epidemiological and practical data, mostly from 
outside Malaysia, invites the consideration that MMT and NSEP have significantly fewer 
protective benefits in controlling HCV incidence and prevalence than HIV within drug-
using populations. The lower effectiveness is possibly attributable to HCV already being 
widespread prior to the initiation of such programmes.382 Additionally, HCV is more 
easily transmitted than HIV, given greater parenteral infectivity.383 It can readily spread 
even through the sharing of drug paraphernalia such as filters and cookers. The infectious 
disease has no effective antiserum and may not be sufficiently controlled by MMT, 
NSEP, detoxification drug treatment or educational programmes alone without other 
measures. This is because, as Pollack claims, the effective prevention for HCV is 
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conditional on more extensive behavioural changes, including the frequency of drug 
injecting and needle sharing, than merely using sterile injection equipment.384 
 Therefore, this inefficacy should not be considered as harm reduction failure. 
Rather, MMT and NSEP must be regarded as key components of more extensive public 
health programmes to prevent or decrease drug taking and blood-borne epidemics. The 
consolidation of various strategies including education, drug treatment, HCV treatment, 
MMT, NSEP and the provision of sterile injection items including filters can confer 
benefit in reducing the incidence, frequency, duration and infectivity of drug injecting, 
thereby somewhat curbing HCV transmission.385 
Overall, there is little doubt that MMT and NSEP do mitigate HIV risk 
behaviours, incidence and prevalence. Drawing on that point, this thesis contends that the 
availability of such strategies possibly constitutes the main factor in the gradually 
declining trend of new HIV infection cases among IDUs in Malaysia in recent years. The 
cases fell from between 70 to 80 per cent of overall cases in the 1990s to 39 per cent by 
2011.386 This achievement rebuts Shan’s presumption in 2008 that the HIV rate in 
Malaysia would not decrease in the following three years despite harm reduction 
services.387 Malaysia’s successful attainment in HIV prevention is endorsed by 
international bodies including the Joint United Nations Programme on HIV and AIDS 
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(hereinafter referred as UNAIDS) and WHO.388 Thus, the hypothesis that both services 
do not contribute to halting HIV is invalid. The outcome is unaffected by negative 
empirical data as there is a compelling expounding explanation for them. Supporting 
evidence regarding this efficacy absolutely exceeds the contradicting evidence. However, 
the interventions cannot effectively contribute to a reduction in the spread of HCV. The 
effectiveness of the interventions for reducing drug taking and blood-borne viruses may 
be further increased by multi-integrated strategies. Additionally, considering scant local 
empirical results, the effectiveness of harm reduction interventions, particularly with 
respect to HCV prevention, warrants further research. 
 
3.3 Effectiveness in Decreasing Drug Use 
 
In addition to the control of blood-borne disease transmission, harm reduction measures 
are regarded critical to reducing drug use. The issue exists whether MMT and NSEP are 
effectual in attaining this outcome. This section will give an account of this issue and 
present related evidence.  
Methadone has been included in the WHO list of essential medicines since 2004. 
It is important in the management of opiate dependency. It can inhibit withdrawal 
symptoms and block heroin and other opiate euphoric effects. It is also clinically proven 
to abolish cravings from opiates which is a factor in continuous opiate consumption. The 
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pharmacological effects of methadone potentially influence the reduction of opiate use, as 
documented by many health scholars.389 Notably, methadone also has the potential to 
mitigate drug injecting as it can be dispensed orally.  
NSEP could further contribute to lessened drug use through its possible role as a 
gateway to other harm reduction, drug treatment and health-care services. Its contact with 
the commonly hidden drug-using population with limited or no access to the services may 
enable their referral to the programme. This may lead them to decrease or cease drug 
taking and thereby improve their health. The NSEP’s potentiality as a referral point is 
confirmed by multiple international research results. It has been found that substantial 
numbers of drug users seek treatment as a result of their participation in NSEP.390 The 
WHO’s policy brief also equates the rising enrolment of drug using individuals in drug 
treatment and health-care initiatives with the NSEPs.391 Arguably, the NSEP’s 
contribution towards decreased drug taking is conditional upon the referral of its clients to 
other services. The unusual or limited practice of referral, as occurs in Malaysia, would 
make the objection to NSEP difficult to be abated.392 To address this, this thesis argues  
that establishing a linkage between NSEP and other services is essential. 
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Despite the overwhelming support of such benefits, there appear to be attacks 
from the opponents of harm reduction in Malaysia and other settings regarding the actual 
effectiveness of the approach in reducing drug taking. The condemnation specifically 
points towards MMT by arguing that it merely replaces dependence on one drug with 
another. PENGASIH Malaysia393 highlights in its official website that ‘Through MMT, 
addiction problem will subsist and the change merely relates to the type of addiction […] 
we cannot extinguish fire with fire […] Methadone will make drug users continuously be 
trapped in drug addicting’.394 The belief behind this argument is that MMT dispenses a 
substitute drug which the client becomes dependent upon. The service is not classed as 
useful for the opponent that upholds the moral model on the grounds that it is a sanction 
for the continuance of drug consuming. For those who subscribe to disease model, it is a 
strategy that effectuates perpetuating reliance on drugs. Their deontological attitude 
against MMT stems from the belief that abstinence is the single admissible method of 
arresting drug dependency. 
Responding to the criticism, there is the tendency of many harm reductionists to 
utilise a pragmatic utilitarian explanation by contending MMT’s benefits to outweigh its 
costs. The example can be seen through the expression of Crofts et al.: ‘Substitution 
programs (including MMT) do not ‘cure’ the addiction, but they allow IDUs to escape the 
criminal world of illegal drugs into a more socially acceptable environment, and have 
                                                          
393 PENGASIH Malaysia is one of the NGOs offering voluntary abstinence-based treatment to drug users. 
394 This is a translation from the original PENGASIH statement written in the Malaysian language. 
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been demonstrated to decrease HIV transmission among IDUs’.395 In other words, this 
type of response holds that even if there are risks accompanied with MMT, the strategy is 
still justifiable as long as it contributes to decreased drug-related harms. Some others (for 
example, Noor Zurani et al. and McLellan et al.) analogise MMT for heroin dependence 
as medications in constant care of chronic disorders such as hypertension and diabetes 
that cannot be fully treated but where resulting harms may be reduced.396 This perspective 
manifests the reliance of commentators to the original philosophy of long-term 
methadone maintenance to stabilise opiate dependence as a ‘metabolic deficiency’, as 
promoted by Dole and Nyswander. 
Both types of arguments cannot sufficiently rebut the opponents’ argument deeply 
rooted in ideological fixation on abstinence from drug use. These arguments may result in 
the perception that instead of a drug treatment, MMT is simply a mean for controlling 
drug consuming behaviour. The proponents of harm reduction neglect the main issue 
regarding abstinence attainment. Arguably, it is more prudent to defend MMT on its role 
as part of a continuing framework of protection for managing drug dependency. (This has 
previously been discussed in Chapter 2, Section 2.5.) It is worthwhile repeating that 
MMT can play a key role in mitigating drug-related harms and preparing unable or 
unready drug users for an abstinence-based process of staying off drugs. Methadone is 
also mistakenly classified as a substitute for other drugs. At an appropriate dose, 
methadone stabilises and normalises drug users’ functioning and wellbeing and is not 
intoxicating. This pharmacology distinguishes it from other opiates and may result in a 
                                                          
395 N. Crofts, G. Costigan, and G. Reid, eds., Manual for Reducing Drug Related Harm in Asia  
(Melbourne: The Centre for Harm Reduction, 2003).B1.9. 
396 Noor Zurani et al., "Heroin Addiction: The Past and Future."4; A.T. McLellan et al., "Drug Dependence, 
a Chronic Medical Illness: Implications for Treatment, Insurance and Outcomes Evaluation," Journal of the 
American Medical Association 284, no. 13 (2000).1693–94. 
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reduction in opiate consumption. Much local and international evidence confirms that the 
MMT’s benefit of ensuring the stability and wellbeing of its clients is not only theoretical 
but real.397 
Additionally, numerous opponents frequently cite concerns that harm reduction 
measures may result in increased drug consumption while not effectively stopping the 
behaviour. Mohamed, for instance, claims that though Malaysian NSEP is effective in 
reducing HIV spread, it is incapable of mitigating drug use.398 This perspective reflects 
that of NADA in its policy to reject involvement in the NSEP programme even though it 
is the main public body entrusted to handle drug issues in the country.399 The constant 
fear of critics is the potential increase of drug taking among drug users. Also, there are 
concerns that methadone may be used by drug users to supplement other drugs they have 
procured such as heroin or given away or sold on to other users to finance their habit of 
illicit drug taking. Central to these concerns is that harm reduction interventions tolerate 
and make room for drug using behaviour, due to their sole focus on the mitigation of 
drug-related harms. The provision of methadone and drug paraphernalia is seen as a 
facilitation of persistent drug taking and consequently impact the growth of its 
prevalence. 
                                                          
397 For example, A.H. Ghodse, F.J. Creighton, and A.V. Bhatt, "Comparison of Oral Preparations of Heroin 
and Methadone to Stabilise Opiate Misusers as Inpatients," British Medical Journal 300, no. 6726 
(1990).720; A.H.M. Hussin et al., "Kajian Amalan Terbaik Program Rawatan dan Pemulihan dalam 
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Kebangsaan, 2011).106. 
398 M.N. Mohamed, "Penyalahgunaan Bahan di Malaysia: Trend Kini dan Cabaran Masa Depan [Substance 
Abuse in Malaysia: The Recent Trend and Future Challenge]," in Mengenali Dadah: Rawatan, Pencegahan 
dan Undang-Undang [Knowing Drug: Treatment, Rehabilitation and Law], ed. M.N. Mohamed (Putrajaya, 
Malaysia: Agensi Antidadah Kebangsaan, 2009).12. 
399 Perubahan dalam Senario Rawatan dan Pemulihan Dadah: Cabaran dalam Pengurusan Pemulihan 
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The opponents’ claim is problematic and has some drawbacks. While most of 
them do not provide supporting evidence for their claim, some point to inconclusive 
statistical data pertaining to high drug use prevalence in certain countries despite the 
approach’s practice for many years.400 The data is not accompanied with coherent 
statistical analysis that considers other potential factors leading to increasing or 
unchanging drug prevalence or that shows a causal relationship between the harm 
reduction approach and prevalence. Moreover, there is no fair comparative analysis with 
the condition in which the harm reduction approach is absent, whether the prevalence will 
be lower or otherwise. Thus, the contention is unreliable due to deficient evidence. 
Furthermore, there exists a handful of scientific evidence that challenges the 
opponents’ contention. Research findings suggest that harm reduction initiatives result in 
a significant decrease in drug use. This indicates that the theory of reduced drug use 
readily translates into actual impact. The research findings in Malaysia demonstrate no 
rise in the quantity of opiate users but, in contrast, a persistent drop is recorded.401 The 
pilot MMT programmes in some cities indicate a fall in persistent opiate use among 
clients from 45 per cent at baseline to 10.7 per cent at 6 months. This finding is supported 
by other empirical data on reduced drug use among MMT clients.402 Similarly, the bulk 
of international assessments found MMT’s effectiveness in mitigating opiate 
consumption was relatively higher than other types of drug treatment such as 
                                                          
400 For example, N. McKeganey, "The Lure and the Loss of Harm Reduction in UK Drug Policy and 
Practice," Addiction Research & Theory 14, no. 6 (2006).563,565–66, 568–69; Controversies in Drugs 
Policy and Practice.38–41. 
401 For example, Shan, "Report on An Interim Review and A Gap Analysis of the Harm Reduction 
Programme in Malaysia."50. 
402 For example, R. Musa, A.Z.A. Bakar, and U. Ali Khan, "Two-Year Outcomes of Methadone 
Maintenance Therapy at a Clinic in Malaysia," Asia-Pacific Journal of Public Health XX no. X (2011).3–5. 
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detoxification and drug-free treatment.403 A study by Vaillant suggests that MMT 
significantly mitigates heroin taking. The data indicates a higher percentage of one-year 
abstinence among MMT clients when compared with other heroin dependents in 
detoxification programmes either in hospital or short-period imprisonment. It has been 
documented that 67 per cent of 15 heroin dependents in MMT sustained the abstinence 
while only 3 per cent of 361 dependents in hospital and 363 in short imprisonments 
became abstinent from heroin without MMT.404 
Many international studies have also discovered a reduction in or stability of drug 
using through injecting among NSEP clients.405 The findings are supported by 
comprehensive reviews by scholars including Wodak and Cooney, and international 
bodies including WHO.406 Additionally, as found by various studies, there is no evidence 
that the NSEP programme raises injecting drug taking407 or shift in the drug consuming 
method from non-injecting to injecting.408 Therefore, it is clear that harm reduction 
interventions do not lead to the growth of drug use but do, on the contrary, impact its 
reduction.  
                                                          
403 For example, National Consensus Development Panel on Effective Medical Treatment of Opiate 
Addiction, "Effective Medical Treatment of Opiate Addiction," Journal of the American Medical 
Association 280, no. 22 (1998).1939; L. Amato et al., "An Overview of Systematic Reviews of the 
Effectiveness of Opiate Maintenance Therapies: Available Evidence to Inform Clinical Practice and 
Research," Journal of Substance Abuse Treatment 28, no. 4 (2005).326. 
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Addiction?," British Journal of Addiction 83, no. 10 (1988).1151–52. 
405 For example, D. Vlahov et al., "Reductions in High-Risk Drug Use Behaviors among Participants in the 
Baltimore Needle Exchange Program," Journal of Acquired Immune Deficiency Syndromes 16, no. 5 
(1997).400, 402–04. 
406 For example, Wodak and Cooney, "Do Needle Syringe Programs Reduce HIV Infection among Injecting 
Drug Users: A Comprehensive Review of the International Evidence."802;World Health Organization, 
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The concern over the risk of methadone diversion or improper use is as plausible 
as it is real, especially in relation to take-away dose dispensing. A study by Mohamed and 
Mohamad Kasa reveals the occurrence of diversion of prescribed substitute drugs in 
Malaysia. The growing opiate-related overdose fatalities recorded in the UK are also 
connected with a relatively more liberal methadone takeaway policy.409 The government 
needs to protect against diverted methadone use given its substantial dangers such as 
increasing opiate use, fatal overdose410 and injection-driven HIV/AIDS infection.411 
Despite that, this thesis strongly dissents that the diversion risk necessitates disallowing 
either methadone prescribing to those in need or takeaway dispensing in necessary 
circumstances. The stance of this thesis relies on some reasons. 
Firstly, methadone prescribing and takeaway policies have public imperatives. 
Methadone accounts for positive impacts including the reduction of HIV/AIDS 
transmission and illicit drug consumption while takeaway dispensing is essential to 
address the troubles of daily-oriented supervised dispensing experienced by certain clients 
such as employed individuals. Secondly, the magnitude of diversion practice is equivocal. 
Arguably, it is not a general phenomenon or an extensive issue considering that there is 
no apparent evidence supporting this. Despite the potentiality of being diverted, the 
legally provided methadone is also not a prime drug of diversion. Research in the USA 
found that much of the diverted and abused methadone is attributable to the analgesic 
                                                          
409 J. Bell and D. Zador, "A Risk-Benefit Analysis of Methadone Maintenance Treatment," Drug Safety 22, 
no. 3 (2000).181. 
410 Babor et al., Drug Policy and the Public Good.193. 
411 Committee on the Prevention of HIV Infection among Injecting Drug Users in High-Risk Countries, 
Board on Global Health, and Institute of Medicine of the National Academies, Preventing HIV Infection 
among Injecting Drug Users in High-Risk Countries: An Assessment of the Evidence  (Washington: 
National Academy Press, 2006).100–01. 
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market rather than the methadone prescribing programme.412 Thirdly, methadone 
diversion is affected by many factors which are not limited to the legal methadone 
administration or takeaway dispensing practices. The evidence shows that the diversion 
relates to multiple determinants including take-home policy, drug preference, the 
availability of drugs, availability of treatment and the scale of treatment coverage.413 
Finally, a pertinent consideration of the benefits of methadone and its risks should be 
undertaken to ensure its total positive impacts. Therefore, the prevention of diversion or 
improper use should be done in a way which does not affect the methadone’s availability 
for harm reduction purposes. The appropriate strategies aimed at minimising its potential 
diversion or improper use may include direct observed methadone consumption; ‘cautious 
clinical judgment’ in dispensing takeaway doses414; suitable regulatory restrictions 
directed at physicians, clients and methadone administration including their eligibility and 
behaviours and the operation’s settings, time and record-keeping; and prescribing 
monitoring (for example, through prescription data submission).415 It is clear that the 
MMT operation, with specific safeguards to prevent diversion or improper use, may not 
trigger increased illegal drug use. 
Overall, harm reduction interventions could significantly result in reduced drug 
consumption. Abundant scientific evidence attests to the benefit and absence of 
consequences of sustained individual drug dependency or growing drug use. With this 
                                                          
412 T.J. Cicero and J.A. Inciardi, "Diversion and Abuse of Methadone Prescribed for Pain Management," 
Journal of the American Medical Association 293, no. 3 (2005).297. 
413 A. Ritter and R. Di Natale, "The Relationship between Take-Away Methadone Policies and Methadone 
Diversion," Drug And Alcohol Review 24, no. 4 (2005).351. 
414 S. Darke, "The Effectiveness of Methadone Maintenance Treatment 3: Moderators of Treatment 
Outcome," in Methadone Maintenance Treatment and Other Opioid Replacement Therapies, ed. J. Ward, 
R.P. Mattick, and W. Hall (Amsterdam: Harwood Academic Publishers, 1998).83. 
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outcome, the measures can complement abstinence-based strategies, thereby assisting the 
attainment of prohibition-based policy for drug use. In contradiction to international 
evidence, there is a lack of local evidence identifying the potential effect of NSEP on 
drug use patterns and frequency. This should trigger an agenda for additional future 
studies. NSEP could link drug users to drug treatment and other health interventions. The 
interconnection may increase the effectiveness of NSEP in contributing to the reduction 
of drug use.  
 
3.4 Cost-Effectiveness for Controlling Drug Use, HIV and HCV Transmission 
 
To justify harm reduction measures, it is vital to consider their economic efficiency given 
that there are limits on resources. The public funds used to bear the expenditures of public 
health programmes are commonly justifiable on the basis of their economic returns in 
terms of improved population-level health and quality of life. Therefore, it is important 
for this section to consider the aspect of MMT and NSEP cost effectiveness and the 
surrounding evidence. 
For determining the monetary advantages of harm reduction measures, the 
assessments that usually employ the standard methods of cost-effectiveness analysis416 
and cost-benefit analysis417 have been undertaken by economic analysts. By applying 
varied methodologies, modelling techniques and cost assumptions while incorporating 
                                                          
416 This method is for determining the cost of one unit of outcome. 
417 Benefits and costs accessed are in terms of money. 
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sensitivity analysis,418 most existing economic evaluations have focused on the cost-
effectiveness of harm reduction programmes as strategies for handling drug dependency 
and HIV and, increasingly, HCV transmissions. Thus, these domains of cost-effectiveness 
are concentrated upon in this section. 
 Many opponents argue that there are no economic gains from the financial 
investment in harm reduction programmes. The state governments of Selangor and 
Terengganu, Malaysia, have previously stated that the provision of harm reduction 
services is a waste of resources due to its vague monetary values.419 Some critics 
substantiate their arguments based on the harm reduction programme’s ineffectiveness in 
reducing drug-related harm. Gyngell, for example, contends that the high investment of 
money for the initiative in the UK does not yield benefits when considering the growing 
harm from drug use. This includes blood-borne seroprevalence and mortality, an 
insignificant decrease in the crime rate, prolonged drug dependency, health problems and 
increasing costs related to welfare dependency and collateral child and family damage.420 
These arguments may be classified as weak when considering the evidence. They are 
unsupported by compelling relevant evidence in terms of reliable economic efficiency 
evaluations and statistical data analysis. Presented statistics indicating the increased drug-
related harms are inconclusive when considering the harm reduction programme’s 
economic inefficiency. This aspect demands prudent economic analysis. Furthermore, 
                                                          
418 Sensitivity analysis is included to indicate the validity of the drawn conclusion. 
419 Z. Raban, "Bazir Wang Rakyat-Jika Bekal Jarum Suntikan, Kondom kepada Penagih Dadah [Waste 
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available empirical data suggests that the measures might provide economic advantages 
to society, rather than wasting public funds. 
 The common finding of empirical assessments across multiple settings is that 
harm reduction policy generally, and MMT and NSEP individually, are significantly cost-
effective and even cost-saving methods for controlling drug use and HIV spread. The 
evidence presented in this section may disavow arising criticism regarding harm 
reduction cost-effectiveness. 
MMT has the potential to economically manage drug dependency. This is 
supported by the results of cost-effectiveness evaluations of MMT, mostly conducted in 
the USA and UK. For example, Zaric and colleagues make estimates relating to mortality, 
life quality, HIV spread and MMT’s consequence on medical care costs to reveal the 
service’s cost-effectiveness ratio ranging from USD9,700 to USD17,200 per life year 
achieved and from USD6,300 to USD10,900 per Quality-Adjusted Life Year (hereinafter 
referred as QALY) attained.421 There is additional evidence for the cost-effectiveness of 
MMT through research findings comparing the variant methods with other drug treatment 
modalities including detoxification.422 Moreover, a small number of cost-benefit analyses 
have discovered the MMT’s net benefits. The evidence is weighted towards its cost 
savings as a result of decreased criminal activity.423 The cost-effectiveness and cost-
                                                          
421 G.S. Zaric, M.L. Brandeau, and P.G. Barnett, "Methadone Maintenance and HIV Prevention: A Cost-
Effectiveness Analysis," Management Science 46, no. 8 (2000).1021,1024. 
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Years after Intake  (London: National Addiction Centre, 2001).17; R.P. Schwartz et al., "Interim versus 
148 
 
saving aspects of MMT are recognised in certain reviews, including that by Simoens et 
al.424 Together, this evidence demonstrates that MMT can control drug dependency in a 
cost-effective way and produce economic benefits for communities.  
Furthermore, harm reduction measures are cost-effective in preventing HIV 
infections. This point is adduced by considering available Malaysian and international 
economic findings. Assessments of the cost-effectiveness of harm reduction programmes 
with respect to HIV prevention are commonly based on the predicted quantity of HIV 
infections averted by the service. The measured outcome is the ratio of the service’s 
expenses for the averted infections to the prospective saving associated with the avoided 
HIV/AIDS medical care expenditure. There are fewer extensive studies across the world 
examining the cost-effectiveness of harm reduction as a policy for HIV prevention. The 
results of a study by Naning et al. demonstrate that harm reduction programmes in 
Malaysia resulted in an estimated saved health-care cost of MYR47.1 million and 
prevented 12,600 HIV cases from 2006 to 2013, suggesting the approach’s high cost-
effectiveness.425 Consistent with the findings, Kumaranayake et al. studied the harm 
reduction approach in Eastern Europe and concluded its cost-effectiveness in the control 
of HIV even in its soaring prevalence.426 This conclusion is confirmed by many seminal 
                                                                                                                                                                             
Standard Methadone Treatment: A Benefit-Cost Analysis," Journal of Substance Abuse Treatment 46, no. 3 
(2014).311–12. 
424 S. Simoens et al., "Pharmaco-Economics of Community Maintenance for Opiate Dependence: A Review 
of Evidence and Methodology," Drug and Alcohol Dependence 84, no. 1 (2006).38. 
425 H. Naning et al., Return on Investment and Cost-Effectiveness of Harm Reduction Program in Malaysia  
(Washington, D.C.: World Bank, 2014).10, 35. 
426 L. Kumaranayake et al., "The Cost-Effectiveness of HIV Preventive Measures among Injecting Drug 
Users in Svetlogorsk, Belarus," Addiction 99, no. 12 (2004).1573. 
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works including those by Wilson et al.427 Notably, despite the lack of research, harm 
reduction policy can be expected to yield economic benefits.  
Some local empirical findings specifically show the MMT’s cost-effectiveness in 
Malaysia in relation to HIV prevention. The research by Naning et al. found that the 
incremental cost-effectiveness of MMT for HIV spread in Malaysia is MYR2,354 per 
QALY gained from 2006 until 2013.428 The programme attained the cost-saving of 
MYR3.85 million in the period and is projected to be MYR41.56 million for the period 
between 2013 and 2023.429 The result indicates that MMT for HIV control is highly cost-
effective.  
This positive outcome is in agreement with international research findings. For 
instance, the economic analysis by Pollack reveals that the estimated MMT cost per HIV 
infection prevented ranges from USD100,000 to USD300,000.430 The supporting 
empirical findings also derive from resource-poor countries such as Indonesia431 as well 
as international bodies. The joint report of WHO, United Nations Office on Drugs and 
Crime (hereinafter referred as UNODC) and UNAIDS mentions the efficacy and cost-
effectiveness of substitution treatments including MMT for managing opiate dependence 
                                                          
427 D.P. Wilson et al., "The Cost-Effectiveness of Harm Reduction," International Journal of Drug Policy 
26(2015).S9. 
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and HIV transmission.432 All findings reinforce the argument that the service has good 
value for money when compared with HIV-related medical care costs.  
Moreover, NSEP for HIV prevention generates monetary benefits. This is 
supported by the results of the study by Naning et al., indicating that the Malaysian NSEP 
for HIV prevention yielded cost-savings of RM45.53 million from 2006 until 2013. The 
cost-saving was projected to increase to RM200.88 million by 2013.433 This indicates that 
the NSEP in Malaysia is a modestly effective financial investment.  
Local evidence reinforces the international evidence that NSEP is a highly cost-
effective method of HIV prevention. The cost-benefit analysis by Reid proved the 
NSEP’s net benefit in preventing HIV infection.434 In Holtgrave et al.’s cost-effectiveness 
evaluation of NSEP in the USA, researchers found a cost-saving of USD34,278 per HIV 
infection prevented. This is substantially below the estimated cost of treatment accrued 
over the lifetime of a HIV case ofUSD108,469. The calculation considers an estimated 
12,350 HIV infections avoided, with subsequent expenditure savings of HIV health-care 
amounting to nearly USD1.3 billion and an overall annual cost of USD423 million for 
100 per cent covered NSEPs (including through pharmacy).435 The conclusion to be 
reached from this study is that NSEP can be expected to become cost-effective and hence 
cost-saving in the control of HIV infection.  
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 Similar positive results are found by other research including that by Laufer and 
Guinness et al. (the first cost-effectiveness evaluation on harm reduction programmes in 
Asia).436 The conclusion regarding the NSEP’s cost-effectiveness for HIV cases is 
confirmed by several reviews (such as Wodak and Cooney backed by WHO and 
Pinkerton et al.).437 In Wodak and Cooney’s review of numerous studies, it is found that 
the average expenses per HIV infection prevented is lower than the lifetime health care 
costs of prevented HIV infections, thereby making the strategy cost-effective and cost-
saving.438 Moreover, the international agencies such as UNAIDS endorse the sterile 
needle provision as one of the cost-effective methods for HIV prevention.439 
No economic analysis in Malaysia has been carried out regarding the cost-
effectiveness of harm reduction services in HCV prevention. Indeed, few international 
evaluations on this aspect have been traced. The calculation of cost-effectiveness often 
relies on the volume of prevented HCV infections. 
Drawing on the limited existing evidence on this aspect, it seems that MMT is 
likely less cost-effective for the prevention of HCV spread. It could therefore be expected 
to be less cost-saving and in fact generate a net economic cost to public money. Studies, 
including those by Brown and Crofts, and Pollack and Heimer, found that the costs per 
                                                          
436 F.N. Laufer, "Cost-Effectiveness of Syringe Exchange as an HIV Prevention Strategy," Journal of 
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HCV case avoided significantly exceeded those associated with HIV infection.440 
Similarly, the Commonwealth Department of Health and Ageing highlighted that the 
NSEP’s cost-effectiveness on HCV prevention is relatively less than for HIV prevention. 
Their comprehensive evaluation of investment return for NSEPs in Australia 
demonstrates that the programmes saved about USD7,808 million of lifetime treatment 
costs of the prevented 25,000 cases of HIV and 21,000 cases of HCV by 2000. The 
averted cases were calculated from 1988 when the NSEPs were initially established. 
However, the findings revealed that the saved costs of treatment for HCV were lower, 
merely almost 10 per cent of overall saved costs. However, this still contributed net 
savings in addition to prevented HIV cases.441 
Moreover, the results of Pollack’s theoretical modelling research assessing the 
cost-effectiveness of NSEPs found that the expense per HCV infection prevented was far 
above the projected health-care costs for the disease. Thus, the study concludes that there 
is less effect from intervention on HCV.442 The NSEP’s lack of monetary benefits is 
further confirmed by several reviews including de Wit and Bos, and Ritter and 
Cameron.443 This indicates that NSEP has no potential to control the transmission of 
HCV pathogens at small per-capita costs and hence is less cost-effective.  
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Obviously, identified empirical data sources are less supportive for the MMT and 
NSEP’s cost-effectiveness in preventing HCV transmission when compared with HIV 
prevention. The low economic benefits are seemingly influenced by its inefficacy in 
reducing the virus spread. Notably, the effectiveness of strategy is always accorded with 
its cost-effectiveness as in the case of harm reduction measures for HIV control. If this 
trend is to reverse, then the intervention might not arise as economically efficient. 
However, this thesis argues that the negative evidence in HCV prevention does not affect 
overall MMT and NSEP cost-effectiveness. The cost-effectiveness of the services for 
drug dependency and HIV prevention is sufficiently strong to justify their continuation. 
As manifested in Degenhardt et al.’s writing, the cost-effectiveness of MMT (and NSEP) 
is sustained, even when taking into account HIV benefits only.444 
 Summarily, MMT and NSEP are economically justified. Bodies of evidence, 
especially from developed countries, support the cost-effectiveness of both interventions 
in the control of drug taking and HIV infection, impacting cost-savings to society. The 
services are seemingly less cost-effective singly in relation to HCV. The opponents who 
are pragmatic or consequentialist in their objection to these interventions should be 
swayed by the economic returns produced. Critics who claim that the interventions are 
not cost-effective do not provide plausible evidence that could desert the measures. 
However, generalising about the cost-effectiveness of such measures is erroneous due to 
the scarce economic evaluations, including in Malaysia where there is an obvious lack of 
evidence. Additionally, the compatibility of cross-studies is limited when considering 
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specific aspects including magnitude of savings, costs, time and epidemiological features 
in localities that affect disease prevalence. Therefore, consideration needs to be given to 
more local cost-effectiveness analyses of harm reduction measures.  
 
3.5 Absence of the Symbolism of Drug Use Encouragement 
 
Harm reduction approach elicits a storm of controversy in Malaysia as it is seen as 
promoting illicit drug consumption. The objective of this section is to examine whether 
harm reduction is a symbolic encouragement of drug use and consider the existing 
relevant evidence.  
The interventions are seen by their opponents in Malaysia, particularly among 
politicians and the public, as transmitting implicit messages that advocate drug taking.445 
Such claims also appear in other jurisdictions, particularly those implementing aggressive 
responses to drug offences. While there appear variances in views among politicians, 
states and drug organisations in the USA, the Office of National Drug Control Policy 
(ONDCP) gives a representative example of the pessimistic view that NSEP (and other 
harm reduction strategies) officially validate drug consumption and thereby undermine 
the societal message of the immorality of drug use.446 The reasoning behind the criticism 
is that the harm reduction approach conveys the message that drug consumption is tacitly 
endorsed by the government. Additionally, by helping to lower drug-related risks, the 
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approach communicates the message that drug use is safe and hence possibly impacts 
upon the initiation of drug use.  
It is hard to accept the argument when considering the harm reduction practices of 
promoting health and wellbeing and reducing the adverse effects of drug consumption, 
rather than legalising and publicising its benefits or risk-free position. The government 
applies the approach for the interest of public health while still pursuing prohibition-
oriented policy and methods against drugs. This draws the conclusion that the 
implementation of harm reduction as an approval and promotion of drug taking is 
unreasonable. Additionally, there seems to be no evidence concerning the interpretation 
of drug-using or non-drug-using individuals of the negative message of harm reduction 
programmes. The claimed implicit message conveyed could be characterised, as 
MacCoun proposes, as rhetorical implications which demand empirical evidence. 
MacCoun clarifies that:  
the rhetorical hypothesis is that irrespective of their effectiveness in reducing 
harms, harm reduction programs literally communicate messages that 
encourage drug use…Without intending to do so, harm reduction sends tacit 
message that are construed as approval - or at least the absence of strong 
disapproval - of drug consumption[…] Ultimately, whether any such 
rhetorical effects occur is an empirical question.447 
Therefore, the contention that harm reduction programmes send message of promoting 
drug use is based on conjecture and is unsupported empirically. 
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Moreover, there appears to be evidence showing that the harm reduction approach 
has the potential to convey the opposite message. For instance, a Malaysian study by 
Sarnon et al. investigated the perception of 13 IDUs who attended NSEP for over 10 
months. They found that most of the IDUs believed that the government’s service 
encouraged the use of sterilised needles to prevent HIV/AIDS infection and alteration of 
methods to obtain needles and caused them to have the feeling of being acknowledged 
and given attention.448 This indicates that drug users and the public may construe a 
positive message from the harm reduction approach. The type of message is dependent on 
the individual interpretation which is verifiable by empirical work, rather than mere 
presumption.  
The second possible rationale for the claim of communicating the wrong message 
through drug-related harm mitigation is in line with the evidence of compensatory 
behavioural reactions to safety measures. Specifically, individuals may initiate or increase 
drug taking behaviour given the decrease of drug-related harms and risks through harm 
reduction initiatives. This is similar to the supposed reaction by drivers to drive faster as a 
result of improved automobile safety including seat belts that reduce driving risks. 
MacCoun states: 
[…S]ome of the safety gains brought about by a reduction in the probability 
of harm given unsafe conduct have been offset by increases in the probability 
of that conduct[…] The compensatory behavioural mechanism suggests that if 
reductions in average drug-related harm were to motivate sufficiently large 
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increases in drug use, micro harm reduction would actually increase macro 
harm.449 
Yet there is no empirical evidence to confirm the notion’s application in a harm reduction 
context. Thus, the opponents’ argument is merely speculative and somewhat reflective of 
their deontological stance against harm reduction policy. 
By contrast, there exists scientific evidence to weaken the hypothesis. Research 
findings demonstrate that harm reduction measures are not associated with growing 
initiates to drug use. A few Malaysian studies, such as by Shan, found that MMT and 
NSEP have not recruited new drug takers, but on the contrary, have decreased their 
number. The number of new drug users declined in the years after the services were 
introduced.450 The University of California’s extensive review of investigations involving 
IDUs in the USA and other countries including Canada, the Netherlands and England also 
concludes that there was neither a rise in drug taking prevalence nor the levels of drug 
injecting by reason of NSEP’s accessibility.451 The comparable result is revealed by 
Norman et al. assessing the evidence from numerous studies.452 Thus, these data sources 
indicate that the harm reduction approach is unlikely to promote and increase drug use. 
This conclusion is consistent with the arguments of scholars including Yoast et al. and 
Vlahov et al.453 
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Even if initiation of drug taking grows after the implementation of the harm 
reduction approach, the approach should not be simply blamed for the personal 
autonomous act to use drugs. It is unfair to link the two variables while presuming that 
the other possible determinants of an individual’s decision to act remain stable, non-
important or non-existent. Carter et al. insist that the action is the result of the application 
of personal autonomy rather than the consequence of the harm reduction approach’s 
availability.454 
It is therefore important to conclude that harm reduction initiatives, both locally 
and globally, have no symbolic encouragement of drug use. The opponents’ concerns 
regarding the implication are unsubstantiated reasonably or empirically either for a 
rhetorical or a compensatory behaviour mechanism notion. Further, their claims are 
repudiated by volumes of scientific findings. More research should be conducted in every 
jurisdiction regarding these subjects. 
 
3.6 Absence of Negative Consequences Diminishing the Amenity of the 
Community 
 
Another area of issues regarding the harm reduction approach in Malaysia and other 
nations that may impact its justification has been in relation to public amenity, including 
concerns pertaining to the rise of crime, and discarded needles and syringes in public 
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settings. Thus, this section focuses on the issue of whether the interventions lead to such 
negative effects and presents related evidence.  
The questions about the negative implications of harm reduction strategy to 
communities are not necessarily driven by conflicting ideology pertaining to the 
appropriate drug controlling methods. Malatesta et al. categorise this debate pertaining to 
the negative effects of the approach as a manifestation of the conflicts between two 
‘logics of action’; the necessity for delivering health and social protection to the drug-
taking population and the necessity for keeping public order.455 While this thesis concurs 
with the potential influence of the public’s commitment to preserving the security of 
communities to their fears upon the negative impact of harm reduction approach, 
considering the Malaysian context, this thesis argues that the concerns stem from mixed 
scepticisms about the approach’s effect on compromising public order and inefficacy to 
tackle drug use and its associated consequences. 
The local community’s worry regarding worsening crimes from the harm 
reduction approach somewhat drives them to challenge the services. In Paul’s report, 
Musa Jantan, a medical practitioner involved in MMT delivery, is mentioned disclosing 
that the interruption occurs owing to the belief of the public on the programme’s 
facilitation of drug consumption that drives criminal acts in the neighbourhood.456 This 
shows that the Malaysian public concern pertaining to the outcome of a rise in crime is 
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grave. The possible reason is that the national media has always reported on the growing 
prevalence of crime in public settings including thefts and bag snatching and associating 
them with drug use. This leads to public stigma towards drug users and pessimism about 
non-prohibition-based drug approaches. Similar grave concerns emerge in other 
jurisdictions.457 
Arguing from an evidence-based point of view, it seems that the prediction of 
rising crime rates as a consequence of harm reduction programmes is implausible due to 
less conclusive supporting evidence. Some critics quote national crime statistics. EURAD 
(Europe against Drugs) for example, draws attention to the crime rate in the UK in 
2005/2006, whereby 178,502 drug-related offences were recorded, marking a 23 per cent 
increase since 2004/2005.458 Additionally, Gyngell contends that since 2007, the rate of 
drug-related crimes has increased by 2.9 per cent and there has been an annual average of 
2.6 crimes committed by every drug user in the UK.459 This statistical data cannot 
effectively give weight to the critics’ claim as no attempt is undertaken to put the data 
into statistical perspective including considering differing factors which may contribute to 
the existing data and converting data into rates.  
Additionally, a few international studies show results that give less support for the 
MMT’s impact on reducing crimes. By way of illustration, the research in London 
comparing self-reported crime by MMT clients with non-client drug users found no 
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significant variances in the overall volume of violent or acquisitive offences.460 The 
researchers state that ‘our data provide another challenge to the idea that there is a simple, 
mechanistic relationship between […] substitute prescribing and criminal desistance’.461 
Despite that, the study results are less notable because they are based on self-reporting 
and small sample sizes (100) and hence make generalising the MMT’s impact on crime 
reduction problematic.  
The presumption of increased crime can be further challenged by contradictory 
evidence. There is overwhelming empirical data that does not demonstrate support for the 
presumption. Norsiah et al. found a nominal proportion of Malaysian MMT clients 
involved in drug-related crimes, with no individuals committing other crimes such as 
theft and robbery after their participation in the programme. The researchers conclude 
that the service’s presence mitigates drug-connected offences.462 Consistently, there are 
some other evaluation reports in Malaysia such as those by Gill et al. and Kaur et al. 
confirming the hypothesis that MMT does not lead to a growing crime rate but instead 
causes its decline.463 Some research also found no significant evidence suggesting the rise 
of criminal acts as a result of NSEP practice.464 
Local research findings correspond with the results of international investigations. 
The study of MMT in New South Wales, Australia discovered a relationship between the 
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strategy and reduced criminal activity. The study used a vast and fairly representative 
sample (8,154) of people obtaining a methadone prescription during a two-year-period. It 
found that 12 months of each 100 individuals in MMT were associated with 12 fewer 
robberies, 57 fewer breaks in and 56 fewer motor vehicle thefts.465 Additionally, the 
Cochrane meta-analysis results indicate that MMT has a positive, even non-significant 
connection to crime decrease.466 Other large-magnitude studies and reviews such as by 
Farrel et al. and Havnes et al. are in agreement with the findings that MMT contributes to 
lowering crime rates.467 
Moreover, international studies have found that NSEP has not resulted in the rise 
of crime or violence but instead has minimised the rates.468 The results of a survey in 
Harlem, New York, USA show that the proximity to NSEP services is not linked to 
violent incidents.469 In reviewing the evidence across a number of studies, Dolan et al. 
point out that ‘there is no evidence to suggest that NSEP increase crime or violence’.470 
Obviously, harm reduction measures have no impact on growing crime, but in contrast, 
have an impact on reducing it.  
Therefore, it is clear that harm reduction approaches do not cause increased crime 
incidences. There is no evidence of a causal relationship between the rise of crimes 
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correlating with the existence of MMT or NSEP. By contrast, the interventions 
substantially lower offending behaviours. The weight of empirical results show 
significantly lower rates of criminal behaviour, particularly property and drug-related 
crime, for most drug users participating in harm reduction programmes compared to those 
who do not. Presumably, this finding is driven by the programmes’ efficacy in decreasing 
illegal drug consumption. (This was discussed in Chapter 3, Section 3.3.) The reduction 
in using drugs to some extent leads to a reduction in drug users’ involvement in drug 
dealing and acquisitive crimes to finance their drug consumption.  
Nonetheless, the thesis’s argument should not be understood to imply that                   
a harm reduction approach is an optimal crime-control device or that it eliminates 
offending behaviour among those engaging in its programmes. Hall’s review of research 
suggests that a significant number of those remaining in MMT persist in their criminality 
although at much lesser rates than prior to their entry to the programme.471 Moreover, 
there are variations in the efficacy of harm reduction strategies in minimising crimes. As 
found by numerous studies, the differences of crime reduction outcome are considerably 
influenced by aspects such as client characteristics and programmes.472 Thus, there is a 
need for caution in making a generalisation regarding the impact of such strategies in 
controlling crimes. Despite that, this analysis rejects the widespread perception pertaining 
to the possible crime growth resulting from the presence of harm reduction facilities and 
shows that it instead does contribute to criminality engagement reduction. This 
wholesome effect benefits both the drug using population and wider society. 
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Furthermore, there is bound to be some degree of anxiety among the Malaysian 
public and law enforcement agencies for the NSEP’s iatrogenic implication of an increase 
in the quantity of discarded needles and syringes in areas close to where the programmes 
are delivered.473 Relative to increased crime, the issue of discarded needles creates less 
intense controversy in Malaysia. The possible reason is that the incidents are rarely 
reported by electronic or printed publications. Fewer used needles and syringes are found 
in public places except in hidden settings such as abandoned buildings. Despite that, the 
arising concern should not be underestimated as it might emerge to be a significant issue 
impacting public health interventions as has happened in some other nations.474 In some 
cases, the controversy relating to this issue has resulted in the closing of NSEPs. 
Broadhead et al. recall the story of an NSEP programme in Windham, Connecticut, which 
was shutdown in 1997. The four year NSEP service came to an end as a consequence of a 
campaign led by the district attorney and public controversy after a child was punctured 
with a discarded needle.475 
Beneath the concern of an increase in discarded needles is a fear of accidental 
needle-stick injuries and blood-borne infections from the discarded items. However, mere 
concern, even heightened, has no sound basis unless supported with credible evidence. 
While many critics fail to provide any supporting evidence, some attempt to certify the 
hypothesis based on limited and unconvincing empirical data. Christian argues that harm 
reduction strategies, including needle distribution, do not result in fewer discarded 
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needles in Sydney as no decrease has been observed.476 Subsequent to the NSEP’s 
initiation in Amsterdam, the figures for accidental needle-stick injuries reported to the 
Municipal Health Service increased. However, this finding does not give plausible 
support for the NSEP’s negative impact given a possible bias in reporting which related to 
the public’s growing awareness about blood-borne pathogens.477 
The other rebuttal to the concern is that, theoretically, the one-for-one rules 
applied by NSEP may remove injection equipment from circulation and hence lessen the 
quantity of discarded items. The proponents including Doherty et al. point out that the 
discard of needles can be averted by the operation of a one-for-one-based NSEP 
programme since the quantity of returned needles will be concomitant to the quantity of 
prescribed needles.478 The impact of discarded injection items may also somewhat be 
prevented by the NSEP’s supplementary operations. In furtherance to distributing 
injection equipment, it provides education on safe disposal, collects used injection items, 
makes containers and disposal bins available and sanitises areas with discarded syringes. 
These aspects support the argument that NSEP may contribute to fewer discarded 
injection instruments in public settings. This is further confirmed by local reports 
showing that the service in practice has effectively collected a number of used needles. 
For example, the MOH of Malaysia discloses that the overall return rate for NEPs at the 
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end of December 2006 was 61.6 per cent of total distribution of 42,000 needles.479 In 
2011, the return rate climbed to 64 per cent.480 In some cases, it is reported to have 
achieved more than 90 per cent.481 
The theoretical explanation is strengthened by direct empirical evidence 
suggesting no rise in the number of discarded needles in public settings following the 
NSEP’s introduction in Malaysia and other countries. The research findings relating to 
Malaysia’s pilot NSEP disclose the gradual increase of the total return rate, achieving 
nearly 60 per cent, and no increased needle and syringe litter in public settings near the 
service sites after the first year of its operation.482 This finding is compatible with the 
results of international studies demonstrating that the NSEP’s establishment does not 
increase the quantity of needles and syringes discarded in the vicinity but instead causes 
its decline.483 The research by Broadhead et al. assessing the condemnations of the local 
residents in association to iatrogenic consequences of NSEPs leading to their closure in 
Windham, reveals that the negative perceptions had no foundation. Discarded needles and 
syringes did not reduce after the closing of NSEPs.484 Also, the results of research in 
Vancouver show an independent relationship between NSEP and the safer disposal of 
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syringes.485 Considering the evidence against the hypothesised increased discard, the 
prediction of such consequence is hence fragile. 
In summary, harm reduction measures have not resulted in unintended negative 
consequences, either worsening crime rates or increasing needle and syringe litter. Failure 
to engage with conclusive and persuasive evidence makes the relevant fears unfounded. 
The theoretical analysis and empirical evidence further demonstrate that harm reduction 
interventions can be expected to produce the opposite outcome. However, it is worth 
noting that caution is needed for applying the findings from specific jurisdictions to other 
countries, as the indicators of public amenity are subject to considerable variances across 
the countries such as socio-culture and drug consuming means. This analysis discovers a 
dearth of research in Malaysia and many other countries specifically evaluating the 
unintended negative impacts of harm reduction measures to the communities. It is timely 
for further specific assessments on the implications and, if discovered, appropriate 




This chapter has shown that harm reduction measures are effective and cost-effective in 
controlling drug use and HIV transmission. There exists compelling scientific evidence 
locally and globally to suggest that MMT and NSEP can reduce drug taking, HIV-risk 
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behaviours and infection incidents among drug users. The strategies may also produce 
economic benefits, considering their proven cost-effectiveness and cost-saving for drug 
use and HIV prevention. The efficacy and financial efficiency of the measures are strong 
enough to justify their implementation despite their less protective and economic effects 
for HCV pathogen prevention. Further, no evidence is found to suggest that the strategies 
result in harms including increased drug consumption, drug taking encouragement and 
negative effects against public amenities in terms of a rise in crime and discarded 
syringes. The encouraging outcomes are unaffected by some negative empirical data, 
considering persuasive expounding explanations for negative research findings and 
generally the overwhelming volume of supporting study results. The opponents’ claims to 
the interventions’ inefficacy, economically inefficiency and adverse consequences are 
implausible due to missing, inconclusive or deficient evidence.  
Drawing on the outcomes of MMT and NSEP, both can be expected to yield 
wider health-related and other benefits to drug-using populations and communities. The 
interventions’ effectiveness and cost-effectiveness could be improved through the 
integration of multiple methods. Given the proven effectiveness and cost-effectiveness, 
their practices are highly justifiable and worthwhile. More research on these aspects 
should be undertaken, particularly in Malaysia where scarce evidence is detected. 
Despite the justifiability of harm reduction measures in Malaysia from ethical (as 
highlighted in chapter 2) and scientific imperatives, the remaining major issue is whether 
their implementation is compatible with existing criminal justice approach. This will be 




IS THE HARM REDUCTION APPROACH IN MALAYSIA COMPATIBLE 




Despite the formal recognition and implementation of the harm reduction approach in 
Malaysia, criminal laws which prohibit drugs have been historically and constantly 
practised in Malaysia. Therefore, there appear an important question relating to the 
compatibility between the harm reduction and criminal justice approaches being pursued 
at the same time. The present widespread assumption and official position is that the two 
approaches are compatible, particularly due to the adoption of government initiatives 
including collaborative efforts towards preventing the conflict. This thesis intends to 
challenge this perspective, arguing that significant conflict between the two approaches 
may occur despite the presence of such mechanisms to eliminate the conflict.  
The main objective of this chapter is to consider whether there is compatibility 
between the harm reduction and criminal justice approaches as they are practised in 
Malaysia, and if not, where the conflict originates and what it reflects. To date, there has 
not been any significant discussion of these issues in Malaysia. The discussion in this 
chapter will focus on several relevant important aspects including: the legislative and 
regulatory framework in Malaysia related to drug use that may clash with and/or affect 
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the harm reduction strategy; the government initiatives to avoid the conflict between the 
two approaches; the impact in practice of the legislative and regulatory framework and 
government initiatives upon the harm reduction operation; the issue of uniqueness of the 
conflict between both approaches to Malaysia; the seriousness and significance of the 
conflict and factors related to the police exercise of their discretion in relation to harm 
reduction. The issue of compulsory drug treatment will also be considered in this chapter. 
The examination of this issue is important because the compulsory drug treatment has 
constituted the principal and dominant approach for drug users in Malaysia for many 
decades. The question of compulsory treatment further relates to the wider issue of 
compatibility between the harm reduction and criminal justice approaches because within 
the Malaysian context, it shapes significantly the criminal justice method for addressing 
the drug use problem, which contrasts strongly with harm reduction principles and 
practice.   
The discussion in this chapter will engage ‘gap’ analysis in which, in the words of 
Feeley, ‘legal aspiration is contrasted with actual practice as a first step toward 
accounting for the ‘gap’’.486 While gap analysis can be a significant analytical tool for 
socio-legal research, there have been criticisms that the attention of gap analysis tends to 
be drawn to organisational level analysis at the expense of broader environmental 
influences.487 This chapter will attempt to apply gap analysis sensitively to the social and 
cultural contexts in which the law operates rather than merely the organisational factors. 
Furthermore, the discussion is supported with local evidence together with consideration 
of the international literature. 
                                                          
486 M.M. Feeley, "Three Voices of Socio-Legal Studies," Israel Law Review 35, no. 2-3 (2001).185. 
487 For example, ibid.187. 
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4.2 A Review of the Legislative and Regulatory Framework in Malaysia relating 
to Drug Use 
 
The development of harm reduction services in Malaysia has not been accompanied with 
any explicit legal provision authorising their operation and Malaysia’s responses to drug 
use are still fundamentally based on the criminal justice approach. This section will assess 
the legislative and regulatory framework in Malaysia relating to drug use and its 
consistency with and/or potential effects to the harm reduction principles and practices. 
For that purpose, an analysis of present various relevant legal provisions is made. 
However, consideration of how the legislative and regulatory framework actually impacts 
in practice on the implementation of harm reduction will be given in a later section of this 
chapter. 
 
4.2.1 Criminal Offences in relation to Self-Administration and Possession of Drugs 
 
4.2.1.1 Self-Administration of Drugs488 
The criminalisation of illicit drug consumption and possession, even for personal use, 
with attendant sanctions ranging from a fine to long-term imprisonment remains the 
primary legal approach for controlling drug use. Self-administration and consumption of 
drugs are made unlawful by section 15 of DDA 1952. The penalties on conviction consist 
                                                          
488 The discussion in this section relates generally to the act of self-administering illicit drugs. The act of 




of imprisonment for a term of up to two years or a fine of up to RM5000.00.489 Section 
15(2) defines the word ‘consumes’ as to include eating, chewing, smoking, swallowing, 
drinking, inhaling or introducing into the body in any manner or by any means 
whatsoever. The statute, however, does not provide the meaning of ‘administer’. 
Considering the exemption of the medical administration of drugs to others under section 
14(2) of the DDA 1952, it is argued that the term ‘administers’ as mentioned in section 15 
similarly refers to the common ways of administering medicines i.e. orally by swallowing 
or intravenously. 
To prove offences, the law authorises the coerced testing of suspects. The High 
Court in PP v Chan Kam Leong490 held that the accused could be convicted of the offence 
upon the proof pertaining to (1) his self-administering of dangerous drugs or allowing 
another person, contrary to section 14, to administer the drugs to him; and (2) that 
dangerous drugs had been found in his urine which had been clinically tested. Despite the 
issues concerning urinalysis such as a possible presence of opiates metabolites in legal 
drugs and a broken chain of evidence491, a biochemist’s report confirming a urine 
sample’s positivity for opiates metabolites may sufficiently convict a person who pleads 
guilty for this offence. In the Drugs Dependants (Treatment and Rehabilitation) 
(Amendment) Act 2002492, the offence may now be proved based on statutory 
presumption as provided in section 37(k) DDA 1952, thereby easing the convicting of the 
                                                          
489 Pursuant to section 376 of Criminal Procedure Code, the public prosecutor is authorised to determine 
whether to charge drug dependants under section 6 of DDTRA 1983 or section 15 of DDA 1952. See the 
High Court’s ruling in PP v Chan Kam Leong [1989] 2 CLJ (Rep) 311, 313. The alternative basis of 
criminal liability for drug users might be consuming prepared opium punishable with imprisonment of not 
more than two years or a fine of not more than MYR5,000 or both upon conviction as provided in section 
10(2)(b) of DDA 1952. Section 10(2)(3) of DDA 1952 provides a similar meaning of consuming as given 
by section 15(2) of the same Act.  
490 [1989] 2 CLJ (Rep) 311, 313. 
491 Majid, Dangerous Drugs Laws.128, 130. 
492 Act A1167. 
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offence. The finding that tested urine contains dangerous drugs may be used to presume 
that the accused has consumed the drug, has self-administered the drug or has allowed 
another person to administer the drug.  
This clearly shows that despite the formal recognition of a public health approach, 
including harm reduction programmes for drug users, the group is highly exposed to 
penal approaches including coercive testing and imprisonment for consuming drugs. This 
is also how the law likely treats those who self-administer drugs as they have a 
connection to a drug use problem and are therefore in need of monitoring and 
rehabilitation. This is manifested by the provision subjecting a person convicted of the 
offence of self-administration of drugs to supervision under a rehabilitation officer of 
between two and three years immediately after discharge from prison.493 The law can 
leave drug users facing the daily risks of investigation and arrest. In the absence of any 
statutory exemption, MMT and NSEP clients found that by consuming illicit drugs they 
can technically be detained and convicted for the offence. Even finding urine to contain 
drugs may lead to incarceration which is generally disconnected from harm reduction 
policy. Drug users bear the burden of challenging the prosecution, given the statutory 
presumption based on the urine test. As we shall see later in this section, the 
criminalisation of drug taking may also influence drug users’ relocation to secluded areas 
and may deter their involvement in community-based drug programmes, including harm 
reduction, for fear of being detected and arrested. This indicates that the legislative 
provisions criminalising drug taking may pose a potential threat of criminal liability for 
                                                          
493 DDA 1952, s 38B. The High Court in Public Prosecutor v Ng Hock Lai [1994] 4 CLJ 1056, 1058 ruled 
that pursuant to section 38B of DDA 1952, the court should make the supervision order after deciding the 
drug offender’s conviction and sentence under section 15. 
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drug users including those participating in MMT and NSEP and possible obstacle to the 
strategies’ accessibility. 
 
4.2.1.2 Possession of Drugs494 
Drug users risk criminal charges for possessing illicit drugs if they are caught with drugs, 
even if they are solely for personal consumption. The law does not distinguish possession 
between personal and commercial use. Possession, even a small quantity of illegal drugs, 
is prohibited as the criminalisation accounts for the possession of drugs, rather than drug 
quantity. The offences relating to possession and their punishments are prescribed under 
several sections of DDA 1952 (shown in Table A). The penalty upon conviction of a 
possession offence ranges from a fine to life imprisonment. The penalty depends on the 
nature and quantity of illicit drugs.  
 
Table A: Types of Offence for Drug Possession under DDA 1952 
Note: (<): Not greater than; (>): Not less than; MYR: Malaysian Ringgit 




Possession of raw opium, coca leaves, 





Imprisonment: <5 years or  
fine: <MYR20,000, or  
both 
                                                          
494 This section provides general discussion on illicit drug possession. Specific discussion on the possession 






Possession of prepared opium 
 
Imprisonment: <5 years or  






Possession of other dangerous drugs 




Imprisonment: <5 years or  






• 2g<5g heroin or morphine or 
monoacetylmorphines or a mixture 
of any of them; 
• 5g<15g cocaine; 
• 20g<50g cannabis or cannabis 
resin or a mixture of them; 
• 100g<250g raw or prepared opium 
or a mixture of them; 
• 250g<750g coca leaves; 
• 5g<30g 2-Amino-1-(2, 5-
dimethoxy-4-methyl) 
phenylpropane or  
Amphetamine ort 2, 5-
Dimethoxyamphine (DMA) or 
Dimethoxybromoamphetamine 
(DOB) or  
2, 5-Dimethoxy-4-
ethylamphetamine (DOET) or 





(MDA) or  
N-ethyl MDA or  




Imprisonment: >2 <5 years and 







3, 4, 5-Trimethoxyamphetamine 






Possession of a prescribed amount of 
certain drugs: 
Possession of: 
• 5g> heroin or morphine or 
monoacetylmorphines or a 
mixture of any of them; 
• 15g> cocaine; 
• 50g> cannabis or cannabis resin or 
a mixture of them; 
• 250g> raw or prepared opium or a 
mixture of them; 
• 750g>coca leaves; 
• 30g>2-Amino-1-(2, 5-dimethoxy-
4-methyl) phenylpropane or 
Amphetamine or 
2, 5-Dimethoxyamphine (DMA) 
or  
Dimethoxybromoamphetamine 
(DOB) or  
2, 5-Dimethoxy-4-
ethylamphetamine (DOET) or 





(MDA) or  
N-ethyl MDA or  




Imprisonment: >2 or 











3, 4, 5-Trimethoxyamphetamine 
(3, 4, 5-TMA) or  
a mixture of any of them. 
 
 
Possession is not defined in drug law or Penal Code but a great number of cases 
show that the accused is regarded to be in possession of a prohibited drug when it is 
proved that he had custody and/or control of dangerous drugs and had knowledge of the 
nature of the drugs found.495 In Director of PP v Brooks496, Lord Diplock, in delivering 
the Privy Council’s judgment, stated ‘In the ordinary use of the word ‘possession’, one 
has in one’s possession whatever is, to one’s own knowledge, physically in one’s custody 
or under one’s physical control’. According to Taylor J in Leow Nghee Lim v R497, 
custody can be interpreted as: ‘[…] having care or guardianship; goods in custody are in 
the care of the custodian and, by necessary implication, he is taking care of them on 
behalf of someone else’. The Lordship also gave elucidation of the word ‘control’: 
‘Control must be proved as a fact and it must arise from the relation of the person to the 
goods, irrespective of whether they are contraband’.498 The custody or control must also 
                                                          
495 For example, PP v Muhamad Nasir bin Shaharuddin & Anor [1994] 2 MLJ 576, 592; PP v Reza Mohd 
Shah bin Ahmad Shah [2009] 2 MLJ 490, 499, 502. 
496 [1974] AC 862, 866. 
497 [1956] 22 MLJ 28, 29. 
498 Ibid., 32. 
178 
 
be shown to be exclusive.499 In the light of judicial decisions, particularly the superior 
courts, the prosecution no longer holds the burden of proving that the accused has the 
power of disposal over the drugs500.501 
The requirements of the offence may be proved by direct evidence or based on 
statutory presumption. Section 37(d) presumes the possession of dangerous drugs and 
knowledge of the nature of drugs when custody or control is established. This may give 
advantage to the prosecution and against the accused. This presumption may only be 
rebutted by the accused discharging the evidential burden on balance of probabilities that 
he was neither in possession of the drugs nor he knew the nature of the drugs.502 
Even though possession and the self-administration of drugs are independent 
offences, drug users may risk a dual charge due to their connection to both acts. They 
often possess a drug before consuming it. A conviction for possession is highly possible if 
they are caught with a drug, facilitated by statutory presumption. Both practitioners and 
law-makers have failed to pay sufficient regard to the effects of the strict liability nature 
of section 37(d) on drug users and the harm reduction approach. 
The continued criminalisation and use of punishments with lengthy incarceration 
and whipping for possession, even for personal use, are problematic from the perspective 
                                                          
499 Abdullah Zawawi bin Yusoff v PP [1993] 3 MLJ 1, 7; PP v Mohd Zambri bin Mohd Zelah [2005] 2 
AMR 23, 28. 
500 Gordon-Smith Ag. CJ’s dictum in Toh Ah Loh &Mak Thim v R [1949] MLJ 54, 55 highlighted the power 
of disposal element of possession. This was followed by several cases including PP v Ang Boon Foo [1981] 
1 MLJ 40, 43 whereby Gun Chit Tuan J elucidated power of disposal to denote the capability of dealing 
with a moveable thing as owner excluding others by saying: ‘There is therefore a power of disposal, and 
therefore possession in law where a person is so situated with respect to a moveable thing, such as a 
dangerous drug in this case, if he has the power to deal with it as owner to the exclusion of all other persons 
and when the circumstances are such that he may be presumed to do so in case of need’. 
501 The Supreme Court in PP v Kau Joo Huat [1988] 2 MLJ 91, 94. 
502 Illian & Anor v PP [1988] MLJ 421, 424. 
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of the harm reduction approach. They reflect the fact that the control of drug use is still 
dominated by the principle of deterrence and retribution rather than by considerations of 
public health. Drug users will hence remain at high risk of receiving criminal sentences. 
The fear of enforcement actions, including investigations, may affect their readiness to 
attend harm reduction services. Legal detention, criminal charges and sanctions may 
further interrupt their accessibility to harm reduction interventions. There is a clear 
possibility that they will lose the opportunity to obtain harm reduction services, given the 
non-existence of any regulatory or policy document securing their rights to obtain the 
services in criminal justice settings, including police lock-ups and prisons. We shall 
consider later in this section the extent to which the law penalising drug possession, even 
for individual consumption, undercuts the missions and efforts of harm reduction 
interventions. 
 
4.2.2 Compulsory Treatment for Drug Use 
 
The law governing compulsory treatment constitutes another feature of the sustained legal 
response to drug use which is inconsistent with the harm reduction approach. It refers to 
the legislated involuntary detention or civil commitment of persons for drug treatment. It 
is important to devote some attention to the justifiability issue of this intervention because 
it is a dominant response to drug use in Malaysia. Support for compulsory drug treatment 
mostly hinges on the argument relating to the role of state-mandated treatment in 
managing and rehabilitating drug users. Some argue that this approach embodies 
180 
 
therapeutic and harm reduction elements albeit with the threat of criminal sanctions if 
drug users fail to comply. As Wu has written, compulsory treatment centres function to 
protect individuals and the community by decreasing drug use and its attendant harms 
including mortality, criminality associated with drugs and risky behaviours. From this, 
Wu claims that compulsory treatment suits the harm reduction and safety imperatives.503 
State-mandated treatment is seen by its advocates as effective in achieving the 
aims of drug treatment. However, there is no evidence to support the approach’s 
effectiveness. By contrast, studies in multiple jurisdictions have found high relapse rates 
ranging from 60 to 100 per cent upon discharge.504 The approach also does not decrease 
but may rather heighten the health and safety problems among people detained. The 
evidence shows that the compulsory drug treatment centres are unaccustomed to 
evidence-based drug interventions, particularly harm reduction measures.505 Additionally, 
the centres lack health programmes and skilled medical personnel.506 Unsurprisingly, the 
cases of blood-borne infections, especially HIV/AIDS, are highly recorded in the 
                                                          
503 Z. Wu, "Arguments in Favour of Compulsory Treatment of Opioid Dependence," Bulletin of the World 
Health Organization 91, no. 2 (2013).142–43. 
504 World Health Organization (Western Pacific Region), Assessment of Compulsory Treatment of People 
who Use Drugs in Cambodia, China, Malaysia and Vietnam: An Application of Selected Human Rights 
Principles  (Geneva: World Health Organization, 2009).29. 
505 Ibid.19; G. Reid, A. Kamarulzaman, and S.K. Sranc, "Malaysia and Harm Reduction: The Challenges 
and Responses," International Journal of Drug Policy 18, no. 2 (2007).137–38; J. Godwin, Regional Issues 
Brief: Laws and Practices Relating to Criminalization of People Living with HIV and Populations 
Vulnerable to HIV  (New York: Global Commission on HIV and the Law, 2011).17. 
506 For example, World Health Organization (Western Pacific Region), Assessment of Compulsory 
Treatment of People who Use Drugs in Cambodia, China, Malaysia and Vietnam: An Application of 
Selected Human Rights Principles.26, 29; United Nations Office on Drugs and Crime Regional Office for 
Central Asia and Canadian HIV/AIDS Legal Network, Accessibility of HIV Prevention, Treatment and 
Care Services for People who Use Drugs and Incarcerated People in Azerbaijan, Kazakhstan, Kyrgyzstan, 
Tajikistan, Turkmenistan and  Uzbekistan: Legislative and Policy Analysis and Recommendations for 
Reform  (Ashgabat: United Nations Office on Drugs and Crime, Regional Office for Central Asia & 
Canadian HIV/AIDS Legal Network, 2010).56. 
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centres.507 The poor therapeutic and harm reduction outcomes of the approach call into 
question the supporters’ claim that it is effective. 
More importantly, mandatory treatment for drug users is also ethically flawed. 
This is because it is still penal in nature508 which is contradictory to ethical medical 
standards including informed consent and international human rights including the rights 
to freedom of movement,509 freedom from arbitrary detention510 and protection from 
inhuman and degrading treatment or punishment,511 subject to the limited guarantee of 
due process of law and strict emphasis on abstinence from drugs. Drug users are forced to 
enter residential drug treatment or be put under the supervision of rehabilitation staff for 
an extended period of time. They are liable to punishment upon returning to drug 
consumption. Obviously, the operation of compulsory treatment is widely carried out 
through what Foucault calls ‘coercive technologies’. According to Seddon, the words 
mean: ‘techniques, devices and mechanisms that use force, violence or threats to govern 
or direct the behaviour of individuals’.512 An additional complication is that the detainees 
are exposed to inhuman or degrading practices such as physical violence and 
mistreatment by in-charge officers as revealed by past studies.513 The argument put forth 
by the proponents in the defence of state intervention relies on its importance for restoring 
                                                          
507 W. Hall et al., "Compulsory Detention, Forced Detoxification and Enforced Labour are not Ethically 
Acceptable or Effective Ways to Treat Addiction," Addiction 107, no. 11 (2012).1891. 
508 Sanuar Kamarudin bin Ahmad v Menteri Hal Ehwal Dalam Negeri Malaysia & Anor [1996] 5 MLJ 1. 
509 International Covenant on Civil and Political Rights (ICCPR), Article 12.  
510 International Covenant on Civil and Political Rights (ICCPR), Article 9. 
511 Universal Declaration of Human Rights (UDHR), Article 5; International Covenant on Civil and 
Political Rights (ICCPR), Article 7; United Nations General Assembly, Resolution 39/46: Convention 
against Torture and Other Cruel, Inhuman or Degrading Treatment or Punishment. Articles 1and 2. 
512 T. Seddon, "Court-Ordered Treatment, Neo-Liberalism and Homo Economicus," in The Drug Effect, ed. 
S. Fraser and D. Moore (Cambridge: Cambridge University Press, 2011).161. 
513 For example, K. Dolan and A. Rodas, "Drug Users and Imprisonment," in Drug Law Reform in East and 
Southeast Asia, ed. F. Rahman and N. Crofts (Plymouth: Lexington Books, 2013).45.  
182 
 
the autonomy of drug users. As argued, individuals who are drug dependent lack the 
ability for autonomy and self-determination.514 This premise is less credible given a 
number of countering scientific findings.515 Additionally, advocates justify this in terms 
of the need to balance drug users’ rights with communities which are negatively affected 
by drug use.516 In response, violations of individual rights are not directly justifiable on 
the basis of the public good unless circumstances make such violations a necessity. The 
deprivation of individual liberty in exceptional situations is, however, subject to certain 
criteria including a short period practice and a prior reliable assessment of conflicting 
interests.517 This is somehow not satisfied by Malaysia as reflected by the current 
legislative provisions and practice. Thus, the ethical arguments for mandatory drug 
treatment based on its good for drug users and the general public seem to be unsound.  
However, it can be noted that compulsory drug treatment can be ethical in certain 
exceptional circumstances. The first situation is connected to critical drug dependency or 
demonstrable high risk behaviour.518 Drug users who have either of these cause harm or 
imminent risk to the health and safety of themselves and others. Mandatory detention 
would serve the public health and security imperative by treating drug dependency and 
altering dangerous behaviour. But, the justifiability of compulsory treatment must be 
made dependent on certain criteria, particularly the due legal process and non-
                                                          
514 For example, A.L. Caplan, "Ethical Issues Surrounding Forced, Mandated, or Coerced treatment," 
Journal of Substance Abuse Treatment 31, no. 2 (2006).118–19. 
515 For example, B. Foddy and J. Savulescu, "Addiction and Autonomy: Can Addicted People Consent to 
the Prescription of Their Drug of Addiction?," Bioethics 20, no. 1 (2006).15.  
516 Wu, "Arguments in Favour of Compulsory Treatment of Opioid Dependence."142. 
517 Discussion of public good vis-à-vis human rights can be found in Chapter 2, Section 2.3. 
518 More discussion on this appears in Chapter 5, Section 5.3. 
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involvement in voluntary or less restrictive strategies.519 This is not the case in Malaysia. 
The structural and procedural framework and practice related to Malaysian compulsory 
treatment has many issues including a lack of consistency to the due process of law; no 
exemption for those undergoing voluntary public health measures in the community; and 
liability to more stringent criminal sanctions in a recidivism case or breach of relevant 
conditions.520 The second situation relates to a referral mechanism. The compulsory 
treatment may be offered as an alternative to criminal justice sanctions for individuals 
who commit property crimes to finance their drug taking.521 The justification relies on the 
preference of treatment over punishment in managing drug-dependent offenders in terms 
of individual right to treatment, and the medical, public health and safety imperatives as 
supported by extensive evidence.522 Further, the diversion to treatment is consistent with 
the principle of proportionality as it is not more severe or restrictive than the alternative 
disposed criminal sanction.523 This, however, must be subject to some prerequisites. 
Gostin suggests that the diversion to treatment should be focused on those with serious 
dependency to drugs and susceptibility to treatment, in compliance with the due process 
of law and being less restrictive of liberty than the usual punishment.524 Indeed, this 
referral mechanism is not generally adopted in Malaysia.  
The above discussion demonstrates that compulsory drug treatment is highly 
problematic in terms of its effectiveness and ethical basis. However, it is acknowledged 
                                                          
519 L. Gostin, "Traditional Public Health Strategies," in AIDS Law Today: A New Guide for the Public, ed. 
S. Burris, et al. (New Haven & London: Yale University Press, 1993).74–75. 
520 More evidence can be found later in this section. 
521 More discussion appears in Chapter 5, Section 5.3. 
522 G. Gerra and N. Clark, From Coercion to Cohesion: Treating Drug Dependence through Health Care, 
Not Punishment  (Vienna: United Nations, 2010).2–4. 
523 A. Stevens, "The Ethics and Effectiveness of Coerced Treatment of People who Use Drugs," Human 
Rights and Drugs 2, no. 1 (2012).13. 
524 L.O. Gostin, "Compulsory Treatment for Drug-Dependent Persons: Justifications for a Public Health 
Approach to Drug Dependency," Milbank Quarterly 69, no. 4 (1991).584, 586. 
184 
 
within the Malaysian legal framework. DDTRA 1983 mandates arrest, forced 
examination and treatment in rehabilitation centres or supervision of drug dependents. 
The Act empowers any police officer or rehabilitation officer to take any person into 
custody who is suspected to be drug dependent.525 Drug dependent is defined by section 2 
as someone who, through the use of any dangerous drug, undergoes a psychic and 
sometimes physical state which is characterised by behavioural and other responses 
including the compulsion to take the drug on a continuous or periodic basis in order to 
experience its psychic effect and to avoid the discomfort of its absence.  
The person may be detained for 24 hours for dependency assessment.526 In the 
case of an incomplete assessment, he may be released on bail (with or without surety) or 
taken to a magistrate for application of further detention for a maximum period of 14 
days.527 This period is worded differently from that envisaged by the Criminal Procedure 
Code governing the criminal procedure of detention in lawful custody.528 Moreover, the 
wording of ‘shall, if the officer reports to the Magistrates that it is necessary to detain him 
for the purpose of undergoing tests, order him to be so detained’ in section 4(1) of 
DDTRA 1983denotes that the court is obliged to issue the order of further detention in 
accordance to the officer’s claim of its necessity. Decided cases show that the order is 
justified based on just one officer’s submission of the need to conduct a drug test. 
Research shows that such an extensive period of remand is unnecessary as the results of 
                                                          
525 DDTRA 1983, ss 2 and 3(1). 
526 DDTRA 1983, s 3(2). 
527 DDTRA 1983, s 4(1). 
528 Section 117(2) of the Criminal Procedure Code, in relation to the offences punishable with imprisonment 
of less than 14 years, authorises a remand order for up to four days for first application and up to three days 
for second application, while for the other offences punishable with minimum 14 years of imprisonment or 




urinalysis in Malaysia are achieved within one day.529 This provision obviously curtails 
judicial discretion. A magistrate has to approve a remand application without judicially 
scrutinising its substantiation. Many assessment reports disclose the cases of Malaysian 
magistrates acting as ‘rubber stamps’ in remand proceedings.530 Moreover, for the 
purpose of the assessment, suspects are subject to a range of forcible acts and 
procedures531 with the common practices being urine tests and observation by medical 
practitioners.532 
The detainee must subsequently be brought before the court upon the medical 
practitioner’s certification confirming drug dependency. By considering the certification, 
rehabilitation officer’s recommendations and drug dependant’s representation (if it is 
made), a magistrate may order him to undergo compulsory treatment in a government-run 
rehabilitation centre for two years and then placed on supervision for two years, or 
otherwise a two to three year supervision.533 There is no detailed procedure or other 
requirement for the recommendation and representation stipulated by legislative 
provision, thereby exposing the risks of incredible or insufficient statements. As 
compared to the position before the amendment by Drugs Dependants (Treatment and 
Rehabilitation) (Amendment) Act 1998534, more mandatory procedural requirements have 
been provided including the magistrate’s consideration of the circumstances of the drug 
dependant’s case, age, education, character, health, employment, antecedents and other 
                                                          
529 S. Mohamed, "Mandatory Assessment of Drug Users in Malaysia: Implications on Human Rights," 
Drugs: Education Prevention and Policy 19, no. 3 (2012).3. 
530 For example, Human Rights Commission of Malaysia (SUHAKAM), Law Reform Report: Rights of 
Remand Prisoners  (Kuala Lumpur: SUHAKAM, 2001).8. 
531 DDTRA 1983, s 5. 
532 Re Roshidi bin Mohamed [1988] 2 MLJ 193,197. 
533 DDTRA 1983, s 6(1). 
534 Act A1018. 
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circumstances, the rehabilitation officer’s report, supplying a copy of the report, reading it 
out and explaining its contents to a drug dependant.535 A further complication is that the 
magistrate’s order, upon treatment or supervision, has a final effect and therefore cannot 
be appealed or revised by the High Court, or held by the Supreme Court in Ang Gin Lee v 
PP536. The court’s reasoning is that the order falls under the jurisdiction of a magistrate 
rather than the magistrate’s court in a criminal case or matter which can be appealed as 
described in section 307(i) of the Criminal Procedure Code. Thus, the related procedures 
and treatment order are likely arbitrary and less congruent to the principle of the due 
process of law. 
Moreover, based on section 38A of DDA 1952, the judicial order of treatment or 
supervision under DDTRA 1983, in lieu of other criminal sanctions, may be made for a 
convicted drug offender below 18 if he is a certified drug dependant and it is expedient to 
do so. This provision is, however, not applicable to those committing drug offences of 
trafficking,537 planting or cultivation,538 or possession,539 which attract severe 
punishments. This provision purports to acknowledge the nexus between drug offences 
and drug problems amongst juvenile offenders. However, no similar lenient treatment is 
provided for adult or other crimes caused by drug dependency, including acquisitive 
crimes. 
                                                          
535 These procedures are stated in sections 6(3) and (4) prior to the amendment. 
536 [1991] 1 MLJ 498, 500–01. 
537 DDA 1952, s 39B. The offence is punishable with death on conviction.  
538 DDA 1952, s 6B. The offence is punishable with life imprisonment and whipping of minimum six 
strokes on conviction. 
539 The offence refers to the possession punishable with maximum life imprisonment and whipping of 
minimum 10 strokes on conviction under section 39A of DDA 1952. 
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For drug dependants who volunteer for treatment, the law permits rehabilitation 
officers to decide whether there will be treatment in a rehabilitation centre or supervision 
after drug dependency tests and certification by a medical practitioner.540 This can take 
place without the need for getting the consent of volunteer drug dependants, as was the 
case before the amendment by Drugs Dependants (Treatment and Rehabilitation) 
(Amendment) Act 1998.541 Even though they will not be subject to court proceedings, 
they cannot choose their own type of treatment whether in a rehabilitation centre or 
supervision, and are not guaranteed by law to obtain harm reduction services. 
The drug dependant placed in a rehabilitation centre needs to undergo an 
abstinence-based treatment and other organised activities.542 A drug dependant 
undergoing supervision in the community must comply with stringent conditions on 
liberty regarding residence, cessation of drug consumption and compulsory procedures 
including drug testing, reporting and participating in rehabilitation programmes.543 The 
person is usually compelled to undergo detoxification to comply with the condition of 
abstaining from drugs. In the case of the contravention of supervision restrictions, the 
individual may be subject to a maximum three-year imprisonment or maximum three-
stroke whipping, or both.544 This may constitute another basis for incarcerating drug users 
even though they still have a dependency problem. This mirrors another penal 
characteristic of drug use control. 
                                                          
540 DDTRA 1983, ss 8 and 9. Pursuant to these provisions, drug treatment can be voluntarily applied for by 
drug dependants, parents, or guardians for those below 18 years. 
541 Act A1018. 
542 DDTRA 1983, s 26.  
543 DDTRA 1983, s 6(2). 
544 DDTRA 1983, s 6(3). 
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Drug users are at a high risk of compulsory treatment if they show signs of drug 
dependency. Even though they may already be involved in MMT or NSEP, those who are 
found to be dependent on illicit drugs could still be subjected to compulsory drug 
treatment programmes because there is no any legal exception for MMT or NSEP clients. 
The risk is enhanced by the relevant procedures which have been put at minima. The 
compulsory treatment is not in line with the harm reduction approach as it emphasises the 
only aim of absolute abstinence from drugs, applies detoxification as the principal 
approach and disregards harm reduction principles. This is confirmed by many 
international and national analyses.545 Obviously, the law and policy applicable to 
treatment and supervision does not take into account the aspects of harm reduction 
programmes. It is not followed by any specific legislative or policy document specifying 
the treatment systems or standards and it does not make the link between institutional 
treatment and harm reduction programmes. Successful completion of treatment means 
sustaining a drug-free state and hence a harsh penalty may be imposed for relapse. The 
law provides for punishment of imprisonment of between five and seven years plus a 
maximum whipping of three strokes. Another punitive approach should a person relapse 
after two periods of discharge or a conviction for self-administration of drugs is the 
penalty of imprisonment of between seven and 13 years, plus whipping of between three 
and six strokes.546 This indicates that drug law, in contradiction to the harm reduction 
approach, is intolerant to persistent drug dependency. 
                                                          
545 For example, World Health Organization (Western Pacific Region), Assessment of Compulsory 
Treatment of People who Use Drugs in Cambodia, China, Malaysia and Vietnam: An Application of 
Selected Human Rights Principles.19; Godwin, Regional Issues Brief: Laws and Practices Relating to 
Criminalization of People Living with HIV and Populations Vulnerable to HIV.17. 
546 DDA 1952, ss 39C(1) and (2). 
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Overall, the legal approach to compulsory drug treatment as currently 
implemented in Malaysia is clearly unethical, ineffective and unsupportive of the harm 
reduction philosophy and operation. Its practice may contribute to conflict between 
criminal justice and harm reduction responses, as we will see later in this chapter. 
 
4.2.3   Criminal Offences in relation to Possession of Injection Equipments and Drug 
Residue in Syringe 
 
4.2.3.1 Possession of Injection Equipments 
Malaysia maintains criminal penalties for possession of any equipment for illegal drug 
consumption. The offence carries a maximum of two years’ imprisonment or a fine of a 
maximum of RM5000.00, or both.547 Section 10(3) of DDA 1952 provides the definition 
of consumption for the purpose of this offence as similar to the one given for a drug 
consumption offence in section 15(2) (refer to Chapter 4, Section 4.2.1.1). The illegality 
of equipment is subject to its characteristics and a person’s intention. Thus, syringes and 
needles for use in injecting drugs into the human body are illegal.  
The offence is committed when all ingredients of possession are proved i.e. 
custody or control and knowledge of the existence of the item (as previously discussed 
with regard to drug possession offences). In addition, the knowledge that the device is to 
be used for drug consumption must be established.548 To the advantage of the 
prosecution, the law may presume the sufficiency of evidence for the fact that the 
                                                          
547 DDA 1952, s 10(2)(a). 
548 For example, Ong Chong Hin v R [1959] 1 MLJ 96, 97. 
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equipment is used for that unlawful purpose based on the evidence of a police officer not 
below the rank of sergeant or by a senior customs officer.549 
Having the paraphernalia law places NSEP, in principle, within an illegal, or at 
least uncertain, legal status. Without any immunity, the law also increases the risk of 
enforcement actions including arrest, raid and criminal prosecution for NSEP staff, 
physicians and/or pharmacists distributing drug paraphernalia, and the IDUs receiving it. 
Burris, while analysing the paraphernalia law in the USA, argues that conviction of the 
physician cannot rest on his issuing the prescription as this is dissimilar to having custody 
or control over the device.550 This argument is less applicable in the Malaysian context as, 
besides pharmacists, physicians, particularly in the private sector, are authorised to 
dispense medicines and medical devices to patients.551 This becomes a traditional system 
endorsed by Malaysia’s National Medicines Policy and clearly varies from the practice in 
many countries including the UK whereby the legal right of medication dispensing is not 
given to health personnel other than pharmacists. Thus, where the physician’s supply of 
injection equipment through NSEP or giving a prescription for injection equipment 
supply to a pharmacist working in the same setting where the physician also has access or 
authority of dispensing medicines and medical devices (even when not supplying the 
items to drug users directly), the physician could be found to have had custody and 
control over the injection equipment. Further, the physician fulfils the element of 
knowledge because he knows, or works in circumstances where one reasonably should 
know, that the injection items they provide will be used to inject drugs.  
                                                          
549 DDA 1952, s 37(i). 
550 S. Burris, P. Lurie, and M. Ng, "Harm Reduction in the Health Care System: The Legality of Prescribing 
and Dispensing Syringes to Drug Users," Health Matrix 11, no. 5 (2001).45–46. 
551 W.S. Sing, "Pharmacy Practice in Malaysia," Malaysian Journal of Pharmacy 1, no. 1 (2001).4. 
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Therefore, it is also reasonable to argue that the provision of injection equipment 
as part of an NSEP service is technically illegal for contravening this law. The clear 
authority of a physician to medically prescribe drugs and devices and the pharmacists to 
provide such a prescription may be insufficient to trigger an immunity as the criminal law 
should be read as placing a restriction on their authority.552 Additionally, the strict 
regulations governing the prescribing of medical drugs state that medical discretion 
regarding drug treatment is subject to limitations (that will be discussed later in relation to 
MMT) even though they are inapplicable to needles and syringes. Drug users obtaining 
sterile injection equipment from NSEP services also commit the offence as they form the 
requisite intent for the offence. 
It may reasonably be argued that a syringe cannot be regarded as equipment for 
drug consumption but instead as a legal ‘medical device’ under section 2 of the Medical 
Device Act 2012 for its original manufacture and use for disease prevention or treatment. 
They are provided through NSEP to control HIV and other blood-borne epidemics. 
However, this argument provides dubious comfort. The offence provision of section 
10(2)(a) of DDA 1952 expressly mentions a ‘utensil used in the preparation of opium for 
smoking or consumption’ and hence exposes the possession of a syringe or other 
instrument intended for drug use as liable for criminal charge, without exemption for 
health care providers. No Malaysian case so far has decided on the issue of whether the 
public health statute of the Medical Device Act could circumvent or take precedence over 
the drug control statute of DDA 1952 in cases involving injection equipment supplied by 
NSEP for disease prevention and intended simultaneously for drug using. It is therefore 
                                                          
552 Malaysia has no syringe prescription law. 
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unclear whether the criminal charge of possession of syringes and needles from NSEP 
could be decided in court that the items are medical devices based on the Medical Device 
Act 2012. 
Further, commentators from several jurisdictions postulate that the NSEP could 
protect itself from criminal liability by contending that its operation involves non-
commercial purposes. The provision and collection of injection equipment is conducted 
on a free basis, performing public health efforts. Thus, any acts related to NSEP could not 
be penalised by paraphernalia laws which have mostly historically been drafted to control 
the commercial business of drugs and paraphernalia, and not to disturb health care 
practice.553 While I have found no reference to argument in Malaysia so far, it might be 
possible to arise given the Malaysian drug law which was originally based on the English 
Dangerous Drugs Acts of 1920 and 1925 and which has been drafted primarily as a 
consequence of the existing illegitimate trade and use of opium. However, there is less 
certainty about this argument as the recognised legal rule of interpretation will not 
recognise the objects and reasons as an ultimate basis for interpreting the true meaning 
and implications of the substantive legal provisions. Moreover, the impetus behind 
regulatory control was the belief that the acts connected to drug paraphernalia promote 
drug use, rather than the commercial purpose of the paraphernalia. 
Some commentators in other jurisdictions advance the legal argument that NSEP 
staff could not be found guilty because they lack criminal intention. Their single intention 
is to provide health care and HIV prevention strategies, rather than condoning the 
                                                          
553 For example, D. Abrahamson, "Federal Law and Syringe Prescription and Dispensing," Health Matrix 
11, no. 1 (2001).68–69. 
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consumption of drugs.554 This argument has commonsense appeal but may fail. Arguably, 
the staff member can clearly make out the intended offence even though they are acting 
for good purpose, and they are aware of the items’ intended use. 
We shall consider later in this chapter the extent to which the existing law relating 
to the possession of injection equipment is in conflict with the NSEP. The criminal law 
which is designed to limit access to tools for the preparation and consumption of drugs 
apparently contradicts the principle and objective of NSEP to ensure IDUs use clean 
injection equipment for each injection for the benefit of public health (particularly for the 
prevention of blood-borne transmission of diseases). While the NSEP distributes and 
advises IDUs to obtain clean needles and syringes and return the used ones for proper 
disposal, the law has potential to create a conspicuous disincentive for the group to 
comply with the advice and strategy. The ambiguous legal basis of NSEP and the fear of 
law enforcement and criminal penalties may hinder potential suppliers and IDUs from 
engaging in NSEP and carrying their own syringes. Research results indicate that the 
paraphernalia laws in some countries have led to the outlawing of NSEPs’ establishment 
and ambiguous legal status, thereby discouraging its utilisation by the drug using 
community.555 It is clear that such criminal law may constrain the supply and access of 
sterile syringe. The law may also inadvertently influence the scarcity of sterile syringes 
and occurrence of risky behaviour among IDUs such as the reusing and sharing of 
                                                          
554 For example, L. Ferguson, M. Perez, and S. Burris, "Syringe Exchange In Pennsylvania: A Legal 
Analysis," Temple Political and Civil Rights Law Review 8(1998).50. 
555 For example, P. Case, T. Meehan, and T.S. Jones, "Arrests and Incarceration of Injection Drug Users for 
Syringe Possession in Massachusetts: Implications for HIV Prevention," Journal of Acquired Immune 
Deficiency Syndromes and Human Retrovirology 18, no. Suppl. 1 (1998).S74–S75; J.A. Taussig et al., 
"Syringe Laws and Pharmacy Regulations are Structural Constraints on HIV Prevention in the U.S.," AIDS 
14, no. Suppl 1 (2000).S48. 
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needles. This can further perpetuate risks of blood-borne viral infections, thereby 
potentially frustrating the preventive goals and efforts of the NSEP.  
 
4.2.3.2 Possession of Drug Residue in Syringe 
It is clear that the current law could be interpreted to penalise someone for possessing 
used syringes containing the residue of an illicit drug. Such possession creates a 
presumption of controlled drugs. It is encompassed as ‘anything whatsoever containing 
drugs’ expressed in section 37(d).556 The court’s ruling in Tong Peng Hong v PP557 
shows that ‘anything whatsoever’ is restricted by the usage of the word ‘containing’ 
implying ‘some measure of holding or restriction’. Thus, once it is proved that a person 
has control or custody of the syringe in which the drug was found, he is deemed to be in 
drug possession and to have knowledge of the nature of the drug. 
Without any regulatory exemption, the possessing of an item containing drugs by 
NSEP staff or drug users could attract criminal penalty as the illegal drugs contained 
therein are not for legitimate medical purposes or are not being handled, or to be handled, 
for crime prevention. Additionally, the staff likely knows that the syringe returned to 
them by drug users may contain the trace, irrespective of whether the quantity of drug is 
visible or not. This is because the NSEP programme functions to distribute and collect 
syringes used for consuming drugs. Drug users also often knowingly possess a used 
syringe to contain trace amount of drugs. It might be possible that the accused is shielded 
from legal effect by the doctrine of de minimis non curat lex which means that ‘the law 
                                                          
556 DDA 1952, s 37(d). 
557 [1955] MLJ 232. 
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does not concern itself with trifles’. Court in The ‘Reward’, which was among the first 
cases referred to the doctrine in a criminal context said: 
The Court is not bound to strictness at once harsh and pedantic in the 
application of statutes. The law permits the qualification implied in the ancient 
maxim De minimis non curat lex. Where there are irregularities of very slight 
consequence, it does not intend that the infliction of penalties should be 
inflexibly severe. If the deviation were a mere trifle, which, if continued in 
practice, would weigh little or nothing on the public interest, it might properly 
be overlooked.558 
However, the case law recognising this doctrine is very limited. In PP v Mohamed 
Ali bin Sani,559 the first case considering the issue of the smallness of drug quantity to 
establish possession, the High Court set aside the president’s order and ordered a retrial 
when it was satisfied with the adequacy of evidence of the chemist indicating the 
existence of heroin in the light brown powder. This was despite the heroin’s 
undetermined amount which had been relied on by the lower court in discharging the 
accused. The High Court distinguished the present case from the English case R v 
Worsell560 which has been relied on by the lower court mainly due to the invisibility and 
in reality no drug being found by the later court. The conflicting decisions likely result 
from different tests by the courts; the measurability test by the lower court and the 
identifiability test by the High Court. 
                                                          
558 [1818] 165 ER 1482, 1484. 
559 [1978] 2 MLJ 109. 
560 [1970] 1 WLR 111. 
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In contrast, the Supreme Court in PP v Alcontara561 has considered the cases of 
Carver562 and R v Worsell563 using a purposive approach. The court, affirming the 
purposive approach applied in Loo Keck Leong v PP564, ruled that the small quantity of 
drugs discovered may be disregarded for falling short of the mischief at which the 
legislative provision was intended. Thus, arguably, the doctrine of de minimis could not 
promise a defence for the charge of drug residue possession, given very limited and 
mixed Malaysian courts’ rulings on its application in drug cases. Some other courts might 
construe the legislature’s intention to encompass any amount of drugs, given the absence 
of a statutory minimum quantity.  
The law pertaining to the possession of a syringe containing drug residue may 
further underlie the dominance of the criminal justice approach in drug use matters and 
may threaten the viability of the NSEP. Aside from that offence, the provision of needles 
and syringes may be construed as abetting drug use and render the provider subject to 
criminal liability.565 The criminalisation of trace amounts of illicit drugs has potential to 
result in another central tension between the criminal law and harm reduction approaches. 
This is because criminal law can undermine the NSEP’s intent of promoting safe syringe 
disposal and exchange for sterile equipment. The law may cast a shadow of criminality 
over the practices under the NSEP, thereby potentially impeding participation in the 
intervention. NSEP workers, clients and other IDUs can be in legal jeopardy by carrying 
or possessing used syringes with trace amounts of drugs. They are vulnerable to police 
stop and search practices, confiscation of syringes and criminal charges for drug 
                                                          
561 [1993] 3 MLJ 568. 
562 [1978] 2 WLR 872. 
563 [1970] 1 WLR 111. 
564 [1993] 2 MLJ 177. 
565 Based on DDA 1952, s 33. 
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possession. Discovery of a syringe may hence become a probable cause for enforcement 
officers to conduct further investigations and make arrests for drug use and confiscate 
injection equipment. By the existence of the punitive law, IDUs may avoid carrying, 
returning or safely disposing of the used injection items at the NSEP sites for the fear of 
arrest. This can influence them to reuse and/or discard the items on the streets. The law of 
possession of a syringe with drug residue may hence present an important barrier to the 
efficient operation of NSEP. We shall consider later in this chapter the extent of this 
impact.   
 
4.2.4  Regulatory Framework Governing Prescribing, Dispensing and Receiving 
Methadone 
 
Methadone remains a controlled substance classified as a Part III substance in the First 
Schedule of the DDA 1952, meaning that its production, supply, possession or any other 
dealings are all criminal offences, unless this is warranted by the regulations of the 
statute.566 Despite the confirmed efficacy of methadone for drug treatment, its use has 
been constrained, a fact mirrored in the expansive regulations governing its use. The 
Dangerous Drugs Regulations 1952 permits Part III controlled substances to be used for 
medical purpose but with limited dealings and strict control measures for its circulation, 
including storing and record-keeping requirements and other requirements to control their 
abuse and diversion. Additionally, legitimately dealing with methadone must comply with 
                                                          
566 DDA 1952, s 16. 
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the requirements of the Poison Act 1952 and Poisons (Psychotropic Substances) 
Regulations 1989 as methadone is also listed as a psychotropic substance in Part I, Group 
B of the First Schedule of Poison Act 1952.  
The provision of methadone is further restricted by the National Policy and 
Standard Operating Procedures for MMT (hereinafter referred to as MMT Policy and 
SOP), the National MMT Guideline, MMT Dispensing Guideline and Guideline on the 
Endorsement of Methadone Dispensing by Assistant Pharmacists at Methadone Clinics of 
Malaysian Ministry of Health that set out the circumscribed situations in which 
methadone may be prescribed and dispensed for drug treatment. 
Generally, the legislative provisions authorise the prescribing and administration 
of controlled drugs, including methadone,567 by a medical practitioner568 or under his 
directions for medical treatment.569 However, unless they are specifically approved for 
the purpose, a medical practitioner is not permitted to prescribe methadone. Handling 
methadone for medical purposes is permitted only under a valid permit issued by the 
licensing officer570.571 Methadone for the administration, supply or sale to patients should 
be prepared by the medical practitioner himself or under his immediate personal 
supervision.572 As for further eligibility to prescribe methadone, the MMT Policy and 
SOP require the physician to register with the MOH and obtain accreditation for the 
                                                          
567 Dangerous Drugs Regulations 1952, s 12(1); Poison Act 1952, s 21. 
568 The term ‘registered medical practitioner’ denotes a medical practitioner registered in the Malaysian 
Medical Council (MMC) pursuant to the Medical Act 1971(DDA 1952, s 2 and the Poison Act 1952, s 2). 
To legally practise medicine, registered practitioners must also possess an Annual Practising Certificate, as 
stipulated by section 20 of the Medical Act 1971.  
569 DDA 1952, s 14(2); Poisons (Psychotropic Substances) Regulations 1989, s 16. 
570 Based on the Poison Act 1952, s 2, a ‘licensing officer’ is a person appointed under the Poison Act 1952 
and includes the Director General of Health. 
571 Poisons (Psychotropic Substances) Regulations 1989, ss 12A and 15. 
572 Poison Act 1952, s 19. 
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purpose from the Addiction Medicine Association of Malaysia and the Federation of 
Private Medical Practitioners Association. The accreditation is not granted unless the 
physician has undergone government-endorsed training in the management of MMT.573 
Registrants bear responsibilities for compliance with detailed prescribing requirements 
under the regulations and guidelines. Thus, the prescribing of methadone for drug 
treatment is permitted but highly restricted and extensively regulated.  
Moreover, methadone dispensing is authorised but contingent on multiple 
conditions including prescription requirement and the dispenser’s eligibility. The 
Regulations provide the authorisation for registered medical practitioners and registered 
pharmacists574 to supply methadone for medical treatment.575 Additionally, a licensed 
pharmacist is sanctioned to sell or supply methadone as a dispensed medicine.576 They 
also retain the authority to compound, mix or dispense methadone with any other 
substance for medical uses.577 In order to be eligible to dispense, pharmacists are required 
by the MMT Dispensing Guideline to obtain exposure and sufficient knowledge on 
medicines used in MMT.578 The authority of dispensing may extend to a pharmacy 
assistant or in his absence a medical assistant in government-run health settings, but must 
be exercised pursuant to the regulative requirements.579 A pharmacy assistant intending to 
                                                          
573 MMT Policy and SOP, s 5. 
574 Based on section 2 of DDA 1952 and section 2 of the Poison Act 1952, a ‘registered pharmacist’ is a 
pharmacist registered under the Registration of Pharmacists Act 1951. Eligible persons are registered with 
the Malaysian Pharmacy Board. In Sabah and Sarawak, pharmacists must also hold a qualification relating 
to the pharmacy profession acknowledged by the Director of Medical Services in Sabah or Sarawak. Each 
pharmacist must also obtain an Annual Retention Certificate to ensure that their names stay on the register, 
as required by section 16 of the Registration of Pharmacists Act 1951.  
575 Dangerous Drugs Regulations 1952, ss 5(1) and 8(1); Poisons (Psychotropic Substances) Regulations 
1989, s 11(1). 
576 Poison Act 1952, s 21(1). 
577 Poison Act 1952, s 12; Poisons (Psychotropic Substances) Regulations 1989, s 17. 
578 MMT Dispensing Guideline, s 7.2. 
579 Poisons (Psychotropic Substances) Regulations 1989, s 32. 
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dispense methadone has to fulfil stricter requirements under the Guideline on the 
Endorsement of Methadone Dispensing by Assistant Pharmacists. He must have passed 
specific training on methadone dispensing and acquired a Pharmacy Service Division, 
MOH’s endorsement certificate enabling dispensing practice.580 The approval is time 
limited and requires the assistant pharmacist to renew his certificate every two years.581 
Methadone must be dispensed in liquid form and consumed under supervision. 
Takeaway doses are only allowed based on careful selection regarding the client’s 
stability, reliability and progress in treatment.582 The legislative provisions legalise the 
possession of methadone by those to whom it is being dispensed when it is obtained 
directly from a medical practitioner or under a prescription which is issued in compliance 
with the Regulations.583 
The methadone is restricted to be dispensed to MMT clients. Legal rules on who 
could be taken on as a client stipulate that he must be capable of giving informed consent 
and have a chronic case of opiate dependency (regular injection of opiates exceeding two 
years or several failures to undertake in-patient treatment in the health care institutions 
and rehabilitation communities). Despite that, individuals are excluded if aged below 18, 
or have dependence on polysubstance non-opiate, a severely impaired liver functions test, 
hypersensitivity to methadone or acute medical and/or psychiatric disorders.584 The quota 
                                                          
580 Based on Parts E and F of the Guideline on the Endorsement of Methadone Dispensing by Assistant 
Pharmacists, assistant pharmacists who want to train in methadone dispensing must be selected by an MMT 
Coordinating Officer at the state level based on fixed criteria including having confirmed employment, a 
minimum of three years’ service, a minimum of two years’ working experience in any outpatient pharmacy 
or specialist clinic’s pharmacy, a professional attitude and conduct, and no disciplinary record. 
581 Guideline on the Endorsement of Methadone Dispensing by Assistant Pharmacists, Part F. 
582 MMT Policy and SOP, s 5; National MMT Guideline, s 3.4. 
583 DDA 1952, s 12(2); Dangerous Drugs Regulations 1952, s 6(2); Poisons (Psychotropic Substances) 
Regulations 1989, s 3. 
584 MMT Policy and SOP, Appendix 2, 15; National MMT Guideline, s 2.1. 
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of new clients is also fixed with a maximum of 20 per physician per month.585 Their 
admission does not guarantee retention in MMT as the clients are subject to review and 
monitoring procedures including toxicological testing for drugs which make dismissal 
possible.586 Drug consumption is seen as improper behaviour which can be a basis for 
involuntary discharge.587 
Therefore, acts such as prescribing, dispensing, possessing, administering and 
consuming methadone for medical purposes are legal subject to their compliance with the 
relevant legislative provisions and guidelines. This offers high protection for MMT 
practice. The current regulatory framework shows that there is no theoretical conflict 
between the criminal justice and harm reduction approaches with respect to drug 
provision for medical impetus. The criminal justice goals and principles regarding 
methadone prescription are broadly consistent with those of MMT. This is in contrast to 
the situation with NSEP which stands in sharp contradiction to the paraphernalia law.  
However, we will consider later in this chapter whether the extensive and 
restrictive regulatory framework has a negative impact on harm reduction and MMT in 
particular. The MMT efficiency may be affected by the extensive and rigid requirements 
and restrictions that apply to methadone provision including accreditation, licensing, 
duration, quota, diagnosis, clients’ admission and maintenance. These restrictions are 
considerably stricter than the limits suggested by the international drug treaties for 
legitimate methadone dispensing.588 The stringent regulations mean that physicians’ 
                                                          
585 MMT Policy and SOP, s 5. 
586 National MMT Guideline, s 3.2. 
587 MMT Policy and SOP, Appendix 1, 14; National MMT Guideline, s 3.6. 
588 The 1961 Convention enumerates certain minimum conditions that must be adopted in the national 
regulations relating to the dispensing of Schedule 1 drugs including methadone. The conditions are: 
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decision on prescribing mainly hinge upon legal rather than medical considerations. 
These have potential to limit the physicians’ attention to the diagnostic and fact-specific 
basis in the examination of the individuals’ need for methadone. In other words, the 
overly tight restrictions may significantly impact doctors’ attitudes and behaviour towards 
prescriptions and usurp their clinical discretion. The international literature shows that the 
strict regulation589 of drug prescription can result in adverse consequences, including 
creating fear among medical practitioners of the threat of sanctions for unintended 
mishandling, constraining the exercise of clinical judgment and giving rise to 
considerable financial costs in complying with legislative requisites.590  
The tight conditions for the participation of drug users in MMT and intolerance to 
their continued drug use while in the programme may cause limited accessibility and 
unmet demands for methadone provision including those identified in health-care settings 
suffering from drug dependence or serious pain from illness. The delay or rejection of 
service may result in drug users continuing to consume illicit drugs, particularly while in 
withdrawal to alleviate severe physical discomfort and craving for relief, indulging in 
high-risk behaviour and recourse to black market drugs.591 The chance to gain drug users’ 
                                                                                                                                                                             
dispensing must be undertaken only by those with a professional practising licence or a special licence for 
doing so, drugs can only be moved between authorised persons and institutions, dispensing must be done 
upon a medical prescription, and any issued prescriptions must comply with sound medical practice and 
regulations for public health and welfare protection. Further requirements may be specified if considered 
necessary by the state to avert drug abuse and diversion (World Health Organization, Guidelines for the 
Psychosocially Assisted Pharmacological Treatment of Opioid Dependence  (Geneva: World Health 
Organization, 2009).79–80; the 1961 Convention). 
589 These include prescribing criteria that are specified only to drug treatment centres and to highly qualified 
medical practitioners in either or both government and private health settings, and rigid admission 
conditions that specify age limits, abstinence and random-based urinalysis during the maintenance period. 
590 R.A. Rettig and A. Yarmolinsky, eds., Federal Regulation of Methadone Treatment (Washington: 
National Academy Press, 1995).4. 
591 Babor et al., Drug Policy and the Public Good.190. 
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admission to treatment in future may vanish because they may not try again to access the 
service after the rejection or delay. 
Obviously, despite the importance of a clear regulatory framework for controlling 
drug prescribing practice, providing care for clients and securing against possible 
unethical actions and diversion of prescribed methadone, the strictness of the current 
framework has the potential to erode and endanger the MMT initiatives.   
It is clear that drug treatment that involves the prescribing of methadone is 
mandated by Malaysian law, though highly regulated and hence any medical suggestion 
to use methadone will be subject to careful scrutiny by law enforcement. The supply of 
methadone without authority may give rise to penalties under the existing Regulations 
including a fine and/or imprisonment. An additional or alternative liability might be for 
committing an infamous conduct under the Code of Professional Conduct, thereby 
incurring medical board disciplinary sanctions or revocation of the license.592 
Furthermore, this may leave open the possibility that a physician who possesses and 
supplies methadone to clients when he has no legal right could be found guilty of 
possession under section 12(2) DDA 1952 if caught with methadone in his possession. 
Once proved as having some measure of custody or control over methadone such as by 
physically handling drugs for the purpose of supplying to drug users, he may be deemed 
                                                          
592 The disciplinary sanctions may be exercised by the Malaysian Medical Council (MMC) pursuant to the 
Medical Act 1971, s 29. The sanctions may be striking off or temporarily suspending the practitioner from 
the Register, reprimand or any of the sanctions plus suspension of application subject to certain conditions 
for a period or periods in the aggregate not exceeding two years (the Medical Act 1971, s 30). Moreover, 
the Board of Inquiry under the MOH is entitled to deal with disciplinary matters regarding medical 
practitioners in the public sector (N.R. Wan Abdullah, "Regulating Malaysia’s Private Health Care Sector," 
in Health Care in Malaysia: The Dynamics of Provision, Financing and Access, ed. C.H. Leng and S. 
Barraclough (Oxon: Routledge, 2007).47).  
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to possess drugs and have knowledge to its presence. He may also risk the charge for 
trafficking or administration of drugs to others.  
Trafficking of illicit drugs is a serious crime provided under section 39B of DDA 
1952 and punishable with a mandatory death penalty.593 To prove the offence of 
trafficking, the prosecution needs to adduce evidence relating to the physical elements of 
possession of the drugs in question and a further act constituting trafficking under section 
2 and the mental element of intention or knowledge of the nature of the drugs.594 The act 
of trafficking is defined broadly in section 2 of DDA 1952, as including manufacturing, 
importing, exporting, keeping, concealing, buying, selling, giving, receiving, storing, 
administering, transporting, carrying, sending, delivering, procuring, supplying or 
distributing any dangerous drugs. Additionally, section 39B includes the offering and 
preparatory act to do any of the enumerated acts. However, the judicial rulings indicate 
that the meaning of each trafficking act is dependent on the facts of a particular case595 
and should be strictly construed, considering the principle of penal statute 
interpretation.596 To constitute an act of trafficking, it must be shown that it involves two 
parties as a minimum; a transfer or intention to transfer possession of drugs to another 
party.597 
A person may also be presumed to be a trafficker when he is in possession of 
dangerous drugs and by virtue of the weight of the dangerous drugs enumerated in the 
                                                          
593 DDA 1952, s 39B(2). The death punishment is inflicted by hanging until death pursuant to Article 277 of 
the Criminal Procedure Code, with the exception of pregnant women (Criminal Procedure Code, s 275) and 
minors (Child Act 2001, s 97). 
594 PP v Zulkefle Abu Bakar & Anor[2000] 2 CLJ 359, 372; PP v Zulkipli bin Othman & Ors [2005] 5 MLJ 
170, 178. 
595 Chow Kok Keong v PP [1998] 2 MLJ 337, 338. 
596 PP v Hairul Din bin Zainal Abidin [2001] 6 MLJ 146, 156. 




section 37(da)(i) to 37(da)(xxv) of DDA 1952.598 The small quantity prescribed for the 
trafficking shows the strict approach over the drug possession, which may implicate drug 
users who have such an amount in their possession even if it is for own consumption. 
However, the prosecution cannot invoke double presumption, relying on the presumption 
of possession to invoke a trafficking presumption under section 37(da) in the light of the 
plethora of cases on this point.599 The rule against double presumption has been likely to 
be annulled by the amendment through the Dangerous Drugs (Amendment) Act 2014,600 
providing that a statutory presumption could be used together or conjunctively with 
                                                          
598 Section 37(da) of DDA 1952 provides: 
 Any person who is found in possession of – 
(i) 15g or more in weight of heroin; 
(ii) 15g or more in weight of morphine; 
(iii) 15g or more in weight of monoacetylmorphines; 
(iv) a total of 15g or more in weight of heroin, morphine and monoacetylmorphines or a total 
of 15g or more in weight of any two of the said dangerous drugs; 
(v) 1,000g or more in weight of prepared opium; 
(vi) 1,000g or more in weight of raw opium; 
(v)        a total of 1,000g or more in weight of prepared opium and raw opium; 
(vii) 200g or more in weight of cannabis; 
(viii) 200g or more in weight of cannabis resin; 
(ix) a total of 200g or more in weight of cannabis and cannabis resin; 
(x) 40g or more in weight of cocaine; 
(xi) 2,000g or more in weight of coca leaves; 
(xii) 50g or more in weight of 2-Amino-1-(2, 5-dimethoxy-4-methyl) phenylpropane; 
(xiii) 50g or more in weight of Amphetamine; 
(xiv) 50g or more in weight of 2, 5-Dimethoxyamphine (DMA); 
(xv) 50g or more in weight of Dimethoxybromoamphetamine (DOB); 
(xvi) 50g or more in weight of 2, 5-Dimethoxy-4-ethylamphetamine (DOET); 
(xvii) 50g or more in weight of Methamphetamine; 
(xviii) 50g or more in weight of 5-Methoxy-3, 4-Methylenedioxyamphetamine (MMDA); 
(xix) 50g or more in weight of Methylenedioxyamphetamine (MDA); 
(xx) 50g or more in weight of N-ethyl MDA; 
(xxi) 50g or more in weight of N-hydroxy MDA; 
(xxii) 50g or more in weight of N-methyl-1 (3, 4-methylenedioxyphenyl)-2-butamine; 
(xxiii) 50g or more in weight of 3, 4-Methylenedioxymethamphetamine (MDMA); 
(xxiv) 50g or more in weight of Paramethoxyamphetamine (PMA); 
(xxv) 50g or more in weight of 3, 4, 5-Trimethoxyamphetamine (3, 4, 5-TMA); or 
(xxvi) a total of 50g or more in weight of any combination of the dangerous drugs listed in 
subparagraphs (xi) to (xxiv),  
otherwise than in accordance with the authority of this Act or any other written law, shall be 
presumed, until the contrary is proved, to be trafficking in the said drug. 
599 For example, Muhammed bin Hassan v PP [1998] 2 MLJ 273, 274–75; PP v Tan Tatt Eek& Other 
Appeals [2005] 2 MLJ 685, 686–87. 
600 Act A1457. 
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another statutory presumption.601 However, arguably, it is unlikely the courts will 
interpret in such a way as the terms ‘found in possession’ used in section 37(da) clearly 
permit the trafficking presumption to be activated only upon a finding of possession. 
The accused, however, may rebut the presumption on the balance of probabilities 
that he was unaware of the existence of drugs in his possession and he was not a 
trafficker. The Supreme Court in Ng Chai Kem v PP602 ruled that the accused person’s 
challenging of the presumption of trafficking by contending that he is a drug dependent, 
rather than a drug trafficker, should be considered by court. The court has to consider 
whether the possession presumption under section 37(d) and trafficking presumption 
under section 37(da) are rebutted on the balance of probabilities separately.603 If the 
accused successfully rebuts the possession presumption, the accused has no need to rebut 
the trafficking presumption. However, if he fails to challenge the presumption of 
possession but successfully rebuts presumption of trafficking, he will be liable for the 
lesser offence of possession under section 39A.  
The possibility of bringing trafficking charges for the illegally supply of 
methadone to drug users would theoretically be possible in numerous ways. The 
physician’s activities carried out in such prescribing may potentially denote trafficking 
acts, such as administering, giving, supplying and distributing. These acts are neither 
defined by DDA 1952 nor case law related to drugs. According to Smith, the offence’s 
physical element happens based on the combined actus reus of the pharmacist’s supply of 
drugs and mens rea of the physician whose intention is to illegally supply drugs to 
                                                          
601 The amendment has been primarily made to overrule the court rulings against the application of double 
presumptions.   
602 [1994] 2 MLJ 210, 219–20. 
603 Mohamad Radhi bin Yaakob v PP [1991] 3 MLJ 169, 172. 
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patients.604 The conviction for the trafficking is only secured if the prosecution adduces 
direct evidence to prove the offence. The trafficking presumption cannot be invoked in 
this case as methadone is not covered by section 37(da).  
Further, as the act of giving out methadone may constitute administering, the 
prosecution could conceivably bring a prosecution for the administration of drugs to 
others under section 14(1) of DDA 1952. Upon conviction, the punishment available is a 
maximum of three years of imprisonment or a maximum RM10000.00 fine, or both. The 
offence must be proved by direct evidence regarding the act of administering drugs to 
another person and the recipient’s tested urine found to contain drugs.605 No statutory 
presumption is specified for this offence when compared to the self-administration 
offence. 
Moreover, notwithstanding whether methadone is received on the advice of a 
medical practitioner for the purpose of treating withdrawal from drugs or relieving critical 
pain, unauthorised individuals receiving methadone face risks of criminal charges. The 
risk also extends to drug users receiving methadone for the purpose of reducing their drug 
dependency, including through MMT, but improperly complying with regulatory and 
guideline requirements as discussed above. The DDTRA 1983 further makes the 
unwarranted treatment of drug dependence illegal.606 Therefore, unauthorised (for any of 
the abovementioned situations) drug users could technically be prosecuted for self-
administration of drugs under section 15 DDA 1952 if found consuming methadone and 
for possessing illegal drugs under section 12(2) of DDA 1952 if caught with methadone. 
                                                          
604 [1986] Crim. L.R. 681.  
605 Implied by the ruling regarding the offence of self-administration of drugs under section 15 of DDA 
1952 in the case of PP v Chan Kam Leong [1989] 2 CLJ (Rep) 311, 313. 
606 S 16(5). 
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However, they are not at risk of committing the offence of possession under sections 6, 
9(1)(b), 39A(1) and 39A(2) as the drugs specified in these provisions do not include 
methadone. 
Additionally, the law opens the potentiality that a person such as a medical 
practitioner prescribing methadone without authority may have secondary liability related 
to the offence of self-administration, consumption or possession of methadone committed 
by drug users. They may be criminally liable on the basis of either conspiracy607 with 
drug users to administer, consume or possess methadone, or instigating, aiding or 
engaging with drug users in conspiracy608 for committing any of these criminal acts. 
Furthermore, the unauthorised prescriber and drug user are exposed to preventive 
detention under the Dangerous Drugs (Special Preventive Measures) Act 1985 if they are 
suspected to be involved or associated with trafficking activities,609 with or without the 
confiscation of property.610  
                                                          
607 Penal Code, s 120A. 
608 All acts of instigating, aiding and engaging in conspiracy to commit crime fall under the offence of 
abetment and are liable for whatever punishment is specified for the abetted crime (DDA 1952, s 33). 
609 It is also possible that drug users and unauthorised methadone prescriber may be arrested without 
warrant and detained for investigations for the period up to 60 days under the authority of section 3 of the 
Dangerous Drugs (Special Preventive Measures) Act 1985 for suspected involvement or association to drug 
trafficking activities. They may be subsequently detained without trial or placed under restrictions for a 
maximum two-year term (section 6(1) and (3)). The order for detention or restriction may be issued by the 
Minister of Home Affairs after considering the reports of police investigation and Inquiry Officer (the 
Attorney General Department’s officer placed in the MOHA) and being satisfied that it is necessary do so 
in public order interest (section 6(1)). It may be renewed for successive two years (section 11A(1)). The 
order and related procedures are controversial for limited due process safeguards and serious violation of 
personal liberty and principle of justice. The arising issues include their prolonged detention period in 
police custody, no court proceeding (except for procedural matters), no judicial review for the order and 
limited transparency of representation proceedings before the Advisory Board.  
610 The property of those who are convicted for drug trafficking under DDA 1952 or detained without trial 
under Dangerous Drugs (Special Preventive Measures) Act 1985 for activities related to drug trafficking 
may be seized and forfeited based on the authority of Dangerous Drugs (Forfeiture of Property) Act 1988. 
(Mainly Sections 10(5), 25, 26, 27, 32 and 33)).  
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The physicians and drug users facing such criminal charges may argue that they 
lack the required intent to commit crimes since the methadone is supplied for treating 
drug dependence, critical withdrawal from drugs or serious pain. This argument is 
seemingly possible but less persuasive as when they have intention or knowledge to do 
any act which is classified as a crime, even for good purpose, they could be said to be 
committing the crime. The other possible defence is through the application of the double 
effect rule which has been recognised in medical cases in some jurisdictions.611 It denotes 
an ethically acceptable act is not to be regarded prohibited for its possible foreseeable but 
not intended secondary implication.612 The accused may contend that the criminal effect 
of therapeutic acts is negated by the secondary effect of saving drug users or relieving 
their pain or dependence on drugs. Despite the rule’s potential to challenge the 
conviction, this could not guarantee acquittal since it depends on the court’s discretion. It 
seems difficult in the absence of any local decided drug case recognising its application.  
Conclusively, the strict legislative controls may put medical practitioners and drug 
users at risk of criminal prosecution for unauthorised drug prescribing, possessing or 
using. This impact has also been recorded in other countries. A study in the USA, for 
example, documented overall 986 cases from the 1998 until 2006 that involved criminal 
and administrative charges against physicians pertaining to opiate prescribing.613 The 
charges relate to various unauthorised actions of prescribers, such as drug illegally 
distributing, unlicensed activity and falsifying or failing in keeping complete medical 
                                                          
611 For example, the USA Supreme Court in the Vacco and Others v Quill and Others[1997] 50 BMLR 119, 
128 acknowledged the applicability of double effect rule for justifying the physician’s permitting of 
patient’s denial to life-saving treatment and considered it as different from assisting suicide. 
612 T.E. Quill, R. Desser, and D.W. Brock, "The Rule of Double Effect - A Critique of Its Role in End-of-
Life Decision Making," New England Journal of Medicine 337, no. 24 (1997).1768. 
613 D.M. Goldenbaum et al., "Physicians Charged with Opioid Analgesic Prescribing Offenses," Pain 
Medicine 9, no. 6 (2008).741. 
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records.614 The criminal provisions delineate the margins of legality for methadone 
prescribing and using acts by providing the strict conditions for its legal practice and 
room for broad inspections, investigation and criminal liabilities for unauthorised 
prescribing and using, even for necessities. The stringent restrictions and criminal 
sanctions somehow reflect the dominant criminal control over methadone provision, 
dispensation and use. They can deplete the efficient implementation of MMT services in 
certain aspects and result in stifling the growth of the interventions.615 We shall consider 
later whether or not the impacts of extensive regulations on MMT occur in practice. 
Overall, while the harm reduction approach is adopted in Malaysia, the laws 
penalising illicit drug self-administration, possession and dependency, possession of 
injection items, possession of trace amount of drugs in injection equipment and 
unauthorised drug prescribing are still sustained. While the provision of methadone is 
legalised, it is strictly regulated in the current legislations, regulations and guidelines. The 
legislative and regulatory framework has the possibility to contradict and/or produce 
implications on the aims and efforts of harm reduction. It may place harm reduction 
workers, clients and other drug users at risk of legal problems, thereby possibly 
discouraging or creating obstacles for them to comply or participate in harm reduction 
promotion and techniques for drug-related harm prevention. To what extent in practice it 
actually impacts harm reduction operation will be examined in section 4.4 of this chapter.  
 
                                                          
614 Ibid.743-744. 
615 D.A. Fiellin et al., "Methadone Maintenance in Primary Care-A Randomized Controlled Trial," Journal 
of the American Medical Association 286, no. 14 (2001).1729–30; R.G. Newman, "Addiction and 
Methadone: One American's View," in War on Drugs, HIV/AIDS, and Human Rights, ed. K. Malinowska-
Sempruch and S.   Gallagher (New York: International Debate Education Association, 2004).275–77. 
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4.3 A Review of Government Initiatives to Encourage the Support of the 
Criminal Justice System to Harm Reduction Interventions 
 
Further to their endorsement of the harm reduction approach, the Malaysian government 
has put in place mechanisms intended to eliminate any conflict, particularly in practice, 
between the criminal justice and harm reduction strategies. This section provides a brief 
discussion of these government initiatives.  
The government has conducted law enforcement advocacy of acceptance and 
uptake in several manners to achieve the harm reduction’s unimpeded operations. The 
role of the police and other criminal justice actors to implement the approach in 
partnership with the MOH and related bodies is depicted in the national HIV/AIDS policy 
documents. The National Strategic Plan on HIV and AIDS 2011-2015 expresses the 
integral role of law enforcement towards the maintenance of facilitating environments for 
HIV responses including harm reduction strategies by minimising obstacles to their 
efficient implementation.616 
To ensure collaboration between public health and law enforcement agencies for 
HIV responses, the composition of important stakeholder committees at federal, state and 
district levels (namely the National Coordinating Committee on AIDS Intervention, the 
National Advisory and Technical Committee on AIDS and National Task Force on Harm 
Reduction) led by MOH includes seats for representatives from the RMP, NADA and 
                                                          
616 Ministry of Health Malaysia, Malaysia: National Strategic Plan on HIV and AIDS 2011-2015.19, 22. 
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Prisons Department, health professionals and NGOs.617 This signals a prevailing 
coordinating power of MOH over other enforcement agencies with regard to the harm 
reduction approach. This high-level coordination is significant for aligning the objectives 
of the harm reduction and criminal justice approaches and providing policy advice on the 
approaches. The coordination also potentially provides a medium for dialogues between 
relevant agencies to address any relevant policy and legal issues that arise.  
Moreover, training related to the concepts and objectives of the harm reduction 
approach is provided by the MOH, with the cooperation of NGOs, to members of the 
police force, drug agencies and the prison department, particularly to senior officers and 
new recruits.618 The training, however, does not represent a regular and comprehensive 
mechanism to cover all ground-level officers. Policy directives, official letters or face-to-
face briefings are ordinarily disseminated by the higher level officers down the 
organisational hierarchy to convey policy information. But the documents and briefings, 
like the training, are merely focused on basic information regarding harm reduction 
rationales and the need for their support by not interrupting the approach’s operations. As 
they are not detailed, arguably, the documents leave too much to the interpretation and 
discretion of street-level officers. 
For police, there are two predominant documents relating to harm reduction 
interventions, namely the National NSEP Guidelines for Police and the MMT Guidelines 
for Police. The documents were released to guide the police in dealing with MMT and 
NSEP clients. The NSEP Guidelines for Police explicitly prohibit the police from 
                                                          
617 Ibid.24–26.  
618 A. Kamarulzaman, "Impact of HIV Prevention Programs on Drug Users in Malaysia," Journal of 
Acquired Immune Deficiency Syndromes 52(2009).S18. 
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specifically targeting NSEP sites for surveillance and other enforcement activities 
possibly deterring drug users from accessing NSEP and safely disposing of used injection 
instruments.619 The police must be informed prior to the NSEP’s operation in their 
jurisdiction.620 The police are only permitted to take appropriate actions in the vicinity of 
NSEP sites in a few situations including rising drug-related crimes, negative implications 
to communities and necessary operations approved by senior personnel.621 The police 
cannot arrest MMT clients unless they are found to be involved in illicit drug 
consumption or criminal activity.622 
Even though the guidelines have no legal effect, they provide considerable 
protection to harm reduction participants. The clients who are generally out of bounds to 
police raiding for using drugs or committing crimes are those in MMT and NSEP areas. 
This has been confirmed by the MOH that the police are not stopped from detaining drug 
users apart from the sites used by the harm reduction services.623 
It can be argued that the mechanisms put in place by the government in order to 
eliminate any conflict between the criminal justice and harm reduction approaches are not 
comprehensive. The administrative mechanisms seemingly focus on the prevention of the 
interruption of street-level enforcement upon harm reduction operations. No consideration 
is devoted to address overall legislative provisions and penal strategies incompatible with 
harm reduction principles and objectives. Also, the mechanisms do not extend to 
                                                          
619 Ministry of Health Malaysia and Royal Malaysia Police, The National Needle and Syringe Exchange 
Programme: Guidelines for Police  (Putrajaya, Malaysia: Ministry of Health Malaysia, 2006). Articles 4.1 
and 4.4. 
620 Ibid. Articles 6.1 and 9.3. 
621 Ibid. Articles 4.3 and 5.1. 
622 Kementerian Kesihatan Malaysia, Program Terapi Gantian dengan Methadone: Garis Panduan untuk 
Polis [Methadone Maintenance Therapy: Guidelines for Police]  (Putrajaya, Malaysia: Kementerian 
Kesihatan Malaysia, 2007). Articles 7.2 and 8. 
623 A.F. Cruez and F.A. D' Cruz, "A Shot in the Arm," News Straits Times, 24 March 2007.13. 
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instigating the extensive partnership between the public health and criminal justice 
systems.   
It is notable that the adopted mechanisms have specific limitations. The advocacy 
and training are not sufficiently far-reaching because of the less systematic inclusion of 
grassroots police officers and of some other criminal justice actors including prosecutors 
and judges. In the absence of any evidence showing court officers’ reluctance to be 
involved in harm reduction policy, this likely indicates the government’s perception that 
the feasibility of the harm reduction approach is relatively more associated with policing 
and the operational activities of drug treatment agencies and prisons, rather than courts. 
Moreover, to date it appears there has been no system for directing law enforcement on 
how actually to engage effectively in wider collaboration. The international literature 
highlights the critical importance of multi-agency working in drug treatment and the harm 
reduction approach. This is encapsulated in the words of Anglin and Hser: ‘Members of 
both systems (criminal justice system and treatment system) need to move away from 
adversarial stances and towards collaboration to produce the desired behaviour change in 
drug users’.624 The agencies’ unification and closer engagement of the different agencies 
are preconditions for the proper operation of harm reduction.625 In the absence of a 
detailed framework and documentation, the actual practice of enforcement is still largely 
left to the discretion of law enforcement officers.  
  
                                                          
624 M.D. Anglin and Y.I. Hser, "Criminal Justice and the Drug‐Abusing Offender: Policy Issues of Coerced 
Treatment," Behavioral Sciences & the Law 9, no. 3 (1991).264. 
625 M. Jardine, "Building Partnerships between Law Enforcement and Harm Reduction Programs," 
International Journal of Drug Policy 24, no. 5 (2013).378. 
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4.4 What Impact in Practice have the Legislative and Regulatory Framework 
and Government Initiatives had on the Operation of Harm Reduction in 
Malaysia 
 
This section will examine the actual impact in practice on harm reduction of the 
legislative and regulatory provisions and of the government initiatives. It is important to 
acknowledge that the section will not present the complete extent of this enforcement, due 
to the absence of detailed case-by-case observation and available research findings. It is 
important to note that most of the enforcement data presented in this discussion is from 
official statistics and hence caution should be observed when relying on it. No other 
agencies produce the data except the government. So far, there has not been any 
significant debate in Malaysia about the use of the government statistical data. 
Additionally, the extent of data is very limited, especially regarding the charges, 
convictions and punishments. The approach of the government towards the availability 
and openness of data is probably the main contributor to this situation. The discussion of 
law enforcement proceeds with an account of international literature, particularly on 
points concerning the possible effects of enforcement.  
The available evidence gives no indication that the incidence of drug use-related 
arrests and associated criminal sanctions has diminished since the adoption of the harm 
reduction approach. A high number of drug users have still been detained and subjected 
to urine tests. In 2008, there were 163,054 arrests by the police for the purpose of 
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urinalysis, growing to 246,151 in 2009 and to 368,846 in 2012.626 Upon positive 
urinalysis for illicit drugs, drug dependants are frequently sent by the courts to 
compulsory treatment detention centres to undergo forced detoxification. The data in 
2009 shows 7,123 new and 8,613 repeating drug dependants were detected. 3,047 of them 
were undergoing treatment for drug dependence under compulsion while 9,097 were 
subjected to supervision in the community.627 In December 2013, there were 5,136 drug 
dependants detained in 18 rehabilitation centres around the nation while 47,161 
underwent compulsory supervision.628 Further, the records indicate a substantial number 
of arrests and prosecutions for the offence of self-administration of drugs. For example, 
as of 2009, 42,304 were arrested and 20,531 were prosecuted under section 15(1) of DDA 
Act 1952. The number of arrests rose to 76,812 in 2012.629 The Attorney General lists 
696 and 256 convicted cases in 2011 and 2012 respectively.630 NADA’s data also 
demonstrates high numbers of arrest and prosecution for drug possession; such as in 2009 
whereby the arrests and prosecution under section 39A(1) were 3,823 and 1,619 
respectively. Under section 39A(2), the figures were 1,715 and 1,377 respectively and 
under sections 6, 9 and 12, the figures were approximately 24,236 and 23,504 
respectively.631 However, in the absence of data specifically showing the possession cases 
involving drug users, the extent of such possession is unknown.  
                                                          
626 Agensi Antidadah Kebangsaan, Maklumat Dadah 2012 [Drug Information 2012].35. 
627 Ibid.3, 37; M.R.M. Diah, E. Muniandy, and M.Y. Ismail, "Senario Penyalahgunaan Dadah bagi Tahun 
2009 [Scenario of Drug Abuse for 2009]," Jurnal Antidadah Malaysia 5, no. 1 (2009).15. 
628 Agensi Antidadah Kebangsaan, Laporan Dadah Bulan Disember 2013 [Report on Drugs for December, 
2013]  (Kajang, Malaysia: Agensi Antidadah Kebangsaan, 2013).26, 32. 
629 Maklumat Dadah 2012 [Drug Information 2012].37. 
630 Attorney General's Chambers, "Status of Latest Cases & Decisions," (2011), 
http://www.agc.gov.my/index.php?option=com_content&view=article&id=1285&lang=en&Itemid=63. 
(Last visited: 07/07/2014) 
631 Diah, Muniandy, and Ismail, "Senario Penyalahgunaan Dadah bagi Tahun 2009 [Scenario of Drug 
Abuse for 2009]."17–18. 
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The abovementioned evidence certainly suggests that despite the practice of the 
harm reduction policy, the criminalisation of drug use and active criminal law 
enforcement remain the dominant strategy. Involvement in the programmes does not 
shield drug users from the criminal measures. Local studies further support that clients 
were arrested for drug use and forcibly sent to government-run treatment centres or 
prisons even when already using MMT and NSEP services.632 The decided cases such 
DPP v Saiful Bahri Bin Abdul Wahid633 indicate that the judges were not ready to 
consider the participation in harm reduction programme either as a defence or mitigating 
factor to punishments for the offence of drug self-administration. In this case, the High 
Court upheld the lower court’s judgment upon the conviction of the accused for the 
offence of self-administration of drugs under section 15(1) of DDA Act 1952 and a 
punishment of imprisonment for 14 months and supervision for three years. By 
emphasising the underlying principle of deterrence for the punishment and the public 
interest in the case of drug use crime, the court decided that the punishment was fair and 
just although the accused based his defence on his present involvement in MMT. All the 
available evidence clearly shows that the threat of criminal liability for drug users under 
the existing Malaysian drug law, without any exclusion to the participants of harm 
reduction programme, is real. This helps to support the argument that there is 
incompatibility between the harm reduction and criminal justice strategies in Malaysia. 
 To complicate matters, harm reduction programmes are being utilised as a way of 
intelligence gathering for drug law enforcement purposes. There is a steady flow of 
reports documenting instances whereby the MMT and NSEP access points continue to be 
                                                          
632 For example, Norsiah et al., "Can Primary Care Clinic Run MMT Service Well?."20, 22. 
633 DPP v Saiful Bahri Bin Abdul Wahid [2012] MLJU 943. 
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targeted by the police.634 Participation in the programmes is considered as a marker of 
illegal drug consumption and hence makes the participants subject to search and 
detention.635 This is a clear disruption to the operation of harm reduction. Additional 
threat is the frequent information exchanges between service providers and the police. 
Some literature discloses that in some cases service providers have been compelled to 
disclose the clients’ records from the registry. Registered clients may subsequently be 
subject to search and forced urinalysis procedures by the officers.636 The disclosure of 
clients’ personal details to enforcement agents appears to be evidence not only of a breach 
of clients’ confidentiality but also a source of fear of being detected as drug users and 
subjected to arrest and other enforcement procedures while participating in the harm 
reduction programme. This may create disincentive for them to access the programme. 
The international evidence further supports the observation that the disclosure of clients’ 
information by service providers to enforcement authorities may deter drug users from 
seeking drug treatment.637  
 Even though NSEP could theoretically be regarded as illegal under paraphernalia 
law, to date it appears that hardly any drug law has been invoked to challenge the service. 
However, the resulting ambiguity regarding NSEPs’ legality may pose questions for its 
sustenance and expansion638 and could disrupt the efficiency of NSEPs. It is also 
significant to note that the enforcement of paraphernalia law is ostensibly relaxed and 
                                                          
634 For example, Kamarulzaman, "Impact of HIV Prevention Programs on Drug Users in Malaysia."S18. 
635 Ministry of Health Malaysia, Global AIDS Response Country Progress Report 2012: Country Progress 
Report Malaysia.92. 
636 For example, R.H. Needle and L. Zhao, HIV Prevention among Injection Drug Users: Strengthening 
U.S. Support for Core Interventions. A Report of the CSIS Global Health Policy Center  (Washington: 
Centre for Strategic & International Studies, 2010).20. 
637 For example, ibid.20; D. Wolfe, M.P. Carrieri, and D. Shepard, "Treatment and Care for Injecting Drug 
Users with HIV Infection: A Review of Barriers and Ways Forward," Lancet 376, no. 9738 (2010).359. 
638 Sarnon et al., "Psychosocial Reactions of Injecting Drug Users` (IDU) towards Needle Syringe 
Exchange Program in Malaysia."80. 
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seemingly less detrimental to harm reduction measures. To date, there is no data to 
indicate that arrest and criminal charges are undertaken in any major way for needle and 
syringe possession. The police have agreed not to enforce the provision regarding 
possession of needles and syringes as it is difficult to prove that the equipment will be for 
injecting illicit drugs and that the needle or syringe belongs to the individual who carries 
it, unless IDUs are found using the items for self-administration of illicit drugs.639 
Moreover, I have failed to find any cases where drug users, NSEP staff or clients have 
ever been prosecuted and sentenced for the possession of drug residue found in syringes 
in the courts. This is mainly influenced by the police and prosecution’s current policy to 
focus on actual quantifiable possession of illicit drugs. Drug residue in injection 
equipment is disregarded to mitigate the difficulty in laboratory testing and to avoid 
‘needle stick’ injury to police.640 
Although there tend not to be prosecutions under paraphernalia law, the law has 
nevertheless had pernicious effect on harm reduction goals and initiatives. The law 
continues to be applied to justify police decisions for their operational policing. 
Anecdotal reports reveal that NSEP workers and drug users who carry syringes and 
needles are often subject to harassment, frisk, detention and informal confiscation or 
destroying of this equipment.641 Moreover, possession of new or used syringes is treated 
as a sign of illegal drug use, thereby justifying the further investigation of suspects. This 
is substantiated by study findings. For example, research involving 53 police officers in 
Malaysia discovered that roughly 53 per cent of them acknowledged seizing IDUs’ 
                                                          
639 N. Mohd. Yasin, "An Overview of Malaysian Law relating to IDUs with HIV,"  Current Law Journal 2 
(2002).xiii. 
640 Ibid.xiii. 
641 For example, Ministry of Health Malaysia, Malaysia: 2010 UNGASS Country Progress Report  (Kuala 
Lumpur: Ministry of Health Malaysia, 2010).60. 
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injection instruments acquired from NSEP despite no arrest having been undertaken.642 It 
is notable that this study has the limit by looking at the question of extent of law 
enforcement practices in relation to the possession of syringes solely through the oral 
testimony of the enforcement agents, rather than independent observation of their actual 
practice or the testimony of drug users. Nevertheless, this study does indicate the 
existence of contradictory criminal justice practices at the ground level despite the formal 
endorsement of harm reduction programmes. 
  Thus, it is clear that street-level law enforcement based on paraphernalia law is 
constantly implemented despite the fact that no criminal charges have been brought for 
possession of injection equipment and drug residue contained in syringes. The 
enforcement activity causes direct and considerable disruption to the NSEP messages and 
operations. The absence of prosecution is also not a guarantee of no criminal action 
against NSEP participants in future as the relaxation of prosecution is not for the purpose 
of supporting the NSEP programme. The bringing of criminal charges is more than a 
mere theoretical possibility in the absence of any legal exemption.  
 Notably, MMT service providers and clients are also not excluded from street-
level law enforcement. According to some Malaysian studies and literature, they too 
continue to be harassed, detained and raided by the police.643 This is so despite the 
MMT’s legal status, given that the service’s operation is governed by explicit legislative 
provisions and totally conducted by the medical fraternity. The international research 
                                                          
642 G. Parasuraman and F. Rahman, "Police Knowledge of Needle-and-Syringe Programs and Harm 
Reduction in Malaysia" (paper presented at the 6th International Society for the Study of Drug Policy 
Conference, Kent, 30 - 31 May 2012).2. 
643 For example, Norsiah et al., "Can Primary Care Clinic Run MMT Service Well?."22; Narayanan, 
Vicknasingam, and Robson, "The Transition to Harm Reduction: Understanding the Role of Non-
Governmental Organisations in Malaysia."315. 
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findings indicate that aside from direct police interference with MMT operations, the 
experience, mistrust and fear of police practices and conviction may dissuade drug users 
from accessing the treatment and potential physicians from delivering it.644 This seems to  
true in the Malaysian context. The finding of Mohamed and Kasa’s study in Malaysia, 
applying a cross-sectional survey involving medical practitioners and participants in harm 
reduction, demonstrates that drug users would shy away from the service if they discover 
that the police officers are present at the site.645 The available evidence allows us to 
conclude that the conflicting law enforcement practices may impact on the accessibility to 
the harm reduction service. This potentially cripples the implementation of the 
programme and suggests a clear gap between legislative and official intentions on the 
hand and their actual implementation in practice, on the other hand. 
  To date, there is no record of arrest and prosecution for the offences of self-
administration, drug dependence and possession involving unauthorised prescribed 
methadone. Further, I am unaware of any evidence that demonstrates that there have been 
criminal prosecutions of medical officers for unauthorised methadone prescribing on the 
basis of possession, trafficking or the administration of drugs to others offences under 
DDA 1952. This may be explained by compliance by medical practitioners with the strict 
legislative provisions concerning methadone prescribing, including on prescribers’ and 
clients’ eligibility, supported by anecdotal report and research findings.646 This may also 
account for the very few prosecutions for the Poison Act 1952’s violation through 
                                                          
644 For example, E. Tkatchenko-Schmidt et al., "Prevention of HIV/AIDS among Injecting Drug Users in 
Russia: Opportunities and Barriers to Scaling-Up of Harm Reduction Programmes," Health Policy 85, no. 2 
(2008).167. 
645 M.N. Mohamed and M.D. Kasa, "Drug Substitution Therapy: Success and Limitations of the Methadone 
and Buphrenorphine Maintenance Programmes," Jurnal Antidadah Malaysia 1, no. 1 (2007).62. 
646 For example, "Research Report. Drug Substitution Therapy: Success and Limitations of the Methadone 
and Buphrenorphine Maintenance Programs."52. 
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unauthorised methadone prescribing. The data in 2009 indicates only 46 cases of offences 
related to psychotropic substances including methadone, of whom one has been jailed, 
five discharged and acquitted, seven discharged not amounting to acquittal and the rest 
fined.647 
  However, the adherence to the strict eligibility requirements governing the 
prescription of methadone impacts MMT’s missions and practice. The number of medical 
officers accredited for prescribing methadone is low. The data of 2009 indicates that only 
631 out of 30,536 doctors obtain accreditation for prescribing methadone.648 In 2010, 
Malaysia counted only 21 out of 6,442 total private clinics accredited for dispensing 
MMT in the country. Thus, it is clear that the practice of rigid regulation considerably 
inhibits the involvement of medical practitioners, particularly of those in the private 
health sector in the prescription of methadone. Further, the stringent restrictions have the 
effect of limiting the prescription of methadone in health settings. This is supported by 
available worldwide research results indicating fewer drug prescriptions for treating 
serious pain due to strict regulations.649 Additionally, WHO study findings reveal that 
medical practitioners in the private sector prioritised the prescribing of less regulated 
substances which may be less effective than methadone such as suboxone.650 The 
physicians’ concerns regarding accreditation and other regulatory requirements the threat 
                                                          
647 Kementerian Kesihatan Malaysia, Laporan Tahunan Kementerian Kesihatan Malaysia 2009 [Annual 
Report of Malaysian Ministry of Health 2009]  (Putrajaya, Malaysia: Kementerian Kesihatan Malaysia, 
2009).275. 
648 World Health Organization (Western Pacific Region) and Ministry of Health Malaysia, Good Practices 
in Asia: Scale-Up of Harm Reduction in Malaysia.26. 
649 For example, C. Beyrer et al., "Time to Act: A Call for Comprehensive Responses to HIV in People who 
Use Drugs," Lancet 376, no. 9740 (2010).555; S.A. Husain, M.S. Brown, and M.A. Maurer, "Do National 
Drug Control Laws Ensure the Availability of Opioids for Medical and Scientific Purposes?," Bulletin of 
the World Health Organization 92, no. 2 (2014).112–13. 
650 World Health Organization (Western Pacific Region) and Ministry of Health Malaysia, Good Practices 
in Asia: Scale-Up of Harm Reduction in Malaysia.27. 
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of law enforcement scrutiny upon methadone prescribing are said to account for this 
practice.  
 Moreover, the strict selection criteria have significantly affected the number of 
those who can gain admission to the MMT. Methadone has commonly not been provided 
to ineligible persons even in the event of critical withdrawal, pain and emergencies. 
Records in 2011 show that there are only 44,428 of 170,000 estimated drug users 
registered for MMT services.651 The research also shows that a high number of drug users 
have been put on a long waiting list. The situation in Malaysia is a worry since harm 
reduction services have not reached even half of the targeted drug users.652 This is further 
exacerbated by the premature termination of those admitted to MMT for specific reasons 
including taking illegal drugs while undergoing the MMT.653 The actual number of active 
MMT clients in 2012 was 27,756. The limited admission into the programme could also 
be traced in other nations. For example, around 85 per cent of those whom MMT might 
assist remained untreated in the USA, as a result of rigid dispensing regulations.654 Thus, 
the implementation of stringent limitations on methadone medication heightens the 
MMT’s inability to accommodate the high demand of drug users. Clearly, the imposition 
of strict admission criteria threatens and damages the effectiveness of MMT.  
  The ways in which Malaysia’s criminal justice operations affect harm reduction 
rationale and programmes can also be traced in closed settings. Drug users who are 
                                                          
651 Ministry of Health Malaysia, Global AIDS Response Country Progress Report 2012: Country Progress 
Report Malaysia.34. 
652 Ibid.34. 
653 N. Mohamad et al., "Better Retention of Malaysian Opiate Dependents Treated with High Dose 
Methadone in Methadone Maintenance Therapy,"  Harm Reduction Journal 7, no. 30 (2010), 
http://www.harmreductionjournal.com/content/7/1/30.2. (Last visited: 10/09/2013) 
654 B.J.  Rounsaville and T.R. Kosten, "Treatment for Opioid Dependence: Quality and Access," Journal of 
the American Medical Association 283, no. 10 (2000).1337. 
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detained in police custody, government-run treatment centres and prisons (for drug-
related crimes or other crimes) have limited access to harm reduction services due to 
dominant abstinence-based policy. While NSEP is not offered in any criminal justice 
settings, MMT is provided for a limited number of inmates in prison institutions and 
compulsory drug centres. The data in 2008 shows that there were only 42 (out of 16,749) 
drug-using inmates (or approximately 22 per cent of the total prison population) receiving 
MMT in three out of 31 prisons in Malaysia.655 The numbers of prisons providing MMT 
programmes increased to 18 by the end of 2010 but the number of inmates admitted for 
the service is still very low.656 MMT was provided in only two government-run 
rehabilitation centres, involving 21 inmates in 2011 and 40 inmates in 2012.657 There 
appear to be several obstacles to the prison-based MMTs’ efficient operation. The 
services are not yet standardised through policy mechanisms and they face significant 
challenges which include sporadic involvement of inmates and prison staff in anti-MMT 
hyperbole and ‘lock down’ times when prison officers bar movements within prisons.658 
The evidence demonstrates that the inclusion of drug users in compulsory rehabilitation 
centres or prisons blocks their voluntary participation in harm reduction services.659 
                                                          
655 World Health Organization (Western Pacific Region) and Ministry of Health Malaysia, Good Practices 
in Asia: Scale-Up of Harm Reduction in Malaysia.37; Agensi Antidadah Kebangsaan, Maklumat Dadah 
2012 [Drug Information 2012].25. 
656 Ministry of Health Malaysia, Global AIDS Response Country Progress Report 2012: Country Progress 
Report Malaysia.34. 
657 S. Kaur, "Transformation Journey of Treatment and Rehabilitation Programs in Malaysia: Compulsory  
to Open Access Services," (Kajang, Malaysia: National Anti Drug Agency, 2012).23. 
658 J.A. Wickersham et al., "Implementing Methadone Maintenance Treatment in Prisons in Malaysia," 
Bulletin of the World Health Organization 91, no. 2 (2013).125–26. 
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Moreover, the effectiveness and credibility of the government’s drug programmes 
are challenged by numerous seminal works and research, mainly for the high rate of drug 
consumption and relapse, and their absolute reliance on abstinence.660 Based on 
international and national assessments, residents of Malaysia’s compulsory treatment 
centres also experienced physical violence, mistreatment and medical neglect.661 
Additionally, the research by Mohamed found that drug users, while undergoing 
mandatory examination procedures for channelling them to residential treatment, have 
been affiliated with practices including unreasonable arrest, improper medical evaluation 
of drug dependency, limited medically-assisted treatment and non-adherence to due 
process.662 Such findings are significantly troubling for human rights violations and 
health-related harms. Emerging research has found a relationship between enforcement 
abuses and the incapability of drug users to decrease adverse drug-related health risks.663 
These studies unanimously suggest that the excessive use of force or ill treatment upon 
drug users has an impact on their subsequent health. 
As shown in this discussion, both the applicable legislative and regulatory 
framework obstruct harm reduction measures by raising legal problems for harm 
                                                          
660 United Nations Asia Far East Institute for the Prevention of Crime and the Treatment of Offenders 
(UNAFEI) and Research Division of the Research and Training Institute, Ministry of Justice Japan, 
Research on the Trends in Drug Abuse and Effective Measures for the Treatment of the Drug Abusers in 
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662 Mohamed, "Mandatory Assessment of Drug Users in Malaysia: Implications on Human Rights."229–31. 
663 For examples, S.K. Koester, "Copping, Running, and Paraphernalia Laws: Contextual and Needle Risk 
Behavior among Injection Drug Users in Denver," Human Organization 53, no. 3 (1994).290–93; H. 
Cooper et al., "Characterizing Perceived Police Violence: Implications for Public Health," American 
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reduction staff and clients and other drug users, thus eroding their engagement with harm 
reduction activities. Further, both would contribute to drug users’ health risks and 
behaviours, thereby contravening harm reduction’s objectives and efforts. International 
literature suggests that drug laws and enforcement elevate drug-associated health risks.664 
They could generate fear among drug users which consequently drives them to engage in 
behaviours prejudicial to public health. It has been reported that the fear of police 
interaction causes IDUs’ disinclination to carry injection equipment and hence leads them 
to borrow or take discarded syringes.665 This has been confirmed by the findings of 
studies including by Sarnon et al.666 A substantial body of studies from many countries 
has also demonstrated that to evade police interference and arrest, IDUs have increased 
their risk of acquiring or transmitting infectious diseases and overdose by involving 
themselves in practices including syringe sharing;667 obtaining the services of street-based 
injectors who likely administer multi-person injections;668 unsafe disposal of needles and 
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syringes;669 associating with fatal overdose risk by relocating their injecting sites;670 and 
dangerous drug storing, particularly in body cavities.671 
 Further, the fear drives IDUs to rush the injecting process and consequently 
exposes them to several harms including bacterial infections or even drug overdose. 
International empirical evidence shows an association between hurried injecting and risky 
behaviour including sharing and reusing drug paraphernalia and abandoning sanitary 
measures such as cleaning used syringes with bleach.672 Criminal legal measures have an 
influence on drug-related risk behaviours as they may become significant contributors to 
the spread of communicable diseases and health harms. Numerous investigations show 
that HIV prevalence in many countries is associated with law enforcement.673 
Additionally, growing macro analyses classify laws, policies and their enforcement as key 
structural factors in creating the ‘risk environment’ for the production of health risks.674 
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Overall, despite the support from the leadership of law enforcement agencies for 
harm reduction programmes and police guidelines and instructions to prevent the 
conflicts between the harm reduction and criminal justice approaches, significant 
conflicts still arise in Malaysia. The available aforementioned evidence suggests that the 
conflicts arise principally from the law enforcement practices. Punitive sanctions, 
coercive drug treatment and highly regulated drug prescribing have not been significantly 
reduced. Unsupportive and disruptive policing activities on the streets against drug users 
including those participate in harm reduction programmes such as raids, crackdowns and 
arrests are still common and dominant practices. This indicates that law enforcement 
discretion is not being exercised to support the operation of harm reduction, and that there 
is lack of real or genuine commitment of the criminal justice system to the harm reduction 
approach. This, according to the international evidence, leads to significant conflicts 
between the two approaches. The local evidence, though limited and not precise on the 
issue, does suggest that serious conflict remains. The threat of criminal law enforcement, 
whether real or perceived, tends to impede the efficiency of the harm reduction 
programme by posing legal risks and barriers to the approach’s optimal availability and 
accessibility, and impacting drug users’ human rights and health risks which would serve 





4.5 Is the Conflict between the Harm Reduction and Criminal Justice 
Approaches Unique to Malaysia and How Significant is the Conflict? 
 
We have seen that conflicts between the harm reduction and criminal justice approaches 
are evident in Malaysia. This raises some relevant important questions, namely, are these 
conflicts exclusive to Malaysia or do they also emerge in other nations? Secondly, how 
significant are these conflicts in Malaysia? These two questions will be addressed in the 
following sections.   
 
4.5.1 Is the Conflict Unique to Malaysia? 
 
This section will look at the question whether conflict between the criminal justice and 
harm reduction strategies is unique to Malaysia and give a general overview of the 
conflicts, if any, that occur in other parts of the world, but will not examine every 
jurisdiction in depth. In this discussion, the various countries are classified based on 
general similarities of the conflict’s nature. This should not be understood to indicate that 
each of the countries shares specific characteristics as regards policies, laws and 
strategies.  
Despite policy commitment to harm reduction mainly due to the HIV/AIDS 
epidemic, significant theoretical and practical clashes between the harm reduction and 
criminal justice approaches, like in Malaysia, have been documented in many countries in 
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Asia (including Indonesia, China and India),675 the Middle East (including Iran, Lebanon 
and Morocco),676 Sub-Saharan Africa (including Kenya and Tanzania),677 Central Asia 
(including Kazakhstan, Turkmenistan and Uzbekistan)678 and Eastern Europe (including 
Ukraine and Poland).679 The general picture that emerges in many of these countries is 
that though the law enforcement authorities recognise the legality of the harm reduction 
policy, they are less committed to the approach and to effective collaborative efforts. 
They regularly apply strategies including arrest, seizure of illicit drugs, confiscation of 
paraphernalia and sanctions in a deterrence mode. For example, despite the legal 
endorsement of the harm reduction approach through HIV laws and the government’s 
advocacy in Vietnam, there are conflicting street-level policing practices and penal 
measures against drug users including mandatory abstinence-oriented drug treatment.680 
This is significantly influenced by the prevailing aim of supply and demand reduction and 
drug law enforcement. The conflicts are thus more about the practical exercise of 
enforcement discretion as efforts have been made to integrate harm reduction, but the 
efforts are hindered by the practices of the enforcement personnel. 
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In some jurisdictions, conflicting enforcement actions have still occurred even 
though the government’s advocacy efforts have been accompanied by legislative changes 
to address relevant legal issues. For example, 17 states in the USA, including the state of 
Rhode Island, have amended their paraphernalia laws to legalise NSEP and/or deregulate 
syringe distribution and possession. Considering the existence of inconsistent law 
enforcement practices in some part of states, the researchers suggest that the amendment 
and/or deregulation has not necessarily resulted in policing discretion being supportive of 
NSEP.681 The persisting inconsistency may be caused by the government’s failure to 
better promulgate new policy and statutory guidance and by the ground level enforcement 
actors’ application of discretion in ways that impede harm reduction efforts. As seen 
earlier in this chapter, the general picture in these countries would appear broadly similar 
to the position in Malaysia. 
Arguably, the experiences in much of Western European and Oceania countries 
including the UK, Portugal, Australia and New Zealand show relatively fewer conflicts 
than other countries such as Malaysia. This is attributed to their recognition of the 
treatment approach for drug users and to the sustained partnership between law 
enforcement and health agencies,682 and would appear to confirm the importance of 
multi-agency working in relation to harm reduction interventions as highlighted above. 
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Enforcement officers continue aggressive punitive measures to disrupt drug production 
and distribution but adopt a minimalist criminal approach to drug users. They support 
harm reduction measures in a handful of ways such as avoiding enforcement against 
service participants, diverting drug users to treatment centres through drug courts and 
police stations, and engaging directly in service delivery. For instance, through the UK 
Drug Referral Scheme, police stations have been used for drug agencies to provide 
assistance and referrals to suitable treatment programmes. The provision of methadone 
and buprenorphine to offenders who are already in drug substitution programmes is also 
carried out at police stations in Australia.683 Additionally, many nations have adopted 
policy, legislative and enforcement changes to accord with the harm reduction approach. 
The above practices reflect a more far reaching commitment and determination to support 
harm reduction by governments and the enforcement sector. 
In the Netherlands, enforcement practices display a high dedication to public 
health and to the principles and praxis of harm reduction and hence greatly reduce the 
conflicts between the approaches.684 They have adopted harm reduction as one of the 
integral aims of enforcement and show great commitment to the goal by perpetually 
undertaking collaborative actions and tailoring measures around drug use, production and 
distribution. Harm reduction receives extensive emphasis in drug policies and laws. 
Harm-oriented classification of illicit drugs into those with ‘tolerable’ harm (soft drugs) 
and ‘intolerable’ harm (hard drugs) to the users’ health appears the essence of Dutch drug 
policy. Even if the policy and practice may potentially lead to unimpeded harm reduction 
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programmes, it is not without risk. This may significantly cause slippage in prohibitionist-
based goals and strategies to address drug prevalence. Thus, it is unsurprising that 
indefinite drug maintenance and drug dependency problems persist in the Netherlands.685 
However, in other countries where government has given steadfast exclusive 
concentration to repressive anti-drug policy based on prohibition and criminalisation, 
there appears to be an uphill battle between the approaches. This can be found in the 
majority of states in the USA and some nations in Eastern Europe such as Russia, 
Tajikistan and Turkmenistan.686 In these countries, harm reduction policy receives little 
or no support from governments and the link between government health and law 
enforcement agencies is almost non-existent. For example, in the USA, while criminal 
justice-oriented prohibition is heavily focused in national drug strategies, the harm 
reduction approach is constantly objected to by the federal government.687 Thus, it is 
difficult, if not impossible, to implement robust harm reduction measures. Considering 
the ultimate weight of the federal and state governments to primary preventive measures, 
abstinence-oriented treatment and stringent law enforcement, the constant antagonism 
towards the harm reduction approach is understandable. The enforcement authorities 
exercise a punitive approach against those consuming illicit drugs, thereby decreasing 
access for any type of intervention, treatment or harm reduction. 
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In short, it is clear that the conflicts between criminal justice and harm reduction 
approaches are not a problem unique to Malaysia. The attempts here to provide a general 
picture of conflicts in other countries go some way to show the position of Malaysia’s 
conflict levels. Malaysia is apparently stronger than in some other countries, especially 
those that totally reject harm reduction approach, due to its clear endorsement of the 
approach. However, Malaysia still experiences significant conflict, particularly arising out 
of limited effective multi-agency partnership and the lack of enforcement discretion 
towards supporting it. This shows a lack of integration of both approaches in Malaysia 
when compared with some other countries such as the UK where collaboration among 
multiple agencies and a positive exercise of enforcement discretion are more prevalent. 
The fact that conflict can be found in multiple jurisdictions should help set the agenda for 
further assessment including comparative analysis which is currently lacking. 
 
4.5.2 How Significant is the Conflict? 
 
Given the conflicts arising from the concurrent implementation of law enforcement and 
harm reduction, the debate on drugs in Malaysia broadly reflects the governing 
assumption that there is compatibility between both approaches. In that vein, this section 
explores this issue and considers the significance of conflict between the two approaches 
and some of its implications for harm reduction policy and practice, taking into account 
both local and international perspectives.  
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Any conflict between these approaches in Malaysia is rendered by some as trivial. 
They argue that hostile law enforcement operations are rare and hence do not negatively 
impact the successful expansion of the harm reduction approach nationwide. Any 
challenges to the programmes are within the government’s control through policy 
guidelines and other mechanisms geared towards collaborative efforts from relevant 
agencies. This kind of view seemingly plays down the significance of conflicts between 
drug policies, thereby overlooking the pivotal importance of maintaining consistency 
between different elements of drug policy.  
Worse than that, the government, the supporting media and public in general 
seemingly close their eyes to the realities of the situation in Malaysia, and conclude that 
there is no practical contradiction between the approaches. According to them, both 
policies are mutually reinforcing in the drive towards controlling the drug problem. 
Considering the government’s constant advocacy initiatives and smart partnership 
between relevant authorities, the harm reduction approach is assumed to be practiced 
harmoniously nationwide within the continuing prohibition framework.  
It is implausible to presume that the policy guidance and other measures will be 
realised in practice. Within the face of repressive law enforcement in the Malaysian 
context, it is clear that the emerging conflicts are more than symbolic and insubstantial, 
and thereby demand attention. The evidence noted in this chapter shows that criminal law 
and its enforcement practices against drug use and its related activities are in obvious 
conflict with harm reduction efforts. The contradictions should not be treated as trivial as 
they are thwarting the objectives of harm reduction and hindering its practices. 
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The inconsistent and counterproductive legal provisions and practices indicate that 
the different intrinsic philosophical frameworks of the criminal justice approach and harm 
reduction as a public health approach in Malaysia have not been properly reconciled, 
particularly with respect to the principles, objectives, strategies and priorities in 
addressing drug problems. This argument shows that unless reconciliation of the two 
approaches is made, the different theories of both policies at international and national 
levels will continue to contribute to the discordance between them.  
What is meant by reconciling is to redefine or adjust the aims and purview of each 
harm reduction and criminal justice approach with reference to a principled approach and 
embodying policies and strategies to build partnership between the two regimes. More 
discussion regarding ensuring the compatibility between both drug responses is provided 
in Chapter 5. It is worth mentioning that the notion of ‘balancing’ is avoided in order to 
resolve the conflicts between the approaches despite its wide use in political and legal 
debate. This is because balancing can be a problematic metaphor in the criminal justice 
sphere for its potential for abuse. It has always been applied as a ‘rhetorical device’ to 
justify changes without appropriate support or sufficient attention and resolution to 
conflicting accounts.688 The lesson of criminal justice is also that the balance is tipped by 
the prediction of future threats with high uncertainty and pursued on the claimed impetus 
for safeguarding the factional interests of community and victims at the expense of 
individual liberties.689 Moreover, despite its advantage in driving the examination of what 
is being balanced including values, interests and rights and their subsidiary aspects such 
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as the basis and weight or priority of every factor, it is barely to be a useful guiding tool 
for decision making. As Zedner argues, this is because the calculations to the 
commensurability of the supplementary factors are convoluted by distribution (the 
interest of majority versus that of small minorities) and temporal dissonance (known 
interest versus future uncertainty).690 
It is worth bringing to mind some important points regarding the criminal justice 
and harm reduction approaches. The criminal justice approach aims to contain drug 
supply and consumption through prevention, treatment and punishment. Preventive 
measures are devised to thwart the occurrence of future drug use while treatment serves to 
address the drug using habit by seeking to stop physical and psychological dependence on 
drugs. Treatment is usually predicated in the punishment matrix and is mainly based on 
coercion and severe penalties upon relapse. The other primary strategies are law and its 
enforcement via police actions, prosecution and punishments, usually in the form of 
incarceration.  
Unlike punitive criminal justice, the harm reduction approach moves the focus 
away from drugs themselves to their adverse consequences to oneself and others. The 
harm reductionists’ arguments point out that harm reduction interventions are not 
constructed to decrease the absolute numbers of drug users. Des Jarlais, for instance, 
points out: ‘Drug use leads to individual and social harms through many different 
mechanisms, so a wide range of interventions is needed to address these harms […] It is 
not always necessary to reduce nonmedical drug use in order to reduce harms’.691 Thus, 
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its achievement is evaluated in terms of actual effects, by the decrease of drug 
consumption and its related harms, not by the decline of drug use prevalence.692 The harm 
reduction framework which is based on pragmatism and voluntariness forms a large part 
of antagonism to the extensive criminalised prohibition.693 
This stance of this thesis regarding the existence of tensions between the harm 
reduction and criminal justice approaches clearly challenges the opposite perspective of 
the conceptual congruity between the approaches. Perhaps the most important view 
regarding the compatibility is the statement of the UNODC that harm reduction 
complements, rather than contradicts, other interventions under the prohibition 
framework. It is clearly stated: ‘Harm reduction is often made an unnecessarily 
controversial issue as if there was a contradiction between prevention and treatment on 
one hand and reducing the adverse health and social consequences of drug use on the 
other. This is a false dichotomy. They are complementary’.694 UNODC observes that 
neither the prevention, dependence treatment or harm reduction in isolation can effectuate 
drug strategy but together they can shape a combined approach to reduce the harmful 
effects of drug use and eliminate the epidemic of blood-borne diseases.695 
Similarly, too often harm reduction policy is viewed reciprocally related to the 
prevention of drug use, treatment and law enforcement in a four-tier drug policy 
framework. As stated by MacPherson, the model ‘seeks to bring together the diversity of 
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views and issues surrounding substance misuse so that we can build a consensus for 
action’.696 Some, for example Kendall and Weir, suggest that the harm reduction 
approach is not antagonistic when it is made as an umbrella strategy in the four-pillar 
framework697 while many regard harm reduction as a complementary fourth tier of four 
pillars under the drug policy model. By way of illustration, as stated by the MOH, British 
Columbia, regarding the position of harm reduction in Canada, ‘harm reduction is an 
essential part of a comprehensive response to problematic substance use that 
complements prevention, treatment and enforcement’.698 The model suggests a 
consistency with the harm reduction approach to other responses to drug problems 
including prevention, treatment and law enforcement under a larger prohibitionist policy. 
While positing the harm reduction approach within the four-tier framework together with 
other vital policies has merits as a means of endorsing it as an important drug policy, it is 
not convincing enough to conclude that there is no conflict among the policies.  
 It is here acknowledged that the harm reduction idea is not a polar opposite to the 
traditional criminal justice approach. Philosophically, there are some similarities and 
mixed linkages between both approaches, including their deep roots and shared concerns 
on the health and welfare of drug users and the principle of social interest protection. 
Harm reduction could form as a paramount approach not to supplant but to be aligned 
with other drug approaches in addressing drug use problems. Hwang affirms this 
asserting that: ‘harm reduction strategies are intended to complement, rather than replace, 
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more traditional means of treatment’.699 However, unless there is a reconciling measure to 
the dissimilar principal goals, principles, methods, priorities, practices and understandings 
of drug use between criminal justice and harm reduction, the assumed compatibility-
approaches, irrespective of whether it is anchored in a four-pillars framework or not, is 
less compelling. The non-reconciled theoretical differences lead to conflicts. Scholars 
such as Caulkins likewise consider that the goals of criminal justice and harm reduction 
approaches are in agreement with each other as it is not inevitable that the former’s 
achievement will counteract the latter’s success. However, the selecting of goals may be 
in conflict as a result of different preferences and other differing aspects.700 
 The arguments for the consistency among drug approaches in the four-pillar 
model provide insufficient justifications on why and how far the compatibility among the 
approaches is attained by being put together in the framework. This is a flaw, particularly 
due to the remaining higher weight of law enforcement, including for funding. The four-
pillars, as one activist depicted, are ‘a tree trunk (law enforcement) and three 
toothpicks’.701 The theoretical pitfall of consistency among the approaches is further 
shown by practical conflicts. For example, the 2003 police crackdown on IDUs in 
Vancouver has disrupted harm reduction accessibility and increased risky behaviour.702 
This shows that the four-pillar framework tends to be a political adjustment but fails to 
lead to extensive reconciliation among drug responses. 
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The notion of the philosophical compatibility of the criminal justice and harm 
reduction approaches is also problematic as it may disregard the insights for investigation, 
weighing and seeking solutions to the conflicts of both methods. To juxtapose the 
contrasts between the harm reduction approach and other drug approaches towards 
addressing the policy barriers, Jourdan advocates for harm reduction to be posited in 
contradiction to other drug policies.703 Arguably, the practical tensions are considerably 
symptomatic to inconsistent ideological underpinnings of the approaches and thereby 
require strategies to reconcile both theoretical and praxis aspects. 
There is also much to learn from the incidents involving tensions between drug 
responses in Malaysia. Criminal justice may run into significant discrepancy to the harm 
reduction approach where there are non-reconciled different philosophical principles and 
the implementation of both approaches. It seems that there is a need to shift away from 
assuming the general compatibility between drug approaches in international and national 
contexts. Instead, a reoriented focus should be on reconciling the philosophical and 
practical gaps and conflicts.  
However, the criminal justice practice is central to the conflict. Even if criminal 
justice emerges to be theoretically contradictory, both responses are not necessarily 
antithetical in practice in any country (as shown in Chapter 4, Section 4.5.1) as policy 
guidance may caveat this for harm reduction interventions. The practical contradiction 
will occur when criminal justice authorities do not take into account a harm reduction 
perspective and apply discretion to support the approach as evidenced in the Malaysian 
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case. This indicates the core influence of criminal justice responding to the 
compatibilities. The challenging Malaysian criminal justice response, characterised by 
pervasive policing surveillance, imprisonment and coercive treatment of drug users is 
influenced by several main factors which will be discussed in the next section.  
To sum up, generally there are differences in the underlying concepts of criminal 
justice and harm reduction approaches which contribute to the contradiction in both 
international and national contexts. Dissimilarities do not mean the impossibility of 
reconciliation, particularly with respect to practice at national level which is a relatively 
more important determinant of actual conflicts. In Malaysia, there are substantial 
philosophical and practical conflicts between the two responses, with no significant 
reconciliation undertaken upon the different theories and praxis.  
 
4.6 What Factors Lie behind the Exercise of Police Discretion as It relates to 
Harm Reduction in Malaysia 
 
Criminal justice actors are commonly conferred vast discretion when deciding what 
incidents to become involved in and how to deal with them. The discretionary power in 
the Common Law system of criminal justice is not limited to police but extends to others 
actors including prosecutors and even judges.704 As discussed before, the evidence shows 
that when it comes to drug use, the police in Malaysia tend to exercise their discretion in 
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ways that impede harm reduction programmes. In view of this, it is important to look at a 
possible explanation of why the police officers have seemingly been reluctant to move 
away from the strict enforcement. There follows a discussion of several important factors 
affecting the exercise of police discretion in relation to harm reduction based on available 
evidence in the Malaysian context, while taking some account of the international 
literature on policing.  
 
4.6.1 Lack of Knowledge or Scepticism about Effectiveness or Morality of Harm 
Reduction Interventions  
 
Positive depictions of the potential of harm reduction measures are likely tempered by the 
poor knowledge and misinterpretation of Malaysian enforcement personnel about the 
principles and local utility of harm reduction. Some local empirical results highlight this 
attitudinal factor whereby they are either ignorant or doubtful of harm reduction 
operations. The findings of a study by Ibrahim indicate that there is unawareness and lack 
of knowledge among the police officers of the NSEP despite the widespread of 
distribution of the Guidelines for Police in relation to the programme.705 Research by 
Parasuraman and Rahman further found police officers still had limited knowledge 
regarding harm reduction approach and its imperatives although they had already 
attended relevant training.706  The available findings are unsurprising, considering the 
lack of local scientific evidence indicating the effectiveness of harm reduction services 
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(as previously shown in Chapter 3), officers at ground-level not being involved in initial 
policy planning and limited communication (as discussed in Chapter 4, Section 4.3).  
Additionally, a few research studies suggest that many Malaysian police officers 
see harm reduction services as encouraging and enabling drug use and are negative 
towards ways of handling drug use problems other than the traditional abstinence-based 
approach. In Rahman and Parasuraman’s study of 53 low to mid-level RMP officials, 
approximately half of the respondents think that NSEP condones the consumption of 
illicit drugs.707 This accords with the findings of studies in South East Asia showing that 
the street-level officials’ pessimistic viewpoints regarding the morality of harm reduction 
programmes inhibit their support.708 These studies suggest that many officials have less 
commitment to supporting harm reduction and also relates to an ideological issue.  
The attitudinal factor is likely coherent as intuitively how individuals conduct 
themselves, including how they exercise discretion, ensues from their attitudes. However, 
the studies on this influence upon the ways in which police perform produce inconsistent 
findings. Mastrofski et al. found that the police’s positive belief regarding community 
policing contributes to their significantly less likelihood of arrests.709 Riksheim and 
Chermak’s comprehensive review of the studies in the 1980s reports the presence of 
individual determinants.710 These studies lend support to the attitude-behaviour linkage 
and would suggest that difference in actions flows from variance in attitudes. By contrast, 
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some studies indicate weak or no support for the link between attitudes and police 
actions. A study by Worden found that the attitudinal indicators including attitudes 
towards their role, legislative constraints and citizenship only weakly relate to police 
practices.711 Terrill and Mastrofski also found no link between attitudes and the police’s 
exercise of coercion.712 Such negative results likely led claims in the literature that the 
personal belief and attitudes of the police provide little guidance to explain police 
decision-making.  
The impact of the police’s attitudes on their behaviour is therefore inconclusive, 
considering the mixed results of these studies. More research is therefore needed to 
examine connections between both variables. Current Malaysian research has started 
looking at the circumstances regarding police behaviour towards harm reduction and 
detects its consistency to the police’s individual knowledge, belief and attitudes. Thus, 
there is clearly an opportunity for additional studies to examine this attitudinal 
explanation.  
 
4.6.2 Perception of Priority for Drug Fighting Responsibility 
 
The promotion of harm reduction measures is also believed to be competing with the task 
of combating drugs, thereby causing dilemmas in Malaysian police works. The evidence 
indicates that the enforcement authorities frequently think that they should give 
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precedence to the task concerning prohibition-based drug control.713 Implicit in this is the 
officers’ viewpoints that drug control is their utmost responsibility, leading them to 
abandon or only provisionally consider public health measures. This is expected given the 
officers’ long immersion within prohibition-oriented strategies. This indicates that the 
connection of police enforcement against the harm reduction to perception issue. It 
accords with the research findings showing the implication of officers’ belief and 
attitudes on their decisions as discussed above. 
Further, despite there being no specific evidence in the literature on the influence 
of police personality to Malaysia’s contradictory police practices, the aforementioned 
evidence of police priority to strict enforcement enables its possibility to be seen. The 
presumption is also driven by the 2005 Royal Commission Report revealing the cultures 
and negative traits among Malaysian police that connect to prevalent abuse of powers and 
public trust.714 Additionally, there is international literature supporting the association 
between police personality and drug use enforcement. Lough, for instance, in highlighting 
to some extent the incompatibility between the criminal justice and harm reduction 
approaches as understood and practised in Australia, considers that repressive actions 
against drug users are somehow counterweighted by the personality characteristics of 
police.715 This argument is consistent with seminal works and studies showing that police 
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behaviours are contributed by their distinct personality.716 However, this subject gets 
scant focus in the recent empirical assessments.  
The notion of police personality suggests the homogeneity of traits among police 
individuals. It, for Berg, connotes the consolidation of characteristics and behaviours 
which are stereotyped to police officers. The characteristics frequently cover ‘a desire to 
be in control of the situation, assertions, cynicism, authoritarian attitude, a wish to be 
aloof from citizens, an increased solidarity with other police officers and a tendency to be 
physically aggressive’.717 Scholars, however, differ in their arguments pertaining to the 
roots of police personality. Some contend that police personality is dispositional. The 
personal traits of individual officers pre-exist before their entry into the police force.718 
Of these certain personality characteristics, they are recruited. This is realised through 
pre-occupational screening processes. Some others argue that police personality builds 
from an employment socialisation process.719 This means that the personality attributes 
are acquired by officers throughout the course of their work. Moreover, there appear to be 
scholars claiming that police personality is a product of police culture. Organisational 
culture comprises ‘values that are common to most of the organisation’s members’.720 
According to Reiner, ‘cop culture’ embodies ‘mission/action/cynicism/pessimism, 
suspicion, isolation/solidarity, conservatism, machismo, racial prejudice and 
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pragmatism’.721 In other words, the police subculture is a trait of police occupation that 
influences elusive police personality. This stance assumes a considerable similitude 
among officers. Arguably, it is less plausible to specify a single basis for the formation of 
police personality. Considering the interrelations of all notions, it is fair to say that police 
personality stems from congruent pre-employment individual attributes and develops 
through occupational experiences and police culture. 
While there are supports to police personality, there appear few studies failing to 
find its evidence.722 Some research found variance in personality among police 
officers.723 The notion is also rejected by some scholars based on several grounds. Firstly, 
the police attributes are regarded as being basically undistinguishable from non-police. 
This reflects the objection to the notion of the distinctive traits of the police. Secondly, 
police personalities may become less prevalent as a result of specific efficient measures. 
According to Wortley, traditional police personalities could be lessened by effective 
strategies including the promotion of professional conduct, training and recruitment 
requirements.724 Presumably, this contention suggests that police personalities are unfixed 
and subject to moderation and hence it is not strong enough to conclude whether it might 
account for differences in actions among officers. It is hard to accept these claims, 
considering the capabilities and opportunities of police to constantly exhibit distinctive 
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traits consistent to their different role, nature of occupation and ways of applying 
authorities. 
To sum up, the link of police personality to their behaviours has been widely 
examined with mixed evidence but this should not discount the potential connection 
between these variables. It has also been supported by compelling arguments. The 
determinant’s influence deserves more studies to confirm its validity. Therefore, it is here 
argued that the police practices in the Malaysian context of drug use are considerably 
attached to their perception and presumed personality. The existence of such factors and 
connection to conflicting enforcement actions needs confirmation through further 
research. However, arguably, it is not strong enough to believe that the beliefs and 
personality, if they exist, will confirm police behaviours. The attitudes are just a part of 
the overall picture due to their subjectivity to other considerations.725 
 
4.6.3 Performance Targets and Policing Policy 
 
The Malaysian literature demonstrates that the police’s decisions on the streets are 
considerably affected by their performance targets or quotas which are usually based 
around law enforcement.726 Thus, while harm reduction is implemented, intense focus on 
drug control is still covered under the target’s commitment. Similarly, the performance 
settings become a major issue for policing in numerous countries including England and 
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Wales.727 Much can be learned from the available evidence that despite its being claimed 
essentially as one component of central performance controlling to heighten public 
services’ effective delivery, the target-setting may lead to negative implications. One 
detrimental consequence connected to the police is the primary emphasising of 
enforcement practices to crimes of greatest opportunity of detection. It is for this reason 
that researchers including Patrick and Chatterson consider shifting the prioritising of 
severe offences to small crimes as part of adverse outcomes from the target’s overuse.728 
It might become an easy way for the police to cope with the pressures from the quota 
imposition. This shows that the commitment to target attainment can have a pernicious 
effect upon police discretion regarding low-level criminality. It is therefore unsurprising 
that drug users in Malaysia are continuously targeted by the police as they seemingly 
constitute ‘low lying fruit’ to meet the performance quotas. More significantly, there is no 
evidence showing the account of supporting harm reduction operations within the quota 
regime. This further explains the police’s harassment upon the participants of services.  
The focusing on minor crimes for reaching quotas is problematic for its danger of 
the ‘gaming’729 of system which is an antithesis to ethical ideals. By devoting high 
preference to actions that directly contribute to performance indicators, it propagates costs 
to other policing purposes and hence constitutes a ‘skewing’; a type of ‘gaming’.730 From 
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the resulting gaming, it is possible to argue that the rigid centrally set-targeting could ruin 
the police’s professional standards and eventually impair not only policing efficiency but 
also harm reduction accessibility. Contributing to the tension of the enforcement officers 
in Malaysia is the national ‘Drug Free Nation’ target to be achieved by 2015, the National 
Key Result Area (NKRA) which includes decreasing street crime and the Government 
Transformation Programmes (GTP) that direct governmental sectors towards providing 
high quality services to society. These policies are emphasised within the police’s vision 
and framework. The inconsistent departmental goal and demands provide insight about 
the potential impact of organisational context on police’s decision-making concerning 
drug control and harm reduction efforts. In contrast to attitudinal determinant that 
intrinsically attaches to individuals, the organisational determinant accords department. 
However, it impacts officers’ behaviour. 
Evidence from a handful of research demonstrates that police’s discretionary 
behaviours may be affected by the organisational context in which it happens. The work 
on this factor has been pioneered by Wilson. He introduced three distinctive categories of 
police agencies. First is the watchman-type agency. By aiming to achieve order 
maintenance, this agency undertakes law enforcement upon major crimes while 
neglecting offences of a minor nature. Second is legalistic-type which is connected to 
strict the law enforcement principle and practice based on wide regulations and 
procedures. It has autonomy from communities but subjects to being centrally controlled. 
Third is service-type agency. In this organisation, they focus on community-based 
policing and implement non-law enforcement problem-solving techniques. There are 
252 
 
lesser degrees of bureaucracy and controlling in this agency than legalistic-type.731 
Conversely, Wilson’s model suggests that differences in police agency patterns influence 
divergences of enforcement actions including arrests, whereby more will be actualised in 
legalistic-type agency than others. 
Wilson’s typology is applied by some studies including Smith and Klein and 
Mastrofski, focusing on the organisational characteristics and their influence on police 
decisions.732 The findings supporting the impact of organisational features include size, 
bureaucracy, supervision level, professionalism and policies on discretionary decision 
making of police are also discovered by other studies such as Monkkonen.733 Further, 
there appear to be research results demonstrating the link between this determinant and 
specific police cases. The findings of Smith’s study, for example, indicate higher arrests 
particularly in cases involving youths and disputes by officers from the legalistic police 
division than other units.734 This shows the significant influence of organisational 
structures on police arrests. 
However, the organisational determinant does not go unchallenged. Few studies 
found non-existent or minimal relationships between organisational features and police 
decision making.735 Several study results also indicate that policing is based principally 
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on other factors, including situational context rather than organisation role.736 Thus, the 
organisational impact is claimed by Chappell et al. as exaggerated in literature.737 
Overall, there are supporters of the organisational indicators of police behaviours from a 
fair amount of existing studies. However, its degree raises calls for further empirical 
studies. There appears to be some evidence for supporting the impact of organisational 
characteristics including vision, administrative policy and work controls to practices 
against drug use and harm reduction in Malaysia. This should be validated by further 
empirical research which is a clear gap.  
 
4.6.4 Contradictory Criminal Laws 
 
Further, for some critics, the Malaysian police’s contradictory enforcement exercises are 
contributed by conflicting drugs laws. Kamarulzaman and Razali, while describing the 
challenges to Malaysian HIV strategies, express: ‘The existence of the current laws 
makes it difficult for police particularly junior officers to reconcile the strict zero 
tolerance policies with the newly introduced harm reduction measures’.738 
This illustrates the point that problematic police practices are related to criminal 
legislation. It seems plausible since the punitive prohibition-oriented laws against drug 
                                                          
736 A.T. Chappell, J.M. Macdonald, and P.W. Manz, "The Organizational Determinants of Police Arrest 
Decisions " Crime & Delinquency 52, no. 2 (2006).302–03. 
737 Ibid.302. 
738 A. Kamarulzaman and K. Razali, "Malaysia," in Public Health Aspects of HIV/AIDS in Low and Middle 
Income Countries: Epidemiology, Prevention and Care ed. D.D. Celentano and C. Beyrer (New York: 
Springer Science & Business Media, 2008).495. 
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users are sustained and have not been amended to accommodate the integration with harm 
reduction as discussed earlier.  
However, some literature on policing highlights that law exerts no significant 
influence upon police actions since they can evaluate and determine their way of 
responding to a specific situation. According to Manning, police always apply ‘situational 
rationality that takes into account the particular times and places of events, rather than a 
set of firm rules, regulations, or laws’.739 This argument tends to suggest that the main 
determinant of police decisions is contextual. The other implicit idea from this stance is 
that in choosing reactions to encountered realities on the streets, officers employ 
enormous discretion.  
Despite the discretion owned while encountering specific situations, it is clear that 
the police are not totally disconnected from the underlying framework of law. The law 
becomes an elementary groundwork or structural predisposition orienting the police in 
interpreting and resolving responses to the circumstances. This is supported by many 
commentators.740 The law is employed primarily to understand the confronted events as 
they emerge and judge the need and approach of reactions.  
The legislative provisions also have ties with enforcement based on their related 
roles. The law constitutes the main reference regarding enforcement work and its 
limitations. It designs the principal obligations, procedures, rooms of flexibility and 
restrictions upon enforcement. Thus, the law arises as the foundation of actions. 
                                                          
739 P.K. Manning, "Information Technologies and the Police," in Modern Policing ed. M. Tonry and N. 
Morris (Chicago: The University of Chicago Press, 1992).357. 
740 For example, R.F. Groeneveld, Arrest Discretion of Police Officers: The Impact of Varying 
Organizational Structures  (New York: LFB Scholarly Publishing LLC, 2005).7. 
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Additionally, the law provides legality and justifications for enforcement practices. 
According to Herbert, ‘officers invoke not just the bare dictums of the legal code in their 
actions, but the broader value of preserving a legally defined social order. This provides a 
powerful normative pull on officers’.741 This shows that the law could be the officers’ 
mediums for certain enforcement objectives or outcome attainment. 
Considering the role and permissiveness of Malaysian drug law to enforcement 
actions, it is not surprising that the actions against drug use including penal surveillance, 
detention and sanctions are continuing. It is also possible to render the contradictory 
criminal laws as a catalyst for organisational demands relating to strict drug control and 
for officers to translate their attitudes against drug use and harm reduction into practice. 
Newburn and Reiner state: ‘The (police) culture is generated and sustained by the 
problems and tensions of the police role, structured by legal and social pressures’. Thus, 
the laws arguably may become the most important structural factor supplementing the 
organisational and individual accounts for enforcement practices in drug use context. 
Further, the existing drug laws have influence on clashing criminal justice practices by 
considerably conveying inconsistent signals. This thereby contributes to the officers’ 
perception of conflicting tasks. At one hand MMT and NSEP are highlighted as crucial 
public health interventions for drug users but on the other hand punitive drug laws remain 
unchanged.742 
                                                          
741 S. Herbert, "Police Subculture Reconsidered," Criminology 36, no. 2 (1998).353. 
742 Canadian HIV/AIDS Legal Network, Legislating for Health and Human Rights: Model Law on Drug 
Use and HIV/AIDS. Sterile Syringe Programs  (Ontario: Canadian HIV/AIDS Legal Network, 2006).6; 




Despite the arguments supporting the law’s impact upon policing practice, yet 
extensively missing from the current international and national research, is the attention 
to this aspect. The available research reveals the connection of laws to officers’ 
behaviours include Chaney and Saltzstein. The study’s findings demonstrate that the state 
and city laws in the USA which demand the arresting of domestic violence perpetrators 
has a strong linkage with the police’s arrest in the event of violence and its threats.743 
More research should be conducted to expound the lacking empirical results regarding 
this aspect. 
In short, the available literature provides an indication of the potential role of 
criminal law as an explanatory factor in the Malaysian police’s drug controlling practices. 
It is essential to empirically examine the extent of law’s influence upon enforcement 
actors’ ways of defining and responding to drug taking and harm reduction operations.  
To summarise this section, it has been highlighted that there is interplay between 
individual police officers’ knowledge, belief and attitudes, and organisational and legal 
factors that may explain their exercise of discretion in relation to harm reduction 
approach in Malaysia. Arguably, even though the officers’ attitudes can be used to 
understand the contradictory enforcement practices, the attitudes are not the whole story. 
The realisation of attitudes is to some extent contributed by codicillary organisational and 
legal structures. This analysis marks a need for a further study pertaining to the gulf 
between localised harm reduction and law enforcement actions by a range of actors such 
as police, prosecutors, judges and prison officials to refine the existing evidences and 
show the real picture. 
                                                          
743 C.K. Chaney and G.H. Saltzstein, "Democratic Control and Bureaucratic Responsiveness: The Police 





This chapter has demonstrated the persistent and dominant prohibition-oriented legal 
response to drug use through penal instruments in Malaysia despite the implementation of 
harm reduction. There appear drug laws which have the clear potential to contradict the 
harm reduction principles and objectives and to impact the approach’s operation. These 
laws have not been changed to keep step with the adoption of harm reduction approach. 
To date, no statutory exemption or protection has been provided for harm reduction 
providers and clients. Conflicting criminal law, however, is not the main problem facing 
the Malaysian harm reduction approach. Rather, it is law enforcement practices, 
particularly ground level actors’ use of discretion and how they respond to drug users that 
is where the tension really arises in Malaysia. Inconsistent street-level policing activities 
are still widespread. This reflects the fact that police officers have not used their 
discretion in ways to support the harm reduction approach. There is limited commitment 
on the part of the criminal justice system to the harm reduction approach. The 
government’s collaborative efforts and administrative arrangements are limited in scope 
and seemingly emerge as a political compromise rather than a genuine effort to avoid 
conflict between both approaches. Even though there is limited evidence in Malaysia, it 
seems to point in the same direction as the international evidence in suggesting that 
inconsistent or antagonistic law enforcement practices create more than a symbolic 
problem. Rather, the evidence suggests that there is a significant clash, between the 
criminal justice and harm reduction approaches. The present contradictory law and 
particularly its enforcement practices directly and indirectly erect formidable obstacles to 
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the promotion and effective practice of harm reduction. They have the clear potential to 
restrict drug users’ accessibility to the services, to reduce the involvement of medical 
personnel and to exacerbate health risks. The analysis in this chapter also reveals that the 
conflicts between the approaches are not a problem exclusive to Malaysia. They also 
occur, though in different ways, in other nations. It is fair to argue that the conflicts in 
Malaysia are clear and significant. At present, the approaches are not reconciled 
sufficiently. The way the police officers exercise their discretion to impede the harm 
reduction interventions is associated with knowledge, belief, attitudes, organisational and 
legal factors. 
This analysis of impact and factors of an incompatible criminal justice approach in 
Malaysia is based on limited available evidence. Additional research is needed to gain 
deeper insights into the impacts and roots of this incompatibility in a Malaysian context 
and to elucidate existing research findings. The effects of the courts’ operation on harm 
reduction practices are also a clear gap in the body of knowledge. The possible reason for 
this is that the courts are not part of public health measures and the examination of their 
operation and impact needs extensive investigation.744 This aspect merits further research.  
In light of the legislative, practical and operational incompatibilities between the 
criminal justice and harm reduction responses in Malaysia, we should consider whether 
both approaches can nevertheless be pursued at the same time, and the appropriate ways 
for addressing the conflicts. These issues will be the focus of the next chapter. 
 
                                                          
744S. Belenko, "The Challenges of Conducting Research in Drug Treatment Court Settings," Substance Use 
& Misuse 37, no. 12-13 (2002).1655. 
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CHAPTER 5  
RECONCILING HARM REDUCTION AND CRIMINAL JUSTICE 




The theoretical and practical incompatibility between harm reduction and criminal justice 
approaches to drug use as they are currently understood and practised in Malaysia 
demands affirmative solutions. This chapter seeks to examine whether or not these 
conflicting approaches can be reconciled. In considering this question, the chapter 
proceeds from the belief that before recommending specific concrete mechanisms and 
initiatives with the goal of harmonising these approaches, it is first essential to determine 
whether these two approaches can genuinely be pursued together and reconciled, at the 
conceptual level. Without giving careful consideration to this major issue, it is unlikely 
that any concrete initiatives will be properly formulated and even less likely that they will 
be properly implemented. The question has been the subject of an extensive debate, 
which I will review as part of this chapter. Therefore, this chapter gives consideration to 
three key relevant aspects: first, the feasibility of the harm reduction approach within a 
larger prohibition-based drug policy; second, its relationship to the criminal justice 
approach; and third, its workability alongside an abstinence-oriented goal. It is hoped that 
these considerations will provide the possible rightful position in which harm reduction 
and criminal justice approaches may properly be reconciled under a prohibition 
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framework in seeking to ensure the effective functioning of both, and to prevent conflict 
between them.  
 
5.2 The Feasibility of Harm Reduction Approach within a Prohibition 
Framework 
 
As previously discussed in Chapter 4, the prohibition framework with its conflicting 
criminal justice approach has inhibited efficient harm reduction practices. To complicate 
matters, the punitive regime has also failed to curtail drug problems and has had other 
unintended negative implications. The negative consequences of prohibition on the harm 
reduction initiatives, failure and other adverse effects of prohibition have instigated the 
issue of whether or not harm reduction policy is feasible within a prohibition framework. 
This section will discuss this issue with consideration to the relevant issue of the viability 
of the prohibition policy, particularly in relation to public health approach for drug users.  
Notably, the Malaysian experiences with illicit drug supply and use show that the 
prohibition framework is less successful in reducing such behaviour despite its long term 
appeal. Considering the high volumes of arrested drug users and traffickers, a 
considerable body of research suggests that Malaysia’s prohibitive control strategies are 
largely ineffective.745 This parallels the failure of the 50-year-old global prohibition 
                                                          
745 For example, Harring, "Death, Drugs and Development: Malaysia's Mandatory Death Penalty for 
Traffickers and the International War on Drugs."405; Md. Isa et al., Laporan Kajian mengenai Undang-
Undang Rawatan dan Pemulihan di antara Malaysia, Negara ASEAN, United Kingdom, Kesatuan Eropah 
(EU), Jepun, Korea, India, China dan Australia serta Pelaksanaannya [Report of Study: The Laws of 
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regime since the 1961 Convention to substantially suppress illicit drug supply and 
demand. Both have expanded to all continents. Exhaustive evidence shows that the drug 
market level across the globe has risen significantly over last few years.746 The UNODC’s 
estimate in 2012 shows substantial drug consumption worldwide; somewhere between 
162 million to 324 million.747 In their report on illegal drugs markets round the world 
from 1998 to 2007, Reuter et al. conclude that ‘We find no evidence that the global drug 
problem was reduced during the UNGASS [UN General Assembly Special Session on 
Drugs] period [from 1998 to 2007]. For some nations the problem declined but for others 
it worsened and for some of those it worsened sharply and substantially’.748 Thus, the 
ability of the criminal justice approach to attain its goals in drug supply and consumption 
contexts, other than retribution, is contestable. 
Beyond its consequences upon the harm reduction approach, public health and 
human rights as demonstrated in the previous chapter, the punitive regime, whether 
international or domestic, has also resulted in other widely acknowledged impacts on 
security, safety and economy. Critics including Nadelmann and Keefer et al. point out 
that prohibition has left in its wake increased crimes due to several reasons such as drug 
use and supply criminalisation, acquisitive crimes to pay for drug habits, systemic crimes 
of violence linked to illicit drug enterprises and highly profitable drugs as a result of its 
                                                                                                                                                                             
Treatment and Rehabilitation in Malaysia, ASEAN Countries, United Kingdom, European Union (EU), 
Japan, Korea, India, China and Australia and Their Implementation].8.  
746 For example, P. Reuter and F. Trautmann, eds., A Report on Global Illicit Drugs Markets 1998-2007 
(Brussels: European Communities, European Commission-Trimbos Institute-RAND Europe, 2009).11; P. 
Reuter, "Main Report: Assessing Changes in Global Drug Problems, 1998-2007," in A Report on Global 
Illicit Drugs Markets 1998-2007, ed. P. Reuter and F. Trautmann (European Communities, European 
Commission-Trimbos Institute-RAND Europe, 2009).23–25. 
747 United Nations Office on Drugs and Crime (UNODC), World Drug Report 2014  (New York: United 
Nations, 2014).1. 
748 Reuter and Trautmann, A Report on Global Illicit Drugs Markets 1998-2007.53. 
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inflated price in black markets.749 It also fosters corruption among enforcement agents.750 
These accompanying crimes lead to the impairment of public safety.  
Moreover, criminal justice approaches including law enforcement, prosecution 
and incarceration cost vast amounts of public money.751 In Malaysia, it was estimated in 
2008 that there was MYR177 million spent annually in tackling the drug problem.752 By 
contrast, the wealth of the illicit drug industry contributed by prohibition is enormous. 
The global illegal drug trade is worth USD320 billion annually or 0.9 per cent of total 
trade.753 Aside from the health risks discussed in the previous chapter, prohibition may 
also exacerbate the health hazards of overdoses or poisoning from adulterated drugs as 
there is no control over their potency and purity.754 
The ongoing debate regarding the viability of the prohibition policy contains a 
number of different strands. Some commentators voice support for the intensification of 
stricter law enforcement and criminal penalties, alongside expanded economic 
opportunities755. The stringent enforcement strategies are seen more essential and 
appropriate than other lenient measures including harm reduction methods to effectively 
                                                          
749 E.A. Nadelmann, "Drug Prohibition in the United States: Costs, Consequences, and Alternatives," Notre 
Dame Journal of Law, Ethics & Public Policy 5, no. 3 (1991).790–93; P. Keefer, N. Loayza, and R.R. 
Soares, "Drug Prohibition and Developing Countries: Uncertain Benefits, Certain Costs," in Innocent 
Bystanders: Developing Countries and the War on Drugs, ed. P. Keefer and N. Loayza (Washington: 
Palgrave Macmillan & World Bank, 2010).18–23. 
750 Pryce, Fixing Drugs: The Politics of Drug Prohibition.107. 
751 Ibid.96–97. 
752 J. Ali, S. Hassan, and N.A.A. Karim, "Kos Ekonomi Penyalahgunaan Dadah [Economic Costs of Drug 
Misuse]," Jurnal Antidadah Malaysia (2010).9. 
753 United Nations Office on Drugs and Crime (UNODC), 2005 World Drug Report, vol. 1 (Vienna: United 
Nations, 2005).17. 
754 Keefer, Loayza, and Soares, "Drug Prohibition and Developing Countries: Uncertain Benefits, Certain 
Costs."15. 
755 For example, E. Koch, "Legalizing Drug-Use: Is it the Only Realistic Solution-No " ABA Journal 
75(1989).37; L.L. Thye, "Iltizam Perangi Dadah [Efforts to Fight Against Drugs],"  
http://www.utusan.com.my/utusan/info.asp?y=2011&dt=0419&pub=Utusan_Malaysia&sec=Rencana&pg=
re_09.htm.10. (Last visited: 02/04/2012) 
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tackle the serious drug use problem. This thesis argues that the case for more aggressive 
criminal justice measures is far from persuasive. They will not offer a solution due to 
their undetermined success. Indeed, increasing the harsh features will bring greater risks 
of detrimental implications including thwarting harm reduction strategies, and increasing, 
both human right violations and state expenditures. Further, drug dependency 
disempowering reasonableness is behind the compulsion to seek drugs and hence cannot 
be simply blocked by imposing harsher punishments.756 
There are also commentators who suggest the adoption of a firm emphasis on an 
exclusively public health goal. This would involve the application of approaches for 
promoting health or minimising harm rather than the traditional criminal justice approach. 
A notable supporting argument is that drug use is more of a public health issue than a 
criminal justice issue, and it therefore necessitates public health methods.757 The primacy 
of the public health aim over the criminal justice aim is also advocated based on critical 
widespread HIV/AIDS and effectiveness of the former over the latter to control drug use 
and the prevalence of HIV/AIDS.758 In addition, commentators such as Caulkins and 
Reuter advocate for primary importance to be given to total harm reduction aim and 
strategies for handling drug dealing and its harmful consequences.759 This means that 
paramount attention is given to the achievement of a decrease in drug-related harms. 
Moreover, the argument is presented to support harm reduction policy through the change 
of drug policy and law based on its effectiveness to mitigate drug-related harms. For 
                                                          
756 Bowser, Word, and Seddon, Understanding Drug Use and Abuse: A Global Perspective.178. 
757 For example, Gostin, "Drug Dependency and HIV."175. 
758 Ibid.152. 
759 J.P. Caulkins and P. Reuter, "Setting Goals for Drug Policy: Harm or Use Reduction? ," Addiction 92, 
no. 9 (1997).1149. 
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instance, the Burnet Institute calls for the modification of local laws to facilitate the 
expansion of an effective harm reduction approach.760 
Exclusive focus on the public health or harm reduction paradigm is not likely to 
be beneficial. It ignores the fact that the criminal justice approach, as Seddon emphasises, 
is also grounded on public health.761 Further, unless strong justifications are given to 
support this type of conceptualisation, it is inappropriate to connect drug use issue and 
drug policy and law exclusively to public health matters. An exclusive focus inevitably 
loses sight of other harms attributable to illegal drug use and other concerns including 
public order and welfare which should also be considered in developing drug policy and 
laws. Additionally, the public health sector’s credibility to fully tackle drug problems 
without any engagement with criminal justice initiatives is doubtful; the problem is too 
complex for a one-dimensioned approach.  
It is also unreasonable to just rely on the harm reduction goal and efforts to reduce 
negative drug taking’s effects to address drug problems. The harm reduction approach, 
even effective, is not a complete answer to the prevalence of illicit drug use. Even though 
it assists with stabilising drug dependants for drug treatment and contributes to 
minimising drug consumption, it itself is incapable of curing and eliminating drug 
dependence (refer to Chapter 3, Section 3.3). Merely emphasising mitigating of drug-
related harms through MMT and NSEP might contribute to undefined drug maintenance 
and long-standing dependency. Moreover, the harm reduction approach has some other 
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limitations in relation to control the wider drug problem, including less consistent 
participation from the drug-using population and subjectivity of its efficacy to wide and 
free accessibility and integration into national health services.762 
Furthermore, many who argue for a stronger focus on public health principles 
frequently call for the implementation of a decriminalisation763 or legalisation764 regime, 
in which harm reduction and other public health measures could be enhanced to reduce 
drug-related harms. The decriminalists’ arguments, supported by research findings, also 
directed towards the advantages of reform including rising attendance in drug treatment 
and mitigated health harms from drug consumption including blood-borne disease 
infections and mortality.765 Supporters also argue that decriminalisation would lead to             
a decline in associated crimes attributable to eradicated proceeds of the illegal drug 
market and financial burden of criminalisation scheme.766 Invariably, based on utilitarian 
accounts, the legalisers argue that benefits of the reforms would include: the improvement 
of drug users’ health and quality of life; a wide availability of drug treatment; protection 
of civil liberty via reduced state interference in individual behaviour; reduction of health 
risks from drug use; reduction in crime levels including drug trafficking and acquisitive 
crimes; and reduced costs of law enforcement.767 
                                                          
762 Bowser, Word, and Seddon, Understanding Drug Use and Abuse: A Global Perspective.179. 
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Decriminalisation and legalisation are unpromising drug models. Withdrawal 
from global prohibition is not easy as it is controlled by the international drug treaties. 
There also appears less clear description regarding their working operations and no 
convincing justifications suggesting their greater efficacy and benefits over the 
prohibition regime. Most arguments for the positive effects of legalisation are likely 
grounded on guesswork owing to insufficient or compelling evidence. Considering the 
facts and history, decriminalisation or legalisation could also bring increased overall 
levels of drug use along with associated health risks, medical costs and other social and 
economic damages to individuals and societies. According to Goldstein and Kalant, the 
removal of criminal penalties against drug-related acts is associated with the easy 
availability of drugs which likely triggers growing consumption.768 This is also supported 
by analyses such as by Kleber and Rosenthal showing significant increase of marijuana 
and cannabis use from 1984 and 1996 in the Netherlands which practises 
decriminalisation policy.769 By contrast, evidence from other countries finds little effects 
of decriminalisation on drug consumption rates.770 Rosmarin and Eastwood, based on 
their assessment of global practices of decriminalisation, concluded that the prognosis of 
soaring drug consumption is false.771 This seemingly suggests that there is somehow an 
agreement among the commentators that there is an increase in drug use by the adoption 
of decriminalisation policy, though, they differ regarding the extent of the increase. Thus, 
                                                          
768 A. Goldstein and H. Kalant, "Drug Policy: Striking the Right Balance," Science 249, no. 4976 
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this thesis argues that the decriminalisation or legalisation likely results to at least small 
increase in drug use. It is therefore possible to contend that even though drug policy 
alternatives might minimise negative consequences, this benefit may be offset by the cost 
of any resultant rising drug consumption. This could be supported by the MacCoun and 
Reuter’s macro analysis framework772.773 Additionally, in the absence of definite 
assessment, the effectiveness of any drug policy to achieve greater total harm reduction is 
unknown and hence any call for making preference to any lenient alternatives over 
prohibition on this contention is unpersuasive.  
The ineffectiveness of prohibition and its negative consequences on the harm 
reduction approach do not mean that states should abandon prohibition, but rather 
requires improvement. It is imperative to give thoughtful consideration to various drug 
use costs aside from just negative health effects. There are numerous roles and goals of 
drug policy and law and multiple principles including social order, human rights and 
social justice if the overall public interest is to be served. Accordingly, public health 
should not be treated as the only pivotal principle to underpin drug policy and law. 
Integrating all of the above goals within a broader aim of public good under a sustained 
prohibition-based framework potentially becomes a precondition to effective drug policy 
planning and implementation.  
It is urgently necessary to affirmatively integrate the harm reduction approach as a 
crucial response to drug use to achieve public health aims, as one of the goals within a 
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wider prohibition regime. Properly understood, harm reduction may be seen to 
complement rather than contradict supply reduction and demand reduction strategies 
under the prohibition framework. Moreover, utilisation of the harm reduction paradigm to 
handle drug use problems would enhance the efficacy of treatment and preventive 
strategies. This would positively impact drug users’ health and welfare and diminish the 
negative implications from fixed dependence on criminal justice methods. This revised 
understanding of the role and place of the harm reduction approach within a broader 
prohibition framework would also help to give harm reduction greater political credibility 
and thereby enable fuller implementation.  
 In short, the harm reduction response should be pursued as an important 
constituent of overall drug policy within a prohibition framework, rather than merely a 
national response to the HIV epidemic or as a minor component of drug policy. This way 
is more credible towards mitigating drug-related harms and drug use prevalence rather 
than intensification of punitive measures on the one hand or adopting sole emphasis on 
harm reduction policy or public health principle, either within or without the prohibition 
framework, on the other hand. 
 
5.3 Further Thought on Relationship between Harm Reduction and Criminal 
Justice Approaches: A Conceptual Analysis 
 
Due to the conflict between the harm reduction and criminal justice approaches in 
Malaysia, it will be worthwhile to consider some issues including whether either of the 
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approaches should be dropped to avoid future conflicts or whether both could be 
reconciled in order to efficiently handle drug use problem and if so, how? 
The discussion will begin with a consideration of the main strands of 
philosophical approaches to the legitimate utilisation of criminal law and public health 
measures; legal liberalism, legal paternalism, legal moralism and public health in 
articulating the jurisdiction of every criminal justice approach and public health approach 
including the harm reduction approach upon drug use and their relative strength. This is 
imperative to determine which approach has the rightful claim of domain over drug use 
and hence must be pursued. 
 
(i) Legal Liberalism 
Legal liberalism demarcates limits on the criminal law’s domain. At its core, competent 
individuals have liberty to act without interference on the grounds of autonomy. The 
autonomy refers to ‘people possess free will and must be allowed, to the maximum extent 
possible, to make free choice’.774 The freedom of action, however, may be subjected to 
state’s restriction if its exercise is harmful to others. This constitutes the essence of ‘harm 
principle’ which sketches a requisite ground for criminalisation. In his essay ‘On Liberty’, 
John Mill, the influent contributor to the harm principle, mentions:  
The only purpose for which power can be rightfully exercised over any 
member of a civilized community against his will is to prevent harm to others. 
                                                          
774 C.M.V. Clarkson, H.M. Keating, and S.R. Cunningham, Clarkson and Keating Criminal Law: Text and 
Materials vol. 7 (London: Sweet & Maxwell, 2010).9. 
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His own good, either physical or moral, is not a sufficient warrant. He cannot 
rightfully be compelled to do or forebear […] because in the opinion of others 
to do so would be wise or even right.775 
Joel Feinberg further elucidates on Mills’ principle: ‘It is always good reason in 
support of penal legislation that it would be effective in preventing (eliminating, 
reducing) harm to persons other than the actor (the one prohibited from acting) and there 
is no other means that is equally effective at no greater cost to other values’.776 
What is important to note is, on liberalism, neither harmless, self-harm nor 
morality are sufficient to justify state interference. A utilitarian harm-oriented approach 
requires the state to present relevant evidence concerning a relation between the conduct 
in issue and its harming effects to anybody except the actor. This, according to Feinberg, 
extends to the threat of harm.777 
  Feinberg, however, limits the harm principle’s application to ‘wrongful harms’ 
being ‘thwarting, setting back, or defeating of an interest’ (of other person)778 that 
‘violates the other’s rights’.779 The interest consists of aspects which enable individual 
chances for enjoying or pursuing his life.780 Feinberg points out that ‘only setbacks of 
interest that are wrongs, and wrongs that are setbacks to interest, are to count as harms in 
                                                          
775 J.S. Mill, "On liberty," in Man and the State: The Political Philosophers ed. S. Commins and R.N. 
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780 A.P. Simester et al., Simester and Sullivan's Criminal Law: Theory and Doctrine, Fifth ed. (Oxford and 
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the appropriate sense’.781 Wrongful harm provides a factor for criminalisation. Merely 
defeating the others’ interest without infringing their rights or vice versa may not be 
legitimately criminalised. The criminal liability is however defensible by the presence of 
victim’s consent as no personal interest is wrongfully set back. 782 
Furthermore, for Mill, the harm principle is qualified for persons of sufficient 
competency to make informed choices and act deliberately. The incompetent persons 
including those with mental illness and children are subject to paternalistic intervention. 
Mill states: ‘It is perhaps necessary to say that this doctrine is meant to apply only to 
human beings in the maturity of their faculties […] Those who are still in a state to 
require being taken care of by others, must be protected against their own actions as well 
as against external injury’.783 Therefore, the state could decide and take actions on behalf 
of persons of diminished capacity to secure their interests, safety, welfare or health. 
Unlike Mill, Feinberg has not specified the harm principle as the only justifiable 
‘liberty-limiting principle’. He added a profound offence principle which recognises the 
proper criminalisation of seriously offensive behaviours. As claimed, ‘if these unpleasant 
experiences are intense or prolonged enough […] or if they recur continuously or occur at 
strategically untimely moments, they can get in the way of our interests’.784 It is the 
commonly unacceptable conduct which happens in public and impacts uncomfortable 
feeling justifies liberty restriction. According to Feinberg, ‘it is always a good reason in 
support of a proposed criminal prohibition that it would probably be an effective way of 
                                                          
781 Feinberg, The Moral Limits of the Criminal Law: Harm to Others, 1.36. 
782 Ibid.35–36. 
783 Mill, "On liberty."145. 
784 Feinberg, The Moral Limits of the Criminal Law: Harm to Others, 1.46. 
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preventing serious offence (as opposed to injury or harm) to persons other than the actor, 
and that it is probably a necessary means to that end’.785 
The application of harm and offence principles will lead the state to scrutinise 
criminalisation issues from a consequentialist lens. However, the related difficulty with 
both principles is the problem of determining these terms’ meanings, given no sound 
clarification provided by their proponents. The vagueness of the term ‘harm’, according 
to some critics, may possibly lead to wider deductions about its application.786 Therefore, 
arguably, the criminal sanction for harm prevention should be limited in serious 
circumstances.  
 
(ii) Legal Paternalism 
Legal paternalism allows the use of penal legislation where conduct harms the actor 
oneself. The label paternalism characterises the belief that ‘it is always a good reason in 
support of a prohibition that it is probably necessary to prevent harm (physical, 
psychological, or economic) to the actor himself and there is probably no other means 
that is equally effective at no greater cost to other values’.787 There is legitimate ground 
for the state, under this theory, to interfere with personal liberty for protecting the safety, 
welfare or other interests or values of the person concerned regardless of his values, 
interests and goals. Paternalism agrees with liberalism by their requirement of harm 
inflicted to a person. It, however, clashes with liberalism for its sanction of self-harm 
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criminalisation. The obvious examples of paternalist regulations include the law 
punishing an attempt to commit suicide and the law punishing the omission of motorbike 
riders to wear helmets. The latter example demonstrates that according to paternalism, the 
control over individual action could extend to the act of posing a risk of harm upon 
himself, such as the risk of more grievous injury in accident of which the helmetless 
cyclist freely assumed. 
The comment against paternalism mainly lies on its inconsistency to the liberal 
notion of autonomy. Even if paternalist legislation is not detrimental to people’s lifestyle 
as in the case of the helmet wearing requirement, it indeed involves the infringement of 
personal liberty to freely act in accordance to his own desires and preferences, including 
to undertake self-regarding action.788 For this reason, it seems fair to say that before the 
legislators decide to criminalise behaviours on paternalist grounds, they need to provide a 
prudent basis for their intervention, including a valid reason why its promotion of actors’ 
safety and welfare could offset their autonomy. 
 
(iii) Legal Moralism  
Legal moralism holds the legitimacy of criminalisation of certain acts based on 
immorality per se. It embraces the belief that ‘it can be morally legitimate to prohibit 
conduct on the ground that it is inherently immoral, even though it causes neither harm 
nor offence to the actor or to the others’.789 Notably, unlike liberalism and paternalism 
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principles, moralism does not subject the utilisation of criminal law upon any adverse 
effects or infringement of rights of particular persons.  
An attempt to qualify the criminalisation against immorality has been made by 
Lord Patrick Devlin, annexing it to the deep social disgust at a particular action. 
Considering moral values as a vital component of society’s structural framework, Devlin 
has suggested the prohibition of its breach to conserve the social structure. Warranting 
morally repugnant conducts, for him, will potentially cause devastation of social fabric 
and ultimately society’s dissolution and anarchy.790 It is suffice to say that in relation to 
the justification of criminal law’s use, Devlin’s critical consequentialist-based concern is 
the law’s effects to the preservation of society but not the conduct’s effects.791 
Devlin’s view is problematic, considering the inconclusive basis of disgust for 
criminalisation. There is no clear link between immorality and depth of disgust. Disgust, 
for Hart, is also potentially influenced by ‘ignorance, superstition or misunderstanding’. 
Further, there is insufficient evidence for confirming Devlin’s consequentialist-based 
hypothesis regarding the effect of immorality to society’s dissolution. 
Moralism, except Devlin’s moralist principle, does not require empirical evidence, 
given its purely deontological nature. Thus, it may likely accelerate the state’s 
promulgating of criminal law which satisfies and advocates the citizens’ rooted moral 
perspectives. However, moralism singly represents an unsubstantial ground upon which 
to invoke criminal law. The cases against moralism rest on the undetermined scope of 
morality and its contradiction to the autonomy principle. There appears the problem of 
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discerning agreed moral values due to people’s diverse opinions in a society with various 
religions, cultures and ethnicities. Moreover, the nature of the morality perspectives is 
such that they alter in consonance to changing times. Additionally, criminalisation 
involves unavoidable deprivation of personal liberty. Thus, defensible infringement via 
criminalisation arguably calls for more compelling grounds, rather than solely moralism. 
 
(iv) Public Health 
The public health principle emphasises the promotion and protection of community’s 
health as a basis for government actions. Public health, according to the Institute of 
Medicine, is ‘what we, as a society, do collectively to assure the conditions for people to 
be healthy’.792 Larry Gostin defines public health law as:  
Public health law is the study of the legal powers and duties of the state, in 
collaboration with its partners (e.g., health care, business, the community, the 
media, and academe), to ensure the conditions for people to be healthy (to 
identify, prevent, and ameliorate risks to health in the population), and of the 
limitations on the power of the state to constrain for the common good the 
autonomy, privacy, liberty, proprietary, and other legally protected interests of 
individuals. The prime objective of public health law is to pursue the highest 
                                                          




possible level of physical and mental health in the population, consistent with 
the values of social justice.793 
Therefore, the primary focus of public health is on populations rather than individuals. It 
obliges the government initiatives to improve the health and wellbeing of populations. It 
also broadens the legitimacy base for actions including promulgating and exercising 
legislations to attain public health targets. 
Consistent to its emphasis on wider population-oriented viewpoints concerning 
causes and risks of health problems, including environmental determinants, public health 
places importance on individual, community and environmental changes through broad-
based means for the purpose of halting or decreasing health threats. The Ottawa Charter 
for Health Promotion, endorsed by WHO, specifies five important types of actions for 
promoting populations’ health: developing public policies supporting health, creating 
conducive environments for health, strengthening community action, building the skills of 
individuals or society and re-orienting health services.794 Hence, public health reorients 
the thinking and ways to deal with health-related issues.  
The public health basis has been challenged for its potential violation of the 
affected individuals’ liberty. This issue commonly arises in relation to coerced-based 
interventions including compulsory testing, treatment and quarantine in the name of 
public health imperative. Voluntary measures are also contestable for their discriminatory 
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coverage.795 The state’s unjustified encroachment of the private zone for public health 
purpose may potentially occur. While contemporary public health acknowledges 
voluntary cooperation, deviating from coercive public health authority or ‘police power’ 
prioritised during the 20th and early 21st centuries, the government is still free to 
determine the breadth of power ambit and need of coercive interventions. This is 
contributed by the lack of specific guiding criterions or clear ethics framework in 
applying the health-oriented strategies.  
Therefore, it is argued here that entire reliance upon the public health rationale is 
insufficient to justify coercive health measures. It should be circumscribed for serious 
health risks after taking into account other alternatives and interests. Arguably, its 
necessity must be subjected to case-by-case assessment based on principles of 
criminalisation due to their overlaps of the state’s coercive power and other priorities 
such as safety and human rights. This is important to ensure that positive outcomes of 
health measures are harmonised with individual liberty burdens. 
Having considered the jurisprudential foundations of criminal law and public 
health strategy, this thesis will now seek to refine the perspectives on whether drug use 
fits the principles and specify the appropriate areas of both approaches in responding to 
the conduct. 
Many liberalists have the view that adults have an individual liberty to use drugs, 
backed by their autonomy to engage in any self-destructive behaviour. Drug consumption 
is deemed normal behaviour and primarily harmful only to oneself, rather than to others 
                                                          
795 L.O. Gostin and Z. Lazzarini, Human Rights and Public Health in the AIDS Pandemic  (New York: 
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and hence the restriction on personal freedom to take drugs represents an unjustifiable 
intrusion of liberty. Thomas Szasz defends the libertarian perspective on drug using by 
the following statements:  
I believe that we also have a right to eat, drink, or inject a substance-any 
substance-not because we are sick and want it to cure us, nor because a 
government-supported medical authority claims that it will be good for us, but 
simply because we want to take it and because the government-as our servant 
rather than our master-does not have the right to meddle in our private dietary 
and drug affairs.796 
It seems right to take the opposite perspective to the liberal ideas. Drug taking 
cannot possibly only impact its actor. The conduct’s resulting intoxication risk damages 
to others. For example, driving under the influence of drugs can endanger passengers and 
other road users. The behaviour also considerably causes a burden on family, society and 
economy. For instance, habitual drug using may lead to abandonment of family-
members’ obligations, financial cost of public health services and reduction of workers’ 
productivity.797 One argument rejecting the claim is that drug consumption’s 
consequences to others are indirect and hence not wrongful harms.798 The potential 
response to this is that considering the liberal criteria, the effects to others may sanction 
criminalisation if they involve the infringement of moral rights including drug users to 
exercise responsible parenthood to children. Alternatively, harms or risks of harms to 
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others, irrespective of whether they are direct or not, if serious enough to the public good, 
could press state into action. However, it might be contested, given the vagueness of the 
harm term to public interest. Therefore, this justification should be associated with more 
other justifications.  
Additionally, there is no merit in the liberalist case of sidestepping drug-related 
damages to the users. Drug consumption in many circumstances risks great self-harms 
and hence may become an acute factor for state concern and interference. A sea of 
evidence leaves little space for ambiguity that illicit drug consumption is physically 
hazardous, causing health-related harms including diseases, damage to organ systems, 
mental impairment and drug overdose. For instance, using opiates including morphine 
and heroin may pose critical or life-threatening health risks such as nervous and 
respiratory problems, constipation and dependency.799 Drug taking is also fraught with 
psychological effects such as depression, anxiety and hallucinations. Further, it may cause 
unintentional sufferings including drug-related vehicle accidents.800 
However, the state’s prohibition, arguably, cannot rest on contended drug-related 
crime. The arguments for drug-crime relation which are frequently based on evidences of 
substantial connection between criminals and drug using numerically could be challenged 
using the common reason model. Seddon, by considering the UK’s history of drug use, 
shows the relation of drug use and crimes to socio-economic disadvantages and social 
exclusion contexts.801 This thesis is persuasive, given the socio-economic problems 
including poverty and low academic qualification among criminals and drug users in 
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many countries.802 Additionally, Goldstein’s explanatory typology of drug-crime 
connection803 is questionable mainly for an uncertain direct causal link. The causality of 
violence to drug’s ‘criminogenic’ property is not well presented given its weak evidence, 
as suggested by multiple reviews.804 The ‘systemic crime’ which involves violence in 
illicit drug dealings and conflicts controlling is also indirectly correlated to drug taking, 
but instead linked to the drug market’s illegal features. It is also fair to say that the 
‘economic-compulsive crime’ of drug users arises from less affordability in fixing drug 
habits, rather than intrinsically attributable to drug taking. However, considering evidence 
upon account of economic-compulsive crimes to fund drug use in some circumstances,805 
the acceptable approach would be diversion into a drug treatment scheme as practised in 
drug courts. 
Notably, despite being less risky or dangerous to self or others, some drugs are 
classified as illegal. Based on experts' rating of the harms of major abused drugs in Nutt 
et al. research, illegal drugs including ecstacy, LSD and bubrenorphine presented the least 
harms to users and other persons with the last score between 7 to 9 respectively out of 
100.806 In Malaysia, these illicit drugs are listed together with more harmful drugs 
discovered by Nutt et al. including heroin (55) and cocaine (27) in Part III of First 
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Schedule, DDA 1952 (Refer to Annexure I). Therefore, their use seems inadequate to 
invoke the legal paternalism. 
The view regarding self-harms of drug using is also challenged by the argument 
that the conduct does not invariably imperil the user. In multiple incidents, most users do 
not suffer the harms.807 Such argument has been usually raised to accommodate less focus 
of legal interventions against recreational users, given no apparent individual and social 
damages from their under control consumption.808 Arguably, this selective criminalisation 
may constitute disproportionate application of criminal justice principles and practice. 
Further, employing social conflict theory,809 this could bring class conflicts and 
perpetuate social inequality. This is because recreational using is commonly annexed to a 
wide range of social structure covering the upper- and middle-class while critical 
consumption and dependence on drugs are predominant among the less powerful poor, 
led by political and economic structural situations.810 Drug use controlling in USA has 
been connected to social divergence when it targeted the black ethnic and economically 
disadvantaged with drug consumption generally swelling across diverse social groups.811 
Additionally, it seems true that whole drugs are not uniformly perilous and in 
certain circumstances, their consuming does not entail great harmfulness. This is because 
drug use effects vary as a result of many factors such as types and dosage of drugs used, 
using techniques, frequency and settings. Therefore, the initial or recreational level of use 
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does not necessarily mean that significant harms will happen. Despite this, there are still 
harms or at least potential risks of harms involved in every drug taking. The probability of 
harms may strengthen the case for equal paternalistic protection, compatible to Feinberg’s 
harm principle.  
Furthermore, many have defended certain drugs of which the most cited are 
cannabis and psychedelics for their potential benefits. It is true that certain illicit drugs 
may bring benefits if properly taken. Cannabis, for example, has been shown by scientific 
evidence to have therapeutic values including for critical pain. This has been confirmed 
by numerous large reviews.812 Therefore, assessment of harms relative to benefits is 
important. The government may permit the use of certain illicit drugs for needs related to 
their significant benefits while controlling them to prevent harm. Arguably, this is more 
tenable than fully prohibiting or legalising it. To facilitate ascertaining which drugs may 
require control and its extent, the government may provide a systematic categorisation of 
illegal drugs accounting a range of dangerousness and risks, harm degrees’ different 
determinants, relative importance of costs versus benefits and use and dependence 
tendencies based on evidence. 
Moreover, the government may enforce drug use control against minors, teenagers 
and those suffering mental incapacity by virtue of their deficient capability for reasoned 
actions. The state intervention is important for protecting their interests and wellbeing. 
This argument finds consistency with Mill’s exception principle. However, it is worth 
repeating (as discussed previously in Chapter 4, Section 4.2.2) that the compulsive state 
actions, including compulsory drug treatment for drug dependants solely on the basis of 
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the resulting reasoning incapacity from drug dependency, is unjustifiable. This is because 
the contradictory scientific evidence indicates that drug dependants retain their ability of 
autonomy and self-determination. Nevertheless, it is argued that drug dependence which 
is at the highest level that may be reached from initial drug use and harmful to oneself 
and others may reinforce the justifications for the state control over drug use. As in the 
issue of drug-related harms, the criticism is that not all drug using is followed by drug 
dependence and hence the generalised prohibitive measures against drug users are 
morally objectionable.813 The defence is that despite different expediency to reach 
dependence, almost all drug users are potentially depending to drugs and hence in 
concern, the prevention of which may therefore substantiate the control against drug 
consumption. 
Furthermore, the moralistic appeal of drug prohibition presupposes the 
intrinsically moral failing of drugs. Drugs are rendered as evil and sinful in themselves 
and their taking is intolerable. This can be illustrated by the signatories’ statement in the 
1961 Convention that they are ‘conscious of their duty to prevent and combat this evil 
[narcotic drugs]’.814 Drug prohibition is defended by the moralists as a moral imperative. 
A major drawback of this argument is its neglect to scientific lens regarding drugs’ 
chemical nature and physical and psychological harms to people. Unless being consumed 
or taken into humans’ body, the drug itself does not impact any damages or benefits and 
hence should not be subjected to moralistic judgment. 
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The stance of this thesis is however on the immorality of using illicit drugs for 
illegitimate purposes. The behaviour, rather than the drug itself, is a vice that has 
profound effects on human excellence, perfectionist ideals and quality of life. It is the 
philosophers including Aristotle and Plato who taught the conceptions’ values. Drug 
consumption effects human disordered lives, thereby making its actor unfit to 
virtuousness or ideal pursuit. Further, drug using potentially undermines society and state. 
Drug takers becomes ill and slave to their lust to drugs and may hence neglect their 
responsibilities, disregard societal standards and ethics, and undermine efforts to 
construct civilisation in the state.815 Consequently, this could lead to the state’s 
destructive security and equilibrium. Moreover, in the Malaysian context, drug 
consumption is contrary to perpetual national culture and religious beliefs. The shared 
morality of drug use is well-documented in numerous literatures.816 
Notably, some prohibitionists’ argument evoking the wickedness of consuming 
drugs centres on the conduct’s harms, rather than its inherent wrongfulness. This 
argument suits neatly into consequentialist types and is impurely moralistic. Wilson, for 
example, makes empirical claim in favour of drug control by utilising several terms such 
as ‘enslaves the mind’ and ‘destroys the soul’ which denotes harm to individuals: 
Even now, when the dangers of drug use are well understood, many educated 
people still discuss the drug problem in almost every way except the right 
way. They talk about the ‘costs’ of drug use and the ‘socioeconomic factors’ 
that shape that use. They rarely speak plainly– drug use is wrong because it is 
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immoral and it is immoral because it enslaves the mind and destroys the 
soul.817 
Therefore, arguably, Husak mistakenly asserts that Wilson’s arguments for drug 
prohibition are underpinned by religious notion.818 
The purely moralistic arguments are reasoned to support the immorality of using 
drugs. Thus, the contradictory views are unconvincing. The liberalists including Husak 
suggest that drug taking per se is not morally wrong but instead a warrantable way of 
gratification.819 As contended, the moral disapproval of drug using is unpersuasive to 
justify drug prohibition as unaccompanied by acceptable explanations, given most merely 
relate to religious accounts inconsistent to cognition, inadequate evidence of causal link 
between drug use and societal impacts and involve consequentialist basis.820 It is 
acceptable that the activities for pleasure are generally not wrong. However, even also for 
recreational purpose, using drugs is immoral due to its adverse impact to human conduct, 
society and state. Moreover, as in the Malaysian case, the immorality of drug use has 
grounded as established social norms and values. The moralistic belief is of deontological 
issue and hence is non-empirical evidence-related.  
However, even drug use amounts to immoral behaviour, immorality alone cannot 
be the appropriate rationale for punishing its actor. It seems imprudent to criminalise 
conducts simply for their moral failing. It bears repeating the improper merely 
compliance to legal moralism, given unfixed sphere of morality and its clear 
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inconsistency to individual freedom principle. Therefore, the criminal sanction should be 
backed by more persuasive justifications in addition to that moral repugnance. This 
secures justice and compromise between personal autonomy and common interests.  
Further, drug consumption may come within the ambit of public health. It is 
undoubtedly a public health problem, considering its adverse implications for individual 
and public health. Extensive evidence shows that drug using contributes to serious effects 
to physical and mental health including fatalities and modified brain function.821 Many 
acknowledge that drug use is a chronic and relapsing disorder, similar to other chronic 
health conditions handled by medical practitioners.822 It is also linked to severe 
communicable diseases including AIDS and HCV. Moreover, it also influences growing 
medical care and drug treatment expenditures. All this thereby seems sufficient to invoke 
a public health approach. This is further supported by increasing empirical findings on the 
approach’s effectiveness in minimising drug taking and its harmful consequences.823 
The approval of a public health approach to drug use problems would mean that 
the latter should be dealt in congruity with the prism of the wider public health method. 
Therefore, as a public matter, it needs to be handled by the government through wide 
ranging techniques aimed at decreasing both drug-related harms and overall drug use 
prevalence. Unless combined with social and environmental measures, the strategies for 
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personal behavioural changes including drug treatment are seemingly inadequate. The 
comprehensive interventions potentially benefit drug user and community health. 
However, concentrating solely on the public health approach makes other issues 
connected to drug use such as safety and welfare unaddressed. This is unlikely realised by 
those arguing for the state’s exclusive adoption of the public health approach for drug 
users.824 As believed, this approach would be more effective than punitive measures 
including imprisonment for addressing drug use and its health effects to the actor and 
population. It is worth repeating (it has been discussed in Chapter 5, Section 5.2) that this 
sort of claim is less compelling for its lack of attention to not only varied priorities 
relevant to drug consumption but also the concomitant public health province of criminal 
law. 
 The provisional summary of this thesis is that almost all illegal drug using may 
present individual and societal harms and risks even though their degrees might differ. 
More adverse effects of certain drugs than others are affected by various factors. The 
degree could be reflected in an appropriate drug classification. The behaviour is also 
against Malaysia’s social norms. The damages, risks of harms and immorality could 
justify the inhibition of all levels of illegal drug use inclusive of experimental, 
recreational, regular, heavy and dependence status and any means towards the 
consumption including drug possession, except for legitimate purposes connected to their 
significant benefits. This seemingly suits the principles of liberalism, paternalism and 
moralism. Simultaneously, it may sufficiently belong in the public health realm, given 
resulting personal and public health consequences. In other words, both criminal justice 
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and public health have the rightful claim of jurisdiction over drug use and thus neither of 
them could simply be dropped. Nonetheless, the unclear lines for the ambits of both 
approaches may impact unresolved conflicts. Therefore, for addressing the conflicts 
between them, it is argued that it is critically necessary to reconcile or harmonise between 
both approaches by redefining or adjusting the purviews and aims for every approach for 
drug use with reference to a principled approach. 
Before any further discussion, this thesis would make clear a value judgment 
regarding drug use. This thesis disagrees with the argument that drug use should be 
treated as a normal conduct but needs focus to its immediate problems and harms in 
accordance to the neutral stance of many harm reductionists.825 This normalising is less 
compelling as the way how the drug use problem is gestated may significantly shape the 
policies and strategies to tackle it. Schuster claims that the conceptualisation of drug 
using constitutes the strong influence of its policy.826 Influenced by Martin’s formulation 
of moral-therapeutic conception related to mental health827, this thesis proposes that 
combined moral-health viewpoints should apply to drug taking, given its justified position 
on moral, medical and public health issues. Arguably, using drugs is a complex issue 
which is insufficiently explained and tackled by one theory, given its limitations 
including narrow perspectives regarding the influences to drug dependency and 
appropriate approaches. The joined conceptions may disband the moral-disease or health 
dichotomy which drives towards contradiction between both. While considering drug 
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users’ sickness, it may ensure their liability for options and accountability for 
wrongdoings. Every drug use stage relates to choices and even dependence to drugs 
develops from chosen initial recreational using. The linked angles are important to trigger 
complementary criminal justice and public health methods instead of either of both to 
manage the drug use problem. It may avoid absolute medical interference and sickness 
excuses for wrongful acts based on the disease model or total punitive responses deriving 
from the moral model.  
For the purpose of redefining or adjusting spheres for each criminal justice and 
public health approach, this thesis makes particular reference to Andrew Ashworth and 
Jeremy Horder’s minimalist principles that furnish a yardstick for the use of criminal law; 
covering deontology, consequentialism and human rights aspects. The principles are as 
follows:  
(a) respecting human rights safeguards; 
(b) acknowledging the right not be susceptible to state punishment; 
(c) making the criminal law as a strategy of last resort, considering the serious 
wrongfulness and harms of behaviour; and 
(d) avoiding the utilisation of counterproductive criminal law.828 
In applying Ashworth and Horder’s criteria and public health principle, it seems 
that problematic drug use829 and dependence should not initially be criminalised but 
instead provided with voluntary-based drug programmes following medical and public 
health models and comprising harm reduction services, drug treatment, testing and 
                                                          
828 Ashworth and Horder, Principles of Criminal Law.31–35. 
829 This refers to drug use which clearly results into problems or negative effects. 
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education. When diagnostic criteria of problematic drug use or dependence are unmet, it 
is justifiable for the government to offer preventive and behavioural changing strategies 
other than drug treatment such as educational programmes including to initial or casual 
users, given its potentiality to develop to problematic use. The interventions may be 
combined with other supporting services recognising multiple modalities to address social 
and welfare issues among the drug using population. All the interventions must be 
underlined with the goal of public good as discussed before. The non-coercive approach 
is more humane, less intrusive to personal rights and credible to address the conduct and 
its varied harms and risks than the usual penal measures including incarceration. 
But, it may be justified to employ criminal compulsion against those who failed to 
engage and committed in such programmes voluntarily. This would become a reliable 
mechanism to attain harm reduction, behavioural change and recovery of extensive 
portions of drug consuming population towards attaining the public good aim. The threat 
of coerced observed programmes may also become an efficient way to instigate voluntary 
participation. This means that criminal law is utilised as a method of last resort, only in 
the failure of other non-restrictive initiatives to attain both pressing personal and public 
health or security objectives in a drug use context.  
It is also suggested that the state coercion is immediately applicable where drug 
using is committed in public and known by others. This satisfies Feinberg’s profound 
offensive principle and the social norms in drug use’s wrongfulness. Furthermore, 
criminal control could operate against any drug users who intentionally, knowingly or 
recklessly expose substantial harms or reasonably anticipated risks of harm including 
HIV and other blood-borne diseases to others through their involvement in dangerous 
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behaviours such as unprotected needle-sharing. This argument is clearly consistent with 
the harm principle. The liability should be irrespective of drug using level and proof of 
the victim’s consent, given sanctity of life principle. Specific modalities for behavioural 
changes and harm reduction conjunctive to coerced drug programmes could be 
considered in pursuit of public health and security. Considering the connection of drug 
consumption to acquisitive crimes and drug possession for personal use, it is also 
justifiable for the government to provide diversion to a drug treatment programme as an 
alternative to the latter’s original punishments. However, this choice should only be 
limited to problematic drug use or dependence and non-violent relations. Moreover, 
incarceration-based treatment could still be provided for other inmates unqualified for the 
diversion scheme but who satisfy drug dependence criteria. This may fit the integrative 
moral-therapeutic model.  
All criminal compulsions must only be exercised after some lesser restrictive 
methods to control harmful or unwanted behaviours have been found insufficient or 
unworkable. The methods between voluntary measure and criminal way may possibly 
encompass prism of persuasion, warning, court enforceable proceedings and civil 
penalties based on Ayres and Braithwaite’s generic business regulatory pyramid.830 
Seddon convincingly advocates for potential deployment of regulatory mechanisms for 
drug responses including treatment and other services for drug users. Regulatory lens 
incorporating normative and non-normative could contribute transformative policy 
direction and medium to harness insights of scholarship from varied disciplines.831 
                                                          
830 I. Ayres and J. Braithwaite, Responsive Regulation: Transcending the Deregulation Debate  (New York: 
Oxford University Press, 1992).35. 




Additionally, the selection of methods should be case-by-case considering several factors 
including the extent of devastating harms, regularity and persistency of conducts. This is 
important to secure fairness, proportionality and criminal law’s role as a last mean to 
maximise the applicability of harm reduction and other drug measures.  
If criminal control is truly necessary in exceptional circumstances, it must be 
undertaken in strict compliance with certain fundamental conditions. Coercive measures 
need to be exercised in facilities and techniques of acceptable quantity that is neither 
under-inclusive nor over-inclusive and quality which is aligned with objective evidences. 
As suggested by Ashworth and Horder, in case of no preferred or poorer implications 
than other techniques, the criminal strategies should be withdrawn. Additionally, they 
should strictly respect and fulfil human rights including freedom from discrimination. 
Further, they are subjected to the principles of health-care ethics such as informed 
consent, confidentiality of health status, fair procedural standards and due process. Rather 
than being extensive, it is necessary that the period of criminal compulsion is ended when 
the requirements for initial liability do not exist anymore. Drug users should be treated 
with respect, dignity and concern like a family member who does not undertake self-
control. Criminal justice agents should aim to educate them and appeal their self-
controlling ability, rather than to punish. These are consistent to the key standpoints of 
Griffiths’ Family Model of criminal process.832 Full observance to the basic criteria 
would add value to criminal law’s justification, proportionality and justice and lead 
directions for reconciliation between diverse interests in the criminal justice procedure.  
                                                          
832 J. Griffiths, "Ideology in Criminal Procedure or A Third "Model" of the Criminal Process," Yale Law 
Journal 79, no. 3 (1970).370, 373–74, 384, 389, 410–11. 
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Therefore, echoing multiple theoretical sources, this thesis puts forwards the 
applicability of criminal law and public health approaches for drug use and has redefined 
their coherent specific terrains over drug use with reference to a principled approach. This 
may address a blurring line and conflicts between them. The primary focus should be 
devoted to drug programmes and behavioural interventions including harm reduction 
measures offered on a voluntary basis to tackle health and safety issues related to drug 
use. Criminal justice measures should be vigilant and adhere to certain basic constraints 
to conserve justice, proportionality, human rights and good health practice. The clear 
specified domains and roles of both approaches moving to address drug use under the 
umbrella goal of public good would advance multiple interests including personal and 
public health, welfare and safety, than merely correspond to moral concerns.  
Nonetheless, the redefining of the provinces of each public health and criminal 
justice approach should not deter the mainstreaming of a partnership across the two 
regimes. It is pertinent that both systems serve as ‘carrot’ and ‘stick’ together in order to 
achieve the shared goal of public good. For example, law enforcement officers could 
provide information and assist in referring drug users to drug treatment and other public 
health programmes, including harm reduction services and ensure accessibility to the 
interventions in criminal justice settings such as prisons, probation and pre-trial detention. 
Interagency collaboration could be mobilised by constructive means including a 
systematic cooperative framework, constant liaison, useful information exchange, 
transformation in management, changes in operational objectives, training, organisational, 
and behavioural-change processes. 
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A need also exists to make appropriate and responsive policy and legal changes 
towards realising all the aforementioned options in order to ensure consistency between 
harm reduction and criminal justice approaches. Equally critical, an important priority 
must be given to the improvement of legislative and regulatory provisions related to the 
distribution and possession of needles and syringes and methadone prescribing and use to 
mitigate the barriers or risks they could pose to MMT and NSEP. The primary step should 
include enacting legislation to specifically legalise or authorise the harm reduction 
measures and exclude their practices from criminal liabilities.833 Such legislation should 
provide a clear and fixed acknowledgement of the interventions and clarify the vagueness 
concerning their legal status, in addition to protecting them from enforcement actions that 
may limit their promotion, extension and efficient operation.  
In addition, the drug law needs to be amended to decriminalise the distribution 
and possession of injection equipment provided by the NSEP service and other authorised 
dealers or sellers such as physicians and pharmacists.834 This is crucial to ensure that the 
criminal prohibition, while being requisite to combat the illegal distribution or sale of 
injection instrument, will not represent an impediment to prescribing such items for 
legitimate public health purpose. It is further advisable not to make the possession of 
injectable items a legally sufficient ground for law practices such as search and urinalysis 
for drug use and the equipment itself as admissible evidence in the court trials involving 
                                                          
833 The sample of such legislative provision can be found in Article 21(1) of Vietnam’s Law on the 
Prevention and Control of HIV/AIDS 2006 that states: ‘Harm reduction intervention measures to prevent 
HIV/AIDS transmission shall be implemented among target groups with risky behaviours through programs 
and projects suitable to socio-economic conditions’. 
834 This has been done in other countries such as Australia. Regulation 4 of South Australia, Controlled 
Substances (Exemptions) Regulations 2004 excludes the offence of drug paraphernalia possession as 
stipulated in section 31(1)(c) of the Controlled Substances Act 1984 from ‘a person having in his or her 
possession a syringe or needle for use in connection with the administration of a drug of dependence or a 
prohibited substance’.  
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the offences, including drug consumption. This policy and legal modification will remove 
any threat of policing and legal liabilities for the NSEP operators, staff and clients for 
supplying, possessing or using needles and syringes. In addition, it would be preferable to 
make explicit in the legislation that the possession of syringes and other related materials 
that contain illicit drug traces have exemption as the criminal offence of the possession of 
a controlled substance.835 Any drug residue contained in injection articles should also not 
be considered as admissible evidence with respect to drug-related offences. This legal 
reform would encourage IDUs to bring their used needles and syringes to be disposed of 
at the NSEP sites without concern for arrest or prosecution and assist a decrease in risky 
behaviour, such as syringe sharing. It would also ensure that health-care practitioners 
dealing with the used injection equipment are secure from the risks of criminal liability.  
Furthermore, the regulations for prescribing methadone should be sustained for 
the imperatives including providing guidance for operations, ensuring medical standards 
and clients’ autonomy and safety and minimising methadone diversion. However, the 
policies and legislation on methadone must be reformed to ensure that the provisions 
governing important aspects (including the eligibilities of prescribing physicians and 
clients, staff-clients ratios, licensing, dosing, duration of prescribing, confidentiality, take-
away, withdrawal or discharge of treatment, improper prescribing and continued illegal 
drug taking) are really rational, necessary and facilitative to greater clinical discretion. It 
                                                          
835 The example of the provision to decriminalise the possession of trace amounts of controlled substances 
could be found in section 38(2) of the Tasmania, Australia, HIV/AIDS Preventative Measures Act 1993. It 
states: ‘A person who is in possession of any trace element of a substance that is contained in a syringe or 
needle is not, by reason only of that possession, taken to have committed an offence under the Misuse of 
Drugs Act 2001 or Poisons Act 1971’. Though the Public Health (Miscellaneous Amendments) Bill 2015 
repeals the HIV/AIDS Preventative Measures Act 1993 (but the Bill is not yet enforced), the similar 
provision relating to the decriminalisation of possession of drug residue is included under amended 
Tasmania, Australia Public Health Act 1997; under section 56K(2). 
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is advisable that the restrictive regulations, guidelines and practices are made in 
accordance with international drug treaties, and with relevant resolutions and suggestions 
of international bodies such as the WHO. To reemphasise the discussion in Chapter 3, 
section 3.3, it is vital to note that the control of diversion, abuse or non-directed ingestion 
could be achieved by the mechanisms other than severe legislative restrictions upon 
methadone provision. These may include proper training for health-care workers on a 
consistent basis and systematic quality assurance and monitoring systems(for example, 
duly keeping the client registers, prescribing and dispensing, transferring records to the 
national central databank and inspections by enforcement officials). Additionally, 
consideration should be given to ensure methadone availability, accessibility and use in a 
sound and controlled manner in absolute emergency such as to relieve critical pain or 
reduce serious drug dependence or opiate withdrawal in the course of normal health care 
or inpatient treatment in health settings.  
It is not easy to address the conflicts between the public health and criminal 
justice approaches, given their considerable philosophical differences. Therefore, I do not 
claim that my overall suggestions in this chapter will definitely put the tensions between 
the two responses to rest. However, the agendas I recommend are promising ways, which 
should make it possible to mitigate the contradictions and their negative impacts upon the 
harm reduction policies and practices. Despite potentially being challenged, I argue that 
the recommended options are more meaningful, comprehensive and concrete than other 
means such as discretionary enforcement, litigation and diversion to treatment strategies.  
It is imperative to pinpoint that the discretionary arrangement methods including 
the police working agreement and prosecutorial pre-trial discretion may afford at times a 
297 
 
mean through which law enforcement agencies’ approval and cooperative efforts towards 
harm reduction approach could be enhanced. The police are capable of undertaking 
discretionary efforts such as avoiding to enter into harm reduction facilities and from 
making arrests on those who take drugs in small quantities. The prosecution could avoid 
proceeding with criminal charges against the acts of harm reduction interventions, despite 
their violations of drug legislation. This option has been implemented productively in 
other nations such as England and Iran836. This seemingly influences some scholars to 
advocate the use of discretionary arrangements in establishing harmonious practices of 
the criminal law and harm reduction policies.837 However, this avenue suffers from a 
variety of potential drawbacks. The administrative enforcement arrangement can be 
subject to disregard or violation for its no legal effect. The research findings reveal many 
situations in which the administrative arrangement is breached.838 The findings suggest 
that such arrangements are difficult to implement without the significant support of the 
police or other enforcement officials. Another possible problem is that this avenue makes 
those involved in harm reduction services rely upon political and enforcement disposition. 
The administrative arrangement could be potentially altered in accordance with the shifts 
in political winds and enforcement management and strategies.839 
                                                          
836 There is prosecutorial and judicial directive in Iran to circumvent the enforcement of laws that otherwise 
undermine the harm reduction operations. (E.M. Razzaghi et al., "Profiles of Risk: A Qualitative Study of 
Injecting Drug Users in Tehran, Iran,"  Harm Reduction Journal 3, no. 1 (2006), 
http://www.harmreductionjournal.com/content/3/1/12.11). (Last visited: 02/09/2015) 
837  For example, C. Spooner, M. McPherson, and W. Hall, The Role of Police in Preventing and 
Minimising Illicit Drug Use and Its Harms  (Canberra ACT: Commonwealth of Australia, 2004).8. 
838 For example, the study by Klein in Canada found that the seizure of syringes from NSEP clients still 
happened despite the existence of police administrative arrangement. (A. Klein, Sticking Points: Barriers to 
Access to Needle and Syringe Programs in Canada  (Toronto: Canadian HIV/AIDS Legal Network, 
2007).21). 
839 For example, the change of government that favours a total abstinence paradigm in drug interventions in 
Germany has led to the substantial reduction of prison-oriented NSEPs; from seven to only one. (Cook and 
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Moreover, broadening discretion is not always necessarily a good thing. I would 
suggest that discretion without statutory and structural changes is problematic if it is to be 
embedded in a harm reduction approach. For example, the government in England and 
Wales are looking at trying to reduce or reform police powers of ‘stop and search’ 
because broad police discretion has led to problematic outcomes, despite the official 
directives. The same can be said for police use of out of court disposals such as cautions. 
In England, these have been used widely due to police discretion. The government has 
since been introducing statutory guidelines and new legislation to try to limit their use.  I 
hence further argue that the discretion the police have is liable to be used to thwart the 
harm reduction approach, as evidenced in Malaysia. Additionally, reliance upon 
enforcement discretion to sidestep what might otherwise be regarded as law contravention 
would result into a lack of uniform law enforcement policy and practice. Therefore, 
depending on the police, prosecutorial and even judicial discretion would not be a 
sufficient, sustainable and effective means of addressing the conflicts between the public 
health and criminal justice approaches. As Elliott et al. contend, ‘dependence on ‘lenient’ 
interpretations of particular provisions would be too tenuous a basis on which reforms 
could be founded and criminal sanctions avoided.’840 
Furthermore, it is undeniable that litigation potentially brings the lawfulness of 
harm reduction interventions to the forefront and defends those against prosecution. 
Existing literature demonstrates that public health advocates have resorted to litigation 
mostly based on the defence of necessity and in seeking a judicial declaration that larger 
                                                                                                                                                                             
Kanaef, The Global State of Harm Reduction 2008: Mapping the Response to Drug-Related HIV and 
Hepatitis C Epidemics.53). 
840 R. Elliott, I. Malkin, and J. Gold, Establishing Safe Injection Facilities in Canada: Legal and Ethical 
Issues  (Toronto: Canadian HIV/AIDS Legal Network, 2002).39. 
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public health interests outdo drug legislation. The use of the necessity doctrine has been 
accepted by the courts in several cases, in some countries such as the USA. This was 
related to the supply of sterile injection items, particularly for curtailing the debilitating 
HIV/AIDS transmission crisis841 and for the provision of unlawful substances, 
particularly for reducing serious pain842. Additionally, the precedence of public health 
law empowering the measures for public health imperatives over contrasting drug laws to 
legitimise the harm reduction approach has been judicially recognised in some decided 
cases.843 Arguably, the future of litigation in securing the harm reduction approach 
remains uncertain. The battle waged in the courts is not only costly and lengthy but also 
far from providing immunity before involving in the harm reduction programmes. In 
addition, litigation is an indefinite tool for justifying these measures, considering the 
disagreements amongst courts (for example in USA and UK) regarding its viability.844 
Even when the courts do uphold the harm reduction approach, the declaratory judicial 
decisions are unable to fully ensure that the total law enforcement, especially street-level 
operations, favour and support the harm reduction programmes. Again, this goes back to 
the crucial point of discretion.  
I also contend that the strategy of diversion to treatment, either through arrest 
referral845 or drug courts846 in isolation (as implemented in numerous jurisdictions 
                                                          
841 For example, People v Bordowitz [1991] 588 N.Y.S.2d 507, 155 Misc. 2d 128.511. 
842 For example, Jenks v State of Florida [1991] 582 So. 2d 676.680. 
843 For example, Spokane County Health District v Brockett[1992] 120 Wash.2d 140, 839 P.2d 324.327. 
844 For example, the court in Commonwealth v Leno[1993] 415 Mass. 835, 839-840, 616 N.E.2d 
453.456.arrivedat a differing conclusion regarding the justifiability of medical necessity for NSEP 
operation, which violates syringe laws. This is predicated mainly on the reasoning that there are no 
situations of imminent or real danger to the public. Also, many courts including English Court of Appeal in 
Quayle and Others v R [2005] EWCA Crim 1415,89 BMLR 169.170. rejected the doctrine of necessity to 
be invoked for someone has possession of, for therapeutic supplying and/or use of illegal drugs.   
845 This scheme involves referencing drug-using offenders to drug programmes via the arrest point within 
police custody sites. Edmunds classified an arrest referral service into three models; ‘information’, 
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including the UK, USA, Canada, Australia and Brazil) cannot adequately address the 
conflicts between the public health and criminal justice approaches. Both strategies seem 
to be ideal ways of connecting drug treatment and harm reduction services. The courts 
exemplifying problem-solving justice, as Donoghue rightly describes, is ‘a window of 
opportunity’ for intervening in the lives of those who are most in need of treatment.847 
The regime is potentially well positioned to aid public health policies and operations, 
considering their large contact with drug users. The diversion to treatment method is, 
however, not without challenges. Considering the dissimilar philosophies, objectives and 
cultures between the criminal justice and treatment and rehabilitation regimes, the clashes 
between the people involved may still occur. The efficient practices and targeted 
outcomes of both arrest referral and drug courts rely substantially on acceptance and 
commitment among police and judges that are conditioned on organisational and 
behavioural shifts. This makes the process of increasing the enthusiasm of relevant people 
more complex.  
Additionally, the treatment mandated, particularly by drug courts, is still strongly 
linked to the drug control criminal prohibitionist framework. It is clearly embraced by the 
threat of criminal penalties. Hunter et al. claim that ‘the most unsatisfactory outcome of 
the collaboration would be one where the criminal justice system is always the dominant 
partner so that harm reduction and health goals are always subservient to those of 
                                                                                                                                                                             
‘proactive’ and ‘incentive’. Within the first model, the police officers simply provide essential information 
about drug programmes to those who pass through custody. The second model involves drug workers 
undertaking a preliminary confidential assessment of detainees and giving advice and referral to appropriate 
drug services. The third model involves incentives to motivate the detainees to get treatment services. (M. 
Edmunds et al., Arrest Referral: Emerging Lessons from Research  (London: Home Office, 1998).IV-V). 
846 The courts are specialised in handling drug-related offences and offer an option between treatment and 
prison to offenders.   




enforcement and crime reduction’.848 Therefore, the strategy is not really treatment or 
therapeutic oriented but criminal justice oriented. Moreover, the arrest referral and drug 
courts are subject to basic questions of fairness and equity. There are obvious risks in 
terms of inequality in intensity of diversion and disparity in relevant operational matters 
such as types of drug programmes connected to the schemes. Arguably, there is the wider 
issue about to what extent judges are involved in making similar decisions concerning a 
defendant’s personal, social and health circumstances in traditional courts.   
In short, my suggested options could provide relatively more extensive, useful and 
practical tools to harmonise the tensions between public health and criminal justice 
approaches for drug use, rather than other ways including discretionary enforcement, 
litigation and diversion to treatment strategies. 
 
5.4 Can Harm Reduction Approach Work Effectively alongside an Abstinence-
Oriented Goal? 
 
The harm reduction approach can be unified with the abstinence-oriented paradigm on the 
basis of consecution of protection for drug users. As discussed in Chapter 2, Section 2.5, 
the integration of both paradigms is beneficial and practical for the augmentation and 
stability of drug use management and treatment within the criminal justice and public 
health systems. However, there is an important question whether the harm reduction 
                                                          
848 G. Hunter, T. McSweeney, and P.J. Turnbull, "The Introduction of Drug Arrest Referral Schemes in 
London: A Partnership between Drug Services and the Police," International Journal of Drug Policy 16, 
no. 5 (2005).345. 
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approach can work effectively alongside an abstinence-oriented goal. Specific attention is 
given to the key issue of whether the abstinence-oriented goal should be a fundamental 
end target or a recommended but unnecessary aim in drug treatment. This issue must be 
addressed as it is one of the critical determinants of the compatibility between the 
criminal justice and harm reduction approaches.  
 Numerous commentators classify the abstinence orientation as an alternative to the 
harm reduction paradigm, rather than a necessary requirement for drug responses. The 
main justification forwarded is that abstinence is practically unrealistic for individuals 
who are unready or unable to quit consuming drugs. Christie et al. explicitly note that 
‘abstinence could be an eventual outcome and is consistent with harm reduction; 
however, abstinence is not a condition of the harm reduction approach’.849 Whilst Riley et 
al. express:  
That is not to say that harm reduction and abstinence are mutually exclusive 
but only that abstinence is not the only acceptable or important goal. Harm 
reduction involves setting up a hierarchy of goals, with the more immediate 
and realistic ones to be achieved in steps on the way to risk-free use or, if 
appropriate, abstinence, it is consequently an approach which is characterised 
by pragmatism.850 
 In line with the abovementioned views, the UK Drug Policy Commission 
(UKDPC) also refers to abstinence as an optional goal for drug treatment. Even though 
                                                          
849 Christie, Groarke, and Sweet, "Virtue Ethics as an Alternative to Deontological and Consequential 
Reasoning in the Harm Reduction Debate."53. 
850 D. Riley et al., "A Brief History of Harm Reduction," in Harm Reduction in Substance Use and High-




recovery is acknowledged as one of the central aims for drug treatment to achieve ‘health, 
wellbeing and quality of life’, it is not singly confined to ending drug consumption but to 
suffice with ‘voluntarily sustained control over substance abuse’. For UK Drug Policy 
Commission (UKDPC), medical drug maintenance is also inclusive as an acceptable 
count of recovery.851 This exemplifies the UK reformulated recovery model which has 
pragmatic perspectives on drug controlling responses. Entrenched in this model is the 
extensive width of recovery beyond staying free from drugs and hence a likely departure 
from the crux of disease model tenets. While recognising the authenticity and benefits of 
abstinence, the model is flexible towards the attainment of abstinence. As concluded in 
the 2010 monograph on recovery-based MMT, the question whether MMT is to be 
continued or ended is determined by individuals.852 Additionally, the strict pursuit of 
abstinence is seen as potentially leading to several negative implications for the harm 
reduction approach. These include restoration of MMT with residential rehabilitative 
services and specification of limited drug maintenance period.853 Obviously, the 
arguments in favour of the harm reduction paradigm accept a certain flexibility regarding 
the aim of recovery eventually. The proponents of this stance regard drug users’ 
participation to reduce drug-related harms and control over their drug-using habit is a 
minimally acceptable case, given their belief that the abstinence may be inappropriate or 
useless for certain people. This view likely rejects the importance and prospect of future 
abstinence-based measures towards achieving reduction of drug use.  
                                                          
851 UK Drug Policy Commission, The UK Drug Policy Commission Recovery Consensus Group: A Vision 
of Recovery  (London: UK Drug Policy Commission, 2008).6. 
852 W.L. White and L. Mojer-Torres, Recovery-Oriented Methadone Maintenance  (Chicago: Great Lakes 
Addiction Technology Transfer Center, Philadelphia Department of Behavioral Health and Mental 
Retardation Services and Northeast Addiction Technology Transfer Center, 2010).5. 




 By contrast, some commentators have taken the view that abstinence is an 
essential end outcome for drug treatment, mainly based on the inability of the harm 
reduction approach to stop the drug using habit. This goal is I said to parallel the hope of 
most people with a drug using problem. In a study evaluating the target of drug users 
entering drug treatment in 33 settings in Scotland, McKeganey et al. state that various 
drug programmes must be concerned to achieve abstinence than merely to decrease 
adverse effects from drug consumption.854 The researchers claim that abstinence is the 
aspiration of almost all drug users, as shown in their research findings in which 56.6 per 
cent of nearly 800 respondents voice abstinence as their ultimate target for accessing the 
drug programme.855 This study has limitations including there being no examination of 
how the respondents interpret abstinence and also the likelihood that the responses from 
prisoners who constitute a high proportion of respondents are driven by the abstinence-
oriented drug treatment offered to them in prisons. However, the finding indicates the 
presence of those among the drug using population who want abstinence. The results of 
this study are frequently applied by the ‘new abstentionists’ to justify the reorientation of 
recovery from illicit drugs. (Previous discussion about this group’s concern for abstinence 
can be found in Chapter 2, Section 2.5.) The insistence on abstinence is to some extent 
consistent with the conservative recovery-oriented model discourse, particularly among 
researchers and drug dependence professionals in the USA.856 It largely echoes the 
disease model as enshrined in the models such as the 12-step and Minnesota Model given 
                                                          
854 N. McKeganey et al., "What Are Drug Users Looking for When They Contact Drug Services: 
Abstinence or Harm Reduction?," Drugs: Education Prevention and Policy 11, no. 5 (2004).434. 
855 Ibid.425–26. 
856 A.B. Laudet, "What Does Recovery Mean to You? Lessons from the Recovery Experience for Research 
and Practice," Journal of Substance Abuse Treatment 33, no. 3 (2007).245. 
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its consideration upon absolute abstinence from drugs to solely denote recovery for drug 
dependency as a chronic and progressive disease. 
 This thesis argues that abstinence should be sustained as the eventual goal of drug 
treatment. The entire range of harm reduction techniques should also be emphasised to 
assist and secure drug users’ health and wellbeing until they are ready or able to attain 
and maintain abstinence. Clearly categorising decrease of drug-related harms as a short-
term goal and abstinence as a long-term aim merits consideration. The importance and a 
wide array of benefits from every paradigm would enhance the capability and efficacy of 
drug use management and treatment in criminal justice and public health settings as 
explained before. Turning attention to the two paradigms is also worthwhile for attaining 
the congruity between them. It is notable that a considerable account of progression 
towards abstinence while adopting harm reduction strategies in drug interventions is 
embedded in the Gradualism and Stages of Change models of respectively Kelogg and 
Prochaska et al.857 Exponents of these models find the harm reduction paradigm alone as 
troubling for giving little positive prospect for drug users. The arguments for ‘abstinence-
eventually’ are driven by the significance of transitions towards the achievement of actual 
demand reduction, rather than merely mitigation of negative effects from drug taking. 
This is vital for the achievement of abolished or decreased prevalence of drug use. 
The unification of both paradigms may influence a more creditable, inspirational 
and cogent drug treatment framework than the exclusive pursuit of either paradigm. An 
abstinence goal may frame a clear eventual target for substance users. It avoids their 
indefinite maintenance on substitute drugs and hence mobilises them to return to a drug-
                                                          
857 Kellogg, "On “Gradualism” and the Building of the Harm Reduction-Abstinence Continuum."243–46; 
Prochaska, Diclemente, and Norcross, "In Search of How People Change."1103–04. 
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free life. Arguing against a neutral stance on the achievement of abstinence, Kellogg says 
that ‘The problem with neutrality is that it runs the risk of encouraging stagnation, of not 
fostering a kind of therapeutic or healing momentum’.858 Abstinence constitutes, as 
Ghodse suggests, an achievable result for most substance dependants despite the chronic 
nature of dependence.859 Harm reduction measures could function to stabilise drug users 
towards achieving cessation from drug consumption. Moreover, the politically credible 
justification of the harm reduction approach could be enhanced if the approach serves the 
goal to reduce the prevalence of drug use. The incorporation of the abstinence-based 
target into the harm reduction approach will not negatively impact the latter provided 
certain key rules are safeguarded. For example, the ‘abstinence-eventually’ goal should 
not subject harm reduction interventions to time limitation or other inappropriate 
constraints when the services are demanded by clients. The programmes should be 
maintained until the clients have capability for embracing abstinence.  
Though it is strongly argued here that there should be a clear focus on the 
abstinence orientation together with the harm reduction paradigm, abstinence should not 
be positioned as an urgent, immediate and rigid endpoint. Consideration should be given 
to the physiological, psychological, cognitive and behavioural characteristics of each drug 
user while assessing the needs, appropriateness, adequacy, time span and other aspects of 
the interventions and processes towards cessation from drug using. In other words, all 
matters related to drug management and treatment must be considered on a case-by-case 
basis. This is because, as discussed in Chapter 2, Section 2.5, drug users vary in many 
aspects including their state of motivation and their ability to abstain from drugs at that 
                                                          
858 Kellogg, "On “Gradualism” and the Building of the Harm Reduction-Abstinence Continuum."244. 
859 Ghodse, Ghodse's Drugs and Addictive Behaviour A Guide to Treatment.253–54. 
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time. A range of strategies and modalities of treatments must also be made available 
throughout the course of treatment to better tailor to personal needs. Moreover, the 
relapse to drug use as a natural occurring phenomenon should be considered as a part of 
the long-term treatment process and a basis for reviewing the approaches and their 
relevant aspects. Appropriate techniques as the routes to their developed skills for 
resisting illicit drugs, constructive behaviours and increased wellbeing in multiple life 
domains must be strengthened. The failure to be abstinent from drugs due to inability as 
evidenced by medical analysis, treatment staff certification and others must be considered 
as an exemption from the requirement of achieving abstinence. There are those who are 
truly unable to abstain or sustain abstinence as discussed before. Arguing in the North 
American drug court context, Werb et al. makes the perspective clear that emphasising 
abstinence and denying relapse puts the participants with critical drug dependence in a 
position with a huge potentiality for failure.860 This thesis agrees that the emphasis on 
abstinence is valuable and advantageous, but it could be unworthy and inimical for drug 
users who are incapable to abstain from drugs. It is hence impractical and implausible to 
urge this subset of the drug using population to cease from using drugs.  
In summary, abstinence should be incorporated as an eventual but not 
instantaneous and inflexible goal in drug treatment while attention must also be accorded 
to other paradigms, especially harm reduction. This is essential in order to develop more 
justifiable, viable and effective drug use interventions towards ensuring a healthy, 
productive and drug-free life for drug users. But, the attainment of abstinence and other 
aspects relevant to drug treatment need to be dealt with on an individual basis.  
                                                          
860 D. Werb et al., "Drug Treatment Courts in Canada: An Evidence-Based Review," HIV/AIDS Policy & 





This chapter has provided possible approaches towards ensuring appropriate 
compatibility between harm reduction and criminal justice approaches in Malaysia. 
Important contentions are made, particularly concerning the rightful positions of the harm 
reduction approach in connection to the prohibition framework, the criminal justice 
strategy and the abstinence-based goal. 
Despite the ineffectiveness and negative effects of the prohibition framework 
including upon harm reduction interventions, the former should be sustained while 
significantly adopting the latter as an important component of overall drug policy towards 
attaining the public good of a reduction of drug-related harms and the prevalence of drug 
use. This is more credible than implementing more aggressive punitive strategies or 
absolute focus to harm reduction or public health paradigm within prohibition or 
alternative drug frameworks. Moreover, due to the rightful claim of jurisdictions of 
criminal law and public health approaches over drug taking, reconciliation between the 
two must be made by redefining the purviews and aims of both approaches with reference 
to a principled approach. The ultimate strategy must be providing voluntary drug 
programmes and behavioural interventions including harm reduction services. Criminal 
justice interventions could be enforced in certain cases, particularly drug users’ 
intractability to participate or less commitment, drug consumption in public settings or 
related to risky conduct and inefficacy of less restrictive methods. However, they must be 
circumspect and satisfy certain essential restrictions to preserve justice, proportionality, 
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human rights and good health practice. All interventions must be intensified towards 
achieving the underlying goal of public good. Further, harm reduction and abstinence 
may be integrated based on specific safeguards as respectively a short-term and long-term 
goal. This could benefit a drug treatment system by pragmatically progressing towards 
stabilisation through drug maintenance and a drug-free life.   
All these paradigm shifts may reconcile not only differing primary goals, 
methods, priorities and practices of two drug responses but also multiple interests 
including private interest, public health and public safety. To effectuate the suggested 
theoretical frameworks, appropriate adjustment to policies, law and its enforcement 











This final chapter consolidates the constituent elements from past chapters and in so 
doing, links the research findings to the original purpose of research in seeking to 
critically examine the justifications for the harm reduction approach in Malaysia, its 
compatibility to the existing criminal justice approach and ways of finding reconciliation 
for both approaches if there are conflicts between them. In addition to summarising the 
study findings, the chapter also provides some observations regarding the experience of 
researching this field and identifies some knowledge gaps and recommendations that are 
relevant to the field. Furthermore, the chapter briefly discusses the limitations of the 
research and gives some suggestions for further research and work. 
 
6.2 Conclusion and Recommendations 
 
This thesis is designed to contribute to our knowledge with respect to the justification of 
the harm reduction approach for drug users and its compatibility with the criminal justice 
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approach. Before summarising the main aim, questions, findings and suggestions of this 
study, it may be worthwhile to note the experience of studying this field.  
Reviewing the available limited literature in Malaysia shows that there appears an 
employment of either exclusively social science or exclusively legal methods in exploring 
the issues concerning the harm reduction approach. This research went beyond that 
dichotomy to use a socio-legal approach in order to widen our understanding and to give 
a more comprehensive picture of some major issues. This approach enables the researcher 
to explore the historical, legal, social and political contexts in which the harm reduction 
approach was initiated and implemented. Additionally, based on this method, the 
researcher could examine the relevant debate and moral, ethical and scientific 
justifications for harm reduction strategies. Applying a socio-legal analysis is also 
pertinent in critically assessing how the drug control law works in practice, the extent of 
its congruity to the harm reduction approach and other relevant issues such as whether the 
government mechanisms developed to prevent clashes with mainstream criminal justice 
strategy actually impact on the operation of harm reduction. Therefore, the socio-legal 
methods are useful tools for the researcher to undertake a more effective assessment of 
justifications of the harm reduction approach and its compatibility with the criminal 
justice approach.  
Further, the application of the socio-legal approach in this research gave valuable 
insights into varied concerns and questions to be considered for further analysis in 
Malaysia. These include limited local evidence regarding the imperatives and benefits of 
MMT and NSEP and the impact of and explanations for antagonistic criminal justice 
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practices. These issues should be examined using socio-legal methods so that more 
comprehensive findings and outcomes can be achieved. 
This thesis is the first in Malaysia to examine the main justifications of the harm 
reduction approach from varied philosophical and scientific perspectives and its 
consistency with criminal law and enforcement practices. Substantial consideration is 
given to the main supporting and opposing arguments because they have the value of 
disclosing potentially crucial questions and coherent concerns related to the imperatives 
of the harm reduction approach and its compatibility with the criminal justice approach. 
This is an important departure from the general tendency in Malaysia (and perhaps in 
other settings) to disregard careful and sufficient examination of the issues addressed in 
this thesis and the emerging controversies in this field. Thus, this thesis constitutes a 
significant original contribution to the body of knowledge in this area. It further intends to 
serve as a foundation for further assessment in this area, considering the worth of 
exploring further compelling rationales for the harm reduction approach and effective 
options to harmonise its relation to the criminal justice approach against drug users.  
In terms of substance, the examination of the Malaysian literature reveals that, in 
general, consideration has been devoted to the imperatives of the harm reduction 
approach from a scientific perspective. This is unsurprising given that the harm reduction 
approach is commonly understood and promoted by the Malaysian government as a 
pragmatic response to HIV/AIDS virus transmission and other drug-related harms. There 
is an absence of serious attention to the ethical and ideological judgments to the approach. 
This leaves relevant normative issues without sufficient attention, including the ethical 
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underpinnings of the harm reduction approach and its congruity to abstinence-oriented 
paradigms within drug prohibition policy.  
Despite the focus on the consequentialist concerns regarding MMT and NSEP in 
Malaysia, gaps still remain concerning the evidence base for these strategies. There is 
scant data on the effectiveness of both interventions in decreasing the transmission of 
HCV virus and their cost-effectiveness in reducing HIV spread. Also, largely missing 
from current study is a focus on the economic benefits of MMT and NSEP for HCV 
prevention. There is also a lack of local evidence regarding the issue of minimising non-
opiate drug consumption and the financial efficiency of MMT in managing opiate 
dependence. Additionally, a lack of evidence is discovered pertaining to the impact of 
NSEP on HIV infection and prevalence, drug taking patterns and frequency and referral 
of drug users to drug treatment and other health interventions. Furthermore, there is very 
limited evidence on the unintended effects of harm reduction services, including the 
transmission of messages encouraging drug use, the recruitment of new drug takers and 
the increase of involvement in criminality and the hazards of discarded needles and 
syringes in public settings. 
Moreover, the existing local materials and literature provide an inadequate focus 
on the issue of compatibility between the harm reduction and criminal justice responses in 
Malaysia. Although several commentators in Malaysia give some overview of several 
inconsistent legal rules and enforcement practices, none has provided detailed scrutiny or 
study of the issue of conflicts between both approaches and related issues such as the 
nature, significance and impacts of conflicts, if any, on the operation of harm reduction, 
and the individual, institutional and environmental factors that influence criminal justice 
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actors including police, prosecutors, prison officials and judges and on possible ways to 
address the tensions in theory and practice.  
Extensive reference to global literature and materials enables me to study the harm 
reduction approach as more than a purely legal issue and assess the issues relating to its 
justifications and congruity to the criminal justice approach in its wider social, political 
and legal context. Generally, the international literature acknowledges the need for the 
adoption of the harm reduction approach. The substantial literature on the harm reduction 
approach reveals the debates surrounding the rationales of MMT and NSEP. In terms of 
substance, however, several knowledge gaps can be identified with respect to the 
justifications of both programmes. Despite growing interest in the ethical and theoretical 
impetus of the harm reduction approach, limited attention is paid to relevant important 
issues such as the approach’s consonance to religious perspectives, consistency between 
human rights norms as an important ideological basis for the approach and community 
good principle, and Asian values and the compatibility between harm reduction and 
abstinence-based paradigms. In terms of scientific justifications for harm reduction 
interventions, there is still a lack of assessment regarding the efficacy and financial-
efficacy of MMT and NSEP for the control of HCV transmission and their unintended 
negative results such as symbolism of drug use promotion, the increased number of new 
initiates to drug consumption, needles and syringes discarded in public places and crimes. 
Further, research on the cost-effectiveness of MMT in managing opiate dependence and 
on the issue of mitigating dependency of non-opiate drugs such as ATS is scarce in many 
countries, with the exception of the UK and USA. 
315 
 
Although extensive international studies have examined the legal and regulatory 
framework enabling or clashing the harm reduction strategies in local context, there is 
limited comprehensive evaluation of the compatibility between harm reduction and 
criminal justice approaches which extends to consider how the law is actually deployed 
and how it actually impacts upon harm reduction policy and measures. The limitation is 
particularly apparent in relation to the prosecutors’ and courts’ practices. Moreover, there 
is generally scant investigation regarding the knowledge, beliefs, attitudes, motivational, 
organisational and structural causes of the behaviours of enforcement officials affecting 
harm reduction interventions. There is also limited research regarding effective ways to 
bring about reconciliation between harm reduction and criminal justice approaches or 
addressing the theoretical and practical conflicts between both approaches.  
In achieving the aims of this thesis, an attempt was made to address the following 
central questions. Firstly, whether Malaysia should implement the harm reduction 
approach for drug users or not? Secondly, if so, whether the harm reduction approach in 
Malaysia is compatible with the existing criminal justice approach against drug users or 
not? Thirdly, if there are conflicts between both approaches, is there a way of finding a 
reconciliation between them or must one or other of these approaches be abandoned? 
Some may believe that addressing these research questions will only be beneficial to the 
Malaysian audience. This is untrue as the interdisciplinary and comprehensive approaches 
applied in this thesis in examining the research questions suggest that this thesis is useful 
for the audience not only in Malaysia but also in other nations. By way of illustration, 
Chapters 2 and 3 provide a holistic understanding of normative, philosophical and 
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scientific imperatives of harm reduction approach in the light of relevant debate and 
evidence at Malaysian and international levels. 
With respect to the first research question of whether Malaysia should implement 
the harm reduction approach for drug users or not, this research reached a positive 
conclusion, considering its philosophical and scientific justifications to be sufficient. It is 
notable that an important point to emerge from this study was the significance of 
considering different justifications for the harm reduction approach and not relying solely 
on scientific judgments. Attention must also be given to the ethical and philosophical 
issues, so that more comprehensive rationales for harm reduction can be established. In 
this thesis, the arguments are deliberately focused on 10 important aspects covering both 
ideological and scientific justifications of the harm reduction approach. The discussion in 
Chapter 2 indicates that none of the main ideological arguments against the harm 
reduction approach is persuasive enough to warrant discarding the approach. In defending 
the harm reduction approach from ethical criticisms, this thesis suggests the worth of the 
approach through several normative bases. The response is anchored principally in public 
health as it suits the prevention for diseases and health risks under the traditional public 
health and health promotion under the new public health. It also meets the utilitarian 
analysis for its effectiveness in contributing good for individuals and society. These 
ideological bases are further reinforced and counterbalanced by the approach’s 
connection to the protection of human rights of health and freedom from inhuman and 
degrading treatment. 
The resistance to the harm reduction approach, particularly in Malaysia, also 
brings forward the claim regarding its contradiction to Islamic values, principally on the 
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grounds that it assists and encourages sinful, illicit drug taking. In response to this 
contention, this thesis argues for the permissibility of MMT based on the Islamic 
principle of ‘hajiyyat’ (needs) given its use in drug dependence treatment while NSEP on 
the Islamic dictums of ‘darurah’ (necessity) and ‘al-∂arar al-ashadd yuzalu bi’l-∂arar al-
akhaff’ (a greater harm is eliminated by tolerating a lesser harm) considering the 
emerging dangers to life in terms of HIV transmission and drug dependence. Another 
main argument against the harm reduction approach lies on the premise of the approach’s 
incongruity to abstinence orientation adopted within drug prohibition policy given its 
ultimate attention to mitigation of drug-related harms. Accordingly, this thesis argues that 
in spite of different focuses, the two paradigms are not wholly exclusive and 
contradictory, and suggests that there are possibilities for collaboration between the 
approaches and for regarding them as providing a continuing framework for protection of 
drug users. Additionally, this thesis finds that opponents of harm reduction are mistaken 
in believing that the harm reduction approach contravenes the international drug control 
conventions based on its divergence from the main thrust of law enforcement policy. In 
giving effect to this point, this thesis stresses the presence of interpretative leeway to 
legitimise the harm reduction practices within the confines of drug treaties. For example, 
as the 1961 and 1971 Conventions allow the production, distribution or possession of 
controlled substances exclusively ‘for medical and scientific purposes’,861 the undefined 
phrase ‘for medical and scientific purposes’ is interpretable to warrant the methadone 
prescribing for decreasing opiate dependence. Embracing all these ideological aspects 
would strengthen the theoretical bases for the harm reduction approach.  
                                                          
861 The 1961 Convention, Article 4(c); the 1971 Convention, Articles 5 and 7.  
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The analysis provided in Chapter 3 further suggests that the implementation of 
MMT and NSEP is justifiable based on their effectiveness and cost-effectiveness in 
reducing drug use and its harmful consequences. The available evidence nationally and 
internationally convincingly shows that both measures are efficacious in decreasing drug 
consumption, HIV-risk behaviours and the viral infection incidence among drug users. 
The interventions also yield economic benefits, given their cost-effectiveness and cost-
saving in the control of drug use and HIV pathogen transmission. The efficacy and 
economic efficiency for the domains are adequately solid to defend the availability of 
MMT and NSEP although there is a lack of evidence to support their protective and 
financial returns in the prevention of HCV transmission. This may call for the 
consolidation of varied interventions to improve and enhance the desirable outcomes, 
rather than the abandonment of harm reduction programmes. Further, there appears no 
evidence indicating their unintended adverse impacts including symbolism of drug using 
promotion, rise in drug consumption initiation, criminal acts and needles and syringes 
litter in public places.  
It is important to recognise that the effectiveness of strategies is not put into 
question by the existence of several negative empirical findings because there are clear 
explanations for these contrary results and in general the strength of the overwhelming 
evidence points in the opposite direction. This weakens the opposing contention that harm 
reduction strategies are ineffective, economically inefficient and have adverse effects. 
Such arguments are also unsupported by credible and conclusive evidence. The scientific 
bases would supplement the ideological imperatives in entailing strong credentials for 
harm reduction practice. 
319 
 
Having identified the justifications for the implementation of the harm reduction 
approach for drug users, this research moved on to respond to the second question of 
whether the harm reduction approach in Malaysia is compatible with the existing criminal 
justice approach against drug users. The present widespread assumption and official 
position is that the two approaches are compatible. However, this thesis has argued that 
the official position is mistaken. It is important that the question of compatibility be 
verified by an extensive empirical research. Unfortunately, at this moment very limited 
empirical research has been conducted on this issue in Malaysia. At present, it is 
impractical and ineffective to do the extensive study although this research recognises its 
impetus. At present, the prospect of conducting such research in Malaysia is still limited, 
given the substantial methodological limitations as explained in the Introductory Chapter. 
However, considering my experience, informal discussion and the limited local literature 
and evidence, taking into account the international evidence, this thesis argues that there 
are significant conflicts between the harm reduction and criminal justice approaches as 
they are currently understood and practised in the Malaysian context. The conflict is not 
necessarily driven by the existence of legislative and regulatory framework relating to 
drug use that is contradictory in principle and/or has potential to affect the harm reduction 
objectives and operation. Rather, the conflict arises from law enforcement practices, 
predominantly street-level policing including raids and crackdowns. This is where the 
source of the tension actually lies in Malaysia. Disruptive ground-level enforcement 
practices somehow mirror the lack of genuine commitment on the part of the criminal 
justice actors to support the harm reduction approach, and this is reflected in the exercise 
of their discretion. State initiatives, such as training and guidelines, likely constitute a 
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political compromise intended to prevent obstruction of the operation of the criminal 
justice process, rather than genuinely support the operation of harm reduction.  
It is pertinent to note that the conflicts between the two approaches are not a 
unique issue in Malaysia. They are also evident in other jurisdictions, although with 
varying degrees of seriousness. The general comparative analysis applied tends to 
reinforce the thesis’s argument that the conflicts in Malaysia are led by limited effective 
multi-agency collaboration and lack of enforcement discretion exercised in such a way as 
to support harm reduction. This thesis therefore argues that the conflicts between these 
approaches in Malaysia are rooted in an incomplete understanding of the conceptual and 
theoretical basis of the approaches on the one hand, and in an incomplete appreciation of 
the gap between official policy and actual enforcement in practice, on the other hand.  
This thesis further considers the possible main explanations for the failure of 
police discretion to support the harm reduction approach in Malaysia, including the 
attitudes, lack of knowledge, misunderstanding and negative perceptions of harm 
reduction held by criminal justice actors, strength of commitment to punitive response 
against drug use embodied in the criminal justice system and failure to understand that 
both approaches can be implemented together. Therefore, it is coherent to conclude that 
the existing conflicts between harm reduction and criminal justice responses are crucially 
contributed by the dominance of the latter to undermine the former’s objectives, 
availability, accessibility and efficiency and exacerbate certain effects, particularly health 
and human rights risks which will counter the harm reduction initiatives.  
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Despite the limitations of this research, it provides an important basis for further 
research. The issue of compatibility between the two approaches, the explanations for and 
impact of conflicts, the perceptions of the harm reduction approach, all deserve further 
extensive investigation. This thesis argues that both approaches can be implemented 
harmoniously, provided that a proper basis for reconciliation is established. The chance of 
genuine collaboration between both regimes is low until we achieve a clearer conceptual 
and theoretical understanding of the two approaches and a deeper understanding of the 
gap between official policy and actual enforcement. 
In addressing the final question concerning a way of finding reconciliation 
between the harm reduction and criminal justice approaches if there are conflicts between 
them, this study reached (as highlighted in Chapter 5), the following main conclusions. 
Firstly, the harm reduction approach is feasible to be incorporated as an important 
component of overall drug policy under the maintained larger drug prohibition policy. 
This will help to ensure the political acceptability, efficiency and consistency of the harm 
reduction approach to the supply and demand reduction principles and strategies 
including the criminal justice approach working towards the public good pursuit of 
minimisation of drug-related harms and drug use prevalence. This thesis contends that the 
incorporation of the harm reduction approach represents a more credible option to 
contribute to the outcomes rather than an intensification of punitive strategies or an 
absolute emphasis on harm reduction or public health policy for drug use, either within 
prohibition or alternative drug frameworks as suggested by the commentators. 
Secondly, echoing relevant philosophical underpinnings for the criminal law and 
public health approaches (comprising the harm reduction approach), it can be argued that 
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each approach has the rightful claim of jurisdictions over drug use. Therefore, this thesis 
suggests that neither of these approaches can simply be abandoned when there are 
conflicts between them and suggests that they can be reconciled by redefining or 
adjusting their terrains with reference to a principled approach. This is crucial to avoid 
any blurring of the lines between them. In applying Ashworth and Holder’s minimalist 
principles, this thesis argues that principal attention must be tailored to appropriate drug 
interventions including harm reduction services on a voluntary basis. Criminal justice 
interventions could be implemented in certain cases including when drug users are 
headstrong or less committed to take part, consume illicit drugs in public settings or 
simultaneously engage in behaviours related to drug use that expose harms or risk of 
harms to others. Nevertheless, this thesis contends that they should only be enforced in 
subsequence of the failure or insufficiency of less restrictive means based on Ayres and 
Braithwaite’s generic business regulatory pyramid862 and in compliance to certain 
fundamental constraints to protect justice, proportionality, human rights and good health 
practice. All interventions must be aligned with the goal of public good and partnership 
between the public health and criminal justice regimes. All the agenda this thesis 
forwards must be supported by suitable changes in relevant policies, law and regulations.  
Thirdly, harm reduction and abstinence could be unified in drug treatment systems 
as respectively short-term and long-term objectives under a continuing framework of 
protection. However, the consolidation must be subject to some safeguards, including 
avoiding making abstinence an immediate and inflexible goal, considering other 
appropriate interventions and dealing with the achievement of abstinence and other 
                                                          
862 Ayres and Braithwaite, Responsive Regulation: Transcending the Deregulation Debate.35. 
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aspects related to drug treatment on an individual basis. The unification of both objectives 
would assist in building more viable, efficacious and compatible multi-component 
measures in both criminal justice and public health settings for handling drug use and its 
harmful effects.  
In the light of the discussions throughout this thesis, several recommendations are 
presented below: 
Recommendation 1: It is critically important for the ethical and philosophical rationales 
behind the harm reduction approach to be firmly created and sustained to enhance the 
credentials of the approach. The ethical and ideological underpinnings of the harm 
reduction approach should be articulated in policy documents and drug discourse and 
maintained within a clear framework for its practices. 
Recommendation 2: The state must conduct an open and transparent public approach 
which increases awareness and knowledge regarding the conception, practice, 
philosophical and scientific imperatives, related issues and future direction of harm 
reduction policy and strategies. This can be effectuated by education, communication and 
information through potential mediums such as extensive government documentation and 
mass media sources. A mitigation of oppositions and intense attacks against the harm 
reduction approach and services may be expected to follow from this strategy.  
Recommendation 3: Harm reduction programmes must be developed within socio-
cultural and religious framework. The services should be community-oriented and 
responsive to social, cultural and religious values and concerns. This could be achieved 
through the commitment and appropriate initiatives of the government such as engaging 
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community councils, community-based organisations, religious scholars, religious 
institutions, NGOs and representatives from the drug-using population at the levels of 
planning, implementation and evaluation, mapping and assessing needs and limits 
embodied in cultural and religious values for the harm reduction practices and providing 
attention to important concerns raised by local communities. This would offer a potential 
route to garnering broad public support and ensuring the fit of harm reduction designation 
and development to local climates.  
Recommendation 4: The importance of harm reduction interventions as part of the 
protection of human rights of health and freedom from inhuman and degrading treatment 
should be explicitly endorsed and enforced by the UN General Assembly, the UN bodies, 
the Commission of Human Rights and all member states. The government must make 
efforts to fulfil their human rights obligation of implementing harm reduction measures 
for drug users at a realistic standard in consonance to the economic faculty of the country. 
Recommendation 5: More supportive interpretation of the international drug control 
conventions to the legality of harm reduction policy and practices should be globalised 
and supported by the UN system and signatory countries. Attention must also be provided 
to initiate strategies towards revising and amending the drug treaties to explicitly warrant 
the harm reduction approach and measures. This would give a clearer and stronger basis 
for their legitimacy under the international law. 
Recommendation 6: Considering the clear ideological and scientific rationales of MMT 
and NSEP, their availability and accessibility need to be substantially extended 
throughout Malaysia. The relative less sufficient local evidence for the efficacy and cost-
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effectiveness of the services must not be used as an excuse to quit or limit the 
programmes. Their imperatives based on overall evidences including from international 
sources are compelling for their urgent practice. The programmes should be scaled up by 
the state to provide sufficient coverage to drug users in all urban and rural areas and in 
closed settings, including prisons. The measures must be targeted at those in need beyond 
the IDUs. For enhancing the accessibility, important attention should be paid to the 
relevant aspects such as policies for equitable access, efficient delivery modes, location 
and time of service. Additionally, specific initiatives to reach hard-to-reach drug using 
subpopulations including women and minors must be central to government efforts. 
Recommendation 7: The government must constantly support and apply effective 
techniques to realise the feasibility, efficiency and efficacy of harm reduction 
interventions. This must cover the means to maintain the infrastructure of the services 
including adequate funding, trained workforce, training and logistics and developing a 
better monitoring and evaluation system for the programmes. This should be coupled with 
strategies to ensure their efficient and effective operations such as assurance of 
management and programmatic system (including quality surveillance, strategic 
information and clinical guidelines), sufficient supply of methadone, adequate methadone 
dosing, sufficient quantity of sterile needles and syringes, duration of service and 
retention of clients. The state should further encourage and support research assessing the 
harm reduction measures, their effectiveness, cost effectiveness and societal impacts in 
the national context. This should be accompanied, if necessary, by appropriate 
modification and improvement to the programmes.  
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Recommendation 8: To make a difference, MMT and NSEP must be integrated as parts 
of an important constituent of a comprehensive approach for drug users. The well-
integrated strategy could comprise varied harm reduction services in conjunction with 
other interventions including education on risk reduction, disposal of used injection 
equipment, non-pharmacological drug treatments, inter-programme referral networks, 
schemes to eradicate stigma and marginalisation among drug users and health and social 
services which could ideally be suited to drug use dynamics and the needs of individual 
drug users. These must be implemented where feasible to enhance the acceptability and 
efficacy in handling drug use (not limited to opiate drugs) and its multiple harmful effects 
(including HCV infection). 
Recommendation 9: The government must adopt the harm reduction approach as a 
paramount component of a whole drug control policy under the sustained larger drug 
prohibition framework. Thus, harm reduction policy and strategies must be streamlined 
together with supply and demand reduction policies and strategies including the criminal 
justice approach within the national drug response towards achieving the public good aim 
of reducing drug use prevalence and drug-related harms. 
Recommendation 10: The government could adopt three levels of actions against drug 
use and dependency. The initial level should be specified for the provision of voluntary 
drug treatment and behavioural interventions including harm reduction services for drug 
users. The secondary level might include the regulatory mechanisms to maximise the 
applicability of the drug treatment and behavioural interventions such as persuasion, 
warning, court enforceable proceedings and civil penalties. This may be undertaken for 
the cases, particularly the intractability of drug users to participate or less commitment in 
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voluntary programmes, drug consumption in public places or engagement with 
behaviours in connection to drug use that expose harms or risk of harms to others. The 
last level may involve the criminal justice interventions in the event of failure or 
insufficiency of the secondary level of action. 
Recommendation 11: Recommendation 10 must be aligned with the government steps to 
enhance the partnership between the public health and criminal justice systems and 
suitable policy and legal shifts. Thought should also be given to reform the policy and 
legislation to explicitly legitimise the harm reduction interventions, decriminalise the 
provision and possession of injection items given by the NSEP programme and other 
authorised distributors and possession of drug residue contained in injection equipment. 
While the regulatory provisions and guidelines related to MMT should be retained, it 
must be ensured that they are truly rational, necessary and supportive of the exercise of 
higher clinical discretion. 
Recommendation 12: The state must update national policy and strategies for drug use 
to distinctly support harm reduction as a pertinent paradigm in drug use, dependency and 
relapse interventions in public health and criminal justice settings. It could be 
consolidated as a short term orientation with abstinence as a long term goal under the 
framework of consecution of protection. Nevertheless, the harm reduction and abstinence 





6.3 Limitations of the Research 
 
Although this study sought to examine the justifications and compatibility of the harm 
reduction approach with the criminal justice approach within a socio-legal sphere of 
analysis, there are several relevant aspects that require detailed analysis but which are 
beyond the scope of this thesis. These aspects include: the imperatives of harm reduction 
in specific settings such as prisons and for drug using subpopulations such as children and 
women;, varied factors such as social, cultural, political, economic, individual and 
organisational factors impacting on drug use problems; the efficacy, cost-effectiveness 
and efficiency of harm reduction programmes; the methodological validity and strength 
of data related to the scientific justifications of MMT and NSEP; environmental 
determinants of criminal justice practices against drug users; and the perceptions and 
experience of the law and of harm reduction held by clients, drug users and law 
enforcement actors. 
 
6.4 Avenues for Future Work 
 
Many salient areas in which further assessment regarding the harm reduction approach 
and interventions, their worth and (in)consistency with the criminal justice approach 
should be done to broaden and improve the current knowledge base. Some research issues 
which deserve to be explored are briefly provided as follows. Future evaluations should 
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look specifically at how to link harm reduction measures including MMT and NSEP to 
values and philosophical imperatives and other relevant ideological issues, the scientific 
supports of the programmes for reducing drug taking and varied harms, possible 
unintended effects and means to address them in case of discovery, eligibility 
requirements for service providers and clients and strategies to prevent methadone 
diversion. The other area that deserves further research is the theoretical and operational 
(in)compatibility of the harm reduction approach with criminal justice response in many 
jurisdictions. This should engage data collection beyond statistics to achieve information 
concerning the actual nature and scale of criminal justice practices that include the 
prosecution and court operations. In addition, more study is important to examine the 
related aspects, particularly impacts, reasons of supporting or hindering law enforcement 
and options to address any conflicts between harm reduction and criminal justice 
approaches. 
Further, more research is needed on the efficacy and economic-efficacy of harm 
reduction techniques, including MMT and NSEP for a particular subpopulation of drug 
users such as women and children and different settings including prisons, the programme 
components such as intensity and access points and clients characteristics which implicate 
in the desirable outcomes of the services, their relative effectiveness in relation to social, 
political and economic variables, effective interventions for reducing non-opiate drug 
dependency and optimal methods to consolidate and coordinate other programmes 
particularly education, abstinence-based drug treatment, behavioural and psychosocial 
interventions with multi-components of harm reduction measures and additional 
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protective and financial returns of such combined approaches and effective ways to 
enhance the partnership between harm reduction and criminal justice actors.  
 
6.5  Conclusion 
 
In this thesis, the argument is for an approach to the research process that begins with the 
examination of the justifications for the implementation of the harm reduction approach 
and moves on to consider the compatibility between the harm reduction approach with the 
criminal justice approach against drug users in Malaysia and ways of finding 
reconciliation for both approaches if there appears conflicts between them. It is hoped that 
the study findings embodied within this thesis will enhance the knowledge in the field, 
contribute to the scholarly debates in Malaysia and in the broader international arena and 
foster further research in the field. The shelf-life of this thesis will be finite if it is 
intended to produce a complete analysis in the field, given its potential developments and 
changes in the future. Nonetheless, the hope is that some of the arguments and 
recommendations of this thesis will have continuing relevance. The conclusions and 
suggestions which have been presented represent an attempt to provide significant bases 
for the harm reduction approach and possible pathways for pursuing its efficient and 
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